fibrinogen has been researched along with Blood Clot in 1685 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 686 (40.71) | 18.7374 |
| 1990's | 250 (14.84) | 18.2507 |
| 2000's | 267 (15.85) | 29.6817 |
| 2010's | 318 (18.87) | 24.3611 |
| 2020's | 164 (9.73) | 2.80 |
| Authors | Studies |
|---|---|
| Battino, M; Chen, H; Cheng, S; Du, M; Liu, H; Wang, L; Wang, Y; Yao, X; Zhu, B | 1 |
| Adelmeijer, J; Bernal, W; Blasi, A; de Haas, RJ; Driever, EG; Fondevila, C; Gregory, S; Heaton, N; Kane, P; Lisman, T; Nagasami, C; Porte, RJ; van den Heuvel, MC; von Meijenfeldt, FA; Weisel, JW; Zen, Y | 1 |
| Butera, D; Hogg, PJ; Pijning, AE | 1 |
| Alves, NJ; Hall, A; Linnemann, AK; Muralidharan, C; Nallan Chakravarthula, T; Zeng, Z | 1 |
| Chen, J; Diamond, SL | 1 |
| Ajjan, RA; Kearney, KJ; Pechlivani, N | 1 |
| Bagby, S; Eggleston, I; Englert, H; Posner, M; Pula, G; Renné, T; Upadhyay, A; Wallis, S; Wolska, N | 1 |
| Adelmeijer, J; Bernal, W; Blasi, A; Calvo, A; Corcoran, E; Fernandez, J; Lisman, T; Patel, VC; Spanke, ENHE; Stamouli, M; Zamalloa, A | 1 |
| Medved, L; Weisel, JW | 1 |
| Bergmeier, W; Bouck, EG; Clark, EG; Cline-Fedewa, HM; Flick, MJ; Hur, WS; Juang, LJ; Kastrup, CJ; Leung, J; Luyendyk, JP; Mwiza, JM; Negrón, OA; Paul, DS; Poole, LG; Ugarova, TP; Wolberg, AS | 1 |
| Carvalho, FA; Domingues, MM; Santos, NC | 1 |
| Majek, P; Pecankova, K; Sovova, Z; Suttnar, J | 1 |
| Irfan, M; Kwon, HW; Kwon, TH; Rhee, MH | 1 |
| Casini, A; Durual, S; Khayat, C; Lecompte, T; Marchi, R; Neerman-Arbez, M | 1 |
| Louw, S; Mayne, A; Mayne, ES | 1 |
| Ceznerová, E; Chrastinová, L; Dyr, JE; Kaufmanová, J; Kotlín, R; Loužil, J; Pastva, O; Stikarová, J; Suttnar, J | 1 |
| Chartrand, C; Cron, GO; DeRosa, MC; Koudrina, A; O'Brien, J; Tsai, EC | 1 |
| Belcher, HA; Daub, CE; Dement, TC; Guthold, M; Hudson, NE; Kirby, NC; Offenbacher, AR; Peterson, KM; Popovic, G | 1 |
| Alexander, PM; Ankola, AA; Bailly, DK; Bell, MJ; Berg, RA; Berger, J; Carcillo, J; Dalton, H; Dean, JM; Doctor, A; Garcia-Filion, P; Harrison, R; Heidemann, S; Meert, KL; Moler, FW; Muszynski, JA; Newth, C; Nicholson, C; Pollack, MM; Reeder, RW; Wessel, D; Zuppa, AF | 1 |
| Duval, C | 1 |
| Al-Amer, OM | 1 |
| Jenkins, T; Johnston, M; Palumbo, JS; Rymeski, BA; Wagner, ML | 1 |
| Barinov, NA; Dubrovin, EV; Klinov, DV; Matveeva, AG; Moskalets, AP; Pavlova, ER; Tolstova, AP | 1 |
| Altemeier, WA; Chen, J; Chung, DW; Fu, H; LaValley, KN; Leary, PJ; Liles, WC; López, JA; Mandrycky, CJ; Rayner, SG; Scholl, Z; Zheng, Y | 1 |
| Bargotya, M; Bhattar, S; Dogra, V; Ganju, L; Garg, I; Ghosh, N; Gupta, U; Hembrom, AA; Hussain, J; Jain, S; Kumar, V; Srivastava, S; Varshney, R | 1 |
| Boccatonda, A; Bucci, M; Cipollone, F; Cocco, G; D'Ardes, D; Fabiani, S; Guagnano, MT; Rossi, I; Schiavone, C | 1 |
| Bai, R; Chen, X; Chun, J; Cong, X; Li, T; Pei, J; Pei, S; Peng, R; Wang, F; Xu, C; Zhang, J | 1 |
| Beinrohr, L; Kolev, K; Lovas, M; Molnár, K; Szabó, L; Tanka-Salamon, A; Voszka, I | 1 |
| Ding, Y; Gu, W; Han, Y; Qi, J; Qiao, J; Zhang, S | 1 |
| Chafa, O; de Mazancourt, P; Fischer, AM; Frigaa, I; Guenounou, K; Hadjali-Saichi, S; Helley, D; Mirault, T; Tapon-Bretaudière, J | 1 |
| Araki, Y; Goto, S; Hattori, M; Izumi, T; Matsushita, T; Nishihori, M; Saito, R; Suzuki, N; Tamura, S; Uda, K; Yokoyama, K | 1 |
| Duan, H; Luo, L; Song, R; Xu, N; Zhang, T | 1 |
| Bauer, A; Fink, P; Holzknecht, M; Klug, G; Lechner, I; Mayr, A; Metzler, B; Plangger, J; Reindl, M; Reinstadler, SJ; Tiller, C | 1 |
| Ariëns, RAS; Asquith, NL; Baker, SR; Barsegov, V; Connell, SDA; Domingues, MM; Duval, C; McPherson, HR; Zhmurov, A | 1 |
| Chen, X; Deng, G; Duan, Z; Jin, L; Lai, R; Li, Y; Liu, M; Luan, N; Meng, P; Tan, Z; Wang, J; Zhang, J; Zhang, Z; Zhao, H | 1 |
| Bos, MHA; Cannegieter, SC; Lisman, T; Nelissen, RGHH; Nemeth, B; Rondon, AMR; Schipper, IB; Touw, CE; van Adrichem, RA; Versteeg, HH | 1 |
| Sang, Y; Wolberg, AS | 1 |
| Ban, Q; Cao, D; Li, Y; Wang, D; Wang, X; Ye, W; Zhan, L; Zhang, Y | 1 |
| Ding, B; Ding, Q; Li, Y; Wang, X | 1 |
| Chen, R; Guo, Y; Huang, Y; Jiang, J; Li, Y; Ren, J; Zhao, Q; Zhou, J | 1 |
| Araujo-Gutierrez, R; Bhimaraj, A; Cruz-Solbes, AS; El Nihum, LI; Estep, J; Graviss, EA; Guha, A; Hannawi, B; Hussain, I; Kassi, M; Kenneth Sims, R; Kim, JH; Nguyen, DT; Srour, N; Trachtenberg, BH | 1 |
| Bramer, WM; de Groot, NMS; de Maat, MPM; Geurts, S; Kavousi, M; Pezzullo, AM; Tilly, MJ | 1 |
| Kar, R; Kar, SS; Muddana, PS | 1 |
| Cao, M; Jiang, X; Lai, H; Li, J; Tu, H; Tu, Y; Wang, X; Yang, Y; Zhang, X | 1 |
| Hong, IH; Hwang, DH; Kang, C; Kim, E; Kim, JH; Kim, S; Prakash, RLM; Yang, HR | 1 |
| Chowdary, P; Davenport, A; Gandhi, T; Riddell, A; Sudusinghe, D | 1 |
| Bóta, A; Farkas, ÁZ; Farkas, VJ; Feller, T; Kellermayer, MZ; Kiss, B; Kolev, K; Komorowicz, E; Longstaff, C; Szabó, L; Tóth, E; Varjú, I; Wacha, A | 1 |
| Huang, L; Kuang, Y; Lan, T; Liu, R; Lu, L; Wang, J; Wang, S; Yao, W; Zhu, N; Zhu, W; Zhu, X | 1 |
| Han, K; Li, D; Li, L; Li, X; Ma, S; Qi, X; Qian, J; Wang, S; Yin, J | 1 |
| Brown, A; Moiseiwitsch, N; Sniecinski, R; Szlam, F; Zwennes, N | 1 |
| Kell, DB; Kruger, A; Laubscher, GJ; Pretorius, E; Turner, S; Venter, C; Vlok, M | 1 |
| Ajjan, RA; Blindauer, CA; Fritzen, R; Hierons, SJ; Regan-Smith, S; Stewart, AJ | 1 |
| Bhargavan, B; Kanmogne, GD | 1 |
| Ariëns, RAS; Curry, N; Feller, T; Laffan, MA; McQuilten, Z; Morrow, GB; Mutch, NJ; Wake, E; Winearls, J | 1 |
| Igor, A; Irina, L; Katsiaryna, D; Tatyana, V; Vladimir, A | 1 |
| Connors, JM; Iba, T | 1 |
| Chandika, P; Choi, IW; Je, JY; Jung, WK; Kang, HW; Kim, CS; Kim, HW; Kim, JI; Kim, SC; Kim, TH; Kim, YM; Lee, B; Park, WS; Ryu, B; Tennakoon, P; Yi, M | 1 |
| Andrianova, IA; Ataullakhanov, FI; Evtugina, NG; Khabirova, AI; Litvinov, RI; Peshkova, AD; Rumyantsev, AG; Safiullina, SI; Sannikova, SS; Tarasova, GR | 1 |
| de Groot, PG; de Laat, B; Heemskerk, JWM; Roest, M; Swieringa, F; Zou, J | 1 |
| Brubaker, LS; Cebula, A; Cruz, MA; Lam, FW; Loor, M; Martinez-Vargas, M; Rosengart, TK; Rumbaut, RE; Seshadri, N; Yee, A | 1 |
| Kirsch-Altena, A; Müller, J; Sachs, UJ | 1 |
| Alves, NJ; Hall, A; Nallan Chakravarthula, T; Stelflug, N; Tran, DQ | 1 |
| Emet, A; Konyaoglu, H; Kose, M; Oyaci, Y; Pehlivan, S; Sayin, GY; Senkal, N | 1 |
| Ariëns, RAS; Undas, A; Ząbczyk, M | 1 |
| Cohen, MJ; Coleman, JR; Dow, N; Freeman, K; Hansen, K; Moore, EE; Schmitt, L; Silliman, CC | 1 |
| Cai, H; Hua, BL; Wei, C; Zhu, TN | 1 |
| Boorman, D; Brown, AC; Downey, LA; Guzzetta, NA; Moiseiwitsch, N; Nellenbach, KA | 1 |
| Cohen, MJ; Coleman, J; Cralley, A; D'Alessandro, A; DeBot, M; Erickson, C; Hansen, K; Kelher, M; LaCroix, I; Moore, EE; Sauaia, A; Schaid, TR; Silliman, CC | 1 |
| Bhoria, P; Cerenzia, E; Chen, P; Chen, Z; Hoard, B; Johnson, PE; Karakas, D; Lei, X; Lin, L; Ma, W; Mackeigan, DT; Ni, H; Shen, C; Shoara, AA; Xu, R; Zhu, G | 1 |
| Hudson, NE; Iavarone, AT; Manandhar, P; Nguyen, Q; Offenbacher, AR; Pinelo, JEE; Popovic, G; Ray, K; Sen, M; Tasdelen, MF | 1 |
| Casini, A; Durual, S; Marchi, R; Neerman-Arbez, M; Pecheux, O | 1 |
| Butenas, S; Malinowski, KP; Paszek, E; Undas, A; Ząbczyk, M | 1 |
| Butt, AL; Mazzeffi, MA; McNeil, JS; Tanaka, KA; Terada, R | 1 |
| Bärnthaler, T; Cvirn, G; Heinemann, A; Klivinyi, C; Mahla, E; Mantaj, P; Prüller, F; Schoerghuber, M; Toller, W | 1 |
| Angelidakis, E; Chen, S; Kamm, RD; Shelton, SE; Wan, Z; Zhang, S | 1 |
| Bisker, G; Gerstman, E; Hendler-Neumark, A; Wulf, V | 1 |
| Coxon, FP; Jalal, MM; Mutch, NJ; Whyte, CS | 1 |
| Barbay, V; Beurrier, P; Biron-Andreani, C; Brungs, T; Carrière, C; Casini, A; Chamouni, P; Claeyssens, S; Desconclois, C; Drillaud, N; Fiore, M; Flaujac, C; Gay, V; Hegglin, A; Hugon-Rodin, J; Lavenu-Bombled, C; Lebreton, A; Maistre, E; Simurda, T; Stieltjes, N; Tardy-Poncet, B; Trillot, N; Wieland, A | 1 |
| Burguburu, S; Camille, W; Genty, T; Imbert, A; Roman, C; Stéphan, F; Thès, J | 1 |
| Adelmeijer, J; Bernal, W; Driever, EG; Koenderink, GH; Lisman, T; Muntz, I; Patel, V | 1 |
| Jin, Q; Liu, J; Liu, Z; Su, T; Zhao, T | 1 |
| Nzulumike, ANO; Thormann, E | 1 |
| Euliano, TY; Harris, NS; Marin, MJ; Mathew, CM; Pelletier, JPR; Pruitt, HD; Rajasekhar, A; Winter, WE; Zumberg, M | 1 |
| Hao, Z; Liu, K; Pang, T; Shi, L; Tuerhong, R; Wang, H; Wang, Y; Yan, M; Zhang, L; Zheng, H; Zhou, Y | 1 |
| Aminpour, M; Santin, AD; Scheim, DE; Tavernini, S; Tuszynski, JA; Vottero, P | 1 |
| Cardenas, JC; Cox, CS; George, MJ; Gill, BS; Mankame, AR; Schriner, JB; Skibber, MA | 1 |
| Kell, DB; Pretorius, E | 1 |
| Barsegov, V; Litvinov, RI; Maksudov, F; Nagaswami, C; Ramanujam, RK; Tutwiler, V; Weisel, JW | 1 |
| Bielosludtseva, K; Konopkina, L; Krykhitna, M; Pertseva, T | 1 |
| Wolberg, AS | 1 |
| Bagot, CN; Martin, J; Mutch, NJ; Narwal, A; Page, AR; Simpson, M; Watson, HG; West, E; Whyte, CS | 1 |
| Fair, JH; Pivalizza, EG; Swift, MM | 1 |
| Cheng, Z; Hu, Y; Ming, Z; Zhou, X; Zhu, R | 1 |
| He, R; Liao, L; Mei, X; Wang, L; Xiong, M; Yang, T; Zeng, J; Zhao, X; Zhou, Y | 1 |
| Higuchi, Y; Kamijo, T; Mukai, S; Okumura, N; Taira, C | 1 |
| Cao, H; Cui, X; Guo, H; Han, C; Wang, S; Wang, W; Zheng, M; Zheng, W | 1 |
| Sakai, T | 1 |
| Anglés-Cano, E; Cantero, M; Marchi, R; Rojas, H | 1 |
| Dahl, AB; Despotis, GJ; Dynis, M; Jackups, RR; Karnes, HE; Marchant, B; Shah, P; Thibodeaux, SR; Zhang, R | 1 |
| Chai, H; Gao, J; Guan, B; Liu, J; Ma, X; Qu, H; Shi, D; Wang, W; Zhang, Y | 1 |
| Delianu, C; Foia, L; Hurjui, LL; Stolniceanu, CR; Tărniceriu, CC; Toma, V; Tuchiluș, C; Vlad, CE | 1 |
| de Lange, Z; Guthold, M; Nunes, CM; Pieters, M | 1 |
| Casini, A; Undas, A | 1 |
| Fang, ZA; Hensch, L; Hui, SR; Navaei, AH; Teruya, J | 1 |
| Lin, J; Lu, Q; Mao, M; Meng, J; Shi, K; Zhou, Q | 1 |
| de Maat, MPM; de Vries, JJ; Rijken, DC; Snoek, CJM | 1 |
| Dewey, EN; Farrell, DH; Rick, EA; Rowell, SE; Schreiber, MA | 1 |
| Bagoly, Z; Kattula, S; Muszbek, L; Tóth, NK; Wolberg, AS | 1 |
| Brown, AC; Guzzetta, NA; Kyu, A; Nandi, S; Nellenbach, KA; Sivadanam, S | 1 |
| Asija, R; Hanley, FL; Irvin, M; Long, J; Margetson, TD; McElhinney, DB; Quinonez, ZA; Wise-Faberowski, L | 1 |
| Gao, HM; He, YX; Jia, XL; Li, SL; Li, XL; Liu, TT; Liu, XY; Wu, RH; Yao, JF; Yin, J; Zhang, R | 1 |
| Ajjan, R; Kyriakakis, N; Lynch, J; Murray, RD; Orme, SM; Oxley, N; Pechlivani, N; Phoenix, F; Seejore, K | 1 |
| Arai, S; Honda, T; Kamijo, T; Nakazawa, H; Okumura, N; Sugano, M; Takezawa, Y; Uehara, T; Yanagisawa, R | 1 |
| Fedorova, DV; Filkova, AA; Martyanov, AA; Morozova, DS; Novichkova, GA; Panteleev, MA; Sorokina, MA; Suntsova, EV; Sveshnikova, AAN; Uzueva, SS; Zharkov, PA | 1 |
| Ajjan, RA; Fishwick, CWG; Jankowski, V; John, V; King, RJ; McPherson, MJ; Ponnambalam, S; Schuett, K; Simmons, K; Storey, RF; Tiede, C; Tomlinson, DC; Trehan, A | 1 |
| Antonova, N; Dibiasi, C; Ivanov, I; Lichtenegger, H; Lotz, EM; Ploszczanski, L; Reinbacher-Koestinger, A; Scharbert, G; Windberger, U | 1 |
| Arai, H; Fujiwara, T; Hijikata, W; Maruyama, T; Mizuno, T; Murashige, T; Ogata, A; Ouchi, K; Seki, H; Yokota, S | 1 |
| Cahill, MR; Gilligan, OM; Meade-Murphy, G; Mykytiv, V; O'Sullivan, LR; Young, PW | 1 |
| Iba, T; Levi, M; Levy, JH; Thachil, J | 1 |
| Higuchi, Y; Kaido, T; Kamijo, T; Okumura, N; Taira, C; Yoda, M | 1 |
| Alves, NJ; Nallan Chakravarthula, T; Zeng, Z | 1 |
| Thachil, J | 1 |
| Asselta, R; Brunclikova, M; Caccia, S; Hudecek, J; Kolkova, Z; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Stasko, J; Zolkova, J | 1 |
| Ahmed, S; Gasparyan, AY; Zimba, O | 1 |
| Ahmed, MU; Andrews, RK; Chakfé, N; Didelot, M; Gachet, C; Gardiner, EE; Jandrot-Perrus, M; Janus-Bell, E; Kaneva, V; Lanza, F; Le Bris, M; Loyau, S; Mangin, PH; Nechipurenko, D; Panteleev, M; Rauch, A; Receveur, N; Susen, S | 1 |
| Erkan, D; James, JA; Merrill, JT; Winakur, J | 1 |
| Bärnthaler, T; Buschmann, E; Heinemann, A; Mahla, E; Prüller, F; Schuligoi, R; Toth, GG | 1 |
| Estep, J; Hodges, K; Hsich, E; Insler, J; Insler, S; Mubashir, M; Soltesz, E; Tong, M | 1 |
| Fillis, T; Kell, DB; Lancry, O; Nunes, JM; Page, MJ; Pretorius, E; Venter, C; Windberger, U | 1 |
| Grunlan, MA; Jain, A; Johnson, JC; Lim, KK; Ngo, BKD | 1 |
| Battinelli, EM; Chen, EC; Connors, JM; Zon, RL | 1 |
| Ahangar, H; Bassiri, HA; Gohari, S; Noohi Bezanjani, F; Reshadmanesh, T | 1 |
| Dong, LJ; Hang, HF; Tang, XB; Wang, AF; Xu, YJ; Yang, F; Zhang, H | 1 |
| Hadi, TK; Mohammad, NS; Nooruldin, SA | 1 |
| Asaad, Y; Korin, N | 1 |
| Denis, CV; Gachet, C; Knapp, Y; Lanza, F; Mangin, PH; Maurer, E; Nechipurenko, D; Panteleev, M; Receveur, N; Yakusheva, A | 1 |
| Carll, T; Wool, GD | 1 |
| Abe, H; Endo, K; Miyata, S; Nogawa, M; Satake, M; Shiba, M | 1 |
| Butera, D; Hogg, PJ | 1 |
| Balla, J; Becs, G; Hurják, B; Katona, É; Muszbek, L; Pénzes, K | 1 |
| Baylis, JR; Chan, KYT; Kastrup, CJ; Ringgold, KM; St John, AE; Wang, X; White, NJ; Yong, ASM | 1 |
| Honkura, N; Horinouchi, T; Miwa, S; Sano, H; Suzuki, Y; Tanaka, H; Unno, N; Urano, T | 1 |
| de Lange-Loots, Z; Litvinov, RI; Pieters, M; Weisel, JW | 1 |
| Bonn, M; Kumar, S; Nisar, A; Parekh, SH; Rausch, MK; Wang, Y | 1 |
| Ataullakhanov, FI; Evdokimova, TA; Litvinov, RI; Peshkova, AD; Sibgatullin, TB; Weisel, JW | 1 |
| Cavallaro, F; Chantarangkul, V; Padovan, L; Peyvandi, F; Pisani, LF; Spina, L; Tripodi, A; Valsecchi, C; Vecchi, M | 1 |
| Chen, S; Cron, GO; DeRosa, MC; Koudrina, A; McConnell, EM; Tsai, EC; Zurakowski, JA | 1 |
| Arai, H; Fujiwara, T; Hijikata, W; Mizuno, T; Murashige, T; Ogata, A; Ohuchi, K; Seki, H; Tahara, T; Yokota, S | 1 |
| Abdelwahab, M; Belhani, M; Casini, A; de Moerloose, P; Djambas Khayat, C; Dorgalaleh, A; Lozeron, ED; Naz, A; Peyvandi, F; Ross, C; Santoro, C; Susen, S; Trillot, N; Ünal, E; von Mackensen, S | 1 |
| Bester, J; de Waal, GM; Goncalves, JPN; Holst, F; Page, MJ; Pretorius, E; Roberts, T; Venter, C | 1 |
| Bazine, M; Cholley, B; Clausse, D; Godier, A; Hamada, SR; Huche, F; Lang, E; Meslin, S | 1 |
| Carlier, MSA; Craigen, FB; Curry, N; Dasgupta, S; Morrow, GB; Mutch, NJ | 1 |
| Ajjan, RA; Campbell, MD; Holmes, M; Kietsiriroje, N; O'Mahoney, LL; Pearson, S; West, DJ | 1 |
| Bonda, TA; Karolczak, K; Kramkowski, K; Polak, D; Przygodzki, T; Talar, M; Watala, C; Wojkowska, DW; Wolska, N | 1 |
| Hemker, HC; Henskens, YMC; Hulshof, AM; Spronk, HMH; Ten Cate, H | 1 |
| Bhavan, PS; Chen, TY; Hou, SM; Hsia, CH; Hsia, CW; Huang, WC; Lin, KC; Sheu, JR | 1 |
| Kim, EA; Patel, H; Srinivasa, DR; Volod, O; Wang, ED | 1 |
| Chen, R; Emerson, M; Gu, B; Huang, Y; Hughes, AD; Liu, X; Longstaff, C; Ren, J; Salles-Crawley, II; Taylor, KA; Thom, SA; Xu, XY; Yu, L | 1 |
| Al Maqrashi, ZAA; Arnold, DM; Blais, N; Bourguignon, A; Kelton, JG; Lessard, MC; Nazy, I; Pannu, T; Shroff, A; Shrum, JM; Smith, JW; Warkentin, TE | 1 |
| Ajjan, RA; Gaule, TG | 1 |
| Costa, P; Dufrost, V; Foret, T; Lacolley, P; Lefevre, B; Regnault, V; Salomon Du Mont, L; Wahl, D; Zuily, S | 1 |
| Bagoly, Z; Berényi, E; Crișan, A; Csiba, L; Lánczi, LI; Nagy, A; Oláh, L; Orbán-Kálmándi, R; Sarkady, F; Sik, M; Szegedi, I; Vasas, N | 1 |
| Cao, H; Du, X; Jiang, P; Li, C; Lin, F; Liu, F; Ma, L; Qin, Y; Shen, Y; Su, N; Sun, P; Wang, Z; Yang, C; Ye, S; Yu, X; Zhang, R | 1 |
| Jou, J; McMurry, HS; Shatzel, J | 1 |
| Fukuda, T; Ichikawa, J; Ishikawa, M; Komori, M; Okazaki, R; Ono, T | 1 |
| Grobbelaar, LM; Kell, DB; Laubscher, GJ; Lourens, PJ; Ngoepe, M; Pretorius, E; Steenkamp, J; Venter, C; Vlok, M | 1 |
| Gruen, RL; Lau, WH; Pervushin, K; White, NJ; Yeo, TW | 1 |
| Demkow, M; Kruk, M; Kryczka, KE; Lubiszewska, B | 1 |
| Lim, MY; May, JE; Wolberg, AS | 1 |
| Lai, R; Liu, M; Ni, H; Shen, C; Wang, G; Xu, R | 1 |
| Attias, J; Brenner, B; Crispel, Y; Ghanem, S; Kogan, I; Nadir, Y | 1 |
| Derijks, HJJ; Keijsers, CKJPW; Nanayakkara, PWB; Péquériaux, NC; Schrijver, EJM; van Marum, RJ; van Strien, AM | 1 |
| Chauhan, AK; Chorawala, MR; Dhanesha, N; Doddapattar, P; Kokame, K; Lentz, SR; Nayak, MK; Staber, JM | 1 |
| Feuerstein, G; Gerstenhaber, JA; Lelkes, PI; Marcinkiewicz, C; Sternberg, M | 1 |
| Cadamuro, J; Felder, TK; Hannes, O; Haschke-Becher, E; Kipman, U; Mrazek, C; Wiedemann, H | 1 |
| Beck, S; Leitges, M; Stegner, D | 1 |
| Fischer, M; Maitz, MF; Sperling, C; Werner, C | 1 |
| Caspers, M; Maegele, M; Schöchl, H | 1 |
| Bonn, M; Fleissner, F; Parekh, SH | 1 |
| Barinov, NA; Galanakis, DK; Klinov, DV; Litvinov, RI; Mukhitov, AR; Nagaswami, C; Protopopova, AD; Weisel, JW | 1 |
| Cheng, Z; Sui, J; Sun, N; Wang, J; Xu, M | 1 |
| Goudie, MJ; Handa, H; Pant, J | 1 |
| Bicknell, AB; Flora, GD; Gibbins, JM; Holbrook, LM; Sahli, KA; Sandhar, GK; Sasikumar, P; Schenk, MP; Stainer, AR | 1 |
| Adebusuyi, JR; Adigun, K; Agbedana, EO; Ajobo, BM; Akinlade, KS; Arinola, OG; Charles-Davies, MA; Ebesunun, MO; Fabian, UA; Fasanmade, AA; Hassan, OO; Olaniyi, JA; Omiyale, W; Owolabi, MO; Oyewole, OE; Popoola, OO; Rahamon, SK | 1 |
| Heikinheimo, M; Långström, S; Loid, P; Mäkipernaa, A; Mäkitie, O; Viljakainen, H | 1 |
| Cronjé, HT; de Lange, Z; Green, FR; Nienaber-Rousseau, C; Pieters, M; Zandberg, L | 1 |
| Gligorijević, N; Katrlík, J; Nedić, O; Penezić, A; Zámorová Križáková, M | 1 |
| Chen, Z; Griffith, BP; Koenig, SC; Mondal, NK; Slaughter, MS; Wu, ZJ; Zheng, S | 1 |
| Brooks, MB; Jeffery, U; LeVine, DN | 1 |
| Bonna, A; Farndale, RW; Howes, JM; Induruwa, I; Jung, SM; Malcor, JD; Moroi, M; Warburton, EA | 1 |
| Chaubet, F; Collet, JP; Ghebouli, R; Jandrot-Perrus, M; Letourneur, D; Loyau, S; Maire, M; Michel, JB; Saboural, P | 1 |
| Kieliszek, M; Lipinski, B | 1 |
| Akaraborworn, O; Lim, EB; Taflin, N; White, NJ | 1 |
| Chang, NC; Chou, DS; Geraldine, P; Hsia, CH; Jayakuma, T; Lin, KH; Lu, WJ; Sheu, JR | 1 |
| Ariëns, RA; Babar, AK; Dupuis, A; Gachet, C; Hardy, AT; Herr, AB; Hughes, CE; Jandrot-Perrus, M; Le Lay, N; Loyau, S; Mangin, PH; Mezzano, D; Miller, JL; Onselaer, MB; Philippou, H; Receveur, N; Sanchez, X; Watson, SP; Wilson, C | 1 |
| Blombäck, M; Boström, F; He, S; Östlund, A; Svensson, J; Wallen, H | 1 |
| Godier, A; Ickx, B; Ozier, Y; Samama, CM; Steib, A; Susen, S | 1 |
| Ariëns, RA; Carvalho, FA; Duval, C; Farrell, DH; Guedes, AF; Macrae, FL; Santos, NC; Swithenbank, L | 1 |
| Jung, JM; Kim, SU; Kwon, DY; Park, JW; Park, MH | 1 |
| Kikuchi, D; Li, J; Maruyama, O; Sakota, D; Sapkota, A; Takei, M | 1 |
| Bilgin, M; Cansu, DÜ; Kaşifoğlu, T; Korkmaz, C; Meltem Akay, O; Teke, HÜ; Türk, SM | 1 |
| Chen, X; Gao, S; Lou, Z; Pan, L; Wang, H; Wang, M; Xia, W; Yu, D; Zhao, M; Zhou, B; Zhu, L | 1 |
| Cao, Y; Li, D; Wu, WKK; Xia, Y; Yao, R; Yu, H; Yu, J; Zeng, Z; Zhang, L; Zhou, Y | 1 |
| Gu, SX; Lentz, SR | 1 |
| Danese, E; Favaloro, EJ; Festa, L; Gelati, M; Lippi, G; Montagnana, M; Salvagno, GL; Sanchis-Gomar, F; Schena, F; Tarperi, C | 1 |
| Boral, LI; Crane, JE; Li, Y; Pagano, MB; Rollins-Raval, MA; Schmidt, AE; Smith, RE; Svensson, AM; Wong, ECC; Wu, Y; Yamada, C; Zantek, ND | 1 |
| Chattopadhyay, P; Deka, RC; Gogoi, D; Mukherjee, AK; Pal, A; Paul, S | 1 |
| Becatti, M; Bettiol, A; Di Scala, G; Emmi, G; Fiorillo, C; Prisco, D; Silvestri, E; Taddei, N | 1 |
| Ajjan, RA; Ariens, RAS; Cheah, R; Kearney, KJ; King, R; Macrae, FL; Manfield, IW; McPherson, MJ; Naseem, KM; Pechlivani, N; Phoenix, F; Simmons, KJ; Smith, KA; Spurgeon, BEJ; Tiede, C; Tomlinson, DC | 1 |
| Beckett, A; Nascimento, B; Peng, HT | 1 |
| Nieswandt, B; Rayes, J; Watson, SP | 1 |
| de Beer, MC; de Villiers, WJS; Engelbrecht, AM; Engelbrecht, L; Kell, DB; Nell, TA; Nunes, JM; Page, MJ; Pretorius, E; Thomson, GJA | 1 |
| Bai, Y; Chen, Y; Duan, L; Huo, L; Mi, R; Shi, M; Sun, K; Wang, C; Waqas Ahmed, HA; Wei, X; Wu, D; Xu, F; Yang, R; Yang, X; Zhang, W | 1 |
| de Lange, Z; Kahler, B; Pieters, M; Smuts, CM | 1 |
| Barrett, A; Clendenen, N; D'Alessandro, A; Darula, Z; Hansen, KC; Henderson, R; Issaian, A; Schmitt, LR | 1 |
| Interlandi, G; Pederson, EN | 1 |
| Becatti, M; Bettiol, A; Emmi, G; Fiorillo, C; Hatemi, G; Prisco, D | 1 |
| DeChristopher, PJ; Glynn, LA; Habeeb, O; Jeske, W; Lai, A; Levin, S; Mooney, S; Muraskas, JK | 1 |
| He, Y; Ke, HH; Li, JY; Lv, XW; Wei, Z; Zhang, EH | 1 |
| Gorbet, M; Maitz, MF; Sefton, MV; Siedlecki, CA; Sperling, C; Werner, C | 1 |
| Brash, JL; Horbett, TA; Latour, RA; Tengvall, P | 1 |
| Cushing, MM; Haas, T | 1 |
| Chabielska, E; Golaszewska, A; Iwanicka, M; Leszczynska, A; Marcinczyk, N; Misztal, T; Rusak, T; Tomasiak-Lozowska, MM | 1 |
| Biasoli, C; Castaman, G; Contino, L; Giacomelli, SH; Radossi, P | 1 |
| Abe, T; Fujimi, S; Gando, S; Hagiwara, A; Kushimoto, S; Matsubara, T; Ogura, H; Otomo, Y; Shiraishi, A; Tarui, T; Umemura, Y; Yamakawa, K | 1 |
| Bhartari, S; Chattopadhyay, P; Gogoi, D; Mukherjee, AK; Ramani, S | 1 |
| Campello, E; Ilich, A; Key, NS; Simioni, P | 1 |
| Andrianova, IA; Litvinov, RI; Nabiullina, RM; Shakurova, MA; Weisel, JW; Zubairova, LD | 1 |
| Bolad, I; Breall, JA; Flockhart, DA; Kreutz, RP; Lu, D; Owens, J; Sinha, A; von der Lohe, E | 1 |
| Brennan, SO; Chitlur, M | 1 |
| Absar, S; Ahsan, F; Kwon, YM; Nahar, K | 1 |
| Aoyama, A; Bando, T; Chen, F; Date, H; Hijiya, K; Motoyama, H; Nakajima, D; Ohsumi, A; Okita, K; Sakamoto, J; Sato, M; Yamada, T | 1 |
| Oo, TH | 1 |
| Coletti, V; De Leonardis, F; Giordano, P; Grassi, M; Luciani, M; Santoro, N | 1 |
| Stang, LJ | 1 |
| Du, LM; Fang, J; North, P; Nurden, AT; Nurden, P; Valentin, N; Wilcox, DA | 1 |
| Chang, HT; Chiu, WC; Hsu, PH; Huang, CC; Jian, JW | 1 |
| Amoako, KA; Bartlett, RH; Brant, DO; Cook, KE; Handa, H; Major, TC; Meyerhoff, ME; Montoya, PJ; Suhaib, AB | 1 |
| Chen, RP; Chen, TZ; Chen, WJ; Huai, JP; Huang, ZM; Lu, GR; Wang, C; Ye, XH; Zhuge, XJ | 1 |
| Ajjan, RA; Anwar, MM; Dunn, EJ; Gamlen, T; Grant, PJ; Hess, K; Mughal, S; Philippou, H; Rabbani, N; Smith, KA; Standeven, KF; Thornalley, PJ | 1 |
| Chen, EP; Hosokawa, K; Ogawa, S; Ohnishi, T; Szlam, F; Tanaka, KA | 1 |
| Ariëns, RA | 2 |
| Casini, A; de Moerloose, P; Neerman-Arbez, M | 2 |
| Cragg, AH; Ehrenwald, E; Gits, CC; Skeik, N | 1 |
| Fischer, AM; Gaussem, P; Godier, A; Le Bonniec, B; Marchand-Leroux, C; Martin, AC; Samama, CM | 1 |
| Bäumer, W; Feige, K; Herrling, GM | 1 |
| Akioka, Y; Asano, T; Chikamoto, H; Hattori, M; Imamura, H; Ishizuka, K; Okumura, N; Sugawara, N; Taki, M; Terasawa, F | 1 |
| Akay, OM; Kaşifoğlu, T; Korkmaz, C; Kuş, G; Yaşar Bilge, NŞ | 1 |
| Cabrales, P; Fries, D; Intaglietta, M; Martini, J; Tsai, AG | 1 |
| Folliguet, T; Frotscher, B; Lecompte, T; Maureira, P; Toussaint-Hacquard, M; Vanhuyse, F; Villemot, JP | 1 |
| Abaeva, AA; Alessi, MC; Ataullakhanov, FI; Canault, M; Chambost, H; Kolyadko, VN; Kotova, YN; Mazurov, AV; Nurden, AT; Obydennyy, SI; Panteleev, MA; Podoplelova, NA; Yakimenko, AO | 1 |
| Ariëns, RA; Brown, R; Duval, C; Lee, KR; Mumford, AD; Murden, SL; Philippou, H; Phillips, E; Reilly-Stitt, C; Westbury, SK; Whalley, D | 1 |
| Catena, C; Colussi, G; Fedrizzi, S; Sechi, LA | 1 |
| Cibor, D; Głowacki, MK; Mach, T; Owczarek, D; Sałapa, K; Undas, A | 1 |
| Cox, D; Haworth, J; Jenkinson, HF; Keane, C; Kerrigan, SW; Petersen, HJ; Tilley, D | 1 |
| Grottke, O; Rossaint, R | 1 |
| Casas, JP; Day, IN; Drenos, F; Gaunt, TR; Guyatt, A; Hingorani, AD; Humphries, SE; Kivimaki, M; Kumari, M; Ladroue, C; Lawlor, DA; Lowe, G; Rumley, A; Shah, S; Shah, T; Talmud, PJ; Whittaker, J; Zabaneh, D | 1 |
| Chiles, PG; Liang, NC; Marsh, JJ; Morris, TA | 1 |
| Cui, XL; Gao, YJ; Guo, SS; Jin, YH; Liu, FZ; Tian, XC | 1 |
| Hu, H; Hu, X; Jiang, L; Liu, P; Liu, Y; Luo, D; Xu, C; Yue, M; Zeng, C; Zhou, Q | 1 |
| Hamano, A; Jin, T; Ohno, N; Ohno, S; Okumura, N; Saiki, I; Saitoh, Y; Terada, N | 1 |
| Ahn, H; Choi, MS; Chun, HS; Kim, CS; Kim, DK; Kim, HJ; Kim, JJ; Kim, JS; Kim, SG; Kim, YH; Lee, SY; Moon, SM; Park, BR; Seo, YW; Shin, YK | 1 |
| Bolliger, D; Esper, S; Tanaka, KA | 1 |
| Brennan, S; Sarode, R; Shen, YM; Trang, V | 1 |
| Alwis, I; Goddard, D; Hughan, SC; Jackson, SP; McFadyen, JD; Nesbitt, WS; Ono, A; Schoenwaelder, SM; Spring, CM; Sturgeon, S; Westein, E; Yamanashi, Y; Yuan, Y | 1 |
| Baskaran, P; Berk, BC; Kim, Y; Modjeski, K; Morrell, CN; Smolock, EM; Soe, NN; Sowden, M; Wang, L; Xu, Y | 1 |
| Alasady, M; Brooks, AG; Dang, J; Lau, DH; Lim, HS; Roberts-Thomson, KC; Sanders, P; Schultz, C; Willoughby, SR; Wong, CX; Worthley, MI; Young, GD | 1 |
| Calfee, CS; Cohen, MJ; Kornblith, LZ; Kutcher, ME; Redick, BJ; Vilardi, RF | 1 |
| Ahmed, F; Brito e Abreu, S; Choudhury, NR; Duncan, E; Dutta, NK; Zannettino, A | 1 |
| Fan, Q; Geng, P; Li, W; Li, Y; Lin, L; Song, L; Wang, N | 1 |
| Gao, H; Xi, S; Xu, L | 1 |
| Mori, J; Okazaki, H; Satake, M; Tadokoro, K; Terada, C | 1 |
| Evans, KS; Hiscox, RJ; Ketchell, I; North, RV; Purslow, C | 1 |
| Meade, T; Ten Cate, H | 1 |
| Cervera, A; Chamorro, Á; de la Rosa, X; Durduran, T; Justicia, C; Kristoffersen, AK; Planas, AM; Valdés, CP; Varma, HM | 1 |
| Beer-Weisel, R; Dukler, D; Erez, O; Mazor, M; Novack, L; Press, F; Than, NG; Tomer, A; Zlotnik, A | 1 |
| Huhtala, J; Joutsi-Korhonen, L; Lassila, R; Leinonen, J; Lemponen, M; Salmela, B; Virtanen, L | 1 |
| Añor, S; Blasco, E; de la Fuente, C; Fernández, F; Pumarola, M; Viu, J | 1 |
| Aguilar-Sosa, E; Anaya-Gómez, F; Galván-Plata, ME; Isordia-Salas, I; Leaños-Miranda, A; Majluf-Cruz, A; Santiago-Germán, D | 1 |
| Ahn, HJ; Glickman, JF; Jno-Charles, OC; Norris, EH; Poon, KL; Strickland, S; Zamolodchikov, D | 1 |
| Furie, B; Furie, BC; Furie, RA; Merrill-Skoloff, G; Proulle, V | 1 |
| Dirkmann, D; Görlinger, K; Hartmann, M; Kirchner, C; Paul, A; Saner, FH; Treckmann, JW | 1 |
| Al-Hilal, TA; Alam, F; Byun, Y; Kim, K; Kwon, IC; Park, JW; Ryu, GH | 1 |
| Du, J; Du, X; Fang, Y; Feng, L; Hou, J; Hu, S; Jia, H; Liu, H; Xie, Z; Yu, B; Zhang, L; Zhao, Q | 1 |
| Chen, BC; Chen, Y; Jin, YH; Wang, MS; Xie, HX; Yang, LH; Yang, XL; Zhang, Z; Zheng, FX | 1 |
| Bergmeier, W; Getz, TM; Lin, FC; Uitte de Willige, S; Walton, BL; Wolberg, AS | 1 |
| Flemming, A | 1 |
| Choi, JH; Kim, S; Kim, SJ; Sapkota, K | 1 |
| Kaempfer, R; Mirzoeva, S; Paunesku, T; Shirvan, A; Small, W; Wanzer, MB; Woloschak, GE | 1 |
| Shavit, JA; Weyand, AC | 1 |
| Kiefer, JD; Matasci, M; Neri, D; Putelli, A; Zadory, M | 1 |
| Astarcioğlu, MA; Aykan, AC; Bayram, Z; Ertürk, E; Gökdeniz, T; Gündüz, S; Gürsoy, OM; Kalçik, M; Karakoyun, S; Oğuz, AE; Ozkan, M | 1 |
| Freedman, J; Gross, PL; Kalantari, J; Marshall, AH; Mosher, DF; Ni, H; Rand, ML; Reheman, A; Spring, CM; Wang, Y; Weitz, JI; Wolberg, AS | 1 |
| Jilma, B; Kulinna-Cosentini, C; Laggner, A; Röggla, M; Schober, A; Schörgenhofer, C; Schwameis, M; Thaler, J | 1 |
| Golovin, A; Kopylov, A; Pavlova, G; Revishchin, A; Samoylenkova, N; Zavyalova, E | 1 |
| Arpagaus, A; Ehlert, U; Huber, S; Kummer, P; Meister, RE; Stutz, M; von Känel, R; Wirtz, PH | 1 |
| Ahn, B; Bao, G; Barker, TH; Brown, AC; Hardy, ET; Kee, MF; Kumar, S; Lam, WA; Mannino, RG; Myers, DR; Qiu, Y; Sakurai, Y; Tran, R | 1 |
| De Angelis, V; de Groot, PG; Herczenik, E; Koekman, AC; Maas, C; Roest, M; Weeterings, C | 1 |
| Choi, JH; Kim, DW; Kim, S; Kim, SJ; Park, SE; Sapkota, K | 1 |
| Ågren, A; Antovic, A; Jörneskog, G; Lins, PE; Tehrani, S; Wallén, H | 1 |
| Bergeron, AL; Da, Q; Gushiken, FC; Khatlani, T; Langlois, KW; Molkentin, JD; Pradhan, S; Rumbaut, RE; Vijayan, KV | 1 |
| Agarwal, S; Johnson, RI; Shaw, M | 1 |
| Davison, GM; Ipp, H; Nkambule, BB | 1 |
| Hemker, HC; Kremers, RM; Peters, TC; Wagenvoord, RJ | 1 |
| Sadowski, M; Undas, A; Ząbczyk, M | 1 |
| Choi, JH; Kim, S; Kim, SJ | 1 |
| Gao, N; Liu, ZY; Lu, H; Sun, JR; Wang, XX; Yu, WZ; Zhang, GQ | 1 |
| Cao, F; Huang, J; Shao, L; Wang, T; Xiong, N; Zhang, P | 1 |
| Hernández-Romero, D; Lip, GY; Marco, P; Marín, F; Orenes-Piñero, E; Pineda, J; Roldán, V; Sogorb, F; Tello-Montoliu, A; Valdés, M | 1 |
| Nowak, P; Tadeusiewicz, J | 1 |
| Olas, B | 1 |
| Bonnefoy, A; Dedeken, L; Laverdière, C; Leclerc, JM; Merlen, C; Rivard, GE; Wagner, E | 1 |
| Favaloro, EJ; Lippi, G; Simundic, AM; Tripodi, A | 1 |
| Chanley, MA; Kerlin, BA; Nieman, MT; Sharma, R; Smoyer, WE; Waller, AP | 1 |
| Averett, RD; Fan, NK; Keegan, PM; Platt, MO | 1 |
| Chandrakala, S; Ghosh, K; Jadli, A; Mukaddam, A; Patil, R; Shetty, S | 1 |
| Brown, MR; D'Silva, L; Davidson, SJ; Evans, PA; Evans, V; Hawkins, K; Lawrence, M; Morris, RH; Potter, JF; Sabra, A; Stanford, SN; Storton, S; Wani, M; Williams, PR | 1 |
| Klaynongsruang, S; Siritapetawee, J; Sojikul, P | 1 |
| Kong, Y; Li, Z; Wang, Y; Xie, Z; Yang, W | 1 |
| Afanasyeva, GA; Simonova, AN | 1 |
| Ali, MS; Crescente, M; Flora, GD; Gibbins, JM; Jones, CI; Moraes, LA; Roweth, H; Stainer, AR; Unsworth, AJ; Vaiyapuri, S | 1 |
| Adamiec, R; Gacka, M; Jakobsche-Policht, U; Kuliszkiewicz-Janus, M; Kwiatkowski, J; Małecki, R; Undas, A | 1 |
| Beck, AW; Ross, RL | 1 |
| Li, JY; Liu, GR; Liu, XW; Ma, N; Mohamed, I; Yang, YJ; Zhang, JY | 1 |
| Kuhn, P; McCarty, OJ; Mitrugno, A; Tormoen, GW | 1 |
| Eller, K; Heinemann, A; Marsche, G; Pasterk, L; Philipose, S; Schuligoi, R | 1 |
| Dai, J; Gao, C; Liu, J; Newman, DK; Newman, PJ; Zhi, H; Zhu, J | 1 |
| Akhtar, M; Khan, S; Najmi, AK; Panda, BP | 1 |
| Gil, L; Grajek, S; Komarnicki, M; Rupa-Matysek, J; Szczepaniak-Chicheł, L; Trojnarska, O; Tykarski, A; Wojtasińska, E | 1 |
| DeRose, G; Dubois, L; Forbes, TL; Istl, A; Kribs, S; Lee, K; Mujoomdar, A; Power, AH; Wiseman, D | 1 |
| Lishko, VK; Owaynat, H; Sheller, MR; Turaga, R; Ugarova, TP; Yermolenko, IS | 1 |
| Ardillon, L; Boon, LM; Eeckhoudt, S; Hermans, C; Lambert, C | 1 |
| Amore, C; Beume, R; Dell'Elba, G; Di Santo, A; Evangelista, V; Martelli, N; Piccoli, A; Tenor, H; Totani, L | 1 |
| Harichandrakumari, KT; Murugesan, V; Pulimamidi, VK; Rajappa, M; Revathy, G; Satheesh, S | 1 |
| Appolloni, V; Battiston, M; De Groot, PG; De Marco, L; Falcinelli, E; Gresele, P; Guglielmini, G; Momi, S | 1 |
| Batko, B; Celińska-Lӧwenhoff, M; Krawiec, P; Mastalerz, L; Tłustochowicz, W; Undas, A | 1 |
| Anglés-Cano, E; Boada, C; Bueno, SR; Carrerra, C; Delgado, P; Fernández-Cadenas, I; Monasterio, J; Montaner, J; Penalba, A; Quiroga, A | 1 |
| Abbate, R; Becatti, M; Bruschi, G; Ciucciarelli, L; Emmi, G; Emmi, L; Fiorillo, C; Goldoni, M; Prisco, D; Silvestri, E; Squatrito, D; Taddei, N; Vaglio, A | 1 |
| Blombäck, M; He, S; Jacobson, SH; Mörtberg, J; Spaak, J; Wallén, Å | 1 |
| Kalish, Y; Lask, A; Rottenstreich, A; Schliamser, L; Seligsohn, U; Zivelin, A | 1 |
| Banno, S; Imai, H; Kato, Y; Miura, N; Mizuno, T; Suga, N; Suzuki, K; Suzuki, N; Yoshino, M | 1 |
| Bhasin, N; Chauhan, AK; Jin, H; Lentz, SR; Nayak, MK; Niki, M; Pandolfi, PP; Plow, EF; Rothman, PB | 1 |
| Braun, A; Chen, W; Gotru, SK; Haining, EJ; Hermanns, HM; Kraft, P; Lesch, KP; Nieswandt, B; Schuhmann, MK; Stoll, G; Tseng, YL; Wolf, K | 1 |
| Adelmeijer, J; Ariëns, RA; Dulfer, S; Hugenholtz, GC; Lisman, T; Macrae, F; Porte, RJ | 1 |
| Ariëns, RA; Bell, JD; Maurer, MC; Mouapi, KN; Philippou, H; Smith, KA | 1 |
| Amadio, P; Barbieri, SS; Bonacina, F; Bottazzi, B; Catapano, AL; Cutuli, L; Doni, A; Garlanda, C; Mantovani, A; Norata, GD; Sironi, M; Tartari, S; Tremoli, E | 1 |
| Chen, Y; Ding, X; Kong, Y; Rwibasira, G; Su, W; Wang, C | 1 |
| Abd, T; George, RT; Mittal, R; Seo, JH | 1 |
| Ariëns, RA; Lisman, T | 1 |
| Chen, Z; Xu, X; Zhu, J | 1 |
| Brophy, DF; Cardenas, JC; Chung, D; Fu, X; Lim, EB; López, JA; Martin, EJ; St John, AE; Stern, SA; Wade, CE; Wang, X; Wang, Y; Ward, KR; White, NJ | 1 |
| Govindarajan, V; Mitrophanov, AY; Rakesh, V; Reifman, J | 1 |
| Kränkel, N; Landmesser, U; Rauch-Kroehnert, U; Steffens, D; Stratmann, B; Tabaraie, T; Tschoepe, D; Weithauser, A; Witkowski, M | 1 |
| Carroza, MA; Montilla, M; Ruiz, FA; Santi, MJ | 1 |
| Casini, A; de Moerloose, P | 1 |
| Meus, R; Sobczyk, D; Son, M; Undas, A | 1 |
| Amri, Y; Becheur, M; Belaaj, H; Dabboubi, R; de Moerloose, P; Elloumi, M; Kallel, C; Kammoun, S; Messaoud, T; Toumi, Nel H | 1 |
| Akhter, MS; Biswas, A; Dodt, J; Gupta, S; Ivaskevicius, V; Krettler, C; Oldenburg, J; Philippou, H; Reinhart, C; Reuter, A | 1 |
| Baumgartner, CK; Mattson, JG; Montgomery, RR; Shi, Q; Weiler, H | 1 |
| Freitas, MO; Lane, DA; South, K | 1 |
| Abdul, S; Leebeek, FW; Malfliet, JJ; Rijken, DC; Uitte De Willige, S | 1 |
| Gurewich, V | 1 |
| Ali, MS; Bishop-Bailey, D; Bye, AP; Dombrowicz, D; Dorchies, E; Flora, GD; Gibbins, JM; Kriek, N; Molendi-Coste, O; Moraes, LA; Sage, T; Sasikumar, P; Staels, B; Unsworth, AJ; Vaiyapuri, S | 1 |
| Adams, G; Fernando, F; Katsarou, AD; Shlebak, AA | 1 |
| Ajzner, É; Bagoly, Z; Bereczky, Z; Kállai, J; Katona, É; Kovács, B; Mezei, ZA; Miklós, T; Molnár, É; Muszbek, L | 1 |
| Ajjan, RA; Alzahrani, S; Ariens, RA; Baxter, PD; Grant, PJ; Greenhalgh, KA; Price, JF; Standeven, KF; Storey, RF; Strachan, MW | 1 |
| Rodger, M; Versteeg, HH | 1 |
| Kameshwar, VH; Maheshwari, M; Nafeesa, Z; Nanjunda Swamy, S; Priya, BS; Sharanappa, P; Uday, P | 1 |
| Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q | 1 |
| Bergström, GM; Böttcher, G; Deinum, J; Jönsson Rylander, AC; Kalies, I; Lindgren, A; Wåhlander, K | 1 |
| Grimbergen, J; Koenderink, GH; Koopman, J; Kurniawan, NA; Piechocka, IK | 1 |
| Gregersen, H; Li, M; Liao, X; Wang, G; Wang, Y; Wu, H; Yin, T; Zhang, X | 1 |
| Byrnes, JR; Kattula, S; Wolberg, AS | 1 |
| Al-Salam, S; Ali, BH; Beegam, S; Nemmar, A; Oulhaj, A; Yuvaraju, P | 1 |
| Ajjan, R; Kearney, K; Smith, K; Tomlinson, D | 1 |
| Gijbels, MJJ; Heestermans, M; Ouweneel, AB; Reitsma, PH; Van Eck, M; van Vlijmen, BJM; Verwilligen, RAF | 1 |
| Balagopal, P; George, D; Mann, KJ; Mauras, N; Sweeten, S; Vaughan, DE; Yarandi, H | 1 |
| Bertini, D; Salmaso, L; Simioni, P; Spiezia, L | 1 |
| Isobe, M; Itai, A; Muto, S; Ogawa, M; Suzuki, J; Yamaguchi, Y | 1 |
| Franchini, M; Guidi, GC; Lippi, G; Montagnana, M; Salvagno, GL; Targher, G | 1 |
| Liu, J; Liu, YM; Qin, H; Wang, B; Wang, CB; Wang, L; Wang, M; Yu, XJ; Zang, WJ; Zhou, XB | 1 |
| Bernard, M; Bologna, S; Bulabois, CE; Chevallier, P; Cornillon, J; Delain, M; Gruel, Y; Hunault-Berger, M; Ifrah, N; Lafon, I; Maakaroun, A; Padrazzi, B; Tizon, A | 1 |
| Ghazali, M; Hayward, GL | 1 |
| Burke, A; Chernysh, I; Fitzgerald, GA; Heijnen, HF; Ischiropoulos, H; Koliakos, G; Liebler, DC; Nagaswami, C; Parastatidis, I; Stamer, S; Thomson, L; Visser, J; Weisel, JW | 1 |
| Hashimoto, A; Nishikawa, M; Ohashi, K; Okuda, M; Onoda, K; Shimono, T; Shimpo, H | 1 |
| BORGSTROM, S | 1 |
| Bagnell, CR; Campbell, RA; Overmyer, KA; Wolberg, AS | 1 |
| Cooley, BC; Diorio, JP; Hernandez, I; Mosesson, MW; Weiler, H | 1 |
| Kubota, R; Munekata, M; Nagai, N; Okahashi, R | 1 |
| Ablooglu, AJ; Ginsberg, MH; Kang, J; Petrich, BG; Shattil, SJ | 1 |
| Butnaru, M; Dimitriu, CD; Filip, D; Macocinschi, D | 1 |
| Andreotti, F; Becker, RC; Chan, MY | 1 |
| Bai, X; Freedman, J; Gross, PL; He, F; Jin, W; Ni, H; Reheman, A; Spring, CM; Yang, H; Zhu, G | 1 |
| Algra, A; Rosendaal, FR; Siegerink, B | 1 |
| Beare, NA; Lewallen, S; Molyneux, ME; Taylor, TE; White, VA | 1 |
| Bové, A; Cervera, R; de la Red, G; Espinosa, G; Monteagudo, J; Plaza, J; Reverter, JC; Tàssies, D | 1 |
| Ahrens, I; Arab, A; Bode, C; Hansi, C; Hehrlein, C; Rzany, A | 1 |
| Auger, JM; Dhanjal, T; Ellison, S; Kalia, N; Kornerup, KN; Lim, J; Mazharian, A; Senis, YA; Thomas, SG; Tomlinson, MG; Watson, SP; Weiss, A; Zhao, Y; Zhu, JW | 1 |
| Jakubowski, H | 2 |
| Berliner, S; Bromberg, M; Cohen, M; Rogowski, O; Shalev, V; Shapira, I; Steinvil, A | 1 |
| Ding, SF; Liu, CX; Liu, XL; Ni, M; Wang, Y; Zhang, M; Zhang, PF; Zhang, Y; Zhao, YX | 1 |
| Hueb, W; Jatene, F; Lopes, NH; Paulitsch, FS; Rached, R; Ramires, J; Schneider, D; Sobel, BE; Stolf, N | 1 |
| Fenger-Eriksen, C; Ingerslev, J; Jensen, KM; Jensen, TM; Kristensen, BS; Sørensen, B; Tønnesen, E | 1 |
| Bonoldi, E; Castaman, G; Lunardi, M; Mastroeni, V; Rigo, L; Rodeghiero, F | 1 |
| Huo, JL; Kong, Y; Li, YM; Wu, WT; Xiong, J; Xu, W | 1 |
| Arnold, E; González-Manchón, C; Green, D; Jayo, A; Lord, ST | 1 |
| Galanakis, D; Miesbach, W; Scharrer, I | 1 |
| Blue, R; Coller, BS; Filizola, M; Fuentes, R; Harrington, A; Hirsch, J; Janczak, CA; Jirouskova, M; Kowalska, MA; Li, J; Murcia, M; Poncz, M; Thornton, MA | 1 |
| Hernandez, I; Nowak-Göttl, U; Schulte, T; Seehafer, T; Stoll, M; Thedieck, S; Weiler, H | 1 |
| Almasy, L; Andersen, M; Barlera, S; Blanco-Vaca, F; Buil, A; Clarke, R; Fontcuberta, J; Hamsten, A; Mälarstig, A; Peden, J; Seedorf, U; Silveira, A; Soria, JM; Souto, JC; Watkins, H | 1 |
| Ahmadinejad, M; Atabak, S; Hedayati, M; Imani, H; Rahmani, L; Tabibi, H | 1 |
| de Moerloose, P; Neerman-Arbez, M | 1 |
| Hiramoto, M; Kaneda, H; Nagahama, S; Tamagawa, M | 1 |
| Czymmek, K; Manrai, P; Millili, P; Naik, MU; Naik, UP; Nigam, A; Sullivan, M | 1 |
| Brayman, AA; Crum, LA; Hwang, JH; Warren, C; Zhou, Y | 1 |
| Bergman, GE; Dickneite, G; Joch, C; Pragst, I | 1 |
| Dyr, JE; Hirmerová, J; Kotlín, R; Malý, M; Reicheltová, Z; Riedel, T; Salaj, P; Sobotková, A; Suttnar, J | 1 |
| Bett, N; Juneja, M; Ray, MJ; Walters, DL | 1 |
| Carter, AM; Grant, PJ; Standeven, KF; Uitte de Willige, S | 1 |
| Fukui, Y; Handa, M; Ikeda, Y; Kabata, K; Okamura, Y; Suzuki, H; Takeoka, S | 1 |
| An, DQ; Ma, N; Sun, HY; Wang, YL; Zhu, M | 1 |
| Gartner, TK; Guerrero, JA; Kyei, M; Liu, J; Russell, S; Storrie, B; Ware, J | 1 |
| Ambrose, JA; Barua, RS; Buhari, C; Huang, G; Javed, U; Margosan, D; Srikanth, S; Sy, F | 1 |
| Abbott, LS; Barnard, DR; Berman, JN; Deevska, M; Dix, D; Fernandez, CV; Fitzgerald, C; Parker, L; Price, VE; Wang, H; Yhap, M | 1 |
| Cimbolaityte, J; Grybauskas, P; Kazaniene, J; Kozlovaite, V; Mongirdiene, A; Ptasekas, J; Sileikis, V; Zabiela, V | 1 |
| Mocatta, TJ; Paton, LN; Richards, AM; Winterbourn, CC | 1 |
| Deng, Z; Hong, M; Ji, X; Li, Q; Wang, S; Zhang, L | 1 |
| Dai, Z; Liu, M; Ma, Y; Yue, X; Zha, Z | 1 |
| Galanakis, D; Henschen, A; Miesbach, W; Neerman-Arbez, M; Scharrer, I; Spitzer, S | 1 |
| Chu, J; Shen, Y; Sun, J; Wei, D; Yang, Y; Zhang, L; Zhu, J | 1 |
| Slowik, A; Szczudlik, A; Tracz, W; Undas, A; Wolkow, P | 1 |
| Ayenew, W; Baker, J; Duprez, D; Henry, K; Hullsiek, KH; Neaton, JD; Quick, H; Tracy, R | 1 |
| Auger, JM; Cosemans, JM; Heemskerk, JW; Munnix, IC | 1 |
| Kasirer-Friede, A; Ruggeri, ZM; Shattil, SJ | 1 |
| Akkerman, JW; de Groot, PG; Moll, FL; Schulte-Merker, S; Tournoij, E; Weber, GJ; Zon, LI | 1 |
| Alrehani, N; Cruz, MA; Gushiken, FC; Hyojeong, H; Langlois, KW; Pradhan, S; Rumbaut, RE; Vijayan, KV | 1 |
| Kolev, K; Komorowicz, E; Machovich, R; Tanka-Salamon, A | 1 |
| Panagiotakos, DB; Vardavas, CI | 1 |
| Maurer, LM; Mosher, DF; Tomasini-Johansson, BR | 1 |
| MacCallum, PK; Meade, TW; Rudnicka, AR; Whitelocke, R | 1 |
| Aleman, MM; Wolberg, AS | 1 |
| Humphrey, JD; Karsaj, I | 1 |
| Gibbs, S; Laffan, M; Szydlo, R; Wong, CL | 1 |
| Akkaya, M; Dogan, A; Erdogan, D; Kaya, S; Onal, S; Ozaydin, M; Turker, Y | 1 |
| HAWN, CV; PORTER, KR | 1 |
| FAVATA, BV | 1 |
| JEANNERET, H; RUTISHAUSER, E | 1 |
| Diamond, SL; Illing, DA; Neeves, KB | 1 |
| Favaloro, EJ; Franchini, M; Lippi, G | 1 |
| Boehlen, F; de Moerloose, P; Neerman-Arbez, M | 1 |
| Caicedo, J; Dong, A; Gairola, CG; Han, SG; Mueller, P; Saha, S; Smyth, SS | 1 |
| Bihari, P; Ettehadieh, D; Fent, J; Karg, E; Khandoga, A; Khandoga, AG; Krombach, F; Lakatos, S; Schulz, H; Stoeger, T | 1 |
| Canpolat, F; Dikmenoglu, N; Duran, FS; Durmazlar, SP; Eren, C; Eskioglu, F; Oktay, B; Tatlican, S | 1 |
| Gluszko, P; Kwasny-Krochin, B; Undas, A | 1 |
| Babineau, DC; Jenny, NS; Mehra, R; Patel, SR; Redline, S; Tracy, RP; Xu, F | 1 |
| Arauz, J; Cartin, M; Hidalgo, A; Mendez, M; Parajeles, A; Salazar-Sanchez, L | 1 |
| Gialeraki, A; Merkouri, E; Neerman-Arbez, M; Politou, M; Sfyridaki, A; Travlou, A | 1 |
| Gamble, LJ; Ishihara, K; Johnson, CA; Murata, H; Wagner, WR; Woolley, JR; Ye, SH | 1 |
| Liu, YF; Wei, Q; Yang, L; Yang, P; Zeng, H | 1 |
| Dyr, JE; Hrachovinová, I; Kotlín, R; Kvasnicka, J; Malý, M; Oravec, M; Reicheltová, Z; Riedel, T; Salaj, P; Suttnar, J | 1 |
| Antoch, M; Byzova, TV; Chen, J; Ma, Y; Marchant, K; Podrez, EA; Somanath, PR | 1 |
| Barker, DJ; Bhargava, SK; Biswas, SD; Fall, CH; Lakshmy, R; Osmond, C; Prabhakaran, D; Ramji, S; Reddy, KS; Sachdev, HS; Tandon, N | 1 |
| Fu, R; Qiu, J; Wu, P; Wu, S | 1 |
| Choi, NS; Chun, HK; Chung, DM; Kim, SH; Maeng, PJ; Park, SB | 1 |
| PINNIGER, JL; PRUNTY, FT | 1 |
| Akkerman, JW; Cate, HT; Hauer, AD; Hildebrand, RB; Hoekstra, M; Korporaal, SJ; Kuiper, J; Meurs, I; Praticò, D; Van Berkel, TJ; Van Eck, M | 1 |
| Deng, H; Ding, Y; Liao, Y; Liu, K; Su, G; Wang, Y; Wang, Z; Zeng, Q | 1 |
| Heinemann, A; Konya, V; Lippe, IT; Marsche, G; Peskar, BA; Philipose, S; Schuligoi, R; Sreckovic, I | 1 |
| Colli, S; Sirtori, CR | 1 |
| Chung, CY; Dong, C; Ozdemir, T; Robertson, GP; Zhang, P | 1 |
| Farah, RA; Farhat, HZ; Jalkh, KS; Kadri, AM; Sayad, PE | 1 |
| Babić, N; Dervisević, A; Huskić, J; Musić, M | 1 |
| Alvarez-Perez, FJ; Alvarez-Sabin, J; Castelo-Branco, M | 1 |
| Fredenburgh, JC; Leslie, BA; MacQuarrie, JL; Stafford, AR; Vu, TT; Weitz, JI; Yau, JW | 1 |
| Alber, M; Kamocka, M; Rosen, ED; Xu, Z | 1 |
| Arkebauer, MR; Bernhardt, BE; Cohen, JB; Machovec, KA; Malayaman, SN; Nielsen, VG | 1 |
| Cardenas, JC; Church, FC; Machlus, KR; Wolberg, AS | 1 |
| Bălşeanu, AT; Dănoiu, S; Iancu, I; Mitran, SI; Moţa, M; Pisoschi, C; Riza, A; Sfredel, V | 1 |
| Delgado-Lista, J; Garcia-Rios, A; Lopez-Miranda, J; Perez-Jimenez, F; Perez-Martinez, P | 1 |
| Chen, G; Chuang, YJ; Ni, N; Pan, Z; Wang, B; Xu, B; Zhou, J | 1 |
| Cohen, JB; Malayaman, SN; Nielsen, VG; Nowak, M; Vosseller, K | 1 |
| Bhadada, SV; Dhamecha, PS; Ghatak, SB; Panchal, SJ | 1 |
| Budnik, I; Einav, Y; Martinowitz, U; Misgav, M; Shenkman, B | 1 |
| Bassler, N; Dezfouli, S; Hickey, MJ; Hohmann, JD; Jackson, S; Jia, F; Krajewski, S; Kurz, J; Nandurkar, H; Peter, K; Selan, C; Straub, A; Wendel, HP; Westein, E; Yuan, Y | 1 |
| Bilici, M; Bosnak, M; Davutoglu, M; Dogru, O; Tavil, B | 1 |
| Han, Y; Hu, L; Hu, X; Lu, X; Ren, Y; Ruan, C; Sun, A; Wang, Z; Wu, D; Wu, X; Zhou, L; Zhu, L | 1 |
| Allen, G; Bernstein, J; Bornikova, L; Manco-Johnson, MJ; Peyvandi, F | 1 |
| Bult, H; Emmerechts, J; Fransen, P; Hemmeryckx, B; Hoylaerts, MF; Kauskot, A; Lijnen, HR; Van Hove, CE | 1 |
| Agrawal, A; Gupta, BK; Gupta, R; Khatri, M; Panwar, RB; Raja, S; Vaishnav, J | 1 |
| Brayman, AA; Crum, LA; Hwang, JH; Starr, FL; Warren, C; Zhou, Y; Zia, J | 1 |
| Antoniades, C; Kardara, D; Koumallos, N; Kyvelou, SM; Papageorgiou, N; Stefanadis, C; Tousoulis, D; Vasiliadou, C; Vlachopoulos, C; Xaplanteris, P | 1 |
| Hamsten, A; Joutsi-Korhonen, L; Kaprio, J; Kaye, SM; Kotronen, A; Lassila, R; Pietiläinen, KH; Rissanen, A; Silveira, A; Yki-Järvinen, H | 1 |
| Conti, E; Favaretto, E; Frascaro, M; Legnani, C; Palareti, G; Sartori, M | 1 |
| Cierpka, L; Król, R; Pawlicki, J; Ziaja, J | 1 |
| Ayala, R; Bustelos, R; Cedena, T; Jimenez, C; Martínez-López, J; Moreno, E; Ribera, C | 1 |
| Bicknell, AB; Gibbins, JM; Holbrook, LM; Sasikumar, P; Simmonds, AD; Stanley, RG | 1 |
| Ajjan, R; Carter, AM; Hess, K; Howes, JM; Keen, JN; Pease, RJ; Richardson, VR; Schroeder, V; Shore, A; Smith, KA; Somani, R; Standeven, KF | 1 |
| Bertling, A; Brodde, MF; Heilmann, C; Horn, M; Jurk, K; Kehrel, BE; Müller, A; Peters, G; Roth, J; Van Aken, H | 1 |
| Gong, J; Li, S; Wei, S; Wu, C; Zhu, R | 1 |
| Bourdon, C; Gachet, C; Lanza, F; Mangin, PH; Ohlmann, P; Receveur, N; Schaff, M | 1 |
| Favaloro, EJ; Koutts, J; Mina, A | 1 |
| Caton, F; Marlu, R; Polack, B; Yeromonahos, C | 1 |
| Bhakta, V; Eltringham-Smith, LJ; Gataiance, S; Sheffield, WP | 1 |
| Ajjan, RA; Alzahrani, SH; Gerdes, VE; Hess, K; Hooper, JM; Orme, SM; Phoenix, F; Rice, P; Smith, KA; Standeven, KF; Stuijver, DJ; van Zaane, B | 1 |
| Eley, KA; Parker, RJ; Pearson, O; Von Kier, S; Watt-Smith, SR | 1 |
| Combescure, C; de Moerloose, P; Dirlewanger, MA; Meier, CA; Reber, G; Roux-Lombard, P; Saudan, S; Schwitzgebel, VM; Stoppa-Vaucher, S | 1 |
| Ruiz-Sáez, A | 1 |
| Choudhry, A; DeLoughery, TG | 1 |
| Farahani, RM; Harty, DW; Hunter, L; Hunter, N; Simonian, MR | 1 |
| Doğan, A; Erdogan, D; Icli, A; Varol, E | 1 |
| Brosolo, G; Catena, C; Colussi, G; Sechi, LA | 1 |
| Ascaso, FJ; Huerva, V | 1 |
| Abram, C; Lowell, CA; Mori, J; Nash, CA; Senis, YA; Séverin, S; Watson, SP; Zhao, Y | 1 |
| Brzoska, T; Buczko, W; Chlopicki, S; Fedorowicz, A; Grochal, E; Kramkowski, K; Leszczynska, A; Mann, B; Mogielnicki, A; Motterlini, R; Urano, T | 1 |
| Chegodaev, DA; Kovtun, OP; L'vova, OA | 1 |
| Egerod, KL; Eickhardt, H; Engelholm, LH; Feldborg, CW; Hald, A; Laerum, OD; Lund, LR; Maerkedahl, RB; Rønø, B | 1 |
| Ding, Z; Du, H; Liu, G; Pan, C; Wei, X; Ye, J; Zhang, S; Zhang, Y | 1 |
| de Maat, MP; Janssen, NA; Kluft, C; Malfliet, JJ; Meijer, P; Rijken, DC; Rudež, G; Spronk, HM; Talens, S | 1 |
| Popat, KC; Smith, BS | 1 |
| Lipinski, B; Pretorius, E | 1 |
| Ai, J; Lakovic, K; Macdonald, RL; Sabri, M | 1 |
| Ahluwalia, M; Bo, ZM; Guevara, E; Tun, NM; Villani, GM | 1 |
| Barsegov, V; Bennett, JS; Litvinov, RI; Mekler, A; Shuman, H; Weisel, JW | 1 |
| Choudhury, GR; Lin, ZJ; Liu, H; Liu, R; Qian, H; Ren, M; Yang, SH | 1 |
| Cabiale, K; Castellino, M; Galloni, MR; Rovere, M; Stolojan, V; Tagliaferro, A; Virga, A | 1 |
| Farrell, DH | 1 |
| Adam, F; Berrou, E; Bryckaert, M; Coupry, I; Favier, R; Fergelot, P; Goizet, C; Jandrot-Perrus, M; Kauskot, A; Lebret, M; Nurden, A; Nurden, P; Rosa, JP | 1 |
| Goyert, G; Green, PM; Hanbali, A; Kuriakose, P; Lambing, A; Munoz, J; Neal, S; Raman, S; Schering, J | 1 |
| Gutiérrez, JM; Herrera, C; Rucavado, A; Warrell, DA | 1 |
| Bester, J; Lipinski, B; Pretorius, E; Vermeulen, N | 1 |
| Burghardt, S; Giers, G; Handschel, J; Kübler, NR; Naujoks, C | 1 |
| Jackson, DE; Linden, MD; Mosawy, S; Woodman, OL | 1 |
| Boylan, B; Cooley, BC; Gao, C; Hayes, V; McKenzie, SE; Newman, DK; Newman, PJ; Poncz, M; Rauova, L; Zhi, H | 1 |
| Chernyshenko, TM; Hornyts'ka, OV; Kolesnikova, IM; Kostiuchenko, OP; Liksunov, OV; Lugovs'koĭ, EV; Lytvynova, LM; Nikul'nikov, PI; Platonova, TM; Ratushniuk, AV | 1 |
| Hatton, MW; Richardson, M; Ross, B; Southward, SM; Timleck-DeReske, M | 1 |
| Karnicki, K; McBane, RD; Miller, RS; Owen, WG | 1 |
| Bal Dit Sollier, C; Drouet, L | 1 |
| Bermejo, E; Dran, GI; Fernández, GC; Gomez, S; Isturiz, MA; Meiss, R; Palermo, MS; Rubel, CJ | 1 |
| Asakura, H; Ishino, C; Kanno, M; Matsuda, T; Minami, S; Morishita, E; Nakao, S; Uotani, C | 1 |
| Chełstowski, K; Foltynska, A; Honczarenko, K; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B | 1 |
| Harada, N; Kushimoto, S; Okajima, K; Uchiba, M | 1 |
| Matsuda, M; Matsui, H; Miyata, S; Mizuno, T; Sugimoto, M; Tsuji, S; Yoshioka, A | 1 |
| Ringdahl, U; Ruggeri, ZM; Sjöbring, U | 1 |
| Catto, AJ; Grant, PJ; Lansbury, AJ | 1 |
| Brieger, D; Bruce, D; Freedman, B; Kril, J; Ploplis, V; Zeng, B | 1 |
| Ginsberg, MH; Riederer, MA; Steiner, B | 1 |
| André, P; Bal Dit Sollier, C; Bellucci, S; Brouland, JP; Caen, J; Drouet, L; Hainaud, P; Simoneau, G | 1 |
| Bellinger, DA; Bode, AP; Fischer, TH; Merricks, EP; Nichols, TC; Read, MS; Reddick, R; Russell, K; Sanders, WE | 1 |
| Dougan, H; Gillespie, KD; Hobbs, JB; Klement, P; Lyster, DM; Stafford, AR; Weitz, JI | 1 |
| Gabazza, EC; Kushiya, F; Mori, Y; Nishikawa, M; Nobori, T; Okabayashi, K; Shiku, H; Wada, H; Watanabe, M | 1 |
| Ayrton, N; Cariolou, MA; Hadjivassiliou, M; Karagrigoriou, A; Nicolaides, AN; Pantzaris, M; Xenophontos, SL | 1 |
| Espinosa, RA | 1 |
| Haas, S | 1 |
| Diamond, SL; Goel, MS | 1 |
| Chase, PB; Galán, JA; Perez, JC; Rodríguez-Acosta, A; Sánchez, EE | 1 |
| Chin, BS; Conway, DS; Heeringa, J; Hofman, A; Lip, GY; Van Der Kuip, DA; Witteman, JC | 1 |
| Alamanni, F; Biglioli, P; Colli, S; Eligini, S; Gandini, S; Mussoni, L; Naliato, M; Parolari, A; Tremoli, E; Wang, X | 1 |
| Aguejouf, O; Doutremepuich, C; Doutremepuich, F; Mayo, K; Megraud, F; Monteiro, L | 1 |
| Collet, JP; Lesty, C; Montalescot, G; Weisel, JW | 1 |
| Chen, JY; Ding, PD; Huang, N; Leng, Y; Leng, YX; Sun, H; Wang, GJ; Wang, J; Xi, TF; Yang, P | 1 |
| Eguchi, Y; Kazahaya, Y; Koga, S; Matsuda, M; Nakahara, K; Shintani, Y; Wada, H; Yamazumi, K | 1 |
| Ahn, JY; Ahn, TH; Choi, IS; Han, SH; Kim, DS; Koh, KK; Park, GS; Shin, EK; Son, JW | 1 |
| Alver, A; Cimşit, G; Orem, A; Uydu, HA; Vanizor Kural, B; Yandi, YE | 1 |
| Chan, CW; Chan, MW; Chen, Y; Clark, DA; Fung, LS; Ghanekar, A; Gorczynski, RM; Grant, DR; He, W; Levy, GA; Luo, X; Marsden, PA; Mendicino, M; Miller, T; Ning, Q; Phillips, MJ; Scott, JA | 1 |
| Barshtein, G; Ben-Ami, R; Berliner, S; Deutch, V; Elkayam, O; Mardi, T; Yedgar, S | 1 |
| Biot, F; Chabuet, M; De Mazancourt, P; Dechavanne, M; Ffrench, PO; Hanss, MM; Mornex, JF | 1 |
| Hoffman, M; Sauls, DL; Wolberg, AS | 1 |
| da Cunha, V; Dong, N; Martin-McNulty, B; Morser, J; Nagashima, M; Tran, K; Wang, YX; Wu, C; Wu, Q | 1 |
| INGRAM, IC | 1 |
| MALAGAMBA, G; OTTAGGIO, G | 1 |
| CHAMPY, C; DEMAY, M; FIEHRER, A | 1 |
| VASCIAVEO, L | 1 |
| REID, DE; ROBY, CC; WEINER, AE | 1 |
| HERTIG, AT; MANSELL, H; McKAY, DG | 1 |
| GRUGNI, C; ROSTI, P | 1 |
| KANOF, A; LOSNER, S; VOLK, BW | 2 |
| POLLOSSON, E | 1 |
| BOCCHETTI, G; LUCIFERO, A | 1 |
| KRUGELIS, EJ; SIZER, IW | 1 |
| AMBRUS, CM; AMBRUS, JL; BACK, N; MIHALYI, E | 1 |
| OLSON, ES | 1 |
| TULLER, MA | 1 |
| ANGLEM, TJ; EMERSON, CP; GRAHAM, JH | 1 |
| BARTA, G | 1 |
| STOICHITA, M | 1 |
| MARX, R | 1 |
| McKAY, DG; SHAPIRO, SS | 1 |
| CLIFFTON, EE; FREIMAN, AH | 1 |
| AMBRUS, CM; AMBRUS, JL; BACK, N; GOLDSTEIN, S; HARRISSON, JW | 1 |
| Watzke, HH | 1 |
| FRANZ, RC; HATHORN, M; KARK, AE | 1 |
| BANG, NU; CLIFFTON, EE; FREIMAN, AH | 1 |
| HOBBS, JT | 1 |
| CHANDRASEKHAR, N; LAKI, K | 1 |
| VERSTRAETE, M | 1 |
| JOHNSON, SA; McKENNA, JL | 1 |
| BETETTO, D; CRISTINA, P; SPANIO, G | 1 |
| HELLE, I | 1 |
| DELLABIANCA, Y; KOLLER, F; LAEUBLI, B; VOGEL-MENG, J | 1 |
| LOEGERING, DA; PILGERAM, LO | 1 |
| BROZMAN, M | 1 |
| BENZER, H; BLUEMEL, G; BRENNER, H; PIZA, F | 1 |
| AMRIS, CJ | 1 |
| FORMAN, WB | 1 |
| WOODS, JR | 1 |
| MACHABELI, MS | 1 |
| HAWKEY, CM; STAFFORD, JL | 1 |
| STAMM, H | 1 |
| BERGKVIST, R; SVAERD, PO | 1 |
| BARNHART, MI; GILROY, J; JOHNSON, JF; MEYER, JS | 1 |
| ABEYARATNE, MR; PORTER, IA; WALDER, DN | 1 |
| ANDERSSON, L | 1 |
| HUME, M | 1 |
| AMRIS, A; AMRIS, CJ | 1 |
| HANDA, J | 1 |
| STAFFORD, JL | 2 |
| DOUGLAS, AS; MCNICOL, GP | 1 |
| PONOMAREV, IuT; TOKAREV, OIu | 1 |
| SHERRY, S | 4 |
| KISELEVA, EN; PETROVA, TR | 1 |
| DAMESHEK, W; RODRIGUEZ-ERDMANN, F; TAUB, RN | 1 |
| TRIANTAPHYLLOPOULOS, DC; TRIANTAPHYLLOPOULOS, E | 1 |
| HITZIG, WH | 1 |
| DEVREKER, RA; VERMYLEN, C; VERMYLEN, J; VERSTRAETE, M | 1 |
| KRIVIT, W; VERNIER, RL; WHITE, JG | 1 |
| KANTOR, FS | 1 |
| FLETCHER, AP; HIRSH, J; SHERRY, S | 1 |
| FULLERTON, HW; OGSTON, D | 1 |
| CRASTNOPOL, P; LOSNER, S; VOLK, BW | 1 |
| DAVIES, JW; HOBBS, JT | 1 |
| HANAWA, K; MAEKAWA, T; NAKAO, K; ONO, H | 1 |
| Bella, JN; Best, LG; Devereux, RB; Howard, BV; Liu, JE; Palmieri, V; Robbins, DC; Roman, MJ; Tracy, RP | 1 |
| Hans, M; Juhan-Vague, I | 1 |
| Jaeger, BR; Labarrere, CA | 1 |
| Ariëns, RA; de Lange, M; Dunn, EJ; Grant, PJ; Snieder, H; Spector, TD; Turney, JH | 1 |
| Baumann, M; Heemann, U; Kribben, A; Niebel, W; Philipp, T | 1 |
| Chen, CC; Liao, JD; Lin, SP; Tyan, YC | 1 |
| Chandler, WL; Hoffer, EK; Nicholls, SC | 1 |
| Cooley, BC; Hendrickson, SB; Hernandez, I; Isermann, BH; Kerlin, B; Lord, S; Mosesson, MW; Sood, R; Weiler, H; Zogg, M | 1 |
| Chang, R; Horne, MK | 1 |
| Bonnin, P; Cupa, M; Fattorutto, M; Mazoyer, E; Morin, F; Pham Tourreau, S; Raphaël, M; Samama, CM | 1 |
| Bennett, JS; Hazen, SL; Ischiropoulos, H; Murciano, JC; Muzykantov, V; Nagaswami, C; Penn, MS; Scheiner, T; Seagraves, A; Souza, JM; Thomson, L; Torbet, J; Vadseth, C; Vilaire, G; Weisel, JW | 1 |
| Chung, NA; Lip, GY; Makin, AJ; Silverman, SH | 1 |
| Birnbaum, M; Brass, LF; Jiang, H; Monks, R; Morgans, A; Woulfe, D | 1 |
| RYAN, EA | 1 |
| CONLEY, CL; ELLICOTT, CE | 1 |
| MORRISON, PR; SEILER, A | 1 |
| Dubois, C; Reigner, SC; Riederer, MA; Steiner, B | 1 |
| Andersson, J; Bengtsson, AA; Ekdahl, KN; Elgue, G; Nilsson, B; Rönnblom, L; Sturfelt, G | 1 |
| Sadler, JE; Shim, K; Westfield, LA; Zhu, H | 1 |
| Chiles, PG; Gamst, AC; Konopka, RG; Loza, O; Marsh, JJ; Morris, TA; Pedersen, CA | 1 |
| Peng, S; Wang, C; Wu, Y; Zhao, M; Zhou, K | 1 |
| Ghanekar, A; Grant, DR; He, W; Levy, GA; Liu, H; Liu, M; Mendicino, M; Phillips, MJ; Zhong, R | 1 |
| Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bernardo, E; Escaned, J; Fernandez-Ortiz, A; Hernández-Antolín, R; Macaya, C; Moreno, R; Ramírez, C; Sabaté, M | 1 |
| Hull, JE; Hull, MK; Urso, JA | 1 |
| Ariëns, RA; Grant, PJ; Scott, EM | 1 |
| Dopheide, SM; Harper, IS; Hughan, SC; Jackson, SP; Kulkarni, S; Nesbitt, WS | 1 |
| Aznar, J; Contreras, T; Micó, L; Ricart, J; Todolí, J; Vayá, A | 1 |
| Degen, JL; Flick, MJ; Jirousková, M; Kombrinck, KW; La Jeunesse, CM; Massari, JV; Palumbo, JS; Talmage, KE | 1 |
| CARMAN, RD; DAY, AJ; TRETHEWIE, ER | 1 |
| Chesebro, JH; Grill, DE; Hassinger, NL; McBane, RD | 1 |
| Chan, C; Criqui, MH; Ferrucci, L; Green, D; Greenland, P; Guralnik, JM; Liu, K; McDermott, MM; Oskin, SI; Pearce, WH; Ridker, PM; Schneider, JR; Taylor, LM | 1 |
| Andrews, RK; Berndt, MC | 1 |
| Beinart, G; Damon, L | 1 |
| Gu, F; Lü, J; Yang, M; Yang, W | 1 |
| Bang, NU; Bruno, A; Cohen, SN; Gorelick, PB; McConnell, JP; Richardson, D; Tietjen, GE | 1 |
| Gao, XY; Hua, ZC; Ju, CW; Ma, GS; Wang, LS; Yang, X | 1 |
| Bleyer, AJ; Chaves, P; Fried, L; Furberg, C; Kuller, L; Newman, A; Seliger, S; Shlipak, M; Solomon, C; Stehman-Breen, C | 1 |
| Evans, A; Lowe, G; McCrum, E; Patterson, C; Rumley, A; Salomaa, V; Yarnell, J | 1 |
| Cackett, KS; Comer, MB; Dawson, KM; Gladwell, S; Wood, LM | 1 |
| Cavallini, C; Doggen, CJ; Mannucci, PM; Martini, CH; Rosendaal, FR | 1 |
| Kasuya, Y; Kimura, S; Matsuo, Y; Sakurai, K; Sudo, T; Takuwa, Y | 1 |
| Assayag, EB; Berliner, S; Bonet, DS; Bornstein, N; Burke, M; Goldin, Y; Mardi, T; Shapira, I; Tolshinski, T; Vered, Y; Zakuth, V | 1 |
| Blann, AD; Lee, KW; Lip, GY | 1 |
| Allman-Farinelli, MA; Dawson, B | 1 |
| Bao, J; Jin, CY; Jin, XY; Lou, JG; Qin, GM; Sun, M; Xu, XH; Xu, YQ; Zhan, XP | 1 |
| Lechner, K; Lehr, S; Pabinger, I; Panzer, S; Quehenberger, P; Sailer, T; Vormittag, R; Vukovich, T; Zoghlami-Rintelen, C | 1 |
| Channer, KS; English, KM; Jones, RD; Jones, TH; Malkin, CJ; Smith, AM | 1 |
| Almasy, L; Blangero, J; Buil, A; Fontcuberta, J; Lathrop, M; Soria, JM; Souto, JC | 1 |
| Jeng, SF; Kuo, YR; Lin, CJ; Sacks, JM; Wu, WS; Yang, KD | 1 |
| Bodary, PF; Dobies, SL; Eitzman, DT; Ginsburg, D; Gu, S; Manning, SL; Shen, Y; Westrick, RJ | 1 |
| Adelmeijer, J; Cauwenberghs, S; De Groot, PG; Heemskerk, JW; Lisman, T; Van Pampus, EC | 1 |
| Flock, JI; Shannon, O; Uekötter, A | 1 |
| Dunn, EJ; Grant, PJ | 1 |
| Bush, A; Eggers, J; Elston, DM; McGlasson, D; Miller, SD; Schmidt, WH; Young, RJ | 1 |
| Brenner, B; Dally, N; Haddad, N; Hoffman, R; Rowe, JM; Sarig, G | 1 |
| Makowski, GS; Ramsby, GR; Ramsby, ML | 1 |
| Bossi, F; Bulla, R; Debeus, A; Durigutto, P; Fischetti, F; Macor, P; Meroni, P; Pellis, V; Sblattero, D; Tedesco, F; Ziller, F | 1 |
| Ariëns, RA; Grant, PJ; Standeven, KF | 1 |
| Esmon, CT; Esmon, NL; Ferrell, GL; Gu, J; Hunter, J; Li, W; Lupu, F; Zheng, X | 1 |
| Fu, X; Li, S; Li, Y; Wang, M | 1 |
| Kawano, HA; Nakajima, T; Suzuki, J; Tomaru, T; Tsujiuchi, Y; Uchida, Y | 1 |
| Lin, WC; Yang, MC; Yu, DG | 1 |
| Castellino, FJ; Iwaki, T | 1 |
| Collet, JP; Gorkun, OV; Lord, ST; Moen, JL; Montalescot, G; Veklich, YI; Weisel, JW | 1 |
| Berry, LR; Chan, AK; Du, YJ; Klement, P; Tressel, P | 1 |
| Ebrahim, S; Harbord, R; Milton, J; Smith, GD; Sterne, JA | 1 |
| Francis, CW; Sahni, A; Sahni, SK | 1 |
| Albertini, F; Archetti, S; Assanelli, D; Galeazzi, G; Grassi, M; Mozzini, C; Negrini, R; Pezzini, A; Salvadori, G | 1 |
| Boncela, J; Cierniewski, CS; Gils, A; Smolarczyk, K; Szymanski, J | 1 |
| Palmaz, JC; Sprague, EA | 1 |
| Arana, C; Cutando-Soriano, A; Gómez-Moreno, G; Scully, C | 1 |
| Ginsburg, D | 1 |
| Aznar, J; Calvo, J; Ricart, JM; Santaolaria, ML; Todolí, J; Vayá, A | 1 |
| Azevedo, GD; Baggio, MS; Franco, RF; Maranhão, TM; Sá, MF | 1 |
| Badimon, L; Casani, L; Sanchez-Gomez, S; Vilahur, G | 1 |
| Bathum, L; Bladbjerg, EM; Christensen, K; de Maat, MP; Hjelmborg, J; Jespersen, J | 1 |
| Carey, HM; Carter, TR; Elliott, MJ; Kull, AD; Morel-Kopp, MC; Philcox, S; Schenck, K; Taylor, BA; Tofler, GH; Ward, C | 1 |
| Bozec, L; Butler, PE; Clatworthy, I; De Groot, J; Horton, M; Kannan, RY; Salacinski, HJ; Seifalian, AM | 1 |
| Gallimore, MJ; Jones, DW; Winter, M | 1 |
| Hoffman, M; Lenkowski, A; Lockhart, E; Sauls, DL; Warren, ME; Wilhelm, SE | 1 |
| Hayashi, K; Kawasaki, T; Miyata, K; Moritani, Y; Saito, T; Takasaki, J; Taniguchi, M; Uchida, W; Uemura, T | 1 |
| Ben Assayag, E; Berliner, S; Bornstein, NM; Bova, I; Peretz, H; Shapira, I; Usher, S | 1 |
| Brennan, SO; Lowen, R; Matsunaga, A; Mosesson, MW; Siebenlist, KR | 1 |
| Camargo, AL; Gabriel, SB; Hirschhorn, JN; Kathiresan, S; Larson, MG; O'Donnell, CJ; Tofler, GH; Yang, Q | 1 |
| Cryan, LM; Fitzgerald, DJ; O'Brien, CJ; Pidgeon, GP | 1 |
| Bao, J; Jin, CY; Jin, XY; Qin, GM; Sun, M; Xu, XH; Zhan, XP | 1 |
| Ahrens, I; Bassler, N; Bode, C; Chen, YC; Fitzgerald, D; Hagemeyer, CE; Kenny, D; Meade, G; Moran, N; Peter, K; Schwarz, M; Stoll, P; Ylanne, J | 1 |
| Chau, LY; Chen, YH; Chiang, MT; Tsai, HL | 1 |
| Adachi, H; Enomoto, M; Furuki, K; Hino, A; Hiratsuka, A; Imaizumi, T; Takajo, Y; Takeuchi, M; Yamagishi, S | 1 |
| Breteler, MM; Conway, DS; Heeringa, J; Hofman, A; Lip, GY; van der Kuip, DA; Witteman, JC | 1 |
| Chen, P; Freedman, J; Hynes, RO; Ni, H; Reheman, A; Wagner, DD; Yang, H; Zhu, G | 1 |
| Burke, T; Lishko, VK; Ugarova, T | 1 |
| Buring, JE; Mora, S; Ridker, PM; Rifai, N | 1 |
| Sun, H | 1 |
| Abia, R; Bermúdez, B; López, S; Muriana, FJ; Pacheco, YM; Villar, J | 1 |
| Meade, TW; Mt-Isa, S; Rudnicka, AR | 1 |
| Kiec-Wilk, B; Kloch, M; Kolasińska-Kloch, W; Rajtari, R | 1 |
| Bertina, RM; Hernandez, I; Medved, L; Mosesson, MW; Raife, TJ; Simpson-Haidaris, PJ; Uitte DE Willige, S; Yakovlev, S | 1 |
| Frangioni, JV; Garfein, ES; Karp, SJ; Ohnishi, S | 1 |
| Ganti, AK; Haire, WD; Vose, JM | 1 |
| Adam, F; Berrou, E; Bryckaert, M; Jandrot-Perrus, M; Kauskot, A; Mazharian, A; Nurden, P; Roger, S | 1 |
| Cao, L; Castner, DG; Chang, M; Horbett, TA; Lee, CY; Ratner, BD; Sukavaneshvar, S | 1 |
| Berliner, S; Melamed, S; Rogowski, O; Shapira, I; Shirom, A; Toker, S | 1 |
| Hayashi, M; Juen, H; Sagesaka, T | 1 |
| Emeis, JJ; Jirouskova, M; Johnson, GJ; Muchitsch, EM; Shet, AS; Smyth, SS | 1 |
| Gopinathannair, R; Hagberg, JM; Lockard, MM; Paton, CM; Phares, DA | 1 |
| Chang, LY; Chang, MC; Huang, TF; Liu, CZ; Tsai, PJ | 1 |
| Gong, R; Li, L; Liu, Z | 1 |
| Appel, IM; Pieters, R; Stigter, R; van Kessel-Bakvis, C | 1 |
| Ebinuma, H; Matsuo, M; Miyazaki, O; Suzuki, A; Yago, H | 1 |
| Ding, K; Hu, W; Ni, H; Ni, R; Sun, Z; Wu, J; Xu, X; Zhai, Z | 1 |
| Alberti, C; Boudailliez, B; Bouissou, F; Deschenes, G; Dragon-Durey, MA; Fischbach, M; Fremeaux-Bacchi, V; Gie, S; Guest, G; Loirat, C; Macher, MA; Morin, D; Niaudet, P; Nivet, H; Sellier-Leclerc, AL; Tsimaratos, M | 1 |
| Barshtein, G; Ben-Ami, R; Yedgar, S | 1 |
| Ablooglu, AJ; Fogelstrand, P; Ginsberg, MH; Partridge, AW; Petrich, BG; Shattil, SJ; Yousefi, N | 1 |
| Grant, PJ | 1 |
| Björck, L; Hertzén, E; Mörgelin, M; Norrby-Teglund, A; Shannon, O; Sjöbring, U | 1 |
| Becker, DM; Becker, LC; Bray, PF; Fallin, MD; Faraday, N; Herrera-Galeano, JE; Mathias, RA; Wilson, AF; Yanek, LR | 1 |
| Höök, M; Rivera, J; Speziale, P; Vannakambadi, G | 1 |
| Badimon, L; Casaní, L; Vilahur, G | 1 |
| Boshkov, LK; Farrell, DH; Hanson, SR; Lovely, RS; Marzec, UM | 1 |
| Carter, AM; Cymbalista, CM; Grant, PJ; Spector, TD | 1 |
| Abrink, M; August, S; Kowalska, MA; Lilliendahl, JK; Pejler, G; Rauova, L; Schick, BP; White, JG; Woulfe, DS | 1 |
| LAM, CR; McCLURE, RD | 1 |
| Fujieda, A; Kaneko, T; Katayama, N; Kobayashi, T; Matsumoto, T; Nobori, T; Sugimoto, Y; Tamaru, S; Wada, H; Yamaguchi, M; Yamamura, K | 1 |
| Ishikawa, T; Mori, D; Tsubota, K; Wada, S; Yamaguchi, T; Yano, K | 1 |
| Badger, GJ; Cushman, M; Johnson, JV; Lowell, J; Rosing, J; Tchaikovski, S | 1 |
| Broekelmann, TJ; Mecham, RP; Pierce, RA; Shifren, A; Tollefsen, DM; Vicente, CP; Weinberg, JS; Werneck, CC | 1 |
| Abraham, GA; Buffa, F; Caracciolo, PC; de Queiroz, AA; Higa, OZ | 1 |
| de Mazancourt, P; Dinc, A; Erdem, H; Horellou, MH; Pay, S; Samama, MM; Simsek, I | 1 |
| Caravan, P; Chasse, JM; Deng, Q; Koerner, S; Kolodziej, AF; Looby, RJ; McMurry, TJ; Overoye-Chan, K; Zech, SG | 1 |
| Bertholim, L; Camargo, AC; Klitzke, CF; Paes Leme, AF; Prezoto, BC; Serrano, SM; Tashima, AK; Yamashiro, ET | 1 |
| Lüscher, EF | 1 |
| Ogston, CM; Ogston, D | 1 |
| Macintosh, DM; Mahmood, A; Shaper, AG | 1 |
| Fletcher, AP | 1 |
| Evensen, SA; Hjort, PJ; Jeremic, M | 1 |
| Kullander, S; Nilsson, IM | 2 |
| Dyr, JE; Vorlová, Z | 1 |
| Cepelák, V; Cepeláková, H; Dvorák, J | 1 |
| Hindersin, P; Hofmann, KD; Niedner, W; Peterseim, H | 1 |
| Brüggener, E; Hauptmann, J; Müller, H | 1 |
| Klöcking, HP; Koth, W; Seeck, W | 1 |
| Shand, RA; Smith, JR; Wallis, RB | 1 |
| Hnidec, O | 1 |
| Larm, O; Larsson, R; Lins, LE; Nilsson, E; Olsson, P; Swedenborg, J | 1 |
| Lowe, LW | 1 |
| Hendolin, H; Mattila, MA; Poikolainen, E | 1 |
| Asbeck, F; de Swart, CA; Knoch, K; Kriessmann, A; Marbert, GA; Theiss, W; Trübestein, G; van de Loo, JC | 1 |
| Forbes, CD; Foulds, WS; Ghafour, IM; Lowe, GD; Trope, GE | 1 |
| Hansen, MS; Schousboe, I | 1 |
| Nemerson, Y; Nossel, HL | 1 |
| Dupuy, E; Guillausseau, PJ; Lubetzki, J | 1 |
| Imaoka, S; Kambayashi, J; Kosaki, G | 1 |
| Fuwa, S | 1 |
| Hellerman, DV; Henry, RL; MacPherson, B; Reid, WO; Urwiller, KL | 1 |
| Lote, K | 2 |
| Khvatov, VB; Permiakov, NK; Platonova, TK; Senianskaia, NL; Titova, GP | 1 |
| Alfano, G; Candido, A; d'Onofrio, G; Mancini, R; Mango, G; Palla, M; Vallone, R | 1 |
| Baguet, J; Eloy, R; Paul, J; Pusinéri, C; Serafini, S | 1 |
| Goodnough, LT; Ratnoff, OD; Saito, H | 1 |
| Stoltz, JF | 1 |
| Amiral, J; Fareed, J; Walenga, JM | 1 |
| Barsotti, G; Giovannetti, S; Lecchini, L; Panicucci, F; Pinori, E; Sagripanti, A; Vispi, M | 1 |
| Barbui, T; Dini, E; Meli, S; Rodeghiero, F | 1 |
| Boulton-Jones, M; Forbes, CD; Lowe, GD; McGinley, E; Prentice, CR | 1 |
| Perico, N; Pusineri, F; Remuzzi, G | 1 |
| Kester, RC; Learoyd, P; McCollum, CN; Pepper, M; Rajah, SM | 1 |
| Bokarev, IN; Butorov, VN; Loginov, LE | 1 |
| Nossel, HL | 3 |
| Atanasov, K; Dzhurdzhev, A | 1 |
| Dupe, RJ; English, PD; Green, J; Smith, RA | 1 |
| Awad, J; Bené, B; Blouch, MT; De La Faye, D; Gosselin, C; Guidoin, R; King, M; Legendre, JM; Turzo, A; Volant, A | 1 |
| Joist, JH | 1 |
| Matsuda, M | 2 |
| Hindersin, P; Körting, HJ; Siegmund, R | 1 |
| Cooper, SL; Grasel, TG; Lambrecht, LK; Lelah, MD; Pierce, JA | 1 |
| Calabrese, D; Castillo, G; Cottonaro, CN; Roohk, HV; Sanematsu, L | 1 |
| Fukumoto, S; Tanaka, K | 1 |
| Copley, AL | 4 |
| Hoffmann, J; Markwardt, F; Nowak, G | 2 |
| Campbell, CD; Jakob, H; Pick, R; Qiu, ZK; Replogle, RL | 1 |
| Bonavita, V; Carlomagno, S; Colucci, M; Donati, MB; Meduri, M; Mussoni, L; Quattrone, A; Roncaglioni, MC; Semeraro, N | 1 |
| Gaffney, PJ | 1 |
| Baluda, MV; Khovanskaia, TP; Novikova, IV; Sokolov, EI | 1 |
| Brauckhoff, KF; Heerdegen, R; Liedloff, H | 1 |
| Blevins, RD; Cascade, PN; Goldberg, MJ; Maltzman, JB; Rubenfire, M | 1 |
| Feinstein, DI; Feinstein, EI; Francis, RB; Levitan, D; Massry, SG; Sandler, RM; Weiner, J | 1 |
| Kondo, M; Murakami, M; Yoshikawa, T | 1 |
| Kaplan, JE | 1 |
| Akazawa, K; Matsuo, O; Mihara, H; Nishida, Y | 1 |
| Penner, JA | 1 |
| Prowse, CV; Williams, AE | 1 |
| Hilgard, P; Linder, KH; Wetter, O | 1 |
| Green, RA; Kabel, AL | 1 |
| Cooper, SL; Lambrecht, LK; Lelah, MD; Young, BR | 1 |
| Zajtchuk, J; Zajtchuk, R | 1 |
| Barker, AF | 1 |
| Francis, RB; Meiselman, HJ; Ozanne, P | 1 |
| Aratake, Y; Kinjo, K; Kosugi, T; Mihara, H; Ohtaki, S; Takagi, I | 1 |
| Brehm, R; Philipp, K | 1 |
| Chizhova, AI; Faĭnshteĭn, FE; Gavrilov, OK; Klimovich, LG; Lagutina, NIa | 1 |
| Ardelt, W | 1 |
| Murakoshi, T | 1 |
| Blanke, H; Karsch, KR; Kostering, H; Leitz, H; Oster, H; Rentrop, P | 1 |
| Dormandy, JA | 1 |
| Conti, A; Cuocolo, R; Ortolani, O | 1 |
| Pickart, L | 1 |
| Seegers, WH | 1 |
| Caen, JP; Wautier, JL | 1 |
| de Gaetano, G; Donati, MB; Mussoni, L; Reyers, I | 1 |
| Bidani, N; Gudas, CJ; Mass, DP; Metz, CE; Simon, MA; Zarins, CK | 1 |
| Ghiringhelli, C; Ghiringhelli, L | 1 |
| Delhon, A; Gaillard, S; Laurresergues, H; Stoltz, JF | 1 |
| Ando, Y; Ikeda, Y; Ono, F; Sugiura, K; Watanabe, K | 1 |
| Horiuchi, K; Ishii, Y; Ohmomo, Y; Suzuki, J; Tanaka, H; Torizuka, K; Yamamoto, K; Yokoyama, A | 1 |
| Cooper, SL; Goode, MG; Lelah, MD; Wilson, RS | 1 |
| Bartlett, RH; Cottonaro, CN; Roohk, HV; Servas, FM; Sperling, DR | 1 |
| Urbaniak, SJ | 1 |
| Carter, CJ; Hirsh, J; Mitchell, L; Ockelford, PA | 1 |
| O'Donnell, MR; Slichter, SJ; Storb, R; Weiden, PL | 1 |
| Hansson, HA; Ishimaru, S; Teger-Nilsson, AC; William-Olsson, EB; William-Olsson, G | 1 |
| Harker, LA; Huang, TW; Slichter, SJ; Smith, K; Stegall, P | 1 |
| Bolińska, H; Judkiewicz, L; Khawam, E; Niewiarowska, J; Wasiak-Radzikowska, M | 1 |
| Dupe, RJ; English, PD; Green, J; Hibbs, MJ; Smith, RA | 1 |
| Berglin, E; Hansson, HA; Ishimaru, S; Teger-Nilsson, AC; William-Olsson, G | 1 |
| Lindenauer, SM; Penner, JA; Schultz, JS | 1 |
| Lu, LH | 1 |
| Bremner, WF; Drummond, MM; Forbes, CD; Lawrie, TD; Lowe, GD; Prentice, CR; Third, JL | 1 |
| McElvany, KD; Welch, MJ | 1 |
| Markwardt, F; Nowak, G | 2 |
| Clagett, GP; Hufnagel, H; Russo, M | 1 |
| Bogdasarov, JB; Narkevic, BJ; Telesev, VA; Varlamova, OA | 1 |
| Anderson, DC; DeGraaf, GL; Geng, JG; Martin, JP; Shebuski, RJ; Toombs, CF | 1 |
| Krska, Z; Kvasnicka, J; Maslowská, H; Tosovský, J; Vacková, I | 1 |
| Bergqvist, D; Lindblad, B; Lundell, A; Matthiasson, SE | 1 |
| Goda, T; Matsui, Y; Oba, J; Sakuma, M; Shiiya, N; Yasuda, K | 1 |
| He, G; Lu, R; Shen, X | 1 |
| Dunn, FG; Lip, GY; Lowe, GD; Rumley, A | 1 |
| Argraves, WS; Haudenschild, CC; Litvinovich, SV; Medved, LV; Tanaka, A; Tran, H | 1 |
| Chandler, AB; Dinsmore, RE; Fuster, V; Glagov, S; Insull, W; Rosenfeld, ME; Schwartz, CJ; Stary, HC; Wagner, WD; Wissler, RW | 2 |
| Bachmeyer, C; Blanche, P; Candia, N; Frere, E; Sereni, D; Sicard, D; Toulon, P | 1 |
| Cabral, C; Kugelmass, AD; Monahan, K; Oda, A; Ware, JA | 1 |
| Hirata, Y; Nakashima, M; Takiguchi, Y; Uematsu, T; Umemura, K | 1 |
| Bini, A; Kudryk, BJ | 1 |
| Cho, JS; Ouriel, K | 1 |
| Aberg, B; Blombäck, M; Carlsson, K; Egberg, N; Fatah, K; Hansson, LO; Kronlund, P; Moor, E | 1 |
| Cyran, EM; George, S; Nagabhushana, MS | 1 |
| Warkentin, TE | 1 |
| Fujiki, K; Ohkusa, T; Sato, C; Tamura, Y | 1 |
| Broschat, K; Haas, NF; Keller, BT; King, LW; Nicholson, NS; Panzer-Knodle, SG; Salyers, AK; Szalony, JA; Taite, BB; Zablocki, JA | 1 |
| Beevers, DG; Lip, GY | 1 |
| Badellino, K; Kowalska, MA | 1 |
| Crawford, GP; Gibbs, NM; Michalopoulos, N | 1 |
| Hashimoto, S; Kaneda, N; Matsumoto, T; Sakai, M; Sansawa, H; Shimura, K; Shishido, Y; Yokokura, T | 1 |
| Abela, GS; Federman, M; Friedl, SE; Gebara, OC; Miyamoto, A; Muller, JE; Picon, PD; Tofler, GH | 1 |
| Meade, TW | 1 |
| Alessandri, C; Basili, S; Cordova, C; Ferroni, P; Gazzaniga, PP; Violi, F | 1 |
| Collen, D; Hoylaerts, M; Nyström, A; Stassen, JM | 1 |
| Béguin, S; Hemker, HC; Kumar, R | 1 |
| Bodenheimer, SL; Emery, JD; Kramer, WS; Lawrence, JB; Leifer, DW; Moura, GL; Southern, P | 1 |
| Serrano Aguilar, PG | 1 |
| Schramm, W; Spannagl, M | 1 |
| Black, RA; Guidoin, R; How, TV; Marois, Y | 1 |
| Badimon, JJ; Badimon, L; Chesebro, JH; Fernández-Ortiz, A; Fuster, V; Mailhac, A; Meyer, BJ | 1 |
| Ruggeri, ZM | 4 |
| Denis, J; Garrigues, JM; Gerentes, I; Taccoen, A; Trochet, JP | 1 |
| Charles, LA; Edwards, T; Macik, BG | 1 |
| Blombäck, B | 3 |
| Boisseau, MR; Drouet, L; Mazoyer, E; Ripoll, L | 1 |
| Blombäck, B; Carlsson, K; Fatah, K; Hessel, B; Procyk, R | 1 |
| Laub, GW; McGrath, LB; O-Yurvati, AH; Southgate, TJ | 1 |
| Badimon, JJ; Badimon, L; Chesebro, JH; Fallon, JT; Fernández-Ortiz, A; Fuster, V; Mailhac, A; Meyer, B | 1 |
| Kessler, P; Kubícková, M | 1 |
| de Groot, PG; Heynen, HF; Lozano Molero, M; Nieuwenhuis, HK; Sixma, JJ | 1 |
| Evans, H; Feldman, PA; McGrath, S | 1 |
| Loscalzo, J; Rabbani, LE | 1 |
| Chen, X; Francis, CW; Harpaz, D; Meltzer, RS | 1 |
| Penttilä, IM; Rankinen, T; Rauramaa, R; Uusitupa, M; Väisänen, S | 1 |
| Gourdin, FW; Smith, JG | 1 |
| Tian, JY; Xu, LN; Zou, ZW | 1 |
| Tanoue, K | 1 |
| Burkholder, D; Fioravanti, C; Francis, B; Gibson, RE; Siegl, PK | 1 |
| Bjørnsen, S; Brosstad, F; Filion-Myklebust, C; Grøn, B; Haidaris, P | 1 |
| Bergqvist, D; Lindblad, B; Lundell, A | 1 |
| Koomans, HA; Rabelink, TJ; Sixma, JJ; Zwaginga, JJ | 1 |
| Caunce, M; Donaldson, GC; Keatinge, WR; Mattock, M; Neild, PJ; Syndercombe-Court, D | 1 |
| Bunce, LA; Francis, CW; Sporn, LA | 1 |
| Ernst, E | 1 |
| Bird, AR; Kahn, D; Kirsch, RE; Kruskal, J; Robson, SC | 1 |
| Esmon, CT; Griffin, JH; Gruber, A; Hanson, SR; Harker, LA; Kelly, AB | 1 |
| Eaglstein, WH; Falanga, V; Katz, MH; Kerdel, FA; Kirsner, RS | 1 |
| Phillips, DA; Sheiman, RG | 1 |
| Knight, LC | 2 |
| Chaturvedi, S | 1 |
| Buchanan, MR; Eisert, WG; Merk, H; Müller, TH; Van Ryn-McKenna, J | 1 |
| DiOrio, JP; Grimbergen, J; Haverkate, F; Koopman, J; Legrand, C; Lord, ST; Mosesson, MW; Siebenlist, KS; Soria, C; Soria, J | 1 |
| Burke, SE; Henkin, J; Lubbers, NL; Nelson, RA | 2 |
| du Laney, TV; Erickson, GR; Greenberg, CS; Klitzman, B; Ritter, EF; Skarada, DJ; Warnecke, KL | 1 |
| Ball, EL; Matsueda, GR; Sheng, D; Song, Y; Taubenfeld, SM | 1 |
| Bihour, C; Nurden, AT; Nurden, P; Raymond, JM; Smith, M | 1 |
| Hawiger, J | 2 |
| Adema, E; Gebert, U | 1 |
| Anderson, RA; Ludlam, CA; Wu, FC | 1 |
| Comerota, AJ; Katz, ML; White, JV | 1 |
| Carpen, O; Lassila, R; Siljander, P | 1 |
| Cichocka, E; Ksiazek, J; Lukasiewicz, H; Teklińska, E; Wyszyńska, T | 1 |
| Chitolie, A; Hudson, M; Hutton, RA; Pounder, RE; Smith, MS; Wakefield, AJ | 1 |
| Braam, MJ; Cooley, BC; Jones, R | 1 |
| Davies, MJ | 1 |
| McCarty, MF | 1 |
| Eichinger, S; Gschwandtner, ME; Hütter, D; Korninger, L; Lechner, K; Pabinger, I; Panzer, S | 1 |
| Bernat, A; Hérault, JP; Herbert, JM; Lormeau, JC; Meuleman, DG; Petitou, M; van Amsterdam, RG; Vogel, GM | 1 |
| Heran, CL; Schumacher, WA; Steinbacher, TE | 1 |
| Agroyannis, B; Bosiolis, B; Bovoleti, O; Dalamanga, A; Darema, M; Fourtounas, C; Kapetanaki, A; Kopelias, I; Koutsikos, D; Rammos, G; Sallum, G; Tzanatos, H | 1 |
| Kalantarov, GF; Mitkevich, OV; Samokhin, GP; Shainoff, JR; Sobel, JH; Streltsova, ZA; Trakht, IN; Vlasik, TN | 1 |
| Chiaranda, G; Ferlito, S; Gallina, M; Mangiameli, S | 1 |
| Andreeff, M; Cortes, J; Kantarjian, H; Keating, M; Koller, C; Kornblau, S; O'Brien, S; Pierce, S; Sarris, A; Smith, T | 1 |
| Abendschein, DR; Eisenberg, PR; Petrinec, D; Rubin, BG; Toursarkissian, B; Yang, LY | 1 |
| Illig, KA; Ouriel, K | 1 |
| N'Guyen, P; Pignon, B; Potron, G | 1 |
| Gallardo Torres, HI; Koenderman, L; Kuijper, PH; Lammers, JW; Sixma, JJ; Zwaginga, JJ | 1 |
| Apitz, R; Bosch, V; de Bosch, NB | 1 |
| Collet, JP; Paysant, J; Soria, C; Soria, J; Vannier, JP; Vasse, M | 1 |
| Abramov, N; Blieden, LC; Gil-Ad, I; Goez, R; Kuberger, N; Laron, Z; Weizman, A | 1 |
| Lavelle, SM; Mhic Iomhair, M | 1 |
| Butchart, EG | 1 |
| Andreani, D; Arcieri, P; Bosco, D; Ciampalini, P; Gargiulo, P; Pantaleo, A; Romani, B; Schiaffini, R | 1 |
| Guidoin, R; King, M; Merhi, Y | 1 |
| Bode, C; Haber, E; Hanson, SR; Harker, LA; Kelly, AB; Mehwald, P; Runge, MS; Schmedtje, JF | 1 |
| Bates, S; Ben-Ari, Z; Burroughs, A; Osman, E; Panagou, M; Pasi, J; Patch, D | 1 |
| Carreras, LO; Colorio, CC; Falcón, CR | 1 |
| Bosmans, JM; Bult, H; De Meyer, GR; Herman, AG; Kockx, MM; Vrints, CJ | 1 |
| Kisiel, W; Lawson, CA; Liao, H; Pinsky, DJ; Sobel, J; Stern, DM; Yan, SD; Yan, SF; Zhou, YS | 1 |
| Mohri, H | 1 |
| Tracy, RP | 1 |
| LaCava, J; Pearson, TA; Weil, HF | 1 |
| Barry, P; FitzGerald, GA | 1 |
| Anand, NK; Chand, G; Chellani, H; Pande, J; Talib, VH | 1 |
| Burstein, SA; Dale, GL; Downs, T; Friese, P; Gilmore, LS; Wolf, RF | 1 |
| Green, F; Humphries, SE; Montgomery, HE; Panahloo, A; Yudkin, J | 1 |
| Abe, A; Baba, T; Hachiro, Y; Ito, T; Kazui, T; Komatu, S; Morisita, K; Sakata, J | 1 |
| Lane, DA; Lowe, GD; Morrison, CE; Philippou, H; Rumley, A; Tunstall-Pedoe, H; Woodward, M | 1 |
| Barrak, ER; de Queiroz, AA; Gil, HA; Higa, OZ | 1 |
| Hagberg, IA; Lyberg, T; Roald, HE | 1 |
| Lowe, GD; Woodburn, KR | 1 |
| Martinez, J | 1 |
| Bortolotti, N; Ceriello, A; Crescentini, A; Giacomello, R; Motz, E; Pirisi, M; Russo, A; Stel, G; Taboga, C; Tonutti, L | 1 |
| Fujiyoshi, T; Katada, J; Muramatsu, M; Takiguchi, Y; Uno, I | 1 |
| Chujo, M; Nakamura, K; Shibatani, M; Suzuki, T | 1 |
| Chamma, F; Denis, A; Jaar, B; Mignon, F; Siohan, P; Verdy, E; Viron, B | 1 |
| Byrne, A; Crean, P; Fitzgerald, DJ; Maher, M; Moran, N; Walsh, N | 1 |
| Ekdahl, KN; Nilsson, B; Rönnblom, L; Sturfelt, G | 1 |
| Beevers, DG; Blann, AD; Jones, AF; Lip, GY; Lip, PL | 1 |
| Brennan, SO; George, PM; Hammonds, B; Spearing, R | 1 |
| Baghestanian, M; Bankl, HC; Binder, BR; Kiener, HP; Lechner, K; Sillaber, C; Valent, P | 1 |
| Goto, S; Ikeda, Y; Ruggeri, ZM; Saldívar, E | 1 |
| Deberdt, W; Deckmyn, H; Nyström, A; Nyström, E; Stassen, JM; Stockmans, F; Vermylen, J | 1 |
| Chang, AC; Ezban, M; Hedner, U; Li, A; Peer, G; Taylor, FB | 1 |
| Brugnara, C; Roback, MG; Saladino, RA; Schwarz, HP; Stack, AM; Thompson, C | 1 |
| Giddings, JC; Ishii, I; Matsuoka, A; Muraki, T; Okita, N; Sasaki, Y; Seki, J; Watanabe, S; Yamamoto, J; Yamashita, T | 1 |
| Cole, CW | 1 |
| Anderson, TJ; Ganz, P; Meckel, CR; Mitchell, RN; Mudge, GH; Selwyn, AP; Simon, DI; Yeung, AC | 1 |
| Banyai, M; Ehringer, H; Haumer, M; Koppensteiner, R; Moidl, R; Moritz, A; Wolner, E | 1 |
| Rosenson, RS; Tangney, CC | 1 |
| Allen, R; Contois, JH; Ens, G; Giri, S; Otvos, J; Taxel, P; Thompson, PD; Waters, DD; Wu, AH | 1 |
| Kakkar, VV; Mohamed, MS; Mukherjee, M | 1 |
| Aguejouf, O; Belougne-Malfatti, E; Doutremepuich, C; Doutremepuich, F | 1 |
| Azzadin, A; Borawski, J; Buczko, W; Mysliwiec, M; Pawlak, K; Rydzewski, A | 1 |
| Hata, N; Kimura, S; Minami, M; Saito, H; Tamayama, M | 1 |
| Gawaz, M; Hiller, E; Holler, E; Kolb, HJ; Mempel, W; Neumeister, P; Pihusch, R; Salat, C; Sill, H; Wittmann, G | 1 |
| Catalfamo, JL; Joshua, IG; Lominadze, D; Schuschke, DA | 1 |
| Beckman, EJ; Deible, CR; Johnson, PC; Petrosko, P; Russell, AJ; Wagner, WR | 2 |
| Biemond, BJ; de Groot, PG; Friederich, PW; Harris, R; Heijnen, HF; Levi, M; Levin, J; Middleton, S; ten Cate, JW; Wu, YP | 1 |
| Andriamampandry, MD; Cazenave, JP; Freund, M; Gachet, C; Leray, C | 1 |
| Henry, JA; Humphries, SE; Montgomery, HE | 1 |
| Bal dit Sollier, C; Drouet, L; Laprade, M; Mazoyer, E; Paolucci, F; Pasqualini, N; Ripoll, L; Vanhove, N | 1 |
| Muhlestein, JB | 1 |
| Gan, TE; Harris, GM; Stendt, CL; Tipping, PG; Vollenhoven, BJ | 1 |
| Cooper, SL; Coury, AJ; Hergenrother, RW; Wabers, HD | 1 |
| Anwar, M; Kaye, AD; Youngberg, JA | 1 |
| Arora, R; Bodenheimer, MM; Brown, MW; Case, RB; Dwyer, EM; Gillespie, JA; Goldstein, RE; Greenberg, H; Hochman, J; Krone, RJ; Liang, CS; Lichstein, E; Little, WC; Marcus, FI; Marder, VJ; Moss, AJ; Oakes, D; Sparks, CE; Van Voorhees, L; Watelet, LF; Weiss, HJ; Zareba, W | 1 |
| Greaves, M; Meiklejohn, DJ; Urbaniak, SJ | 1 |
| Maksimenko, AV; Tischenko, EG | 1 |
| Blöndal, T; Franzon, M; Gudmundsson, TV; Lúdvíksdóttir, D; Säwe, U | 1 |
| Blanc-Brude, O; Gray, A; Herrick, S; Laurent, G | 1 |
| Marchant, RE; Sit, PS | 1 |
| Peverill, RE; Smolich, JJ | 1 |
| Chandy, T; Das, GS; Rao, GH; Wilson, RF | 1 |
| Lip, GY; Spencer, CG | 1 |
| Jo, S; Kidane, A; Lantz, GC; Park, K | 1 |
| Weber, N; Wendel, HP; Ziemer, G | 2 |
| Lowe, GD; Rumley, A | 2 |
| Ferber, P; Koschinsky, T; Moll, K; Rösen, P; Schwippert, B; Susanto, F; Tschöpe, D | 1 |
| Bjørnsen, S; Brosstad, F; Matsueda, G; Nieuwenhuizen, W; Sandbaek, G; Sobel, JH | 1 |
| Laffan, M; Manning, R; Mille-Baker, B; Mumford, A; Vakalopoulou, S | 1 |
| Giddings, JC; Hashimoto, M; Kawano, M; Sasaki, Y; Taka, T; Watanabe, S; Yamamoto, J; Yamashita, T | 1 |
| Banerjee, R; Puniyani, RR | 1 |
| Baron, JH; de Bono, DP; Foo, RS; Garner, I; Gershlick, AH; Hogrefe, K; Hussey, AJ; Johnston, TW | 1 |
| Blann, AD; Li-Saw-Hee, FL; Lip, GY | 1 |
| Bairey Merz, CN; Kaul, S; Paul-Labrador, MJ; Shah, PK; Shechter, M | 1 |
| Anastasopoulou, J; Athanasiou, A; Karafoulidou, A; Kyriakidis, M; Terpos, E; Tsoukala, C | 1 |
| Alves, J; Ames, PR; Hughes, GR; Khamashta, MA; Pap, AF; Ramos, P | 1 |
| Elikowski, W; Grzywacz, A; Psuja, P; Zawilska, K; Zozulińska, M | 1 |
| Marckmann, P | 1 |
| Badimon, JJ; Chesebro, JH; Fuster, V; Rauch, U; Reis, ED; Roqué, M | 1 |
| Bennett, RL; Côté, HC; Kindelan, J; Linenberger, ML; Reiner, AP | 1 |
| Degen, JL; Denis, CV; Hynes, RO; Ni, H; Sato, TN; Subbarao, S; Wagner, DD | 1 |
| Arocha-Piñango, CL; Hernández, LR; Lundberg, U | 1 |
| Aagaard, S; Balling, E; Hakami, A; Hjortdal, VE; Husted, SE; Kristensen, SD; Marqversen, J; Thorwest, M | 1 |
| Aguejouf, O; Belon, P; Doutremepuich, C; Malfatti, E | 1 |
| Kim, JH; Kim, WG; Na, MH | 1 |
| Kageyama, S; Yamamoto, H; Yoshimoto, R | 1 |
| Hirose, G; Hori, A; Kataoka, S; Saigan, T; Shirakawa, T | 1 |
| Biesenbach, G; Brücke, P; Gross, C; Hubmann, R; Janko, O | 1 |
| Lip, GY | 1 |
| Aissa-Benhaddad, A; Baskürt, O; Bouchahda, C; Brun, JF; Granat, MC; Mercier, J; Sagnes, C | 1 |
| Gaugler, MH; Gourmelon, P; Mouthon, MA; Van der Meeren, A; Vandamme, M; Wagemaker, G | 1 |
| Bergmeier, W; Cazenave, JP; Gachet, C; Mokhtari-Nejad, R; Nieswandt, B; Ohlmann, P; Rackebrandt, K; Schulte, V; Zirngibl, H | 1 |
| Esmon, CT; Ferrell, G; Lockhart, MS; Peer, GT; Taylor, FB | 1 |
| Dewanjee, MK; Eigler, NL; Park, K; Shim, HS | 1 |
| Fujita, H; Ishihara, K; Iwasaki, Y; Yoneyama, T | 1 |
| Cooper, JA; Miller, GJ; Oakley, FR; Sanders, TA | 1 |
| Castel, D; Freidman, M; Hedner, U; Hess, JR; Holcomb, JB; Macaitis, JM; Martinowitz, U; Onaca, N; Pusateri, AE; Stein, M | 1 |
| Campeau, L; Forman, S; Fox, NL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hoppensteadt, D; Hunninghake, DB; Pifarré, R; Probstfield, JL; Terrin, ML; Walenga, JM | 1 |
| Daub, M; Dierichs, R; Morgenstern, E | 1 |
| Green, FR | 1 |
| Li, H; Mirshahi, F; Pourtau, J; Soria, C; Soria, J; Trochon, V; Vannier, JP; Vasse, M; Vincent, L | 1 |
| Antunes, F; Aragäo, A; Barbosa, B; Palmeiro, A; Saldanha, MH; Sousa, A; Veríssimo, MT | 1 |
| Gabriel, DA; Roberts, HR; Stinchcombe, TE | 1 |
| Norman, Z | 1 |
| Hanrahan, LR; Nguyen, NP; Sallah, S; Sigounas, G; Wan, JY | 1 |
| Asko-Seljavaara, S; Lassila, R; Olsson, E; Svartling, N | 1 |
| Andrade-Gordon, P; Corcoran, T; Damiano, BP; de Garavilla, L; Giardino, E; Haertlein, BJ; Hoekstra, WJ; Kauffman, JA; Maryanoff, BE; Mitchell, JA | 1 |
| Kerr, R; Ludlam, CA; Stirling, D | 1 |
| Barmeyer, J; Bojara, W; Germing, A; Grewe, P; Lawo, T; Lemke, B; Machraoui, A; von Dryander, S | 1 |
| Cwalina, L; Herman, ZS; Kalina, Z; Kowalski, J; Lebek, M; Okopien, B; Wisniewska-Wanat, M; Zielinski, M | 1 |
| Callas, PW; Jenny, NS; Lewis, MR; Tracy, RP | 1 |
| Brash, JL; Cornelius, RM; Jahangir, AR; McCloskey, CB; McClung, WG; Santerre, JP | 1 |
| Chen, Z; Gong, R; Li, L; Liu, Z | 1 |
| Blumenthal, RS; Braunstein, JB; Bray, P; Gerstenblith, G; Kershner, DW; Post, WS; Schulman, SP | 1 |
| Gu, L; Guan, H; Ji, Y | 1 |
| Lip, GY; Makin, A; Silverman, SH | 1 |
| Ascari, E; Ferrari, R; Galeazzi, G; Portera, C; Raddino, R; Sarasso, L; Scarabelli, TM; Visioli, O | 1 |
| Giannitsis, E; Katus, HA; Steen, H | 1 |
| Barsotti, A; Brunelli, C; Ghigliotti, G; Leslie, S; Olivotti, L; Rossettin, P; Spallarossa, P | 1 |
| Chen, JY; Chu, PK; Huang, N; Leng, YX; Tian, XB; Wang, LP; Yang, P | 1 |
| Hamilton, A; Huang, SL; Kane, B; Klegerman, M; MacDonald, R; Madhav, T; McPherson, D; Nagaraj, A; Rabbat, M; Stein, A; Warnick, D | 1 |
| Acevedo, M; Kottke-Marchant, K; Pearce, GL; Sprecher, DL | 1 |
| Bilodeau, L; Merhi, Y; Tabrizian, M; Thierry, B; Trépanier, C | 1 |
| Furlan, M | 1 |
| Eimleitung, I; Markwárdt, F | 1 |
| Kurdrjashov, BA | 1 |
| Eger, H; Endert, G; Kleinert, P; Klose, E | 1 |
| Loo, J | 1 |
| Andreenko, GV | 1 |
| Bokarew, IN; Schumbalina, LF; Smolenski, WS; Smoljanizki, AJ | 1 |
| Laky, R; Losonczy, H; Nagy, I | 1 |
| Albrechtsson, U; Olsson, CG | 1 |
| Kher, A | 1 |
| Hirsh, J | 1 |
| Braun, W; Domula, M; Friedel, D; Lenk, H; Weissbach, G | 1 |
| Alexander, B | 1 |
| Cooper, SL; Ihlenfeld, JV | 1 |
| Dietz, HS; Smith, EB; Smith, RH; Staples, EM | 1 |
| Benz, A; Da Silva, MA; Duckert, F; Madar, G; Müller, G; Nyman, D; Prisender, S; Schmitt, HE; Widmer, LK | 1 |
| Edgar, W; Forbes, CD; McKillop, C; Prentice, CR | 3 |
| Hladovec, J; Koutský, J | 1 |
| Braunstein, KM; Craig, WR; Eurenius, K; Hepfer, TW; Kinard, HB | 1 |
| Notelovitz, M | 1 |
| Browse, NL; Clemenson, G | 1 |
| Endert, G; Ritter, H; Schumann, E | 1 |
| Anger, H | 1 |
| Morikawa, M; Shimano, N; Uete, T | 1 |
| Coleman, RE; Harwig, JF; Harwig, SS; Sherman, LA; Siegel, BA; Welch, MJ | 1 |
| Harbury, C; Kaplan, EN; Pearl, RM; Rubenstein, E; Wustrack, KO | 1 |
| Straub, PW | 3 |
| Aberg, M; Arfors, KE; Bergentz, SE | 1 |
| Poller, L | 1 |
| Beck, EA | 1 |
| Heene, DL | 1 |
| Harker, LA | 1 |
| Olsson, CG | 1 |
| Davies, GC; Mowschenson, PM; Salzman, EW | 1 |
| Casarella, WJ; Wilner, GD | 1 |
| Berglin, E; Hansson, HA; William-Olsson, G | 1 |
| Glynn, MF | 1 |
| Allison, AC; Ferluga, J; Kaplun, A; Prydz, H | 1 |
| Ben-Menachem, YB; Cimo, PL; Khalil, KG; Moake, JL; Weinger, RS | 1 |
| Bruck, SD | 1 |
| Lange, D; Zeltsch, C; Zimmermann, R | 1 |
| Aledort, LM | 1 |
| Gaffney, PJ; Marsh, NA; Talalak, P | 1 |
| Aberg, M; Bergentz, SE | 1 |
| Hofmann, V; Mombelli, G; Roux, A; Straub, PW | 1 |
| Heene, DL; Matthias, FR | 1 |
| Dawson, AA; Dhall, DP; Mavor, GE | 2 |
| Fonkalsrud, EW; Sanchez, M; Webber, M; Zerubavel, R | 1 |
| Dahlgrün, H; Sippel, K; Wuppermann, T | 1 |
| Heidrich, H | 1 |
| Láger-Gauthier, C; Latour, JG | 1 |
| Liapina, LA | 1 |
| HAle, TI; Jucker, A | 1 |
| Bjørnson, J | 1 |
| Noujaim, AA; Shysh, A; Stevens, AM | 1 |
| Caen, JP; Dupuy, E; Fleming, AF | 1 |
| Goldberg, RB; Gomperts, ED; Hockley, J; Joffe, BI; Judelman, JJ; Meyers, AM; Mindel, A; Myburgh, JA; Salant, DJ; Seftel, HC | 1 |
| Kakkar, VV; Lane, DA; Scully, MF | 1 |
| Bergut, FA | 1 |
| Dumpe, EP; Iablokov, EG; Kirienko, AI; Maliutina, AG; Savel'ev, VS | 1 |
| Blainey, JD; Hall, CL; Pejhan, N; Terry, JM | 1 |
| Bang, NU; Barton, RD; Hansen, MS; Mattler, LE | 1 |
| Mason, RG; Shinoda, BA; Wolf, RH; Zucker, WH | 1 |
| Bjorklid, E; Giercksky, KE | 1 |
| Mitchell, JR; Morris, GK | 1 |
| Harwig, SL; Knight, LC; Welch, MJ | 1 |
| Albert, JP; Bruhn, HD; Petermann, W | 1 |
| Economopoulos, TC; Papayannis, AG; Stathakis, NE; Thomopoulos, D | 1 |
| Frey, C; Gruber, UF; Rutishauser, G; von Hospenthal, J | 1 |
| Kakkar, VV; Lane, DA; Rampling, MW; Robbins, A | 1 |
| Kakkar, VV | 2 |
| Dintenfass, L | 1 |
| Hornstra, G | 1 |
| Andersen, CA; Collins, GJ; McDonald, PT; Rich, NM; Scialla, S | 1 |
| Kudriashov, BA; Liapina, LA; Shitnikova, ES; Ul'ianova, AM | 1 |
| Blaisdell, FW; Effeney, DJ; Graziano, CJ | 1 |
| Abe, T; Kazama, M | 1 |
| Hartert, HH | 1 |
| Copley, AL; King, RG | 1 |
| Bartlett, RH; Hill, R; Hung, E; Pick, J; Roohk, HV | 1 |
| Ciarkowski, A; Goddard, JD; Lindenauer, SM; Penner, JA; Schultz, JS | 1 |
| Daniel, TM; Mckee, PA; Pizzo, SV | 1 |
| Gomes, AS; Grollman, JH; Webber, MM | 1 |
| Kakkar, VV; Lane, DA; Rampling, MW | 1 |
| Blombäck, M; Egberg, N; Ekeström, S; Olsson, P | 1 |
| Fueger, GF; Kronberger, D; Prexl, HJ; Suppan, G | 1 |
| Bol'shakova, RM; Dukhina, MA; Furkalo, NK; SolovtsovA, KM | 1 |
| Barbenell, J; Forbes, CD; Prentice, CR | 1 |
| Andreev, SV; Iurkov, VA; Kol'tsova, NL; Kubatiev, AA | 1 |
| Havlik, E; Höfer, R; Sabeti, M; Weidinger, P | 1 |
| Bernhard, A; Harke, H; Schwarze, EW; Stambolis, C | 1 |
| Camargo, EE; Carvalho, N; dos Reis, JM; Ferreira, JM; Langer, B; Leão, LE | 1 |
| Heyes, H; Hilgard, P; Theiss, W | 1 |
| Lough, J; Moore, S | 1 |
| Beller, FK; Bröcker, W; Pfefferkorn, G; Schmidt, EH; Wagner, H | 1 |
| Bingley, JB; Lloyd, LC; Piercy, DW | 1 |
| Meuwissen, OJ | 1 |
| Bolton, JP; Hoffman, VJ | 1 |
| Bourgain, RH; Six, F | 1 |
| Kisker, CT; Rush, RA | 1 |
| Davis, HL | 1 |
| Coleman, RE; Sherman, LA; Welch, MJ | 1 |
| Aberg, M; Bergentz, SE; Hedner, U | 1 |
| Chepurov, AK; Shumakov, VI | 1 |
| Emerson, PA | 1 |
| Gladstone, W; Phillips, LL; vande Wiele, R | 1 |
| Cormier, JM; Flessinger, JN; Lagneau, P | 1 |
| Coleman, RE; Harwig, JF; Harwig, SS; Sherman, LA; Welch, MJ | 1 |
| Savel'ev, VS | 1 |
| Hosokawa, T; Ikematsu, S; Itoh, O; Samori, T | 1 |
| Vaisrub, S | 2 |
| Campbell, WG; Cassel, WA; Sottnek, HM | 1 |
| Markwardt, F; Meerbach, W; Nowak, G; Rüdiger, KD | 1 |
| Hladovec, J; Kornalík, F | 1 |
| Kudriashov, BA; Liapina, LA | 1 |
| Budzynski, AZ; Marder, VJ | 2 |
| Friederici, HH; Furey, NL; Kwaan, HC; Schmid, FR | 1 |
| Abe, T; Miwa, T | 1 |
| Duckert, F; Fridrich, R; Gruber, UF; Müller-Brand, J; Schmitt, HE | 1 |
| Coleman, RE; Harwig, JF; Welch, MJ | 1 |
| Brash, JL; Brophy, JM; Feuerstein, IA | 1 |
| Araújo, A; Ferreira, D; Geraldes, MJ; Monteiro, J; Nunes, V; Pais, F; Perdigão, C; Ribeiro, C; Varela, MG | 1 |
| Brennan, PJ; Cruickshank, JK; Dawson, SJ; Green, FR; Hamsten, A; Henney, AM; Kelleher, CH; Lane, A; Thomas, AE; Wilkes, HC | 1 |
| Torchilin, VP | 1 |
| Chesebro, JH; Fuster, V; Grill, DE; Heras, M; Mruk, JS; Webster, MW | 1 |
| Aiach, M; Capron, L; Costa, JM; Fiessinger, JN | 1 |
| Dawson, S; Green, FR; Hamsten, A; Henney, A; Humphries, SE; Kelleher, CH; Meade, TW; Temple, A; Wilkes, H; Wiman, B | 1 |
| Haverkate, F; Thompson, SG; van de Loo, JC | 1 |
| Barrett, JS; Cuca, GC; Gardell, SJ; Holahan, MA; Li, P; Lynch, JJ; Mellott, MJ; Stabilito, II; Wang, S | 1 |
| Akamatsu, N; Fujimoto, T; Fukuda, S; Katagiri, Y; Onozawa, Y; Suzuki, H; Tanoue, K; Yamazaki, H | 1 |
| Annino, L; Defazio, D; Gugliotta, L; Leone, G; Mandelli, F; Mattioli-Belmonte, M; Mazzucconi, MG; Tura, S | 1 |
| Gardell, SJ; Hare, TR | 1 |
| Hatton, MW; Richardson, M; Winocour, PD | 1 |
| Cooley, BC; Dollinger, BM; Gould, JS; Mlsna, JS | 1 |
| Andrew, M; Brooker, L; Leaker, M; Paes, B; Weitz, J | 1 |
| Erhart, R; Kemmler, G; Kunz, F; Pechlaner, C; Zwierzina, WD | 1 |
| Cooley, BC; Fowler, JD; Gould, JS | 1 |
| Bovill, EG; Tracy, RP | 1 |
| Ofosu, FA; Okwusidi, JI | 1 |
| Gutiérrez Díaz, JA; Ortega, MP; Priego, JG; Sunkel, C; Tolón, RM | 1 |
| Kundu, SK; Mammen, EF; McMath, LP; Ozawa, T; Patel, RH; Spears, JR; Yellayi, S | 1 |
| Bolz, A; Schaldach, M | 1 |
| van Wersch, JW | 1 |
| Anastasi, AM; Banci, M; Centi Colella, A; Ciancarella, W; de Santis, R; Di Loreto, M; Di Macio, L; Mele, A; Schillaci, O; Scopinaro, F | 1 |
| Agnelli, G; Hirsh, J; Nenci, GG; Renga, C; Weitz, JI | 1 |
| Akoum, A; Guidoin, R; King, MW; Marois, Y; Sigot, M; Sigot-Luizard, MF | 1 |
| Boschetti, C; Catalano, M; Cofrancesco, E; Cortellaro, M; de Gaetano, G; Gabrielli, L; Lombardi, B; Specchia, G; Tavazzi, L; Zanussi, C | 1 |
| Hadcock, SJ; Hatton, MW; Peltier, SL; Richardson, M; Winocour, PD; Witmer, MR | 1 |
| Lunetta, M; Salanitri, T | 1 |
| Burns, TL; Olson, JD; Skorton, DJ; Stuhlmuller, JE | 1 |
| Imanishi, Y; Ito, Y | 1 |
| Brash, JL; Cornelius, RM; Garrett, KO; Johnson, PC; Kaplan, SS; Warty, V | 1 |
| Foerster, F; Groth, T; Richter, G; Vassilieff, C; Wolf, H | 1 |
| Hanano, M; Niwano, H; Shibata, A; Takahashi, H; Takizawa, S; Wada, K; Yazawa, Y | 1 |
| Sutherland, SK; Tibballs, J | 1 |
| Mosesson, MW | 1 |
| Hirsh, J; Kuint, J; Leslie, B; Weitz, JI | 1 |
| Eddi, A | 1 |
| Maksimenko, AV; Petrov, AD; Samarenko, MB; Tischenko, EG; Torchilin, VP | 1 |
| Bini, A; Kudryk, BJ; Rosebrough, SF; Schaible, TF | 1 |
| Hayashi, S; Ogata, K; Ogino, H; Yagawa, K | 1 |
| Hayashi, S; Ichinose, Y; Koga, T; Miyagawa, Y; Miyazaki, M; Ogata, K; Ogino, H; Yagawa, K | 1 |
| Demina, NS; Lysenko, SV | 1 |
| Cheresh, DA | 1 |
| Hedin, U; Ljungqvist, A; Olsson, P; Pasche, B; Swedenborg, J | 1 |
| Griffin, JH; Gruber, A; Hanson, SR; Harker, LA; Kelly, AB | 1 |
| Hara, N; Hayashi, S; Ichinose, Y; Ohta, M; Yagawa, K | 1 |
| Bucha, E; Markwardt, F; Nowak, G | 1 |
| Eschenfelder, V; Rübsamen, K | 1 |
| Engelberg, H | 1 |
| De Maat, MP; Knot, EA; Kroneman, H; Nieuwenhuizen, W; Van Bergen, PF | 1 |
| DiBello, PM; Graor, R; Lucas, FV; Shainoff, JR; Urbanic, DA; Valenzuela, R | 1 |
| Ehringer, H; Fenzl, G; Koppensteiner, R; Moritz, A; Roedler, S; Schlick, W; Wollner, E | 1 |
| Berridge, DC; Frier, M; Hopkinson, BR; Makin, GS; Westby, JC | 1 |
| Beightler, E; Diven, DG; Sanchez, RL; Solomon, AR | 1 |
| Coccheri, S; Fiacchini, M; Finelli, C; Gugliotta, L; Palareti, G; Poggi, M; Ricci, P; Torricelli, P; Vianelli, N; Zuffa, E | 1 |
| Bernstein, J; Koitabashi, Y; Rosenberg, BF; Shapiro, H | 1 |
| Goldhaber, SZ; Hirsch, DR | 1 |
| Balsano, F; Ferro, D; Grandilli, MA; Quintarelli, C; Saliola, M; Valesini, G; Violi, F | 1 |
| Jones, AJ; Meunier, AM | 1 |
| Bridel, MP; Combe, S; Kieffer, E; Koskas, F; Mouren, S; Samama, CM; Viars, P | 1 |
| Bismuth, H; Fabiani, B; Gugenheim, J; Reynes, M; Samuel, D | 1 |
| Andoh, K; Kobayashi, N; Maekawa, T; Naruse, T; Tanaka, H; Uchiyama, T | 1 |
| Kondo, M; Naito, Y; Takeda, S; Yoshikawa, T | 1 |
| Ames, PR; Cerbone, AM; Cirillo, F; Di Minno, G; Grandone, E; Margaglione, M; Tremoli, E; Vecchione, G | 1 |
| Brus, F; Hazelzet, JA; Hess, J; Hofhuis, WJ; Witsenburg, M | 1 |
| Bashkov, GV | 1 |
| Christenson, JT; Strauss, HW | 1 |
| Balcke, P; Ehringer, H; Jahn, C; Koppensteiner, R; Minar, E; Stockenhuber, F | 1 |
| Runge, MS | 1 |
| Asai, K; Funaki, C; Hayashi, T; Kuzuya, F; Kuzuya, M; Naito, M | 1 |
| Eisenberg, PR; Jaffe, AS; Kaufman, L; Lucore, C; Rich, S; Sobel, BE | 1 |
| Hachiya, Y; Hirata, K; Iida, M; Kawamura, Y; Matsuzaki, K; Morishita, T; Noguchi, M; Obara, T; Uchi, T; Yamazaki, J | 1 |
| Chalenko, VV | 1 |
| Badimon, L; Bowie, EJ; Chesebro, JH; Fuster, V; Grill, DE; Heras, M; Mruk, JS; Penny, WJ; Webster, MW | 1 |
| Hatanaka, K; Kitamura, Y; Minamiyama, M; Taguchi, T; Tajima, S; Tanaka, K; Yamamoto, A | 1 |
| Maksimenko, AV; Papisov, MI; Smirnov, VN; Tishchenko, EG; Torchilin, VP | 1 |
| Stuart, J | 1 |
| Egbring, R; Karges, HE; Lange, H; Michalik, R; Seitz, R | 1 |
| Auel, H; Martin, H; Riedel, C | 1 |
| Tilsner, V | 1 |
| Vogel, G | 1 |
| Ihle, E; Ziemer, S | 1 |
| Vinazzer, H | 1 |
| Ashton, F; Slaney, G; Walton, KW | 1 |
| Paintz, M; Richter, M; Stürzebecher, J | 1 |
| Cornelli, U; Fareed, J; Hoppensteadt, DA; Kumar, A; Ulutin, ON; Walenga, JM | 1 |
| Nakamura, F; Sonoki, H; Sugimoto, T; Tomaru, T; Tsukamoto, M; Uchida, Y | 1 |
| Koh, S; Ratnam, SS; Singh, K; Singh, P; Viegas, OA | 1 |
| García Frade, LJ; Loren, M; Navarro, JL; Torrado, MC | 1 |
| Badimon, L; Bailey, KR; Chesebro, JH; Fuster, V; Heras, M; Penny, WJ | 1 |
| Arosio, E; Lechi, C; Pancera, P | 1 |
| Bruckert, E; Caen, JC; Carvalho Sousa, J; Soria, C; Soria, J; Tobelem, G | 1 |
| Matsuyama, K; Miyagi, H; Ogawa, H; Okumura, K; Oshima, S; Yasue, H | 1 |
| Kakkar, VV; Melissari, E | 1 |
| Andersen, E; Bülow, J; Holstein, P; Jørgensen, B; Jørgensen, M; Nielsen, JD; Tønnesen, KH | 1 |
| Fernando Cortizo, W; Hau, L; Jackson, SP; Jane, SM; Mitchell, CA; Pfueller, SL; Salem, HH | 1 |
| Fuzimaki, M; Koshihara, K | 1 |
| Arndt, JW; Emeis, JJ; Feitsma, RI; Koppert, PW; Nieuwenhuizen, W; Pauwels, EK; Wasser, MN | 1 |
| Bini, A; Kaplan, KL | 1 |
| Heilmann, L; Miller, B | 1 |
| Cooper, SL; Grasel, TG; McCoy, TJ; Okkema, AZ | 1 |
| Hara, N; Hayashi, S; Ichinose, Y; Iwami, T; Kinjo, M; Maruyama, M; Nakanishi, M; Ogata, K; Ohta, M; Yagawa, K | 1 |
| Dewanjee, MK; Mashburn, JP; McCarthy, PM; Schaff, HV | 1 |
| Kirk, CR; Qureshi, SA | 1 |
| Kinoshita, M; Sakoda, S; Suzuki, T | 1 |
| Firkin, BG; Sloan, IG | 1 |
| Fung, BM; Nguyen, PD; O'Rear, EA | 1 |
| Buss, DH; Doellgast, GJ; Triscott, MX; West, J | 1 |
| Forbes, CD; Lowe, GD | 1 |
| Hawiger, J; Hoffmann, T; Ruggeri, ZM; Thiagarajan, P; Turitto, VT; Weiss, HJ | 1 |
| Kolts, RL; Kuehner, ME; Maki, HS; Roberts, RC; Sautter, RD | 1 |
| Antignani, PL; Bartolo, M; Ceccarelli, V; Murgiano, GA; Todini, AR | 1 |
| Francis, CW; Marder, VJ | 1 |
| Sakuragawa, N | 1 |
| Bini, A; Fejgl, M; Fenoglio, J; Kaplan, KL; Owen, J; Sobel, J | 1 |
| Donaldson, MC; Hadjimichael, J; Matthews, ET; Rickles, FR | 1 |
| Bonnar, J | 1 |
| Forest, JC; Guidoin, R; Merhi, Y | 1 |
| Catalfamo, JL; Dodds, WJ; Raymond, SL; White, JG | 1 |
| Blumenstock, FA; Cerda, J; Conran, R; Kaplan, JE; Malik, AB; Simon, R; Urizar, RE | 1 |
| Latour, JG; Léger-Gauthier, C | 1 |
| Comp, PC | 1 |
| Davies, JA; Grant, PJ; Prentice, CR; Tate, GM; Williams, NS | 1 |
| Geisinger, MA; Graor, RA; Grossbard, EB; Lucas, FV; Risius, B; Young, JR; Zelch, MG | 1 |
| Cercek, B; Ganz, W; Hod, H; Lew, AS; Reddy, NK; Yano, J | 1 |
| Beven, EG; Graor, RA; Grossbard, EB; Lucas, FV; Risius, B; Ruschhaupt, WF; Young, JR | 1 |
| Conard, J; Samama, MM | 1 |
| Mellbring, G; Nilsson, TK | 1 |
| Alegre, VA; Winkelmann, RK | 1 |
| Koehn, JA; Liu, CY; Morgan, FJ | 1 |
| Higashihara, M; Kume, S | 1 |
| Kamiya, T; Sakaguchi, S; Takada, A; Takada, Y; Urano, T | 1 |
| Bruckner-Kardoss, E; Gargan, PE; Jing, SL; Pollard, M; Scheu, JD | 1 |
| Bautovich, GJ; Boniface, GR; Bundesen, PG; Khafagi, F; Rylatt, DB; Walker, KZ | 1 |
| Fujimoto, T; Fujimura, K; Kuramoto, A; Maehama, S; Oda, K; Takemoto, M | 1 |
| Andrew, M; Brooker, L; Buchanan, MR; Hirsh, J; Ofosu, F; Schmidt, B | 1 |
| Bale, MD; Ferry, JD | 1 |
| Akioka, K; Hirota, K; Itagane, H; Ochi, H; Oku, H; Takeda, T; Takeuchi, K; Teragaki, M; Yasuda, M | 1 |
| Abbate, R; Bonechi, F; Carnovali, M; Casolo, GC; Fazi, A; Gensini, GF; Neri Serneri, GG; Prisco, D; Rogasi, PG | 1 |
| Matsuo, T | 1 |
| Macura, T; Styrska, M | 1 |
| Ali, AA; Bottoms, SF; Farag, AM; Hosni, MA; Mammen, EF; Moghissi, KS | 1 |
| Domogatsky, SP; Kratasjuk, GA; Popov, NV; Sakharov, DV; Sinitsyn, VV | 1 |
| Blohm, D; De Waal, R; Gerlach, H; Handley, D; Matsueda, G; Nawroth, P; Stern, D | 1 |
| Dock, W; Duma, S; Grabenwoeger, F | 1 |
| Albrecht, RM; Cooper, SL; Lambrecht, LK; Mosher, DF; Park, K; Stafford, RE; Young, BR | 1 |
| Hansen, MS | 1 |
| Smith, EB | 1 |
| Ishida, Y; Kawaguchi, Y; Kimura, Y; Kinoshita, M; Miyahara, T; Unemura, S | 1 |
| Kobayashi, N | 1 |
| Connaghan, DG; Francis, CW; Marder, VJ; Scott, WL | 1 |
| Comerota, AJ; Rubin, RN; Sherry, S; Soulen, RL; Tyson, RR; White, JV; Williams, FF | 1 |
| Chantarangkul, V; Mannucci, PM; Tripodi, A | 1 |
| de Almeida, PJ; Pires, JG | 1 |
| Kawasaki, Y | 1 |
| Cooper, SL; Grasel, TG; Lelah, MD; Pierce, JA | 1 |
| Aksik, IA; Apshkalne, DL; Kikut, RP | 1 |
| Cattaneo, M; D'Angelo, A; Haverkate, F; Kluft, C; Koopman, J; Mannucci, PM | 1 |
| Belloc, F; Bricaud, H; Chevaleyre, J; Lefebvre, F; Piquet, Y; Rabaud, M; Roudaut, MF | 1 |
| Cooper, SL; Gerndt, SJ; Park, K | 1 |
| Gorczyńska, E | 1 |
| Besse, P; Chayon, J; Colle, JP; Ledain, L; Lorient-Roudault, MF; Roudault, R | 1 |
| Besse, P; Colle, JP; Ledain, L; Lorient-Roudaut, MF; Ohayon, J; Roudaut, R | 1 |
| Cooper, SL; Grasel, TG | 1 |
| Klein, MD; Splittgerber, FH; Whittlesey, GC | 1 |
| Cooper, SL; Park, K | 1 |
| Brosstad, F; Godal, HC; Holm, B; Kierulf, P; Nilsen, DW | 1 |
| Allen, C; Dosekun, A; Frazier, J; Glas-Greenwalt, P; Kant, KS; Pollak, VE | 1 |
| Hayslett, JP | 1 |
| Lohse, W; Winkler, H; Wolff, H | 1 |
| Llach, F | 1 |
| Chandy, T; Sharma, CP | 1 |
| Bithell, TC | 1 |
| Camagna, P; Dinelli, CA; Donati, M; Magni, S; Porta, A | 1 |
| Avellone, G; Di Gesù, G; Di Vita, G; Longo, A; Mandalà, V | 1 |
| Bernier, JM; Bernier, JP; Guidoin, R | 1 |
| Latour, JG; Léger-Gauthier, C; Solymoss, BC | 1 |
| Davis, J; Edmark, KW; Milligan, HL | 1 |
| Ham, JM; Lawrence, J | 1 |
| Klöcking, HP; Markwardt, F | 1 |
| Heady, JA; O'Brien, JR; Tulevski, V | 1 |
| Douglas, AS; Warlow, C | 1 |
| Erhardt, LR; Lundman, T; Mellstedt, H | 1 |
| Allenby, F; Boardman, L; Jeyasingh, K | 1 |
| Blatt, SJ; Kaye, MP; Schneider, MD; Tobin, HG | 1 |
| Corrigan, TP; Field, ES; Flute, PT; Fossard, DP; Friend, JR; Kakkar, VV | 1 |
| Bieselt, R; Sedlarik, K; Stanulla, H | 1 |
| Edwards, DH; Haynes, DW | 1 |
| Evensen, SA; Garner, R | 1 |
| Shumbalina, LF; Smolianitskiĭ, DIa | 1 |
| Laki, K | 2 |
| Kudriashov, BA | 1 |
| Brain, MC; Regoeczi, E; Rubenberg, ML | 1 |
| Ashburn, WL; Kramer, RS; Morrow, AG; Vasko, JS | 1 |
| Bell, WR; Goodwin, JF; Pitney, WR | 1 |
| Allington, MJ; Paxton, AM; Sharp, AA; Warren, BA | 1 |
| Chan, KE; Reid, HA | 1 |
| Evans, G; Mustard, JF | 1 |
| Hiemeyer, V; Rasche, H | 1 |
| Farmer, RG; Roenigk, HH | 1 |
| Skjorten, F | 1 |
| Douglas, AS; Hassanein, AA; McNicol, GP; Prentice, CR; Turpie, AG | 1 |
| Biró, J; Rosdy, E; Szabó, V | 1 |
| Breddin, K | 1 |
| Cronberg, S | 2 |
| O'Brien, JR | 2 |
| Hauss, WH | 1 |
| Abildgaard, U; Fagerhol, MK; Refvem, O | 1 |
| Baele, G; Mussche, M; Pannier, R; Vermeire, P | 1 |
| Blatný, J; Fischerová, E | 1 |
| Ernst, A; Gastroph, R; Graeff, H; Kuhn, W; Scholz, H; von Hugo, R | 1 |
| Görög, P; Kovács, IB | 1 |
| Hawkey, CM | 1 |
| Harker, LA; Ross, R; Scott, CR; Slichter, SJ | 1 |
| Bang, NU; Hansen, MS; Mosesson, MW; Smith, GF | 1 |
| Cliffton, EE; Fleming, LB | 1 |
| Cremer-Elfrink, HM; den Ottolander, GJ; Leijnse, B | 1 |
| Bogoliubov, VM | 2 |
| Bleyl, U; Wegener, K | 1 |
| Gurewich, V; Hawiger, J; Niewiarowski, S; Thomas, DP | 1 |
| Ashford, T; Deykin, D; Silversmith, P | 1 |
| Lipiński, B | 1 |
| Farrell, GW; Walton, KW; Wolf, P | 1 |
| Judkiewicz, L; Pawlowski, J | 1 |
| Patman, RD; Persson, AV; Thompson, JE | 1 |
| Edgar, W; McNicol, GP; Prentice, CR | 1 |
| Beisswenger, JG; Carroll, ET; Creech, RH; Nilsson, UR; Taylor, FB | 1 |
| Bang, NU; Chang, ML; Hansen, MS; Latallo, ZS; Mattler, LE; Smith, GF | 1 |
| Bokarev, IN; Dreĭzina, AM; Kuzin, MI; Shumbalina, LF; Smolianitskiĭ, AIa | 1 |
| Triantaphyllopoulos, E | 1 |
| Barnhart, MI; Riddle, JM | 1 |
| Bunce, I; Dowling, SV; Nicoll, P; Whitaker, AN | 1 |
| Douglas, AS | 2 |
| Jenkins, CS; Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 1 |
| Buszynski, AZ; Marder, VJ | 1 |
| Olson, PS | 1 |
| Dolgosh, SS; Shtefanets, BIu; Sil'vaĭ, MV | 1 |
| Lahiri, K; Manskopf, G; Moschos, CB; Oldewurtel, HA; Regan, TJ | 1 |
| Dechavanne, M; Lagarde, M | 1 |
| Vroman, L | 2 |
| Mason, RG | 1 |
| Padar, E | 1 |
| Fukushima, Y; Hayakawa, D; Komatsu, K; Suzuki, K; Tomita, S | 1 |
| Lippmann, HI | 1 |
| Abe, M; Chikatsu, I; Iida, A; Isogai, Y; Mochizuki, K | 1 |
| Cotton, RC | 1 |
| Avanesian, RM; Grigorian, AA; Melkonian, VK | 1 |
| Bĕles, P; Sova, J | 1 |
| Salaman, JR | 1 |
| Pitcher, PM | 1 |
| Carroll, JJ; Gallus, AS; Hirsh, J; Hudecki, SM; Minden, JH; O'Brien, SE; Trebilcock, R; Tutle, RJ | 1 |
| Baxter, TJ; Blamey, RW; Deans, BJ; Renney, JT | 1 |
| Fujimaki, M; Ikematsu, S; Takeuchi, I | 1 |
| Sobel, JD | 1 |
| Howard, RJ; Najarian, JS; Sutherland, DE | 1 |
| Dintenfass, L; Forbes, CD; Milton, GW; Stewart, JH | 1 |
| O'Leary, DS; Rickles, FR | 1 |
| Bonnar, J; Denson, KW; Fairweather, J; Haddon, M; Walsh, JJ | 1 |
| Brinkhous, KM; Mason, RG | 1 |
| Hocke, M; Müller-Berghaus, G | 1 |
| Ratnoff, OD | 1 |
| George, CR; Harker, LA; Quadracci, LJ; Slichter, SJ; Striker, GE | 1 |
| Ardlie, NG | 1 |
| Bergentz, SE; Ljungqvist, U; Olson, PS | 2 |
| Chandler, AB; Chapman, I; Erhardt, LR; Ness, PM; Roberts, WC; Schwartz, CJ; Sherry, S; Simon, TL; Sinapius, D; Spain, DM | 1 |
| Didisheim, P; Fuster, V; Kazmier, FJ | 1 |
| Niewiarowski, S | 1 |
| Bierme, R; Boneu, B; Delsol, G; Fabre, J; Familiades, J; Tapie, C | 1 |
| Levine, PH | 1 |
| Barth, P; Zimmermann, R | 1 |
| Faivre, J; Favre-Gilly, J; Michel, D; Schott, B; Tommasi, M | 1 |
| Arkin, C; Smith, SB | 1 |
| Nowak, G | 1 |
| Brandon, JM; Lewis, JH; Wilson, JH | 1 |
| Harker, LA; Slichter, SJ | 1 |
| Bielski, J | 1 |
| Schorn, D | 1 |
| Lau, OJ; McCaffrey, JF; Williams, OB | 1 |
| Provan, JL; Thomson, C | 1 |
| Myers, WO; Ray, JF; Sautter, RD; Wenzel, FJ | 1 |
| Javid, JP; Lackner, H | 1 |
| Schlossman, D | 1 |
| Adelstein, EH; Anderson, PC; Berger, RS | 1 |
| Butterfield, WJ; O'Brien, JR | 1 |
| Greenfield, LJ; Hartsuck, JM | 1 |
| Kingsbury, B; Regelson, W; Roberts, PS | 1 |
| Egberg, N | 2 |
| Call, FL; Davey, FR; Parker, FB; Schroeder, ET | 1 |
| Aronowski, E; Chajek, T; Izak, G | 1 |
| Duckert, F; Marbet, GA | 1 |
| Stoner, GE | 1 |
| Duckert, F | 1 |
| Graeff, H; von Hugo, R | 1 |
| Dintenfass, L; Forbes, CD | 1 |
| Bazazi'ian, GG; Sytina, NP | 1 |
| Patrushev, VI; Shekhtman, MA | 1 |
| Fridrich, R | 1 |
| Farrell, GW | 1 |
| Scrobohaci, ML; Stăncioiu, N | 1 |
| Caprini, JA; Gaylor, JD; Mockros, LF; Murphy, JF; Zukerman, L | 1 |
| Clarkson, AR; Davison, AM; MacDonald, MK | 1 |
| Brooks, JD; Kravis, TC; Moser, KM; Shibel, EM | 1 |
| Alkjaersig, N; Etherington, M; Fletcher, A; Madgwick, T; O'Brien, JR; Tulevski, VG | 1 |
| Browse, NL | 1 |
| Kakkar, VV; Scully, MF; Strachan, CJ | 1 |
| Ferguson, EW | 1 |
| Chakrabarti, R; Fearnley, GR | 1 |
| Erhardt, IR | 1 |
| Chang, ML; Frenkel, EP; Wilson, JE | 1 |
| Terry, G; Warlow, CP | 1 |
| Busch, C; Lindquist, O; Olson, PS | 1 |
| Barnhart, MI; Cress, DC; Henry, RL; Riddle, JM | 1 |
| Lerner, RG; Rapaport, SI; Spitzer, JM | 1 |
| Ananchenko, VG; Zaĭtsev, VF | 1 |
| Coopland, AT | 1 |
| Macfarlane, RG | 1 |
| Wessler, S; Yin, ET | 1 |
| Calne, RY; Flute, PT; Rake, MO; Seaman, MJ; Williams, R | 1 |
| Abildgaard, CF; Bolger, JF; Forman, EN; Schulman, I; Seeler, RA | 1 |
| Zetterqvist, E | 1 |
| Barnhart, MI; Walsh, RT | 1 |
| Hedlund, PO; Sjögren, S | 1 |
| Zürn, H | 1 |
| Biggs, JC; Chesterman, CN | 1 |
| Josso, F; Kanfer, A | 1 |
| Wessler, S | 1 |
| Attar, S | 1 |
| Schneider, CL | 1 |
| Niléhn, JE | 1 |
| Fekkes, N; Hemker, HC; Hensen, A; Loeliger, EA; Schrijver, H | 1 |
| Adams, HR; Berendt, RF; Finegold, MJ; Petery, JJ | 1 |
| Bütler, R; Lopez, V; Pflugshaupt, R | 1 |
| Murray, M; Smith, GF | 1 |
| Gormsen, J; Laursen, B | 1 |
| Broyer, M; Josso, F; Kanfer, A; Kleinknecht, D | 1 |
| Khoury, NY; Vanstone, JC | 1 |
| Becker, J; Bergqvist, D; Dahlgren, S | 1 |
| Austen, WG; Buckley, MJ; Caulfield, JB; Leinbach, RC; Nyilas, E | 1 |
| Holzknecht, F | 2 |
| Barton, BP; Chandler, AB; Shirasawa, K | 1 |
| Askherkhanov, RP; Safarov, SIu | 1 |
| Brüster, H | 1 |
| Bradley, J; Brearley, R; Cuschieri, A; Moossa, AR | 1 |
| Kostiuchenko, AL; Shanin, IuN; Solov'eva, OV | 1 |
| Cheng, HF; Fry, GL; Hankenson, RR; Hoak, JC; Warner, ED | 1 |
| Becher, R; Müller-Wiefel, H | 1 |
| Bollinger, A | 1 |
| Loew, D; Remmele, W; Wiedemann, R | 1 |
| Alkjaersig, N; Fletcher, A; Owens, O; Smith, JR; Wolff, G | 1 |
| Alkjaersig, N; Fletcher, A; Jacob, A; Roy, L | 1 |
| Korvald, E | 1 |
| Ramot, B; Rosenthal, T; Seligsohn, U; Shapiro, Y | 1 |
| Woolf, N | 1 |
| Balme, M; Claudy, A; Perrot, H; Thivolet, J | 1 |
| Barth, P; Czygan, P; Zimmermann, R | 1 |
| Ivanova, NA | 1 |
| Flute, PT | 1 |
| Button, L; Moloney, WC; Murray, JE; Rodriguez-Erdmann, F | 1 |
| Kauppilva, A; Kiviniitty, K; Taskinen, PJ; Ylöstalo, P | 1 |
| Ygge, J | 1 |
| Hardaway, RM | 1 |
| Blombäck, M; Nordström, S; Olsson, P | 1 |
| Pinkus, SSh | 1 |
| Giacobino, JP; Simon, G | 1 |
| Sánchez Avalos, JC | 1 |
| Carstairs, KC; Woolf, N | 1 |
| Chandler, AB; Shirasawa, K | 1 |
| Gaertner, H | 1 |
| Appelgren, L; Bergentz, SE; Leandoer, L; Lim, RC | 1 |
| Langr, F; Mazak, J; Recek, C | 1 |
| Del Pino, MC; Morelli, AC; Pollini, H | 1 |
| Saldeen, T | 1 |
| Moe, N | 1 |
| Goldie, H; Paterson, N; Scott, JM | 1 |
| Cordonnier, D; Couderc, P; Kolodie, L; Martin, H; Massot, C; Muller, JM; Schaerer, R | 1 |
| Lebedeva, RN; Zaikina, LV | 1 |
| Dabizzi, RP; Donnini, L; Masotti, G; Neri Serneri, GG; Paoletti, P; Silvestrini, E | 1 |
| Miller, ML; Ziegler, TF | 1 |
| Azzopardi, JG; Baker, LR; Brain, MC; Dacie, JV; Pineo, GF; Roberts, PD | 1 |
| Fernholz, HJ; Müller, G | 1 |
| Iolster, NJ | 1 |
| Zola-Sleczek, E | 1 |
| Longmore, D | 1 |
| Allwork, SP; Bell, WR; Bentall, HH; Olsen, EG; Singh, MP | 1 |
| Isacson, S; Nilsson, IM | 1 |
| Jaques, R; Riesterer, L; Rüegg, M | 1 |
| Belousov, IuB; Liusov, VA | 1 |
| Alkjaersig, N; Fletcher, AP; O'Brien, J; Tulevski, VG | 1 |
| Kampmann, H; Nuri, M; Sinn, H | 1 |
| Fernoolz, HJ; Müller, G | 1 |
| Denson, KW; Lurie, A | 1 |
| Hashimoto, Y | 1 |
| Buchanan, MR; Glynn, MF; Hirsh, J; Jorgensen, L; Mustard, JF | 1 |
| Fekete, JF; MacKinnon, HH | 1 |
| Froggatt, DL | 1 |
| Biggs, JC; Chesterman, CN; Nash, T | 1 |
| Becker, J | 1 |
| Gralnick, HR; Greipp, P | 1 |
| Chernysheva, GV | 1 |
| Melrose, DG; Pitney, WR; Singh, MP | 1 |
| Zavartseva, MN | 1 |
| Moreno Castelazo, EG | 1 |
| Nikolaeva, LF | 1 |
| Lombardi, V; Torsellini, A | 1 |
| Gritsiuk, AI | 1 |
| Brain, MC; Bull, BS; Dacie, JV; Regoeczi, E; Rubenberg, ML | 1 |
| Cotton, RC; Johnson, FL | 1 |
| Slunský, R | 1 |
| Dintenfass, L; Stewart, JH | 1 |
| Merskey, C | 1 |
| Mc Kay, DG | 1 |
| De Nicola, P | 1 |
| Tanaka, K | 1 |
| Bonnabeau, RC; Carlson, RG; Edlich, RF; Gans, H; Landé, AJ; Lillehei, CW | 1 |
| Clarke, EJ; Fresh, JW; Reyes, V; Uylangco, CV | 1 |
| Koroxenidis, GT; Lehan, PH; Moschos, CB; Oldewurtel, HA; Regan, TJ; Weisse, AB | 1 |
| Martin, M; Schoop, W; Zeitler, E | 1 |
| Baier, RE; Dutton, RC | 1 |
| Amery, A; Vermylen, J; Verstraete, M | 1 |
| Raby, C | 1 |
| Basu, HK; Williamson, GF | 1 |
| Abildgaard, CF; Bolger, JF; Forman, EN; Johnson, CA; Schulman, I | 1 |
| Amstutz, P; Gibert, C; Pocidalo, JJ; Szekely, AM | 1 |
| Brain, MC; Regoeczi, E | 1 |
| Haustein, UF | 1 |
| Puder, H | 1 |
| Kim, DN; Lee, KT; Thomas, WA | 1 |
| Cash, JD | 1 |
| Jones, R; Kim, DN; Lee, KT; Thomas, WA | 1 |
| Cronberg, S; Niléhn, JE; Nilsson, IM; Nordén, G | 1 |
227 review(s) available for fibrinogen and Blood Clot
| Article | Year |
|---|---|
Not one, but many forms of thrombosis proteins.
Topics: Blood Platelets; Cysteine; Disulfides; Fibrinogen; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 2022 |
Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.
Topics: alpha-2-Antiplasmin; Anticoagulants; Carboxypeptidase B2; Complement C3; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Plasminogen Activator Inhibitor 2; Thrombosis | 2021 |
The Story of the Fibrin(ogen) αC-Domains: Evolution of Our View on Their Structure and Interactions.
Topics: Estrone; Fibrin; Fibrinogen; Humans; Peptide Fragments; Polymers; Protein Structure, Tertiary; Thrombosis | 2022 |
Nanomechanics of Blood Clot and Thrombus Formation.
Topics: Fibrin; Fibrinogen; Humans; Thrombosis | 2022 |
Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.
Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Hemorrhage; Humans; Mutation; Thrombosis | 2021 |
The role of thrombin in haemostasis.
Topics: Anticoagulants; Carboxypeptidase B2; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Hemostatics; Humans; Protein C; Thrombin; Thrombosis | 2022 |
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
Topics: Blood Coagulation Disorders; COVID-19; Fibrinogen; Humans; Liver Diseases; SARS-CoV-2; Thrombosis | 2022 |
Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.
Topics: Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Hemostatics; Humans; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2022 |
Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review.
Topics: Afibrinogenemia; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Humans; Thrombosis | 2022 |
The association of coagulation and atrial fibrillation: a systematic review and meta-analysis.
Topics: Atrial Fibrillation; Biomarkers; Blood Coagulation Factors; Cross-Sectional Studies; Fibrinogen; Humans; Plasminogen Activator Inhibitor 1; Thrombosis | 2023 |
Increased risk of dialysis circuit clotting in hemodialysis patients with COVID-19 is associated with elevated FVIII, fibrinogen and D-dimers.
Topics: Aged; Aged, 80 and over; Antithrombins; COVID-19; Factor VIII; Female; Fibrinogen; Heparin; Humans; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Thrombosis | 2023 |
Strategies for Therapeutic Amelioration of Aberrant Plasma Zn
Topics: Fatty Acids; Fatty Acids, Nonesterified; Fibric Acids; Fibrinogen; Hemostatics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kininogen, High-Molecular-Weight; Lipase; Plasma; Serum Albumin; Serum Albumin, Human; Thrombosis; Zinc | 2022 |
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer.
Topics: COVID-19; COVID-19 Vaccines; Fibrinogen; Humans; Neoplasms; Pandemics; Pharmaceutical Preparations; Purpura, Thrombocytopenic, Idiopathic; SARS-CoV-2; Syndrome; Thrombocytopenia; Thrombosis; Vaccines | 2022 |
Marine Biological Macromolecules and Chemically Modified Macromolecules; Potential Anticoagulants.
Topics: Anticoagulants; Enzyme Precursors; Fibrin; Fibrinogen; Hemorrhage; Heparin; Humans; Thrombosis | 2022 |
Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability.
Topics: Actomyosin; Adenosine Diphosphate; Animals; Blood Platelets; Fibrin; Fibrinogen; Mice; Phosphatidylinositols; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Proto-Oncogene Proteins c-akt; Thrombosis; von Willebrand Factor | 2022 |
Markers of Hereditary Thrombophilia with Unclear Significance.
Topics: Endothelial Protein C Receptor; Factor IX; Fibrinogen; Humans; Plasminogen Activator Inhibitor 1; Thrombophilia; Thrombosis | 2022 |
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.
Topics: Brain Ischemia; Cardiovascular Diseases; Fibrin; Fibrinogen; Humans; Hypertension; Prospective Studies; Stroke; Thrombosis | 2023 |
Factor VIII: A Dynamic Modulator of Hemostasis and Thrombosis in Trauma.
Topics: Anticoagulants; Factor VIII; Fibrinogen; Fibrinolysin; Hemostasis; Hemostatics; Humans; Inflammation; Thrombin; Thrombosis; Venous Thromboembolism; von Willebrand Factor | 2023 |
Fibrinogen and fibrin: synthesis, structure, and function in health and disease.
Topics: Fibrin; Fibrinogen; Hemostatics; Humans; Inflammation; Thrombosis | 2023 |
Comparison between thromboelastography and thromboelastometry.
Topics: Fibrinogen; Fibrinolysis; Hemostatic Techniques; Humans; Thrombelastography; Thrombosis | 2019 |
Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation.
Topics: Anticoagulants; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Factor VIII; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Heparin; Humans; Plasma; Platelet Transfusion; Thrombosis | 2020 |
Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review.
Topics: Acetylation; Animals; Fibrinogen; Fibrinolysis; Glycosylation; Humans; Oxidation-Reduction; Polymerization; Protein Processing, Post-Translational; Thrombosis | 2020 |
Coagulopathy in COVID-19.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; Cytokines; Disseminated Intravascular Coagulation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Inflammation; Lung; Lymphocytes; Partial Thromboplastin Time; Protease Inhibitors; Prothrombin Time; Sepsis; Thrombosis | 2020 |
Genetic Variants in the
Topics: Afibrinogenemia; Blood Coagulation Tests; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Hemostatics; Humans; Phenotype; Thrombosis | 2020 |
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Betacoronavirus; Blood Platelets; Blood Viscosity; Coronavirus Infections; COVID-19; Endothelium, Vascular; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Pandemics; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Platelet Activation; Platelet Aggregation Inhibitors; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thrombophilia; Thrombosis; Tissue Plasminogen Activator | 2020 |
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Topics: Anticoagulants; Antiviral Agents; Betacoronavirus; Complement System Proteins; Coronavirus Infections; COVID-19; Cytokines; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Pandemics; Plasma Exchange; Platelet Count; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Thrombosis; Thrombotic Microangiopathies | 2020 |
Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.
Topics: Anticoagulants; Biomarkers; Blood Coagulation Disorders; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; SARS-CoV-2; Thromboembolism; Thrombosis | 2020 |
Basic principles of viscoelastic testing.
Topics: Adult; Anemia; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Device Approval; Elasticity; Equipment Design; Fibrinogen; Fibrinolysis; Humans; Indicators and Reagents; Microfluidic Analytical Techniques; Shear Strength; Specimen Handling; Thrombelastography; Thrombosis; United States; United States Food and Drug Administration; Vibration; Viscosity | 2020 |
Fibrinogen and Fibrin.
Topics: Blood Coagulation; Fibrin; Fibrinogen; Hemostasis; Humans; Polymerization; Thrombosis | 2021 |
Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis.
Topics: Animals; Fibrin; Fibrinogen; Hemostasis; Humans; Immune System; Thrombin; Thrombosis | 2021 |
Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.
Topics: Animals; Factor XIIIa; Fibrin; Fibrinogen; Fibrinolysis; Humans; Thrombosis | 2021 |
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
Topics: Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; beta 2-Glycoprotein I; C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Lupus Coagulation Inhibitor; SARS-CoV-2; Severity of Illness Index; Thrombosis | 2021 |
The hemostatic and thrombotic complications of liver disease.
Topics: Anticoagulants; Blood Platelets; Blood Transfusion; Fibrinogen; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Liver Cirrhosis; Thrombosis; von Willebrand Factor | 2021 |
Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease.
Topics: Atherosclerosis; Coronary Artery Disease; Estrogens; Female; Fibrinogen; Humans; Inflammation; Male; Renin-Angiotensin System; Sex Factors; Smoking; Thrombosis | 2021 |
Disorders of Fibrinogen and Fibrinolysis.
Topics: Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Hemostatics; Humans; Thrombosis | 2021 |
[Viscoelasticity-based treatment of bleeding injuries].
Topics: Algorithms; Antifibrinolytic Agents; Blood Coagulation Factors; Blood Coagulation Tests; Blood Transfusion; Blood Viscosity; Consensus; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Monitoring, Physiologic; Multiple Trauma; Platelet Aggregation; Platelet Transfusion; Point-of-Care Testing; Resuscitation; Shock, Hemorrhagic; Thrombosis | 2017 |
Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis.
Topics: Animals; Arthritis; Cardiovascular Diseases; Diabetes Mellitus; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Diseases; Lung Diseases; Models, Biological; Neoplasms; Nervous System Diseases; Polymerization; Protein Interaction Domains and Motifs; Serum Albumin, Human; Solubility; Thrombosis | 2018 |
The place of fibrinogen concentrates in the management of perioperative bleeding: A position paper from the Francophone Working Group on Perioperative Haemostasis (GIHP).
Topics: Blood Loss, Surgical; Fibrinogen; Hemostasis; Hemostatics; Humans; Perioperative Care; Thrombosis | 2018 |
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects.
Topics: Behcet Syndrome; Fibrinogen; Humans; Immunosuppressive Agents; Inflammation; Reactive Oxygen Species; Thrombosis | 2019 |
Thromboelastography and Thromboelastometry in Assessment of Fibrinogen Deficiency and Prediction for Transfusion Requirement: A Descriptive Review.
Topics: Afibrinogenemia; Blood Coagulation Tests; Blood Transfusion; Fibrinogen; Humans; Thrombelastography; Thrombosis | 2018 |
Functional significance of the platelet immune receptors GPVI and CLEC-2.
Topics: Amino Acid Motifs; Animals; Collagen; Extracellular Matrix; Fibrin; Fibrinogen; Humans; Inflammation; Lectins, C-Type; Membrane Glycoproteins; Neoplasm Proteins; Neoplasms; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Thrombosis | 2019 |
Behçet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils.
Topics: Animals; Behcet Syndrome; Cytokines; Disease Susceptibility; Extracellular Traps; Fibrinogen; Humans; Inflammation; Models, Biological; NADPH Oxidases; Neutrophils; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Thrombosis | 2019 |
The blood compatibility challenge. Part 3: Material associated activation of blood cascades and cells.
Topics: Adsorption; Animals; Biocompatible Materials; Blood Coagulation; Blood Platelets; Complement System Proteins; Fibrin; Fibrinogen; Hemolysis; Humans; Inflammation; Leukocytes; Materials Testing; Microspheres; Platelet Adhesiveness; Surface Properties; Thrombosis | 2019 |
The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.
Topics: Adsorption; Animals; Biocompatible Materials; Blood Coagulation; Blood Platelets; Blood Proteins; Complement Activation; Fibrinogen; Humans; Materials Testing; Platelet Adhesiveness; Protein Binding; Protein Conformation; Surface Properties; Thrombosis | 2019 |
Fibrinogen concentrate for perioperative bleeding: what can we learn from the clinical trials?
Topics: Clinical Trials as Topic; Fibrinogen; Hemorrhage; Humans; Thrombosis | 2019 |
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues.
Topics: Animals; Anticoagulants; Antithrombin III; Cell-Derived Microparticles; Disease Models, Animal; Extracellular Traps; Factor VIII; Factor Xa Inhibitors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Glucuronidase; Heparin; Humans; Leukocytes; Membrane Glycoproteins; Mice; Molecular Targeted Therapy; Pancreatic Neoplasms; Protein C; Thrombophilia; Thromboplastin; Thrombosis | 2019 |
Fibrin(ogen) and thrombotic disease.
Topics: Causality; Fibrin; Fibrinogen; Humans; Thrombosis | 2013 |
Congenital fibrinogen disorders: an update.
Topics: Afibrinogenemia; Animals; Fibrinogen; Genetic Association Studies; Genotype; Hemorrhage; Humans; Mutation; Thrombosis | 2013 |
Perioperative factor concentrate therapy.
Topics: Antithrombins; Blood Coagulation Factors; Blood Component Transfusion; Fibrinogen; Hemostasis; Humans; Point-of-Care Systems; Thrombosis | 2013 |
The Northwick Park Heart Study: evidence from the laboratory.
Topics: Antigens; Atherosclerosis; Blood Coagulation; Coronary Disease; Disease Progression; Factor VII; Fibrinogen; Hemostasis; Humans; Inflammation; Phenotype; Prospective Studies; Risk Factors; Thrombosis | 2014 |
Zebrafish as a model system for the study of hemostasis and thrombosis.
Topics: Animals; Blood Platelets; Fibrinogen; Hemostasis; Humans; Thrombosis; von Willebrand Factor; Zebrafish | 2014 |
[The role of post-translational modification of fibrinogen in the pathogenesis of thrombosis].
Topics: Extracellular Space; Fibrin; Fibrinogen; Fibrinolysis; Glycation End Products, Advanced; Halogenation; Homocysteine; Humans; Lysine; Protein Processing, Post-Translational; Thrombosis | 2015 |
Gasomediators (·NO, CO, and H₂S) and their role in hemostasis and thrombosis.
Topics: Blood Platelets; Carbon Monoxide; Endothelial Cells; Fibrinogen; Hemostasis; Humans; Hydrogen Sulfide; Nitric Oxide; Peroxynitrous Acid; Platelet Activation; Superoxides; Thrombosis; Vasodilation | 2015 |
Fibrinogen and catheter-directed thrombolysis.
Topics: Animals; Biomarkers; Catheterization, Peripheral; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Practice Guidelines as Topic; Predictive Value of Tests; Risk Assessment; Risk Factors; Thromboembolism; Thrombolytic Therapy; Thrombosis; Treatment Outcome | 2014 |
The prothrombotic activity of cancer cells in the circulation.
Topics: Anticoagulants; Antineoplastic Agents; Blood Coagulation; Blood Platelets; Factor VIIa; Fibrin; Fibrinogen; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplastic Cells, Circulating; Platelet Activation; Prothrombin; Thromboplastin; Thrombosis | 2016 |
Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
Topics: Afibrinogenemia; Animals; Fibrinogen; Hemorrhage; Humans; Mutation, Missense; Thrombosis | 2016 |
Alterations in Fibrin Structure in Patients with Liver Diseases.
Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Protein Processing, Post-Translational; Thrombosis | 2016 |
Novel mechanisms that regulate clot structure/function.
Topics: Animals; Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Hemorrhage; Humans; Thrombosis | 2016 |
Can the phenotype of inherited fibrinogen disorders be predicted?
Topics: Afibrinogenemia; Blood Coagulation Tests; Fibrinogen; Genotype; Hemorrhage; Humans; Phenotype; Thrombosis | 2016 |
Fibrinogen and Fibrin in Hemostasis and Thrombosis.
Topics: Animals; Fibrin; Fibrinogen; Fibrinolytic Agents; Hemostasis; Hemostatics; Humans; Protein Conformation; Protein Processing, Post-Translational; Protein Stability; Structure-Activity Relationship; Thrombin; Thrombosis | 2017 |
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thrombosis | 2017 |
Hypercoagulable states in cardiovascular disease.
Topics: Blood Coagulation Factors; Cardiovascular Diseases; Disease Susceptibility; Fibrinogen; Fibrinolysis; Humans; Polymorphism, Single Nucleotide; Prothrombin; Risk Factors; Thromboembolism; Thrombophilia; Thromboplastin; Thrombosis | 2008 |
The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cystathionine beta-Synthase; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Methionine-tRNA Ligase; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Thrombosis; Vascular Diseases | 2008 |
Congenital fibrinogen disorders.
Topics: Afibrinogenemia; Blood Coagulation Tests; Female; Fibrinogen; Genotype; Hemorrhagic Disorders; Humans; Infant, Newborn; Phenotype; Pregnancy; Pregnancy Complications, Hematologic; Prenatal Diagnosis; Risk; Thrombosis | 2009 |
Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P).
Topics: Adolescent; Adult; Animals; Female; Fibrinogen; Humans; Incidence; Infant, Newborn; Male; Pulmonary Embolism; Rabbits; Thrombosis; Thrombotic Microangiopathies; Young Adult | 2009 |
Heritability of clot formation.
Topics: Blood Coagulation; Factor XIII; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Thrombosis | 2009 |
Platelet response heterogeneity in thrombus formation.
Topics: Animals; Blood Platelets; Cellular Senescence; Fibrin; Fibrinogen; Hemorheology; Humans; Models, Cardiovascular; Platelet Aggregation; Thrombosis | 2009 |
The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: a review of the evidence.
Topics: Animals; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Inflammation; Nicotiana; Oxidative Stress; Risk Factors; Thrombosis; Tobacco Smoke Pollution | 2009 |
Emerging roles of fibronectin in thrombosis.
Topics: Animals; Blood Proteins; Cricetinae; Extracellular Matrix; Fibrinogen; Fibronectins; Morphogenesis; Thrombosis; Wound Healing | 2010 |
Influence of cellular and plasma procoagulant activity on the fibrin network.
Topics: Animals; Blood Coagulation; Coagulants; Fibrin; Fibrinogen; Hemostasis; Humans; Models, Biological; Plasma; Thrombin; Thromboplastin; Thrombosis | 2010 |
The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
Topics: Animals; Aryldialkylphosphatase; Autoimmunity; Fibrinogen; Homocysteine; Humans; Immune System; Methionine-tRNA Ligase; Mice; Mice, Transgenic; Models, Biological; Risk Factors; Thrombosis | 2010 |
Fibrinogen and the risk of thrombosis.
Topics: Atherosclerosis; Cardiovascular Diseases; Fibrinogen; Genome-Wide Association Study; Humans; Polymorphism, Genetic; Risk; Thromboembolism; Thrombosis | 2010 |
Computational approaches to studying thrombus development.
Topics: Animals; Blood Coagulation; Computational Biology; Computer Simulation; Fibrin; Fibrinogen; Humans; Kinetics; Models, Cardiovascular; Platelet Activation; Protein Conformation; Structure-Activity Relationship; Thrombosis | 2011 |
Olive oil and haemostasis: platelet function, thrombogenesis and fibrinolysis.
Topics: Animals; Anticoagulants; Dietary Fats; Factor VII; Fatty Acids, Monounsaturated; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Olive Oil; Phenols; Plant Oils; Plasminogen Activator Inhibitor 1; Platelet Activation; Thromboplastin; Thrombosis; Thromboxanes; von Willebrand Factor | 2011 |
Fibrinogen replacement therapy for congenital fibrinogen deficiency.
Topics: Adolescent; Adult; Afibrinogenemia; Child; Child, Preschool; Female; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis; Young Adult | 2011 |
Bleeding and thrombosis in acute promyelocytic leukemia.
Topics: Antifibrinolytic Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation Tests; Clinical Trials as Topic; Combined Modality Therapy; Cysteine Endopeptidases; Disseminated Intravascular Coagulation; Factor VIIa; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Plasma; Platelet Count; Platelet Transfusion; Recombinant Proteins; Thromboplastin; Thrombosis; Treatment Failure; Tretinoin | 2012 |
γ' Fibrinogen as a novel marker of thrombotic disease.
Topics: Biomarkers; Fibrinogen; Humans; Inflammation; Thrombosis | 2012 |
[Fibrinogen: factor and marker of cardiovascular risk].
Topics: Alternative Splicing; Amino Acid Sequence; Biomarkers; Cardiovascular Diseases; Fibrinogen; Hemorrhage; Humans; Inflammation; Risk Factors; Sequence Alignment; Thrombosis | 2002 |
[Fibrinogen: cardiovascular risk factor].
Topics: Arteriosclerosis; Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors; Thrombosis | 2002 |
Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.
Topics: Adolescent; Adult; Anticoagulants; Blood Coagulation Factors; Child; DNA, Complementary; Exons; Factor IX; Factor V; Factor VIII; Factor XIII; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Genetic Techniques; Hemophilia A; Hemophilia B; Hemorrhage; Homozygote; Humans; Introns; Logistic Models; Male; Mutation; Odds Ratio; Point Mutation; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombosis; Venous Thrombosis | 2003 |
THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.
Topics: Blood Platelets; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperlipidemias; Lipid Metabolism; Lipoproteins; Plasminogen; Thrombosis | 1964 |
FIBRINOLYSIS AND INTRINSIC HAEMOSTASIS.
Topics: Adsorption; Blood Coagulation; Blood Platelets; Blood Viscosity; Calcium; Fibrinogen; Fibrinolysis; Hemostasis; Homeostasis; Humans; Peptides; Research; Thromboplastin; Thrombosis | 1964 |
THROMBOLYTIC THERAPY.
Topics: Aminocaproates; Aminocaproic Acid; Anticoagulants; Biomedical Research; Deoxyribonuclease I; Drug Therapy; Fibrinogen; Fibrinolysin; Hemorrhage; Humans; Plasminogen; Pulmonary Embolism; Streptodornase and Streptokinase; Streptokinase; Thrombolytic Therapy; Thrombophlebitis; Thrombosis; Toxicology | 1964 |
[From fibrinogen to fibrin and its dissolution].
Topics: Animals; Arteriosclerosis; Carboxypeptidase B2; Cell Movement; Diabetes Mellitus; Disease Models, Animal; Endothelial Cells; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Metalloproteases; Mice; Mice, Transgenic; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombin; Thrombosis; Wound Healing | 2003 |
[Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Arteriosclerosis; Blood Component Removal; Coronary Restenosis; Female; Fibrinogen; Fibrinolytic Agents; Humans; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Myocardial Infarction; Predictive Value of Tests; Primary Prevention; Prospective Studies; Risk Factors; Stents; Stroke; Syndrome; Thrombosis | 2003 |
Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease.
Topics: Afibrinogenemia; Arteriosclerosis; Blood Coagulation; Diabetes Mellitus; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Glycosylation; Humans; Hyperhomocysteinemia; Life Style; Lipoproteins; Polymorphism, Genetic; Protein Conformation; RNA Splicing; Structure-Activity Relationship; Thrombosis | 2004 |
Platelet physiology and thrombosis.
Topics: ADAM Proteins; ADAMTS13 Protein; Binding Sites; Blood Platelets; Collagen; Disulfides; Endothelium, Vascular; Fibrinogen; Humans; Leucine; Ligands; Macrophage-1 Antigen; Metalloendopeptidases; Models, Biological; P-Selectin; Platelet Activation; Platelet Adhesiveness; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Structure, Tertiary; Thrombosis; von Willebrand Factor | 2004 |
Diet and aging: bearing on thrombosis and hemostasis.
Topics: Aging; Alcohols; Bleeding Time; Carbohydrate Metabolism; Diet; Dietary Fats; Factor VII; Fatty Acids; Fatty Acids, Unsaturated; Fibrinogen; Hemostasis; Humans; Isoflavones; Niacin; Nutritional Physiological Phenomena; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk; Thrombophilia; Thrombosis; Thromboxane A2; Tissue Plasminogen Activator | 2005 |
Type 2 diabetes: an atherothrombotic syndrome.
Topics: Animals; Blood Coagulation; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium, Vascular; Factor VII; Factor VIII; Factor XII; Factor XIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin Resistance; Plasminogen Activator Inhibitor 1; Syndrome; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2005 |
The molecular physiology and pathology of fibrin structure/function.
Topics: Blood Coagulation; Factor XIIIa; Fibrin; Fibrinogen; Humans; Structure-Activity Relationship; Thrombosis; Vascular Diseases | 2005 |
Maternal fibrinogen is necessary for embryonic development.
Topics: Adult; Afibrinogenemia; Animals; Blood Coagulation Disorders; Embryonic Development; Female; Fibrinogen; Humans; Mice; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis | 2005 |
Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
Topics: Coronary Disease; Fibrinogen; Genetic Predisposition to Disease; Humans; Risk Factors; Thrombosis | 2005 |
Hereditary blood coagulation disorders: management and dental treatment.
Topics: Blood Coagulation Disorders, Inherited; Coagulation Protein Disorders; Dental Care for Chronically Ill; Fibrinogen; Hemostasis; Humans; Thrombosis | 2005 |
The interaction between pathogens and the host coagulation system.
Topics: Animals; Bacterial Infections; Blood Coagulation; Blood-Borne Pathogens; Fibrinogen; Genetic Variation; Hemostasis; Humans; Plasminogen; Thrombosis | 2006 |
[Fibrinogen--acute phase protein as a marker of immunological process as atherosclerosis].
Topics: Acute-Phase Proteins; Atherosclerosis; Biomarkers; Female; Fibrinogen; Fibrinolysis; Humans; Inflammation; Male; Risk Factors; Sensitivity and Specificity; Thrombosis | 2005 |
A guide to murine coagulation factor structure, function, assays, and genetic alterations.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Fibrinogen; Hemostasis; Humans; Mice; Models, Biological; Models, Genetic; Partial Thromboplastin Time; Prothrombin Time; Thrombosis | 2007 |
Role of red blood cell flow behavior in hemodynamics and hemostasis.
Topics: Anion Exchange Protein 1, Erythrocyte; Blood Sedimentation; Endothelium, Vascular; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Fibrinogen; Hematocrit; Hemostasis; Humans; Immunoglobulins; Microcirculation; N-Acetylneuraminic Acid; Platelet Adhesiveness; Regional Blood Flow; Rheology; Thrombosis | 2007 |
Diabetes mellitus as a prothrombotic condition.
Topics: Blood Coagulation Factors; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium, Vascular; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperglycemia; Insulin Resistance; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Tissue Plasminogen Activator | 2007 |
Fibrinogen-binding proteins of Gram-positive bacteria.
Topics: Adhesins, Bacterial; Animals; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Blood Coagulation; Carrier Proteins; Coagulase; Fibrinogen; Humans; Models, Molecular; Peptide Hydrolases; Protein Conformation; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Thrombosis | 2007 |
[Somatostatin and the hemostatic system (author's transl)].
Topics: Animals; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hormones; Humans; Plasminogen Activators; Plasminogen Inactivators; Platelet Aggregation; Platelet Count; Rats; Somatostatin; Thrombosis; Whole Blood Coagulation Time | 1980 |
Venous thrombosis and embolism.
Topics: Angiography; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Auscultation; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Dextrans; Endothelium; Fibrinogen; Fibrinolysis; Heparin; Humans; Iodine Radioisotopes; Phlebography; Platelet Aggregation; Rheology; Thrombophlebitis; Thrombosis | 1981 |
Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Factor V Deficiency; Factor X Deficiency; Factor XI Deficiency; Factor XII Deficiency; Female; Fibrinogen; Hemophilia A; Hemophilia B; Humans; Kininogens; Male; Middle Aged; Myocardial Infarction; Ohio; Prekallikrein; Thrombocytopenia; Thrombosis; von Willebrand Diseases | 1983 |
Vascular potential and thrombosis.
Topics: Adsorption; Animals; Blood Platelets; Blood Vessels; Chemical Precipitation; Electrophysiology; Endothelium; Erythrocytes; Fibrinogen; Humans; Leukocytes; Membrane Potentials; Surface Properties; Thrombosis | 1983 |
[Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
Topics: Antithrombin III; Blood Coagulation Disorders; Blood Coagulation Tests; Chromogenic Compounds; Disseminated Intravascular Coagulation; Factor X; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Kallikreins; Kinins; Substrate Specificity; Thrombin; Thrombosis | 1981 |
[Nonenzymatic fibrinolysis].
Topics: Animals; Blood Coagulation; Blood Proteins; Cardiovascular Diseases; Factor XIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemostasis; Heparin; Humans; Hydrolysis; Plasminogen; Thrombosis | 1981 |
Hypercoagulation and thrombosis.
Topics: Arteries; Arteriosclerosis; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Blood Vessels; Cell Survival; Endotoxins; Factor V; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Thromboplastin; Thrombosis; Veins | 1980 |
Haemorheological aspects of thrombosis.
Topics: Adenosine Diphosphate; Arteries; Blood Flow Velocity; Blood Viscosity; Erythrocytes; Fibrinogen; Hematocrit; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis | 1980 |
[Physiopathology of consumption coagulopathies].
Topics: Animals; Antithrombin III; Blood Coagulation; Disseminated Intravascular Coagulation; Embolism, Air; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemodynamics; Humans; Platelet Count; Pregnancy; Shock; Surgical Procedures, Operative; Thrombosis | 1980 |
Fat metabolism, the fibrinogen/fibrinolytic system and blood flow: new potentials for the pharmacological treatment of coronary heart disease.
Topics: Arteriosclerosis; Coronary Circulation; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Hypolipidemic Agents; Lipid Metabolism; Regional Blood Flow; Thrombosis | 1981 |
[The endothelium: protective barrier or irritating thorn].
Topics: Anemia, Sickle Cell; Cell Adhesion; Cells, Cultured; Diabetes Mellitus; Endothelium; Erythrocytes; Fibrinogen; Fibronectins; Humans; Leukocytes; Neoplasms; Rheology; Thrombosis | 1982 |
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
Topics: Aneurysm; Arteriosclerosis; Blood Vessels; Calcium; Collagen; Coronary Artery Disease; Coronary Vessels; Elastin; Extracellular Matrix; Fibrinogen; Foam Cells; Humans; Lipid Metabolism; Lipoproteins; Lymphocytes; Muscle, Smooth, Vascular; Proteoglycans; Thrombosis; Tunica Intima | 1995 |
Fibrinogen in human atherosclerosis.
Topics: Arteriosclerosis; Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Humans; Risk Factors; Thrombosis | 1995 |
Hemostasis and atherosclerosis.
Topics: Anticoagulants; Arteriosclerosis; Blood Coagulation Disorders; Blood Coagulation Factors; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Lipoprotein(a); Male; Platelet Adhesiveness; Risk Factors; Thrombosis; von Willebrand Factor | 1995 |
Abnormalities of rheology and coagulation in hypertension.
Topics: Animals; Blood Coagulation; Blood Viscosity; Fibrinogen; Humans; Hypertension; Rheology; Thrombosis; von Willebrand Factor | 1994 |
Haemostatic function, arterial disease and the prevention of arterial thrombosis.
Topics: Adult; Aged; Anticoagulants; Arteries; Aspirin; Blood Coagulation Factors; Cardiovascular Diseases; Case-Control Studies; Clinical Trials as Topic; Factor VII; Factor VIII; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemophilia A; Hemostasis; Humans; Male; Middle Aged; Models, Biological; Models, Cardiovascular; Prospective Studies; Regression Analysis; Risk Factors; Thrombosis | 1994 |
[Beta blockers, fibrinogen, and atherosclerosis].
Topics: Adrenergic beta-Antagonists; Arteriosclerosis; Female; Fibrinogen; Humans; Hypertension; Lipoproteins; Male; Myocardial Ischemia; Risk Factors; Thrombosis | 1994 |
[Rational diagnosis in blood coagulation disorders].
Topics: Blood Coagulation Tests; Diagnosis, Differential; Fibrin; Fibrinogen; Hemorrhagic Disorders; Humans; Thrombosis | 1994 |
New insights into the mechanisms of platelet adhesion and aggregation.
Topics: Animals; Fibrinogen; Humans; Platelet Adhesiveness; Platelet Aggregation; Platelet Membrane Glycoproteins; Stress, Mechanical; Thrombosis; von Willebrand Factor | 1994 |
Fibrinogen structure, activation, polymerization and fibrin gel structure.
Topics: Animals; Fibrin; Fibrinogen; Gels; Polymers; Protein Conformation; Structure-Activity Relationship; Thrombosis; Vertebrates | 1994 |
How does ticlopidine treatment lower plasma fibrinogen?
Topics: Blood Viscosity; Clinical Trials as Topic; Fibrinogen; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Thrombosis; Ticlopidine; Vascular Diseases | 1994 |
Heparinless cardiopulmonary bypass with ancrod.
Topics: Adult; Ancrod; Cardiopulmonary Bypass; Fibrinogen; Follow-Up Studies; Foreign Bodies; Heart Atria; Heparin; Humans; Male; Syndrome; Thrombocytopenia; Thrombosis; Vena Cava Filters | 1994 |
Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque.
Topics: Arteriosclerosis; Blood Coagulation; Blood Platelets; Fibrinogen; Fibrinolysis; Foam Cells; Hemostasis; Humans; Lipoprotein(a); Thrombin; Thrombosis | 1994 |
Etiology of venous ulceration.
Topics: Capillary Permeability; Cell Hypoxia; Chronic Disease; Fibrin; Fibrinogen; Humans; Hypertension; Leg Ulcer; Leukocytes; Microcirculation; Necrosis; Terminology as Topic; Thrombosis; Venous Insufficiency; Venous Pressure | 1993 |
von Willebrand factor and fibrinogen.
Topics: Animals; Blood Platelets; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Leukocytes; Protein Structure, Secondary; Thrombosis; von Willebrand Factor | 1993 |
Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
Topics: Amino Acid Sequence; Animals; Cell Adhesion; Endothelium, Vascular; Fibrin; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Inflammation; Macromolecular Substances; Molecular Sequence Data; Neoplasms; Platelet Adhesiveness; Thrombosis; von Willebrand Factor | 1993 |
The role of fibrinogen as a cardiovascular risk factor.
Topics: Arteriosclerosis; Cardiovascular Diseases; Fibrinogen; Humans; Risk Factors; Thrombosis | 1993 |
Mechanisms involved in platelet vessel wall interaction.
Topics: Amino Acid Sequence; Blood Platelets; Endothelium, Vascular; Fibrinogen; Humans; Molecular Sequence Data; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Signal Transduction; Thrombosis | 1995 |
The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces.
Topics: Endothelium, Vascular; Fibrinogen; Hemorheology; Humans; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Protein Structure, Tertiary; Stress, Mechanical; Thrombosis; von Willebrand Factor | 1995 |
The contribution of thrombosis to the clinical expression of coronary atherosclerosis.
Topics: Animals; Blood Coagulation Factors; Circadian Rhythm; Coronary Artery Disease; Disease Models, Animal; Endopeptidases; Endothelium, Vascular; Fibrinogen; History, 19th Century; History, 20th Century; Humans; Myocardial Infarction; Myocardial Ischemia; Thrombosis | 1996 |
Fibrinogen and fibrin--proteins with complex roles in hemostasis and thrombosis.
Topics: Amino Acid Sequence; Animals; Biological Evolution; Biopolymers; Fibrin; Fibrinogen; Fibrinolysis; Gels; Hemostasis; Humans; Molecular Sequence Data; Molecular Structure; Thrombosis | 1996 |
Ancrod: understanding the agent.
Topics: Ancrod; Animals; Anticoagulants; Blood Coagulation; Coronary Artery Bypass; Fibrinogen; Fibrinolysis; Heparin; Humans; Pulmonary Embolism; Thrombocytopenia; Thrombosis; Vascular Surgical Procedures | 1996 |
[Fibrinogen: a risk factor].
Topics: Arteries; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Fibrinogen; Humans; Risk Factors; Thrombosis | 1996 |
Dietary fatty acids in athero-thrombogenesis: influence of palm oil ingestion.
Topics: Adult; Animals; Arteriosclerosis; Child; Cholesterol; Diet, Atherogenic; Dietary Fats; Factor VII; Feeding Behavior; Female; Fibrinogen; Fish Oils; Humans; Hypercholesterolemia; Linoleic Acid; Linoleic Acids; Lipoproteins; Male; Palm Oil; Plant Oils; Platelet Aggregation; Rabbits; Rural Population; Sunflower Oil; Thrombosis; Triglycerides; Urban Population; Venezuela | 1996 |
Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk.
Topics: Arteriosclerosis; Biomarkers; Carcinoma, Hepatocellular; Cytokines; Endothelium, Vascular; Fibrinogen; Gene Expression Regulation; Humans; Interleukin-6; Liver; Liver Neoplasms; Models, Biological; Monocytes; Oncostatin M; Peptide Biosynthesis; Peptides; Risk; Thrombosis; Tumor Cells, Cultured | 1996 |
[Role of fibrinogen in arterial vascular pathology].
Topics: Adult; Arteriosclerosis; Blood Viscosity; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Obesity; Platelet Aggregation; Prospective Studies; Risk Factors; Sex Factors; Smoking; Thrombosis | 1997 |
[RGD-dependent and -independent binding domains of fibronectin to GPIIb/IIIa].
Topics: Fibrinogen; Fibronectins; Oligopeptides; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1997 |
Assays for thrombosis factors: relations to plasma lipids.
Topics: Blood Coagulation; Blood Coagulation Tests; Dietary Fats; Enzyme Precursors; Factor VII; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Lipids; Thrombosis | 1997 |
Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease.
Topics: Blood Coagulation; Cardiovascular Diseases; Factor VII; Factor VIII; Fibrinogen; Hemostasis; Humans; Incidence; Lipoprotein(a); Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk Factors; Thrombosis; Tissue Plasminogen Activator | 1997 |
Dietary factors in thrombosis and hemostasis: summary and conclusions.
Topics: Animals; Cardiovascular Diseases; Cholesterol; Diet; Dietary Fats; Disease Models, Animal; Fibrinogen; Hemostasis; Humans; Incidence; Lipids; Platelet Activation; Thrombosis | 1997 |
Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis.
Topics: Chromosome Mapping; Environment; Fibrinogen; Fibrinolysis; Genetic Variation; Hemostasis; Humans; Myocardial Ischemia; Thrombosis | 1997 |
Mechanisms initiating platelet thrombus formation.
Topics: Biomechanical Phenomena; Blood Flow Velocity; Disease Progression; Fibrinogen; Humans; Platelet Adhesiveness; Platelet Aggregation; Thrombosis; von Willebrand Factor | 1997 |
Fibrinogen, fibrin turnover, endothelial products and vascular surgery.
Topics: Arteriosclerosis; Biomarkers; Blood Vessel Prosthesis; Fibrin; Fibrinogen; Humans; Peripheral Vascular Diseases; Plasminogen Inactivators; Thrombosis; von Willebrand Factor | 1997 |
Congenital dysfibrinogenemia.
Topics: Afibrinogenemia; Fibrinogen; Fibrinogens, Abnormal; Humans; Models, Molecular; Thrombosis; Wound Healing | 1997 |
What have mast cells to do with edema formation, the consecutive repair and fibrinolysis?
Topics: Animals; Edema; Fibrinogen; Heparin; Humans; Mast Cells; Mice; Plasminogen Inactivators; Proto-Oncogene Proteins c-kit; Stem Cell Factor; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1998 |
Controlling acute elevation of plasma fibrinogen with ancrod.
Topics: Ancrod; Dose-Response Relationship, Drug; Fibrinogen; Fibrinolytic Agents; Hemorheology; Humans; Thrombosis | 1998 |
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.
Topics: Animals; Antithrombins; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Endothelium, Vascular; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Lovastatin; Muscle, Smooth, Vascular; Platelet Aggregation; Pravastatin; Simvastatin; Thromboplastin; Thrombosis | 1998 |
Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis.
Topics: Adult; Age Factors; Aged; Alleles; Fibrinogen; Fibrinolysis; Genotype; Hemostasis; Humans; Middle Aged; Polymorphism, Genetic; Sex Factors; Thrombosis | 1999 |
Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?
Topics: Biomarkers; Blood Coagulation; Fibrinogen; Humans; Myocardial Ischemia; Risk Factors; Thrombosis | 1999 |
Fibrin-fibrinogen and dethrombosis.
Topics: Animals; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Thrombosis | 1999 |
New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
Topics: Animals; Dogs; Drug Combinations; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1999 |
Fibrinogen.
Topics: Cardiovascular Agents; Cell Adhesion; Fibrinogen; Humans; Integrins; Mitogens; Models, Molecular; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Thrombosis | 1999 |
Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.
Topics: Animals; Arterial Occlusive Diseases; Biomarkers; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ischemia; Thrombosis | 1999 |
Dietary treatment of thrombogenic disorders related to the metabolic syndrome.
Topics: Coronary Disease; Cross-Sectional Studies; Diet, Fat-Restricted; Dietary Fiber; Factor VII; Fibrinogen; Humans; Insulin; Insulin Resistance; Obesity; Thrombosis; Triglycerides | 2000 |
[Hemorheological aspects of leuko-platelet activation in atheromatous diseases: clinical applications].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Biomarkers; Blood Platelets; Blood Viscosity; Cytokines; Endothelium, Vascular; Feedback; Fibrinogen; Free Radicals; Hemorheology; Humans; Inflammation; Ischemia; Leg; Leukocytes; Nitric Oxide; Risk Factors; Thrombophilia; Thrombosis | 2000 |
Fibrinogen polymorphisms and atherothrombotic disease.
Topics: Arteriosclerosis; Fibrinogen; Haplotypes; Humans; Linkage Disequilibrium; Polymorphism, Genetic; Thrombosis | 2001 |
Fibrinogen and its degradation products as thrombotic risk factors.
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Ischemia; Risk Factors; Thrombosis | 2001 |
The dysfibrinogenaemias.
Topics: Afibrinogenemia; Blood Coagulation Tests; Carcinoma, Hepatocellular; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Neoplasms; Mutation; Thrombosis | 2001 |
Interleukin 6 and haemostasis.
Topics: Arteriosclerosis; Blood Coagulation Factors; Blood Platelets; Endothelium, Vascular; Factor VIII; Fibrinogen; Hemostasis; Hepatocytes; Humans; Interleukin-6; Leukocytes; Models, Biological; Receptors, Interleukin-6; Thromboplastin; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2001 |
Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.
Topics: Blood Coagulation Factors; Blood Platelets; Coronary Disease; Estrogen Replacement Therapy; Factor V; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Plasminogen Activator Inhibitor 1; Point Mutation; Polymorphism, Genetic; Postmenopause; Prothrombin; Thrombosis | 2002 |
Peripheral vascular disease and Virchow's triad for thrombogenesis.
Topics: Arteries; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Peripheral Vascular Diseases; Regional Blood Flow; Thrombosis | 2002 |
[Clinical implications of rheology in cardiovascular diseases].
Topics: Adult; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cerebrovascular Disorders; Child; Diabetic Angiopathies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Leukemia; Leukocytes; Malaria; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Thrombosis | 2002 |
Sticky and promiscuous plasma proteins maintain the equilibrium between bleeding and thrombosis.
Topics: Blood Coagulation; Blood Coagulation Factors; Factor VIII; Factor XIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Polymers; Thrombin; Thrombosis; Thrombospondins; Tissue Adhesions; Vitronectin; von Willebrand Factor | 2002 |
[Urokinase. Biochemical therapeutical and therapeutical data (author's transl)].
Topics: alpha-Macroglobulins; Animals; Arteriovenous Shunt, Surgical; Chemical Phenomena; Chemistry; Coagulants; Endopeptidases; Enzyme Activation; Fibrinogen; Fibrinolysis; Humans; Hyphema; Intracranial Embolism and Thrombosis; Myocardial Infarction; Plasminogen Activators; Pulmonary Embolism; Retinal Vein; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator | 1976 |
Hypercoagulability.
Topics: alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cell Survival; Factor V; Factor VII; Factor VIII; Factor XII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Fibrinopeptide B; Humans; Kinetics; Liver; Mononuclear Phagocyte System; Platelet Aggregation; Thrombosis | 1977 |
Effects of plasma expanders on coagulation and hemostasis: dextran hydroxyethyl starch, and other macromolecules revisited.
Topics: Blood Coagulation; Blood Platelets; Chemical Precipitation; Dextrans; Factor VIII; Female; Fibrinogen; Fibrinolysin; Hemostasis; Humans; Hydroxyethyl Starch Derivatives; Male; Middle Aged; Molecular Weight; Plasma Substitutes; Platelet Adhesiveness; Prothrombin; Thrombosis; von Willebrand Diseases | 1978 |
Antifibrinolytics gynaecology and obstetrics.
Topics: Adolescent; Adult; Animals; Antifibrinolytic Agents; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Child; Endometritis; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Hyperplasia; Menstruation Disturbances; Middle Aged; Phosphotransferases; Plasminogen; Pregnancy; Pregnancy Complications; Rats; Thrombosis; Uterine Hemorrhage; Uterine Neoplasms | 1975 |
Diffuse intravascular coagulation in liver disease?
Topics: Afibrinogenemia; Blood Cell Count; Blood Platelets; Disseminated Intravascular Coagulation; Factor V Deficiency; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Half-Life; Hemophilia A; Heparin; Humans; Liver Diseases; Peptide Hydrolases; Thrombocytopenia; Thrombosis | 1977 |
Oral contraceptives, blood clotting and thrombosis.
Topics: Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Contraceptives, Oral; Estrogens; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Progestins; Thrombosis | 1978 |
Congenital abnormalities of fibrinogen.
Topics: Afibrinogenemia; Blood Platelets; Chemical Phenomena; Chemistry; Child; Diagnosis, Differential; Fibrin; Fibrinogen; Humans; Male; Thromboembolism; Thrombosis | 1979 |
Hypercoagulability.
Topics: Animals; Antithrombin III; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Fibrinogen; Fibrinolysis; Humans; Mononuclear Phagocyte System; Thrombosis | 1979 |
Platelet and fibrinogen kinetic evaluation of thrombogenesis.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Platelets; Cell Survival; Dipyridamole; Fibrinogen; Heparin; Humans; Platelet Adhesiveness; Platelet Aggregation; Thromboembolism; Thrombosis | 1979 |
[Changes in the blood coagulation system and fibrinolysis during growth and metastasis of malignant neoplasms].
Topics: Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Neoplasm Metastasis; Neoplasms; Thromboplastin; Thrombosis | 1976 |
[Diagnosis of postoperative thrombosis and prevention by means of coumarin derivatives].
Topics: Coumarins; Fibrinogen; Humans; Iodine Radioisotopes; Postoperative Complications; Thrombosis | 1976 |
Possibilities of DNA analysis for the detection of predisposition to thrombotic disease.
Topics: Biomarkers; DNA; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Plasminogen Activator Inhibitor 1; Thrombosis | 1992 |
Targeting of thrombolytic agents: current state of knowledge and perspectives.
Topics: Animals; Antibodies; Drug Carriers; Fibrinogen; Fibrinolytic Agents; Humans; Liposomes; Magnetics; Thrombin; Thrombosis | 1992 |
Thrombosis and cardiovascular risk in the elderly.
Topics: Age Factors; Aged; Aging; Cardiovascular Diseases; Factor VII; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Risk Factors; Thrombosis | 1992 |
The roles of fibrinogen and fibrin in hemostasis and thrombosis.
Topics: Amino Acid Sequence; Cross-Linking Reagents; Fibrin; Fibrinogen; Hemostasis; Humans; Molecular Sequence Data; Protein Conformation; Thrombosis | 1992 |
[Enoxaparin in the prevention of deep venous thrombosis in general surgery].
Topics: Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Phlebography; Postoperative Complications; Thrombosis | 1991 |
Fibrinogen and fibrin formation and its role in fibrinolysis.
Topics: Afibrinogenemia; Amino Acid Sequence; Animals; Blood Proteins; Calcium; Epitopes; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Gels; Glycosylation; Hemostasis; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Phylogeny; Polymers; Thrombin; Thrombosis | 1991 |
Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Arteriosclerosis; Dogs; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Kidney Diseases; Neoplasms; Pregnancy; Pregnancy Complications; Radioimmunodetection; Thrombosis | 1991 |
[Microorganisms synthesizing enzymes with thrombolytic action].
Topics: Bacteria; Culture Media; Exopeptidases; Fibrin; Fibrinogen; Fibrinolytic Agents; Fungi; Humans; Peptide Hydrolases; Thrombosis | 1991 |
Integrins in thrombosis, wound healing and cancer.
Topics: Amino Acid Sequence; Fibrinogen; Humans; Integrins; Molecular Sequence Data; Neoplasms; Platelet Membrane Glycoproteins; Thrombosis; Wound Healing | 1991 |
Adhesive interactions of platelets and their blockade.
Topics: Amino Acid Sequence; Blood Platelets; Cardiovascular Diseases; Fibrinogen; Humans; Models, Biological; Molecular Sequence Data; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Thrombosis | 1991 |
Radiopharmaceuticals for thrombus detection.
Topics: Antibodies, Monoclonal; Blood Platelets; Deferoxamine; Fibrinogen; Fibrinolysin; Humans; Iodine Radioisotopes; Organotechnetium Compounds; Radionuclide Imaging; Starch; Thrombophlebitis; Thrombosis | 1990 |
Searching for the thrombogenic mechanism(s) of fibrinogen.
Topics: Blood Platelets; Blood Viscosity; Endothelium, Vascular; Fibrinogen; Humans; Monocytes; Protein Binding; Risk Factors; Thrombosis | 1990 |
[Usefulness of several laboratory tests on prethrombotic status in arterial vascular pathology].
Topics: Arteriosclerosis; beta-Thromboglobulin; Biomarkers; Fibrinogen; Fibrinopeptide A; Humans; Platelet Factor 4; Risk Factors; Thrombosis | 1989 |
Thrombosis in atherogenesis.
Topics: Antigens; Arteriosclerosis; Endothelium, Vascular; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunochemistry; Immunohistochemistry; Thrombosis | 1989 |
Concepts of clot lysis.
Topics: alpha-2-Antiplasmin; Animals; Blood Coagulation; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Dogs; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Homeostasis; Humans; Iatrogenic Disease; Plasminogen; Plasminogen Activators; Rabbits; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
[Physiopathology of thrombosis: blood coagulation factors and fibrinolytic factors].
Topics: Antithrombin III Deficiency; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysis; Glycoproteins; Humans; Protein C; Protein S; Thrombosis | 1986 |
Hereditary disorders predisposing to thrombosis.
Topics: Antithrombin III; Antithrombin III Deficiency; Blood Coagulation; Blood Proteins; Complement C4; Complement C4b; Disease Susceptibility; Enzyme Activation; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Glycoproteins; Humans; Pedigree; Plasminogen; Protein Binding; Protein C; Protein C Deficiency; Protein C Inhibitor; Protein S; Receptors, Cell Surface; Receptors, Thrombin; Thrombosis | 1986 |
Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
Topics: Blood Coagulation Tests; Blood Specimen Collection; Clinical Laboratory Techniques; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Monitoring, Physiologic; Plasminogen; Streptokinase; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1987 |
[Platelet aggregation, thrombosis formation and prostaglandins].
Topics: Animals; Arachidonic Acids; Blood Vessels; Collagen; Dogs; Epoprostenol; Fibrinogen; Glycoproteins; Humans; Membrane Proteins; Platelet Aggregation; Platelet Membrane Glycoproteins; Prostaglandins; Rabbits; Thrombosis; Thromboxane A2 | 1985 |
[Congenital dysfibrinogenemia and thrombosis].
Topics: Afibrinogenemia; Antithrombins; Fibrinogen; Humans; Thrombosis | 1987 |
[Fibrinogen: physiological and pathological aspects].
Topics: Blood Coagulation; Fibrinogen; Humans; Thrombosis | 1987 |
Platelets and plasma proteins in the early phases of thrombusformation.
Topics: Antifibrinolytic Agents; Blood Coagulation; Blood Platelets; Blood Proteins; Cell Membrane; Fibrin; Fibrinogen; Fibronectins; Humans; Macromolecular Substances; Thromboembolism; Thrombosis | 1986 |
Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
Topics: Animals; Arteriosclerosis; Coronary Disease; Disease Models, Animal; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Lipoproteins, LDL; Muscle, Smooth, Vascular; Risk; Thrombosis | 1986 |
[Artificial organs and thrombosis: CAPD and thrombosis].
Topics: Blood Viscosity; Creatinine; Erythrocyte Deformability; Fibrinogen; Hematocrit; Humans; Peritoneal Dialysis, Continuous Ambulatory; Platelet Aggregation; Serum Albumin; Thrombosis | 1986 |
[Pathophysiology and treatment of thrombosis. 1. Hypercoagulable state. (1) Study on the role of tissue thromboplastin in the formation of thrombosis].
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Humans; Thromboplastin; Thrombosis | 1987 |
Current concepts. Postpartum renal failure.
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Blood Coagulation Factors; Female; Fibrinogen; Hemolytic-Uremic Syndrome; Hemostasis; Humans; Kidney; Platelet Aggregation; Pregnancy; Prognosis; Puerperal Disorders; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Thrombosis | 1985 |
Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.
Topics: Antithrombin III; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Fibrin; Fibrinogen; Fibrinolysis; Humans; Nephrotic Syndrome; Renal Veins; Thromboembolism; Thrombophlebitis; Thrombosis | 1985 |
Fibrinolysis.
Topics: Alpha-Globulins; Biological Assay; Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; Metabolic Diseases; Peptide Hydrolases; Plasminogen; Streptokinase; Thromboembolism; Thrombosis | 1968 |
Some current views on arteriosclerosis and its origins. Notes on the perfusion theory of W. Doerr.
Topics: Aorta; Arteries; Arteriosclerosis; Blood Circulation; Blood Proteins; Collagen; Coronary Vessels; Elasticity; Fibrin; Fibrinogen; Glycosaminoglycans; Humans; Lipid Metabolism; Muscle, Smooth; Plasma; Thrombosis | 1969 |
Fibrinolytic agents.
Topics: Aminocaproates; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; In Vitro Techniques; Infusions, Parenteral; Injections, Intravenous; Nicotinic Acids; Peptide Hydrolases; Plasminogen; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thrombosis; Trypsin | 1969 |
[Principles of thrombolytic treatment].
Topics: Embolism; Fibrinogen; Fibrinolysin; Heparin; Humans; Injections, Intravenous; Peptide Hydrolases; Plasminogen; Recurrence; Streptokinase; Thromboembolism; Thrombosis | 1972 |
Degradation of fibrinogen by plasmin: physicochemical characteristics and their correlation to antithrombic activity.
Topics: Amino Acids; Ammonium Sulfate; Animals; Antithrombins; Blood Coagulation; Cattle; Chemical Precipitation; Chromatography, Ion Exchange; Depression, Chemical; Dialysis; Electrophoresis, Disc; Electrophoresis, Paper; Electrophoresis, Polyacrylamide Gel; Ethyl Ethers; Fibrinogen; Fibrinolysin; Hot Temperature; Humans; Hydrolysis; Peptide Fragments; Peptides; Solubility; Thrombin; Thrombosis; Trichloroacetic Acid | 1973 |
Microangiopathic haemolytianaemia.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anemia, Hemolytic; Blood Coagulation Disorders; Cerebrovascular Disorders; Dialysis; Factor V; Factor VIII; Fibrinogen; Heparin; Humans; Ischemia; Kidney; Purpura, Thrombocytopenic; Shwartzman Phenomenon; Splenectomy; Thrombocytopenia; Thrombosis | 1969 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
[Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
Topics: Agglutination Tests; Blood Coagulation Tests; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Immunoelectrophoresis; Latex Fixation Tests; Methods; Protamines; Staphylococcus; Sulfates; Thrombin; Thrombosis | 1973 |
On biorheology.
Topics: Biology; Blood Circulation; Blood Proteins; Blood Viscosity; Fibrinogen; History, 19th Century; History, 20th Century; Humans; Microcirculation; Rheology; Subcellular Fractions; Thermodynamics; Thrombosis | 1973 |
Recent advances in venous thrombo-embolism. A review article.
Topics: Adult; Anticoagulants; Dextrans; Female; Femoral Vein; Fibrinogen; Heparin; Humans; Iliac Vein; Iodine Radioisotopes; Leg; Middle Aged; Thrombophlebitis; Thrombosis; Veins | 1973 |
Role of coagulation system in pathophysiology of sickle cell disease.
Topics: Anemia, Sickle Cell; Anticoagulants; Blood Coagulation; Blood Platelets; Cell Survival; Dextrans; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Mononuclear Phagocyte System; Platelet Adhesiveness; Rheology; Thrombosis | 1974 |
Fibrinogen: requirement for platelet aggregation and adhesion.
Topics: Adenosine Diphosphate; Adsorption; Afibrinogenemia; Animals; Blood Platelets; Blood Proteins; Calcium; Fibrinogen; Glass; Hemostasis; Humans; In Vitro Techniques; Magnesium; Microscopy, Electron; Platelet Adhesiveness; Snakes; Species Specificity; Swine; Thrombin; Thrombosis; Venoms | 1972 |
Some recent advances in the study of hemostasis.
Topics: Angioedema; Animals; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Complement System Proteins; Enzyme Precursors; Factor VIII; Factor XII; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemophilia A; Hemostasis; Humans; Kallikreins; Male; Platelet Adhesiveness; Thrombin; Thromboplastin; Thrombosis; von Willebrand Diseases | 1974 |
Mechanism of platelet aggregation and release: their possible role in vascular injury.
Topics: Adenosine Diphosphate; Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Coagulation; Blood Platelets; Blood Proteins; Blood Vessels; Collagen; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Glass; Graft Rejection; Hemostasis; Humans; Ischemia; Kidney Transplantation; Platelet Adhesiveness; Platelet Aggregation; Thrombosis; Transplantation, Homologous | 1973 |
Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction.
Topics: Adult; Aged; Arteries; Arteriosclerosis; Coronary Disease; Coronary Vessels; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Necrosis; Thrombosis; Time Factors | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
Degradation products of fibrinogen and crosslinked fibrin-projected clinical applications.
Topics: Diagnosis, Differential; Disseminated Intravascular Coagulation; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Peptide Hydrolases; Peptide Termination Factors; Peptides; Streptokinase; Thrombosis; Venoms | 1974 |
Interaction of fibrin with various cells.
Topics: Animals; Blood Platelets; Cell Adhesion; Cell Membrane; Chemotaxis; Clot Retraction; Eosinophils; Erythrocytes; Fibrin; Fibrinogen; Fibroblasts; Hemostasis; Humans; Iodine Radioisotopes; L Cells; Leukocytes; Mice; Microscopy, Electron; Neutrophils; Peptide Hydrolases; Polymers; Prostaglandins; Rabbits; Skin; Snake Venoms; Swine; Thrombin; Thrombosis | 1973 |
[Significance of thrombogenesis in the pathogenesis of arteriosclerosis (literature review)].
Topics: Animals; Aorta; Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Blood Vessels; Endocrine Glands; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Heparin Antagonists; Hepatitis; Humans; Lipid Metabolism; Lipoprotein Lipase; Liver; Liver Cirrhosis; Stress, Physiological; Thrombin; Thrombosis; Triglycerides | 1967 |
Blood clotting abnormalitis in relation to pre-eclampsia: a review.
Topics: Abruptio Placentae; Adrenal Glands; Aminocaproates; Animals; Basement Membrane; Biopsy; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Brain; Female; Fibrin; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Hemorrhage; Hemorrhagic Disorders; Heparin; Humans; Hypertension, Malignant; Kidney Cortex Necrosis; Kidney Failure, Chronic; Kidney Glomerulus; Liver; Maternal Mortality; Microscopy, Electron; Myocardium; Placental Extracts; Pre-Eclampsia; Pregnancy; Rabbits; Shwartzman Phenomenon; Thromboplastin; Thrombosis | 1969 |
The hemostatic mechanism and its defects.
Topics: Adenosine Triphosphate; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Blood Vessels; Capillary Permeability; Clot Retraction; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Kinins; Phospholipids; Prothrombin; Purpura; Telangiectasis; Thrombin; Thrombocytopenia; Thrombosis; von Willebrand Diseases | 1968 |
On the mechanism of thrombosis.
Topics: Adenine Nucleotides; Blood Coagulation; Blood Flow Velocity; Blood Platelets; Blood Vessels; Factor X; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Inflammation; Lipid Metabolism; Liver; Prothrombin; Thrombin; Thrombosis | 1969 |
Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
Topics: Aminocaproates; Animals; Anticoagulants; Antifibrinolytic Agents; Antigens; Aprotinin; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Chromatography; Chromatography, Gel; Dogs; Epidermolysis Bullosa; Fibrinogen; Fibrinolysis; Hematocrit; Immunoelectrophoresis; Injections, Intravenous; Iodine Isotopes; Liver Cirrhosis; Peptides; Polycythemia Vera; Potassium Iodide; Thrombin; Thromboplastin; Thrombosis | 1969 |
[Problems of directed hemostasis and coagulation stimulation in pathological tendency to bleed].
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Benzoates; Blood Coagulation; Blood Platelets; Calcium; Cortisone; Epinephrine; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Muscle Contraction; Muscle, Smooth; Prothrombin Time; Thrombin; Thrombosis; Vitamin B 12 | 1969 |
The role of hypercoagulability in venous and arterial thrombosis.
Topics: Anticoagulants; Antithrombins; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Flow Velocity; Blood Group Antigens; Collagen; Contraceptives, Oral; Disseminated Intravascular Coagulation; Estrogens; Female; Fibrinogen; Humans; Lipid Metabolism; Platelet Adhesiveness; Thrombin; Thromboembolism; Thrombophlebitis; Thrombosis | 1971 |
Blood coagulation changes in disease.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Extracorporeal Circulation; Fibrinogen; Fibrinolysis; Heparin; Humans; Kallikreins; Kinins; Plasminogen; Platelet Adhesiveness; Prothrombin Time; Shock; Thrombosis; Wounds and Injuries | 1971 |
Disseminated intravascular coagulation: thrombosis versus fibrination, in clinical disease states.
Topics: Abruptio Placentae; Disseminated Intravascular Coagulation; Embolism; Female; Fibrinogen; Fibrinolysis; Humans; Pregnancy; Thromboplastin; Thrombosis | 1969 |
61 trial(s) available for fibrinogen and Blood Clot
| Article | Year |
|---|---|
Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial.
Topics: Blood Coagulation Disorders; Factor XIII; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemostatics; Humans; Plasminogen Activator Inhibitor 1; Thrombosis | 2022 |
Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia.
Topics: Adolescent; Adult; Afibrinogenemia; Age Factors; Cerebral Hemorrhage; Child; Child, Preschool; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Quality of Life; Risk Factors; Thrombosis | 2021 |
Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis.
Topics: Adult; Biomarkers; Blood Coagulation; Blood Glucose; Body Mass Index; Cluster Analysis; Diabetes Mellitus, Type 1; Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk Assessment; Thromboplastin; Thrombosis | 2021 |
Haloperidol Does Not Activate Thrombogenic Factors in Older, Nonpsychotic Hospitalized Patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Biomarkers; Fibrin Fibrinogen Degradation Products; Fibrinogen; Haloperidol; Humans; Osteoprotegerin; P-Selectin; Thrombosis; von Willebrand Factor | 2017 |
Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients.
Topics: Adult; Aged; Atrial Appendage; Atrial Fibrillation; Blood Coagulation Tests; Female; Fibrinogen; Humans; Male; Middle Aged; Rivaroxaban; Thrombosis; Treatment Outcome; Warfarin | 2019 |
Effects of dark chocolate consumption on the prothrombotic response to acute psychosocial stress in healthy men.
Topics: Acute Disease; Adult; Biomarkers; Cacao; Candy; Catechin; Epinephrine; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Functional Food; Healthy Volunteers; Humans; Male; Mathematical Concepts; Middle Aged; Norepinephrine; Single-Blind Method; Speech; Stress, Psychological; Switzerland; Thrombosis; Time Factors; Treatment Outcome; von Willebrand Factor; Young Adult | 2014 |
Response of fractional synthesis rate (FSR) of fibrinogen, concentration of D-dimer and fibrinolytic balance to physical activity-based intervention in obese children.
Topics: Adolescent; Exercise; Exercise Therapy; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Kinetics; Life Style; Male; Obesity; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Tissue Plasminogen Activator | 2008 |
Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery.
Topics: Aged; Aspirin; Cilostazol; Coronary Artery Bypass, Off-Pump; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Tetrazoles; Thrombosis; Time Factors; Treatment Outcome; von Willebrand Factor | 2008 |
Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study.
Topics: Aged; Biomarkers; Blood Loss, Surgical; C-Reactive Protein; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Inflammation Mediators; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Postoperative Hemorrhage; Prospective Studies; Thrombosis; Time Factors; Treatment Outcome | 2009 |
Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial.
Topics: Blood Transfusion; Cystectomy; Fibrinogen; Hemodilution; Hemorrhage; Humans; Hydroxyethyl Starch Derivatives; Placebos; Thrombelastography; Thrombosis | 2009 |
Effects of soy consumption on oxidative stress, blood homocysteine, coagulation factors, and phosphorus in peritoneal dialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Factor IX; Female; Fibrinogen; Homocysteine; Humans; Iran; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Phosphorus; Risk Factors; Soy Foods; Soybean Proteins; Thrombosis | 2009 |
A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagu
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; Blood Coagulation; CD40 Ligand; Clopidogrel; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Hirudins; Humans; Lipoproteins; Male; Membrane Glycoproteins; Middle Aged; Monocytes; Peptide Fragments; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin; Recombinant Proteins; Thromboplastin; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke.
Topics: Aged; Biomarkers; Blood Pressure; Blood Sedimentation; Brain Ischemia; C-Reactive Protein; Electrocardiography; Embolism; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Socioeconomic Factors; Stroke; Thrombosis | 2011 |
Atorvastatin reduces plasma levels of factor VII activity and factor VII antigen in patients with hyperlipidemia.
Topics: Aged; Anticholesteremic Agents; Antigens; Atorvastatin; Blood Glucose; Factor VII; Female; Fibrinogen; Hemostasis; Heptanoic Acids; Humans; Hyperlipidemias; Isoantigens; Male; Middle Aged; Pyrroles; Risk Factors; Thrombosis; Triglycerides | 2002 |
A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation.
Topics: Albumins; Drug Synergism; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Immunoglobulins, Intravenous; Male; Risk Factors; Thrombosis | 2003 |
Failure of peripheral arterial thrombolysis due to elevated plasminogen activator inhibitor type 1.
Topics: Female; Fibrinogen; Humans; Male; Peripheral Vascular Diseases; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombin Time; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Failure; Urokinase-Type Plasminogen Activator | 2003 |
Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity.
Topics: Aged; Arteries; Arteriosclerosis; Asian People; Biomarkers; Black People; Causality; Comorbidity; Endothelium, Vascular; Female; Fibrinogen; Humans; Intermittent Claudication; Male; P-Selectin; Peripheral Vascular Diseases; Risk Assessment; Risk Factors; Severity of Illness Index; Statistics as Topic; Thromboplastin; Thrombosis; United Kingdom; von Willebrand Factor; White People | 2003 |
Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
Topics: Adenosine Diphosphate; Clopidogrel; Coronary Vessels; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Stents; Thrombosis; Ticlopidine; von Willebrand Factor | 2004 |
Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.
Topics: Administration, Cutaneous; Androgens; Angina Pectoris; Blood Coagulation; Chronic Disease; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Testosterone; Thrombosis; Tissue Plasminogen Activator | 2005 |
Procoagulant state after raloxifene therapy in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Female; Fibrinogen; Humans; Longitudinal Studies; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Postmenopause; Prospective Studies; Protein C; Protein Precursors; Prothrombin; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thrombosis | 2005 |
Ratio of oleic to palmitic acid is a dietary determinant of thrombogenic and fibrinolytic factors during the postprandial state in men.
Topics: Adult; Area Under Curve; Cardiovascular Diseases; Cross-Over Studies; Dietary Fats; Dietary Fats, Unsaturated; Enzyme Inhibitors; Fibrinogen; Humans; Male; Oleic Acid; Palmitic Acid; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Postprandial Period; Risk Factors; Thromboplastin; Thrombosis; Triglycerides | 2006 |
Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
Topics: Age Factors; Aged; Coronary Disease; Factor VII; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Stroke; Thrombosis | 2006 |
Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Antithrombins; Blood Coagulation; Blood Proteins; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Factor VIII; Female; Fibrinogen; Humans; Norgestrel; Oximes; Protein S; Risk Factors; Thrombosis; von Willebrand Factor | 2008 |
Venous thrombosis and embolism.
Topics: Angiography; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Auscultation; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Dextrans; Endothelium; Fibrinogen; Fibrinolysis; Heparin; Humans; Iodine Radioisotopes; Phlebography; Platelet Aggregation; Rheology; Thrombophlebitis; Thrombosis | 1981 |
The effect of lumbar epidural analgesia on the development of deep vein thrombosis of the legs after open prostatectomy.
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Prostatectomy; Prostatic Hyperplasia; Thrombosis; Transfusion Reaction | 1981 |
Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
Topics: alpha-2-Antiplasmin; alpha-Macroglobulins; Blood Coagulation Tests; Clinical Trials as Topic; Drug Administration Schedule; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Plasminogen; Prospective Studies; Random Allocation; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator | 1983 |
The effect of a thigh tourniquet on the incidence of deep venous thrombosis after operations on the fore part of the foot.
Topics: Adult; Aged; Auscultation; Female; Fibrinogen; Foot; Humans; Iodine Radioisotopes; Male; Middle Aged; Plethysmography, Impedance; Prospective Studies; Random Allocation; Thrombosis; Tourniquets; Ultrasonography | 1982 |
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Chronic Disease; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Longitudinal Studies; Male; Middle Aged; Thrombosis; von Willebrand Factor; Warfarin | 1995 |
[Rheological parameters in hemorrhoid pathology].
Topics: Acute Disease; Adult; Aged; Chronic Disease; Erythrocyte Aggregation; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hemorheology; Hemorrhoids; Humans; Male; Middle Aged; Prolapse; Regional Blood Flow; Thrombosis | 1994 |
Haemostatic effects of supraphysiological levels of testosterone in normal men.
Topics: Adult; Antithrombin III; Blood Proteins; Fibrinogen; Hemostasis; Humans; Male; Peptide Fragments; Prothrombin; Risk Factors; Sperm Count; Spermatogenesis-Blocking Agents; Testosterone; Thrombosis | 1995 |
[Molecular markers of hemostasis activation in children with nephrotic syndrome].
Topics: Biomarkers; Blood Coagulation; Child; Child, Preschool; Dicumarol; Female; Fibrinogen; Humans; Male; Nephrotic Syndrome; Platelet Count; Recurrence; Thrombosis | 1995 |
A cross-over study of a new low molecular weight heparin (Logiparin) in hemodialysis.
Topics: Adult; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Female; Fibrinogen; Hematocrit; Heparin, Low-Molecular-Weight; Humans; Kidney Failure, Chronic; Male; Middle Aged; Molecular Weight; Partial Thromboplastin Time; Prothrombin; Renal Dialysis; Thrombosis | 1996 |
Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biphenyl Compounds; Bleeding Time; Cell Division; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Muscle, Smooth, Vascular; P-Selectin; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Thrombosis; Thromboxane A2; Thromboxane B2; Vasoconstriction | 1997 |
Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men.
Topics: Administration, Oral; Aged; Antithrombin III; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Estradiol; Fibrinogen; Fibrinolysis; Follow-Up Studies; Homocysteine; Humans; Lipids; Lipoprotein(a); Male; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Prothrombin; Risk Factors; Thrombosis | 1998 |
Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.
Topics: Adolescent; Adult; Bleeding Time; Blood Platelets; Child; Erythropoietin; Female; Fibrinogen; Hemostasis; Humans; Ketanserin; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Storage Pool Deficiency; Renal Dialysis; Serotonin; Thrombosis; Time Factors | 1998 |
Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessation.
Topics: Administration, Inhalation; Administration, Intranasal; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Erythrocyte Indices; Female; Fibrinogen; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Nicotine; Nicotinic Agonists; Platelet Count; Prospective Studies; Risk Factors; Smoking Cessation; Thrombosis | 1999 |
High dose supplementation of RRR-alpha-tocopherol decreases cellular hemostasis but accelerates plasmatic coagulation in type 2 diabetes mellitus.
Topics: Aged; Antigens, CD; Antioxidants; Arteriosclerosis; Case-Control Studies; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Female; Fibrinogen; Hemostasis; Humans; Leukocytes; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Vitamin E | 1999 |
Thromboviscometry as a tool for evaluation of thrombotic risk in systemic hypertension.
Topics: Adult; Blood Coagulation; Blood Viscosity; Evaluation Studies as Topic; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Risk Factors; Thrombosis | 2000 |
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Dose-Response Relationship, Drug; Drug Combinations; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Prospective Studies; Reference Values; Thrombosis; von Willebrand Factor; Warfarin | 2000 |
Plasma apolipoprotein B levels predict platelet-dependent thrombosis in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Apolipoproteins B; Biomarkers; Blood Glucose; Blood Platelets; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Magnesium; Male; Middle Aged; Platelet Aggregation; Platelet Count; Prognosis; Prospective Studies; Risk Factors; Thrombosis | 1999 |
Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects.
Topics: Adult; Cross-Over Studies; Dietary Fats; Factor VII; Factor VIIa; Female; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Lipids; Male; Middle Aged; Oleic Acid; Postprandial Period; Risk Factors; Stearic Acids; Thrombosis; Time Factors; Tissue Plasminogen Activator; Triglycerides | 2001 |
The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.
Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor VII; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; International Normalized Ratio; Male; Middle Aged; Peptide Fragments; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Recurrence; Saphenous Vein; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; von Willebrand Factor; Warfarin | 2001 |
Physical excercise and thrombotic risk in the elderly.
Topics: Age Factors; Aged; Aged, 80 and over; Blood Viscosity; Exercise; Factor VII; Female; Fibrinogen; Humans; Male; Plasminogen Activator Inhibitor 1; Prospective Studies; Risk Factors; Thrombosis | 2001 |
Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemia.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Female; Fenofibrate; Fibric Acids; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; Triglycerides | 2001 |
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes.
Topics: Acute Disease; Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Platelet Aggregation; Pyrroles; Thromboplastin; Thrombosis | 2002 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy; Early Ambulation; Exercise Therapy; Fibrinogen; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Physical Therapy Modalities; Platelet Aggregation; Postoperative Complications; Posture; Pulmonary Embolism; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombosis | 1975 |
Effect of dextran on factor VIII and thrombus stability in humans. Significance of varying infusion rates.
Topics: Clinical Trials as Topic; Dextrans; Drug Evaluation; Factor VIII; Fibrinogen; Fibrinolytic Agents; Hematocrit; Humans; Infusions, Parenteral; Thrombosis; Time Factors | 1977 |
[Prevention of thromboembolic complications in transurethral resection of the prostate (author's transl)].
Topics: Adult; Aged; Dextrans; Fibrinogen; Humans; Iodine Radioisotopes; Male; Middle Aged; Prospective Studies; Prostatectomy; Pulmonary Embolism; Thrombosis; Urethra | 1977 |
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
Topics: Aged; Angina Pectoris; Arteriosclerosis; Factor VII; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Thrombosis; Vascular Diseases | 1992 |
Lowering of plasma viscosity by the oral administration of the glycosaminoglycan sulodexide in patients with peripheral vascular disease.
Topics: Administration, Oral; Adult; Blood Coagulation; Blood Viscosity; Double-Blind Method; Female; Fibrinogen; Glycosaminoglycans; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Thrombosis | 1992 |
[Enoxaparin in the prevention of deep venous thrombosis in general surgery].
Topics: Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Phlebography; Postoperative Complications; Thrombosis | 1991 |
Double-blind randomized trial of perioperative fibrinolytic enhancement for femoropopliteal bypass.
Topics: Aged; Double-Blind Method; Femoral Artery; Fibrinogen; Humans; Plasminogen; Popliteal Artery; Postoperative Care; Postoperative Complications; Stanozolol; Thrombolytic Therapy; Thrombosis | 1991 |
Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled study.
Topics: Aged; Aged, 80 and over; Blood Viscosity; Double-Blind Method; Fibrinogen; Humans; Male; Middle Aged; Patient Compliance; Polycythemia Vera; Risk Factors; Thrombosis; Ticlopidine; Time Factors | 1991 |
Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts.
Topics: Adult; Aged; Blood Vessel Prosthesis; Clinical Trials as Topic; Female; Fibrinogen; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Leg; Male; Middle Aged; Popliteal Artery; Radiography; Recombinant Proteins; Thrombosis; Time Factors; Tissue Plasminogen Activator | 1986 |
Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: a controlled cross-over randomized study.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Drug Administration Schedule; Female; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Male; Patient Compliance; Random Allocation; Thrombosis | 1988 |
Small doses of heparin in the prevention of deep venous thrombosis.
Topics: Fibrinogen; Heparin; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Subcutaneous; Iodine Radioisotopes; Lipoprotein Lipase; Platelet Adhesiveness; Postoperative Complications; Thrombosis | 1971 |
Fibrinolytic activity and postoperative deep-vein thrombosis.
Topics: Abdomen; Adult; Age Factors; Aged; Blood Coagulation; Blood Coagulation Tests; Blood Specimen Collection; Clinical Trials as Topic; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Humans; Hysterectomy; Iodine Radioisotopes; Leg; Middle Aged; Phenformin; Postoperative Complications; Thrombophlebitis; Thrombosis; Vagina | 1974 |
Small subcutaneous doses of heparin in prevention of venous thrombosis.
Topics: Adult; Aged; Blood Coagulation Tests; Blood Transfusion; Clinical Trials as Topic; Female; Femoral Fractures; Femoral Vein; Fibrinogen; Hematocrit; Heparin; Hip; Humans; Injections, Subcutaneous; Iodine Isotopes; Male; Middle Aged; Myocardial Infarction; Phlebography; Popliteal Vein; Postoperative Complications; Prospective Studies; Radionuclide Imaging; Thrombophlebitis; Thromboplastin; Thrombosis | 1973 |
Coagulation system changes induced by pelvic surgery and the effect of Dextran 70.
Topics: Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Clinical Trials as Topic; Dextrans; Factor V; Factor VIII; Female; Fibrin; Fibrinogen; Humans; Hysterectomy; Iodine Radioisotopes; Middle Aged; Pelvic Exenteration; Thrombophlebitis; Thrombosis; Uterine Neoplasms | 1973 |
Platelet function studies before and after operation and the effect of postoperative thrombosis.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Cell Count; Blood Platelets; Chromatography; Collagen; Epinephrine; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Neoplasms; Placebos; Platelet Adhesiveness; Postoperative Complications; Radionuclide Imaging; Surgical Procedures, Operative; Thrombin; Thrombosis | 1974 |
Anti-inflammatory drugs and the prevention of thrombosis.
Topics: Analgesics; Aspirin; Blood Coagulation; Cell Membrane; Female; Fibrinogen; Humans; Iodine Isotopes; Male; Placebos; Platelet Adhesiveness; Sex Factors; Thrombosis | 1971 |
1399 other study(ies) available for fibrinogen and Blood Clot
| Article | Year |
|---|---|
Anticoagulant Dodecapeptide Suppresses Thrombosis In Vivo by Inhibiting the Thrombin Exosite-I Binding Site.
Topics: Animals; Anticoagulants; Binding Sites; Fibrinogen; Mice; Protein Binding; Thrombin; Thrombosis | 2021 |
Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.
Topics: Anticoagulants; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Portal Vein; Retrospective Studies; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2022 |
Fluorescently conjugated annular fibrin clot for multiplexed real-time digestion analysis.
Topics: Crystallization; Fibrin; Fibrinogen; Fluorescein-5-isothiocyanate; Microscopy, Electron, Scanning; Optical Imaging; Thrombosis | 2021 |
Sensitivity analysis of a reduced model of thrombosis under flow: Roles of Factor IX, Factor XI, and γ'-Fibrin.
Topics: Alternative Splicing; Blood Circulation; Blood Coagulation; Factor IX; Factor XI; Fibrin; Fibrinogen; Humans; Models, Biological; Thrombosis | 2021 |
A peptide from the staphylococcal protein Efb binds P-selectin and inhibits the interaction of platelets with leukocytes.
Topics: Blood Platelets; Fibrinogen; Humans; Inflammation; Leukocytes; P-Selectin; Peptides; Platelet Activation; Thrombosis | 2022 |
Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates.
Topics: Blood Coagulation; Blood Coagulation Factors; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Thrombosis | 2022 |
Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation.
Topics: Afibrinogenemia; Animals; Blood Platelets; Fibrinogen; Hemostasis; Mice; Mice, Knockout; Mutation; Platelet Aggregation; Thrombosis | 2022 |
Pharmacological actions of dieckol on modulation of platelet functions and thrombus formation via integrin α
Topics: Animals; Benzofurans; Blood Platelets; Fibrinogen; Hemostasis; Humans; Mice; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thrombosis | 2022 |
Impact of Fibrinogen Infusion on Thrombin Generation and Fibrin Clot Structure in Patients with Inherited Afibrinogenemia.
Topics: Afibrinogenemia; Fibrin; Fibrinogen; Hemostatics; Humans; Thrombin; Thrombosis | 2022 |
Diagnosis of human immunodeficiency virus associated disseminated intravascular coagulation.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Female; Fibrinogen; HIV; HIV Infections; Humans; Male; Middle Aged; Prothrombin Time; Retrospective Studies; Severity of Illness Index; South Africa; Tertiary Care Centers; Thrombosis | 2022 |
Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications.
Topics: Adult; Afibrinogenemia; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Hemostatics; Humans; Male; Oxidative Stress; Protein Processing, Post-Translational; Thrombosis | 2022 |
Fibrinogen aptamer functionalized gold-coated iron-oxide nanoparticles for targeted imaging of thrombi.
Topics: Aptamers, Nucleotide; Fibrinogen; Gold; Humans; Magnetic Iron Oxide Nanoparticles; Magnetic Resonance Imaging; Thrombosis | 2022 |
Development of Transient Recombinant Expression and Affinity Chromatography Systems for Human Fibrinogen.
Topics: Biocompatible Materials; Chromatography, Affinity; Fibrin; Fibrinogen; Humans; Thrombosis | 2022 |
Anticoagulation practices associated with bleeding and thrombosis in pediatric extracorporeal membrane oxygenation; a multi-center secondary analysis.
Topics: Anticoagulants; Child; Extracorporeal Membrane Oxygenation; Fibrinogen; Hemorrhage; Heparin; Humans; Retrospective Studies; Thrombosis | 2023 |
Fibrinogen levels and thrombosis prevention.
Topics: Anticoagulants; Blood Coagulation Tests; Fibrinogen; Humans; Thrombosis | 2022 |
Use of thromboelastography in children on extracorporeal membrane oxygenation.
Topics: Child; Extracorporeal Membrane Oxygenation; Fibrinogen; Hemostatics; Humans; Retrospective Studies; Thrombelastography; Thrombosis | 2022 |
Myeloperoxidase-induced fibrinogen unfolding and clotting.
Topics: Blood Coagulation; Fibrin; Fibrinogen; Humans; Peroxidase; Thrombin; Thrombosis | 2022 |
Endothelial-derived von Willebrand factor accelerates fibrin clotting within engineered microvessels.
Topics: Endothelial Cells; Endothelium; Fibrin; Fibrinogen; Humans; Microvessels; Thrombin; Thrombosis; von Willebrand Factor | 2022 |
Implications of COVID-19 on Thrombotic Profile of Severely Affected Patients.
Topics: Anticoagulants; COVID-19; Fibrinogen; Humans; Retrospective Studies; SARS-CoV-2; Thrombosis | 2022 |
Lysophosphatidic Acid Receptor 3 Suppress Neutrophil Extracellular Traps Production and Thrombosis During Sepsis.
Topics: Animals; Extracellular Traps; Fibrinogen; Lipopolysaccharides; Mice; Receptors, Lysophosphatidic Acid; Sepsis; Thrombosis | 2022 |
Polyphosphate nanoparticles enhance the fibrin stabilization by histones more efficiently than linear polyphosphates.
Topics: DNA; Fibrin; Fibrinogen; Histones; Humans; Nanoparticles; Polyphosphates; Thrombin; Thrombosis | 2022 |
Inhibition of Hypoxia-Inducible Factor Prolyl-Hydroxylase Modulates Platelet Function.
Topics: Adenosine Triphosphate; Animals; Blood Platelets; Collagen; Fibrinogen; Hemostatics; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; P-Selectin; Platelet Activation; Platelet Aggregation; Prolyl Hydroxylases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Thrombin; Thrombosis | 2022 |
Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria.
Topics: Adult; Afibrinogenemia; Algeria; Child; Fibrinogen; Hemorrhage; Humans; Thrombin; Thrombosis | 2022 |
Medical Management of a Mural Thrombus Inducing Repeated Ischemic Strokes in a Patient with Congenital Afibrinogenemia.
Topics: Afibrinogenemia; Female; Fibrinogen; Heart Diseases; Hemorrhage; Humans; Ischemic Stroke; Middle Aged; Thrombosis | 2022 |
Diagnostic Value of Aortic Dissection Risk Score, Coagulation Function, and Laboratory Indexes in Acute Aortic Dissection.
Topics: Aortic Dissection; Fibrinogen; Humans; Natriuretic Peptide, Brain; Retrospective Studies; Risk Factors; Tenascin; Thrombosis | 2022 |
Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction.
Topics: Aged; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Fibrinogen; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Thrombosis; Treatment Outcome; Ventricular Function, Left | 2022 |
Fibrin protofibril packing and clot stability are enhanced by extended knob-hole interactions and catch-slip bonds.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Fibrin; Fibrinogen; Humans; Thrombin; Thrombosis | 2022 |
Role of LL-37 in thrombotic complications in patients with COVID-19.
Topics: Antimicrobial Cationic Peptides; Blood Coagulation Factors; Cathelicidins; COVID-19; Fibrinogen; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thrombosis | 2022 |
Lower-leg injury and knee arthroscopy have distinct effects on coagulation.
Topics: Arthroscopy; Fibrinogen; Humans; Interleukin-6; Leg Injuries; Thrombosis; Venous Thromboembolism; von Willebrand Factor | 2022 |
A point-of-care microfluidic channel-based device for rapid and direct detection of fibrinogen in whole blood.
Topics: Fibrinogen; Humans; Microfluidics; Plasma; Point-of-Care Systems; Thrombin; Thrombosis | 2022 |
A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Topics: Animals; Arginine; Aspartic Acid; Chitosan; Fibrinogen; Fibrinolytic Agents; Glycine; Hemorrhage; Hemostatics; Mice; Oligopeptides; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 2022 |
Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation.
Topics: Anticoagulants; Fibrinogen; Gastrointestinal Hemorrhage; Heart Failure; Heart-Assist Devices; Hemolysis; Humans; Retrospective Studies; Thrombosis; Tissue Plasminogen Activator | 2022 |
Evaluation of the International Society on Thrombosis & Haemostasis scoring system & its modifications in diagnosis of disseminated intravascular coagulation: A pilot study from southern India.
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Hemostasis; Humans; Pilot Projects; Thrombosis | 2022 |
The Predictive Value of Neutrophil-Lymphocyte Ratio in Patients with Polycythemia Vera at the Time of Initial Diagnosis for Thrombotic Events.
Topics: Fibrinogen; Humans; Lymphocytes; Middle Aged; Neutrophils; Polycythemia Vera; Prognosis; Retrospective Studies; Thrombosis | 2022 |
Exploring the Fibrin(ogen)olytic, Anticoagulant, and Antithrombotic Activities of Natural Cysteine Protease (Ficin) with the κ-Carrageenan-Induced Rat Tail Thrombosis Model.
Topics: Animals; Anticoagulants; Carrageenan; Cysteine Proteases; Estrone; Fibrin; Fibrinogen; Fibrinolytic Agents; Ficain; Rats; Rats, Sprague-Dawley; Thrombosis | 2022 |
Citrullinated fibrinogen forms densely packed clots with decreased permeability.
Topics: Animals; Fibrin; Fibrinogen; Hemostatics; Humans; Mice; Microscopy, Electron, Scanning; Permeability; Scattering, Small Angle; Thrombosis; X-Ray Diffraction | 2022 |
Exploring the mechanism of the antithrombotic effects of Pueraria lobata and Pueraria lobata var. thomsonii based on network pharmacology.
Topics: Amino Acids; Animals; Cyclooxygenase 2; Epoprostenol; Fibrinogen; Fibrinolytic Agents; Flavonoids; Molecular Docking Simulation; Network Pharmacology; Nitric Oxide Synthase Type III; Peroxidase; Pueraria; Rats; Reproducibility of Results; Superoxide Dismutase; Thrombosis; Thromboxane A2 | 2023 |
Quantifying Shear-induced Margination and Adhesion of Platelets in Microvascular Blood Flow.
Topics: Blood Platelets; Fibrinogen; Humans; Microcirculation; Microvessels; Platelet Adhesiveness; Thrombosis | 2023 |
COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid.
Topics: COVID-19; Fibrin; Fibrinogen; Fibrinolysis; Hemostatics; Humans; N-Acetylneuraminic Acid; Neuraminidase; Polymerization; SARS-CoV-2; Thrombosis | 2022 |
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system.
Topics: alpha-2-Antiplasmin; Biomarkers; C-Reactive Protein; COVID-19; Diabetes Mellitus, Type 2; Fibrin; Fibrinogen; Humans; Interleukin-6; Plasma Kallikrein; Platelet Factor 4; Post-Acute COVID-19 Syndrome; Proteomics; Thrombosis; von Willebrand Factor | 2022 |
SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Topics: Angiotensin-Converting Enzyme 2; Blood Coagulation Disorders; Cell Communication; COVID-19; Endothelial Cells; Endothelium; Fibrinogen; Humans; Lipoproteins; Lung; Neutrophils; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Sulfhydryl Compounds; Thrombin; Thrombomodulin; Thromboplastin; Thrombosis | 2022 |
Efficiency of targeted delivery of streptokinase based on fibrin-specific liposomes in the in vivo experiment.
Topics: Animals; Dogs; Fibrin; Fibrinogen; Liposomes; Streptokinase; Thrombosis | 2023 |
[Peculiarities of blood coagulation disorders in patients with COVID-19].
Topics: Anticoagulants; Blood Coagulation Disorders; C-Reactive Protein; COVID-19; Disseminated Intravascular Coagulation; Ethanol; Fibrinogen; Hemostatics; Heparin, Low-Molecular-Weight; Humans; Inflammation; Interleukins; SARS-CoV-2; Thrombophilia; Thrombosis | 2021 |
A novel interaction between extracellular vimentin and fibrinogen in fibrin formation.
Topics: COVID-19; Critical Illness; Extracellular Space; Fibrin; Fibrinogen; Hemostatics; Humans; Inflammation; Thrombosis; Vimentin | 2023 |
Microplastic Effects on Thrombin-Fibrinogen Clotting Dynamics Measured via Turbidity and Thromboelastography.
Topics: Fibrin; Fibrinogen; Humans; Microplastics; Plastics; Thrombelastography; Thrombin; Thrombosis | 2022 |
The effect of hereditary thrombotic factors and comorbidities on the severity of COVID-19 disease.
Topics: Comorbidity; COVID-19; Fibrinogen; Genotype; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Patient Acuity; Thrombosis | 2023 |
Estradiol provokes hypercoagulability and affects fibrin biology: A mechanistic exploration of sex dimorphisms in coagulation.
Topics: Blood Coagulation Disorders; Estradiol; Female; Fibrin; Fibrinogen; Humans; Male; Prospective Studies; Proteomics; Sex Characteristics; Thrombelastography; Thrombin; Thrombophilia; Thrombosis | 2023 |
[Analysis of a family with congenital hypodysfibrinogenemia presented with thrombosis].
Topics: Afibrinogenemia; Fibrinogen; Humans; Thrombosis | 2022 |
Influence of Fibrinogen Concentrate on Neonatal Clot Structure When Administered Ex Vivo After Cardiopulmonary Bypass.
Topics: Cardiopulmonary Bypass; Fibrin; Fibrinogen; Hemorrhage; Hemostatics; Humans; Infant, Newborn; Thrombosis | 2023 |
Platelet and cryoprecipitate transfusions from female donors improve coagulopathy in vitro.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Cohort Studies; Factor V; Factor XIII; Female; Fibrinogen; Hemostatics; Humans; Inflammation; Male; Proteome; Sex Factors; Thrombosis | 2023 |
Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα.
Topics: Animals; Blood Platelets; Fibrinogen; Humans; Mice; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Polysaccharides; Protein Binding; Thrombosis; von Willebrand Factor | 2023 |
Systematic mapping of the conformational landscape and dynamism of soluble fibrinogen.
Topics: Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Molecular Conformation; Thrombosis | 2023 |
Physiological correction of hereditary mild hypofibrinogenemia during pregnancy.
Topics: Afibrinogenemia; Blood Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostatics; Humans; Pregnancy; Thrombin; Thrombosis | 2023 |
Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
Topics: Coronary Artery Disease; Factor XIa; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Fibrinolysis; Humans; Plasminogen Activator Inhibitor 1; Stroke; Thromboembolism; Thrombosis | 2023 |
Supplemental fibrinogen restores thrombus formation in cardiopulmonary bypass-induced platelet dysfunction ex vivo.
Topics: Annexin A5; Cardiopulmonary Bypass; Fibrinogen; Hemostatics; Humans; P-Selectin; Platelet Aggregation; Thrombosis | 2023 |
Impact of Fibrinogen, Fibrin Thrombi, and Thrombin on Cancer Cell Extravasation Using In Vitro Microvascular Networks.
Topics: Animals; Blood Coagulation; Fibrin; Fibrinogen; Hemostatics; Humans; Neoplasms; Thrombin; Thrombosis | 2023 |
Monitoring the Formation of Fibrin Clots as Part of the Coagulation Cascade Using Fluorescent Single-Walled Carbon Nanotubes.
Topics: Blood Coagulation; Fibrin; Fibrinogen; Hemostatics; Humans; Nanotubes, Carbon; Thrombin; Thrombosis | 2023 |
Atorvastatin-mediated inhibition of prenylation of Rab27b and Rap1a in platelets attenuates their prothrombotic capacity and modulates clot structure.
Topics: Adenosine Diphosphate; Atorvastatin; Blood Platelets; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Prenylation; rab GTP-Binding Proteins; rap1 GTP-Binding Proteins; Thrombosis | 2023 |
Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study.
Topics: Abortion, Spontaneous; Afibrinogenemia; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hematoma; Hemostatics; Humans; Postpartum Hemorrhage; Pregnancy; Prospective Studies; Retrospective Studies; Thrombosis | 2023 |
Circuit change during extracorporeal membrane oxygenation: single-center retrospective study of 48 changes.
Topics: Cohort Studies; Extracorporeal Membrane Oxygenation; Fibrinogen; Hemorrhage; Hemostatics; Humans; Retrospective Studies; Thrombosis | 2023 |
Fibrin clots from patients with acute-on-chronic liver failure are weaker than those from healthy individuals and patients with sepsis without underlying liver disease.
Topics: Acute-On-Chronic Liver Failure; Fibrin; Fibrinogen; Fibrinolysis; Fibrosis; Hemostatics; Humans; Liver Cirrhosis; Sepsis; Thrombosis | 2023 |
Thromboelastography and Traditional Coagulation Testing in Non-ICU-Admitted Patients with Acute Kidney Injury: An Observational Cohort Study.
Topics: Acute Kidney Injury; Anticoagulants; Citric Acid; Cohort Studies; Fibrinogen; Heparin; Humans; Thrombelastography; Thrombocytopenia; Thrombosis | 2023 |
Fibrin Adsorption on Cardiovascular Biomaterials and Medical Devices.
Topics: Adsorption; Biocompatible Materials; Blood Coagulation; Fibrin; Fibrinogen; Humans; Polymers; Thrombosis | 2023 |
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen.
Topics: Afibrinogenemia; Fibrinogen; Hemorrhage; Hemostatics; Humans; Thrombosis | 2023 |
Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation.
Topics: Animals; Anti-HIV Agents; Blood Platelets; Drug Repositioning; Fibrinogen; Humans; Integrin beta3; Mice; Molecular Docking Simulation; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Rilpivirine; Thrombosis | 2023 |
Computational Prediction of the Interaction of Ivermectin with Fibrinogen.
Topics: COVID-19; Fibrin; Fibrinogen; Hemostatics; Humans; Ivermectin; Molecular Docking Simulation; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Thrombosis | 2023 |
Design and Development of a Clot Burst Pressure Device to Investigate Resuscitation Strategies.
Topics: Blood Coagulation; Blood Coagulation Disorders; Fibrinogen; Hemostatics; Humans; Resuscitation; Thrombelastography; Thrombosis | 2023 |
Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases?
Topics: Amyloid; Amyloidogenic Proteins; Autoimmunity; COVID-19; Fibrinogen; Humans; Post-Acute COVID-19 Syndrome; Prions; Thrombosis | 2023 |
Biomechanics, Energetics, and Structural Basis of Rupture of Fibrin Networks.
Topics: Biomechanical Phenomena; Fibrin; Fibrinogen; Hemostatics; Humans; Thrombosis | 2023 |
THE ROLE OF THROMBOSIS RISK SCALES LIKE PROGRESSION PREDICTORS OF COVID-19-ASSOCIATED PNEUMONIA.
Topics: Blood Coagulation; COVID-19; Fibrinogen; Humans; Pneumonia; Thrombosis | 2023 |
Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis.
Topics: COVID-19 Vaccines; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Thrombosis; Vaccines | 2023 |
Inversed, disproportionate contribution of fibrinogen to clot strength.
Topics: Blood Coagulation; Fibrinogen; Hemostatics; Humans; Thrombelastography; Thrombosis | 2023 |
The mechanism of oleic acid inhibiting platelet activation stimulated by collagen.
Topics: Animals; Blood Platelets; Collagen; Fibrinogen; Humans; Mice; Oleic Acid; Phosphorylation; Platelet Activation; Thrombosis | 2023 |
Abnormalities of the Serum proteomic in thrombosis after CVC catheterization in patients with end-stage renal disease.
Topics: Angiopoietin-Like Protein 3; Biomarkers; Catheterization, Central Venous; Fibrinogen; Humans; Kidney Failure, Chronic; Proteomics; Quality of Life; Renal Dialysis; Thrombosis | 2023 |
γD318Y fibrinogen shows no fibrin polymerization due to defective "A-a" and "B-b" interactions, whereas that of γK321E fibrinogen is nearly normal.
Topics: Afibrinogenemia; Animals; Binding Sites; Calcium; CHO Cells; Cricetulus; Fibrinogen; Humans; Models, Molecular; Point Mutation; Polymerization; Protein Binding; Protein Conformation; Protein Multimerization; Recombinant Proteins; Thrombin; Thrombosis | 2019 |
Study on the Effect of Ginsenosides Rb on Blood of Tumor Mice.
Topics: Anemia; Animals; Blood; Blood Platelets; Cell Line, Tumor; Disease Models, Animal; Erythrocytes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Ginsenosides; Hemoglobins; Hemostatics; Mice; Neoplasms; Panax; Plant Leaves; Thrombosis | 2019 |
Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure.
Topics: Blood Coagulation; Cell Line; Endothelial Cells; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysis; Humans; Peptide Fragments; Plasminogen Activator Inhibitor 1; Thrombin; Thrombosis; Urokinase-Type Plasminogen Activator | 2019 |
Optimizing management of replacement fluids for therapeutic plasma exchange: Use of an automated mathematical model to predict post-procedure fibrinogen and antithrombin levels in high-risk patients.
Topics: Anticoagulants; Antithrombins; Automation; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Homeostasis; Humans; Models, Theoretical; Plasma Exchange; Plasmapheresis; Risk; Thrombosis | 2020 |
PBMCs-Derived microRNA Signature as a Prethrombotic Status Discriminator in Stable Coronary Artery Disease.
Topics: Aged; Biomarkers; Cohort Studies; Coronary Artery Disease; Female; Fibrinogen; Humans; Leukocytes, Mononuclear; Male; Microarray Analysis; MicroRNAs; Middle Aged; Predictive Value of Tests; Prognosis; Risk; Thrombosis; Transcriptome | 2020 |
Blood Clot Identification Procedures in Clinical Laboratory Sampling.
Topics: Blood Coagulation; Blood Coagulation Tests; Clinical Laboratory Techniques; Fibrinogen; Humans; Partial Thromboplastin Time; Prothrombin Time; Thrombosis | 2019 |
Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
Topics: Aged; Blood Coagulation; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Fibrinolysis; Hemostatics; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Nephelometry and Turbidimetry; Plasma; Thrombosis | 2020 |
Congenital structural and functional fibrinogen disorders: a primer for internists.
Topics: Adult; Afibrinogenemia; Blood Coagulation Tests; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Hemorrhage; Humans; Male; Middle Aged; Poland; Thrombosis; Young Adult | 2019 |
The thromboelastography G parameter as a potential biomarker of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Area Under Curve; Biomarkers; Blood Coagulation Tests; Blood Platelets; Early Diagnosis; Elastic Modulus; Female; Fibrinogen; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Activation; ROC Curve; Sensitivity and Specificity; Thrombelastography; Thrombosis | 2020 |
γ' fibrinogen levels are associated with blood clot strength in traumatic brain injury patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Brain Injuries, Traumatic; Female; Fibrinogen; Humans; Male; Middle Aged; Retrospective Studies; Thrombosis; Young Adult | 2020 |
The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
Topics: Factor XIII; Factor XIIIa; Fibrinogen; Humans; Polymorphism, Genetic; Thrombosis | 2020 |
Comparison of Neonatal and Adult Fibrin Clot Properties between Porcine and Human Plasma.
Topics: Adult; Animals; Animals, Newborn; Blood Coagulation; Fibrin; Fibrinogen; Humans; Infant, Newborn; Models, Animal; Species Specificity; Swine; Thrombosis | 2020 |
Transfusion Outcomes in Patients Undergoing Unifocalization and Repair of Tetralogy of Fallot With Major Aortopulmonary Collaterals.
Topics: Aorta; Blood Coagulation Factors; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child, Preschool; Coagulants; Collateral Circulation; Erythrocyte Transfusion; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Fibrinogen; Heart Defects, Congenital; Humans; Infant; Intensive Care Units; Length of Stay; Male; Operative Time; Perioperative Care; Plasma; Platelet Transfusion; Pulmonary Artery; Pulmonary Circulation; Retrospective Studies; Tetralogy of Fallot; Thrombosis | 2020 |
[FGA gene variation causing congenital dysfibrinogenemia with recurrent arteriovenous thrombosis].
Topics: Afibrinogenemia; Fibrinogen; Genetic Variation; Humans; Thrombosis | 2020 |
Prothrombotic fibrin network characteristics in patients with acromegaly: a novel mechanism for vascular complications.
Topics: Acromegaly; Adult; Aged; Blood Coagulation Tests; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; Pilot Projects; Thrombosis | 2020 |
Acquired dysfibrinogenemia: monoclonal λ-type IgA binding to fibrinogen caused lower functional plasma fibrinogen level and abnormal clot formation.
Topics: Adult; Blood Coagulation Disorders; Fibrinogen; Humans; Immunoglobulin A; Male; Polymerization; Thrombin; Thrombosis | 2020 |
Heterogeneity of Integrin α
Topics: Adolescent; Blood Coagulation; Blood Platelets; Calcium; Calcium Signaling; Child; Child, Preschool; Cluster Analysis; Computer Simulation; Cytosol; Female; Fibrinogen; Flow Cytometry; Hemorrhage; Humans; Male; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Thrombasthenia; Thrombosis | 2020 |
Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk.
Topics: Complement C3; Fibrin; Fibrinogen; Fibrinolysis; Humans; Thrombosis | 2021 |
The effect of hematocrit, fibrinogen concentration and temperature on the kinetics of clot formation of whole blood.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Healthy Volunteers; Hematocrit; Humans; Kinetics; Male; Temperature; Thrombosis; Young Adult | 2020 |
Verification of a thrombus induction method at the target point inside the blood pump using a fibrinogen coating for a thrombus detection study.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Equipment Design; Fibrinogen; Heart-Assist Devices; Heparin; Heparin Antagonists; Humans; Magnetics; Protamines; Reproducibility of Results; Swine; Thrombosis | 2020 |
Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Female; Fibrinogen; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Platelet Activation; Thrombosis | 2021 |
Comparison of molecular structure and fibrin polymerization between two Bβ-chain N-terminal region fibrinogen variants, Bβp.G45C and Bβp.R74C.
Topics: Adult; Afibrinogenemia; Child; Female; Fibrin; Fibrinogen; Genetic Variation; Hemorrhage; Heterozygote; Humans; Male; Molecular Structure; Polymerization; Risk; Thrombosis | 2020 |
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization.
Topics: Adult; Animals; Blood Coagulation Tests; Cattle; Fibrinogen; Humans; Thrombelastography; Thrombosis | 2020 |
The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.
Topics: Acute Disease; Acute-Phase Proteins; Betacoronavirus; Biomarkers; Blood Platelets; Coronavirus Infections; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Models, Cardiovascular; Pandemics; Pneumonia, Viral; Risk; SARS-CoV-2; Thrombophilia; Thrombosis; von Willebrand Factor | 2020 |
Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
Topics: Afibrinogenemia; Blood Platelets; Computer Simulation; Fibrinogen; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Kinetics; Microscopy, Video; Models, Biological; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Signal Transduction; Stress, Mechanical; Thrombin; Thrombosis | 2020 |
Supplemental Fibrinogen Restores Platelet Inhibitor-Induced Reduction in Thrombus Formation without Altering Platelet Function: An In Vitro Study.
Topics: Aged; Aspirin; Calcium Signaling; Female; Fibrinogen; Hemorheology; Heparin; Hirudins; Humans; In Vitro Techniques; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Ticagrelor; Tirofiban | 2020 |
Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Blood Transfusion; COVID-19; Cytokine Release Syndrome; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart-Assist Devices; Hematoma; Hematuria; Hemorrhage; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Retroperitoneal Space; Thrombocytopenia; Thrombosis | 2020 |
Gingipain R1 and Lipopolysaccharide From
Topics: Adult; Blood Coagulation; Female; Fibrin; Fibrinogen; Gingipain Cysteine Endopeptidases; Humans; Lipopolysaccharides; Male; Mechanical Phenomena; Microscopy, Atomic Force; Microscopy, Confocal; Middle Aged; Porphyromonas gingivalis; Recombinant Proteins; Rheology; Spectrum Analysis, Raman; Thrombosis; Young Adult | 2020 |
Thromboresistance of Polyurethanes Modified with PEO-Silane Amphiphiles.
Topics: Adsorption; Biocompatible Materials; Fibrinogen; Humans; Platelet Adhesiveness; Polyethylene Glycols; Polyurethanes; Silanes; Silicones; Surface Properties; Tensile Strength; Thrombosis; Water | 2020 |
Risk Factors Associated with Heart Valve Thrombosis in Patients with Prosthetic Heart Valve Dysfunction.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Cross-Sectional Studies; Female; Fibrinogen; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Iran; Logistic Models; Male; Middle Aged; Risk Assessment; Risk Factors; Thrombosis | 2020 |
Bone Microthrombus Promotes Bone Loss in Iron Accumulation Rats.
Topics: Animals; Blood Coagulation; Bone Density; Bone Resorption; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Iron; Rats; Thrombosis | 2020 |
Protein C and Protein S Levels in β-Thalassemia Major Patients in Erbil, Kurdistan Region.
Topics: Adult; beta-Thalassemia; Case-Control Studies; Erythrocytes; Female; Fibrinogen; Hemoglobins; Humans; Male; Protein C; Protein S; Thrombophilia; Thrombosis; Young Adult | 2020 |
From weakly adhesive to highly thrombogenic: the shear gradient switch.
Topics: Adhesives; Blood Platelets; Fibrinogen; Humans; Thrombosis; von Willebrand Factor | 2020 |
Shear rate gradients promote a bi-phasic thrombus formation on weak adhesive proteins, such as fibrinogen in a VWF-dependent manner.
Topics: Adhesives; Blood Platelets; Fibrinogen; Humans; Platelet Adhesiveness; Platelet Aggregation; Thrombosis; von Willebrand Factor | 2020 |
In vitro thrombus formation and in vivo hemostasis mediated by platelets irradiated with bactericidal ultraviolet C from xenon flash under flow conditions.
Topics: Adenosine Diphosphate; Animals; Bacteria; Blood Platelets; Collagen; Fibrinogen; Hemostasis; Humans; Male; Mean Platelet Volume; Microscopy, Fluorescence; Models, Animal; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Plateletpheresis; Rabbits; Thrombosis; Ultraviolet Rays; Xenon | 2021 |
Fibrinogen function achieved through multiple covalent states.
Topics: Alkylation; Blood Coagulation Tests; Disulfides; Fibrin; Fibrinogen; Fibrinolysis; Hepatocytes; Humans; Mass Spectrometry; Oxidation-Reduction; Polymerization; Thrombin; Thrombosis | 2020 |
Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.
Topics: Adolescent; Adult; Aged; alpha-2-Antiplasmin; Blood Coagulation; C-Reactive Protein; Complement Membrane Attack Complex; Factor XIII; Female; Fibrinogen; Fibrinolysis; Hemodiafiltration; Hemorrhage; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Thrombosis; Young Adult | 2020 |
The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII.
Topics: Administration, Topical; Animals; Blood Platelets; Erythrocytes; Factor XIII; Femoral Artery; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Rats, Sprague-Dawley; Thrombosis; Wounds and Injuries | 2020 |
Fibrinolysis-resistant carbonylated fibrin detected in thrombi attached to the vascular wall of abdominal aortic aneurysms.
Topics: Aged; Aortic Aneurysm, Abdominal; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Plasminogen; Thrombosis; Tissue Plasminogen Activator | 2020 |
Probing fibrin's molecular response to shear and tensile deformation with coherent Raman microscopy.
Topics: Fibrin; Fibrinogen; Humans; Microscopy; Stress, Mechanical; Thrombosis; Wound Healing | 2021 |
Accelerated Spatial Fibrin Growth and Impaired Contraction of Blood Clots in Patients with Rheumatoid Arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Coagulation; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; P-Selectin; Thrombosis; Young Adult | 2020 |
Anti-TNF-α Treatment Reduces the Baseline Procoagulant Imbalance of Patients With Inflammatory Bowel Diseases.
Topics: C-Reactive Protein; Factor VIII; Fibrinogen; Humans; Inflammation; Inflammatory Bowel Diseases; Infliximab; Thrombin; Thrombomodulin; Thrombosis; Tumor Necrosis Factor Inhibitors | 2021 |
Exploring the Unique Contrast Properties of Aptamer-Gadolinium Conjugates in Magnetic Resonance Imaging for Targeted Imaging of Thrombi.
Topics: Aptamers, Nucleotide; Contrast Media; Coordination Complexes; Fibrin; Fibrinogen; Gadolinium; Humans; Magnetic Resonance Imaging; Proof of Concept Study; Thrombosis | 2021 |
Evaluation of real-time thrombus detection method in a magnetically levitated centrifugal blood pump using a porcine left ventricular assist circulation model.
Topics: Animals; Centrifugation; Disease Models, Animal; Equipment Design; Fibrinogen; Heart-Assist Devices; Magnetics; Swine; Thrombosis | 2021 |
The Value of Detecting Pathological Changes During Clot Formation in Early Disease Treatment-Naïve Breast Cancer Patients.
Topics: Blood Coagulation; Blood Coagulation Tests; Breast Neoplasms; Female; Fibrinogen; Humans; Thrombosis | 2021 |
Major bleeding complications in critically ill patients with COVID-19 pneumonia.
Topics: Aged; Anticoagulants; Biomarkers; Blood Coagulation; COVID-19; Critical Illness; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Inflammation Mediators; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome | 2021 |
Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?
Topics: Blood Coagulation Disorders; Coagulants; Dose-Response Relationship, Drug; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Microscopy, Confocal; Thrombelastography; Thrombin; Thrombosis | 2021 |
Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in vivo by Decreasing of Fibrinogen Density in Thrombus.
Topics: Adenosine Monophosphate; Adenosine-5'-(N-ethylcarboxamide); Adult; Animals; Antithrombins; Blood Pressure; Blood-Brain Barrier; Chlorides; Diastole; Female; Ferric Compounds; Fibrinogen; Humans; Laser-Doppler Flowmetry; Male; Mice, Inbred C57BL; Permeability; Platelet Activation; Platelet Aggregation; Prasugrel Hydrochloride; Purinergic P1 Receptor Agonists; Purinergic P2Y Receptor Antagonists; Systole; Thrombosis | 2021 |
The Antithrombotic Agent Pterostilbene Interferes with Integrin α
Topics: Animals; Blood Coagulation; Blood Platelets; Clot Retraction; Collagen; Fibrinogen; Hemostasis; Humans; Integrin alpha2; Integrin beta3; Integrins; Mice; P-Selectin; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction; Stilbenes; Thrombosis | 2021 |
Rotational Thromboelastometry Derivative Fibrinogen-Platelet Ratio Predicts Thrombosis in Microsurgery.
Topics: Fibrinogen; Free Tissue Flaps; Humans; Microsurgery; Thrombelastography; Thrombosis | 2021 |
Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.
Topics: Fibrinogen; Fibrinolytic Agents; Humans; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 2021 |
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Topics: Aged; ChAdOx1 nCoV-19; COVID-19 Vaccines; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Platelet Count; Platelet Factor 4; Serotonin; Thrombocytopenia; Thrombosis | 2021 |
Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.
Topics: Administration, Intravenous; Aged; Case-Control Studies; Factor XIII; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome | 2021 |
Effects of long-term high-altitude exposure on fibrinolytic system.
Topics: Adult; Aged; Altitude; Antithrombin III; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Thrombosis; Young Adult | 2021 |
Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.
Topics: C-Reactive Protein; COVID-19; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Retrospective Studies; Thrombophilia; Thrombosis | 2022 |
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19.
Topics: Adult; Aged; Amyloid; Blood Platelets; Complement C3; COVID-19; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Lung; Male; Microfluidic Analytical Techniques; Middle Aged; Prothrombin; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Thrombosis; Trypsin | 2021 |
Tracking oxidation-induced alterations in fibrin clot formation by NMR-based methods.
Topics: Fibrin; Fibrinogen; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Oxidation-Reduction; Protein Domains; Protein Multimerization; Solubility; Thrombosis | 2021 |
Soy Isoflavones Inhibit Both GPIb-IX Signaling and αIIbβ3 Outside-In Signaling via 14-3-3ζ in Platelet.
Topics: 14-3-3 Proteins; Animals; Blood Platelets; Fibrinogen; Genistein; Glycine max; Immobilized Proteins; Isoflavones; Male; Mice, Inbred C57BL; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Signal Transduction; Thrombosis | 2021 |
Involvement of the heparanase procoagulant domain in bleeding and wound healing.
Topics: Animals; Blood Coagulation; Coagulants; Factor Xa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glucuronidase; Glycoproteins; Hematologic Agents; Hemorrhage; Humans; Inflammation; Male; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Partial Thromboplastin Time; Peptides; Protein Domains; Prothrombin Time; Thrombelastography; Thromboplastin; Thrombosis; Wound Healing | 2017 |
ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
Topics: ADAMTS13 Protein; Albuminuria; Animals; Cell Proliferation; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Extracellular Matrix; Fibrinogen; Genetic Predisposition to Disease; Kidney Glomerulus; Male; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plasminogen Activator Inhibitor 1; Platelet Membrane Glycoprotein IIb; Streptozocin; Thrombosis; Urea; von Willebrand Factor | 2017 |
Bitistatin-functionalized fluorescent nanodiamond particles specifically bind to purified human platelet integrin receptor α
Topics: Animals; Benzodiazepines; Blood Platelets; Fibrinogen; Humans; Nanodiamonds; Peptides; Piperidines; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Rats, Inbred F344; Receptors, Fibrinogen; Snake Venoms; Thrombin; Thrombosis | 2017 |
What´s floating on my plasma?
Topics: Blood Chemical Analysis; Blood Glucose; Blood Platelets; Blood Specimen Collection; Cholesterol; Fats; Fibrinogen; Gels; Heparin; Humans; Hydrogen-Ion Concentration; Leukocytes; Particulate Matter; Reproducibility of Results; Thrombosis | 2017 |
Protein kinase Cι/λ is dispensable for platelet function in thrombosis and hemostasis in mice.
Topics: Animals; Blood Platelets; Collagen; Female; Fibrinogen; Hemostasis; Humans; Integrins; Isoenzymes; Male; Mice, Inbred C57BL; Mice, Knockout; Platelet Adhesiveness; Platelet Glycoprotein GPIb-IX Complex; Protein Kinase C; Signal Transduction; Thrombosis | 2017 |
Neutrophil extracellular trap formation upon exposure of hydrophobic materials to human whole blood causes thrombogenic reactions.
Topics: Biocompatible Materials; Blood Platelets; Extracellular Traps; Fibrinogen; Humans; Hydrophobic and Hydrophilic Interactions; Neutrophils; Reactive Oxygen Species; Surface Properties; Thrombosis | 2017 |
Microscale spatial heterogeneity of protein structural transitions in fibrin matrices.
Topics: Animals; Blood Coagulation; Fibrin; Fibrinogen; Humans; Hydrogels; Protein Conformation, alpha-Helical; Thrombosis; Wound Healing | 2016 |
Morphometric characterization of fibrinogen's αC regions and their role in fibrin self-assembly and molecular organization.
Topics: Fibrin; Fibrinogen; Humans; Microscopy, Atomic Force; Microscopy, Confocal; Microscopy, Electron, Scanning; Nephelometry and Turbidimetry; Protein Conformation; Thrombin; Thrombosis | 2017 |
Factors associating with the presence of residual thrombosis after 3-month treatment of acute pulmonary embolism.
Topics: Acute Disease; Aged; Anticoagulants; Computed Tomography Angiography; Female; Fibrinogen; Humans; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; Thrombosis | 2018 |
Liquid-infused nitric oxide-releasing (LINORel) silicone for decreased fouling, thrombosis, and infection of medical devices.
Topics: Adsorption; Animals; Bacterial Adhesion; Biocompatible Materials; Cell Line; Cell Survival; Equipment and Supplies; Fibrinogen; Mice; Nitric Oxide; Nitric Oxide Donors; Penicillamine; Platelet Adhesiveness; Pseudomonas aeruginosa; Silicone Elastomers; Staphylococcus aureus; Swine; Thrombosis | 2017 |
A humanized monoclonal antibody that inhibits platelet-surface ERp72 reveals a role for ERp72 in thrombosis.
Topics: Animals; Antibodies, Monoclonal, Humanized; Blood Platelets; Calcium; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Humans; Male; Membrane Glycoproteins; Mice, Inbred C57BL; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Disulfide-Isomerases; Signal Transduction; Thrombosis | 2018 |
Changes in mediators of inflammation and pro-thrombosis after 12 months of dietary modification in adults with metabolic syndrome.
Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Diet; Female; Fibrinogen; Humans; Inflammation; Interleukin-10; Interleukin-6; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Nigeria; Plasminogen Activator Inhibitor 1; Thrombosis; Triglycerides; Waist Circumference | 2017 |
Prothrombotic state in young females with severe early-onset obesity.
Topics: Adolescent; Adult; Blood Coagulation; Body Mass Index; C-Reactive Protein; Case-Control Studies; Child; Child, Preschool; Factor VIII; Female; Fibrinogen; Humans; Insulin; Leptin; Linear Models; Male; Obesity; Pediatric Obesity; Sex Factors; Thrombosis; Young Adult | 2018 |
Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations.
Topics: Adult; Aged; Black People; Fibrinogen; Haplotypes; Humans; Interleukin-6; Linkage Disequilibrium; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Thrombosis; White People | 2017 |
Structural and functional changes of fibrinogen due to aging.
Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrinogen; Glycosylation; Healthy Volunteers; Humans; Middle Aged; Spectrometry, Fluorescence; Structure-Activity Relationship; Thrombosis; Young Adult | 2018 |
High shear induces platelet dysfunction leading to enhanced thrombotic propensity and diminished hemostatic capacity.
Topics: Adult; Blood Platelets; Collagen; Female; Fibrinogen; Healthy Volunteers; Hemostatics; Humans; Male; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Propensity Score; Shear Strength; Thrombosis; von Willebrand Factor; Young Adult | 2019 |
Development of a fibrinolysis assay for canine plasma.
Topics: Animals; Blood Coagulation Tests; Dog Diseases; Dogs; Female; Fibrinogen; Fibrinolysis; Male; Plasma; Predictive Value of Tests; Thrombelastography; Thrombosis | 2017 |
Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation.
Topics: Binding Sites; Blood Platelets; Case-Control Studies; Collagen; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Platelet Activation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein Binding; Protein Interaction Domains and Motifs; Protein Multimerization; Signal Transduction; Structure-Activity Relationship; Thrombasthenia; Thrombosis | 2018 |
Amino-Fucoidan as a Vector for rtPA-Induced Fibrinolysis in Experimental Thrombotic Events.
Topics: Amines; Animals; Carotid Arteries; Dipeptides; Disease Models, Animal; Fibrinogen; Fibrinolysis; Fucose; Glucose; Humans; Intravital Microscopy; Lysine; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Polysaccharides; Serum Albumin; Sulfates; Thrombelastography; Thrombosis; Tissue Plasminogen Activator; Venous Thrombosis | 2018 |
Increased resistance to tissue plasminogen activator-induced fibrinolysis in healthy subjects from Thailand.
Topics: Blood Coagulation Tests; Blood Specimen Collection; Fibrinogen; Fibrinolysis; Healthy Volunteers; Hemostasis; Humans; Thailand; Thrombelastography; Thrombosis; Tissue Plasminogen Activator; Washington | 2018 |
Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
Topics: Adenosine Triphosphate; Adult; Antineoplastic Agents; Blood Coagulation; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Enzyme Activation; Fibrinogen; Focal Adhesion Protein-Tyrosine Kinases; Humans; L-Lactate Dehydrogenase; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protective Agents; Protein Binding; Signal Transduction; Thrombosis | 2018 |
Immobilized fibrinogen activates human platelets through glycoprotein VI.
Topics: Animals; Blood Platelets; Fibrinogen; Humans; Leukemia, Basophilic, Acute; Mice; Platelet Activation; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Rats; Syk Kinase; Thrombosis; Tumor Cells, Cultured | 2018 |
An increased tendency in fibrinogen activity and its association with a hypo-fibrinolytic state in early stages after injury in patients without acute traumatic coagulopathy (ATC).
Topics: Adult; Blood Coagulation Disorders; Case-Control Studies; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Inflammation; Male; Thrombosis; Time Factors; Wounds and Injuries | 2018 |
The
Topics: Binding Sites; Erythrocytes; Fibrin; Fibrinogen; Humans; Integrins; Microscopy, Atomic Force; Mutation; Protein Binding; Receptors, Fibrinogen; Thrombosis | 2018 |
Is a variability of platelet inhibitory effect of anti-platelet agents important for predicting new lesion in atherothrombotic stroke?
Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Diffusion Magnetic Resonance Imaging; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis | 2018 |
Red blood cells aggregability measurement of coagulating blood in extracorporeal circulation system with multiple-frequency electrical impedance spectroscopy.
Topics: Biosensing Techniques; Blood Coagulation; Dielectric Spectroscopy; Electric Impedance; Erythrocyte Aggregation; Erythrocytes; Extracorporeal Circulation; Fibrinogen; Humans; Thrombosis | 2018 |
Can we predict thrombotic tendency in rheumatoid arthritis? A thromboelastographic analysis (with ROTEM).
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Cell Count; C-Reactive Protein; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Thrombelastography; Thrombosis | 2018 |
Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen.
Topics: Afibrinogenemia; Asian People; Family; Fibrinogen; Humans; Polymerization; Sequence Analysis, DNA; Sequence Deletion; Thrombosis | 2018 |
Evaluation of a novel prognostic score based on thrombosis and inflammation in patients with sepsis: a retrospective cohort study.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Intensive Care Units; Interleukin-6; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Platelet Count; Procalcitonin; Prognosis; Regression Analysis; Respiration, Artificial; Retrospective Studies; ROC Curve; Sepsis; Severity of Illness Index; Thrombosis | 2018 |
Fibrin films: overlooked hemostatic barriers against microbial infiltration.
Topics: Biofilms; Fibrin; Fibrinogen; Hemostasis; Hemostatics; Humans; Thrombin; Thrombosis | 2018 |
Prothrombotic State Induced by Middle-Distance Endurance Exercise in Middle-Aged Athletes.
Topics: Adult; Athletes; Blood Coagulation; Exercise; Factor VIII; Fibrinogen; Humans; Male; Middle Aged; Partial Thromboplastin Time; Physical Endurance; Running; Thrombin; Thrombosis; von Willebrand Factor | 2018 |
Hemostasis management and therapeutic plasma exchange: Results of a practice survey.
Topics: Afibrinogenemia; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Plasma Exchange; Plasmapheresis; Practice Patterns, Physicians'; Serum Albumin; Surveys and Questionnaires; Thrombosis | 2018 |
First Report of Plant-Derived β-Sitosterol with Antithrombotic, in Vivo Anticoagulant, and Thrombus-Preventing Activities in a Mouse Model.
Topics: Animals; Anticoagulants; Antithrombins; Catalysis; Disease Models, Animal; Female; Fibrinogen; Humans; Male; Mice; Plants; Platelet Aggregation Inhibitors; Sitosterols; Thrombin; Thrombosis | 2018 |
Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications.
Topics: Blood Proteins; Fibrin Clot Lysis Time; Fibrinogen; Fibrinolysis; Humans; Thrombosis; Tissue Plasminogen Activator | 2019 |
Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation.
Topics: Acute-Phase Reaction; Adult; Agglutination; Alzheimer Disease; Amyloid; Blood Coagulation; Blood Platelets; Female; Fibrinogen; Humans; Middle Aged; Platelet Activation; Platelet Aggregation; Protein Binding; Serum Amyloid A Protein; Thrombosis | 2019 |
The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Child; Child, Preschool; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Thrombosis; Young Adult | 2019 |
Plasma phospholipid fatty acids are associated with altered fibrin clot properties in a population-based setting.
Topics: Blood Coagulation; Body Mass Index; Cross-Sectional Studies; Fatty Acids; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Osmolar Concentration; Phospholipids; South Africa; Thrombosis | 2019 |
Mass spectrometry-based molecular mapping of native FXIIIa cross-links in insoluble fibrin clots.
Topics: Amino Acid Sequence; Chromatography, High Pressure Liquid; Factor XIIIa; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lysine; Mass Spectrometry; Peptide Mapping; Peptides; Thrombosis | 2019 |
Oxidation-induced destabilization of the fibrinogen αC-domain dimer investigated by molecular dynamics simulations.
Topics: Animals; Cattle; Fibrinogen; Humans; Methionine; Models, Molecular; Molecular Dynamics Simulation; Oxidation-Reduction; Peptide Fragments; Polymers; Protein Conformation; Protein Domains; Protein Multimerization; Protein Structure, Tertiary; Thrombosis | 2019 |
ABO blood group and procoagulant factors: the hypercoagulation hypothesis ABO and Procoagulant Factors.
Topics: ABO Blood-Group System; Blood Coagulation; Factor VIII; Female; Fibrinogen; Humans; Immune System; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Intensive Care, Neonatal; Male; Prospective Studies; Referral and Consultation; Thrombosis; von Willebrand Factor | 2019 |
The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Topics: Blood Coagulation; Blood Platelets; Clot Retraction; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypochlorous Acid; Inflammation; Peroxidase; Thrombin; Thrombosis | 2019 |
Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Alleles; Amino Acid Substitution; Blood Coagulation; Blood Coagulation Tests; Child; Child, Preschool; DNA Mutational Analysis; Female; Fibrinogen; Genotype; Hemorrhage; Humans; Male; Middle Aged; Mutation; Risk Assessment; Risk Factors; Thrombosis; Young Adult | 2019 |
Significance of plasma fibrinogen level and antithrombin activity in sepsis: A multicenter cohort study using a cubic spline model.
Topics: Aged; Aged, 80 and over; Cohort Studies; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Sepsis; Thrombosis | 2019 |
Characterization of active anticoagulant fraction and a fibrin(ogen)olytic serine protease from leaves of Clerodendrum colebrookianum, a traditional ethno-medicinal plant used to reduce hypertension.
Topics: Animals; Anticoagulants; Clerodendrum; Cytochrome P-450 Enzyme System; Factor Xa; Female; Fibrin; Fibrinogen; Fibrinolytic Agents; HEK293 Cells; Humans; Hypertension; Male; Medicine, Traditional; Mice; Plant Extracts; Plant Leaves; Plants, Medicinal; Serine Endopeptidases; Thrombin; Thrombosis | 2019 |
Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.
Topics: Adult; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Lupus Erythematosus, Systemic; Male; Microscopy, Electron, Scanning; Thrombosis | 2019 |
C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Coagulation; C-Reactive Protein; Calcium Chloride; Coronary Artery Disease; Female; Fibrin; Fibrinogen; Humans; Inflammation; Kaolin; Male; Middle Aged; Risk Factors; Stents; Thrombelastography; Thrombophilia; Thrombosis | 2013 |
Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted).
Topics: Afibrinogenemia; Aspartic Acid; Binding Sites; Chromatography, High Pressure Liquid; Dimerization; Fibrinogen; Gene Deletion; Genetic Variation; Histidine; Humans; Infant; Male; Mutation; Phenotype; Sequence Analysis, DNA; Thrombosis; Tyrosine | 2013 |
Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
Topics: Animals; Blood Coagulation; Blood Platelets; Chemistry, Pharmaceutical; Drug Carriers; Fibrin; Fibrinogen; Fibrinolytic Agents; Half-Life; Hemorrhage; Humans; Liposomes; Male; Nanoparticles; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Sprague-Dawley; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 2013 |
Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model.
Topics: Animals; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Lung; Lung Transplantation; Male; Perfusion; Rats; Rats, Inbred Lew; Reperfusion Injury; Thrombolytic Therapy; Thrombosis; Vascular Resistance | 2013 |
Hypofibrinogenemia, dysfibrinogenemia or hypodysfibrinogenemia?: comment on 'The dilemma of inherited dysfibrinogenemia during pregnancy'.
Topics: Afibrinogenemia; Anticoagulants; Female; Fibrinogen; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis | 2013 |
Supplementation of fibrinogen concentrate in children with severe acquired hypofibrinogenaemia during chemotherapy for acute lymphoblastic leukaemia: our experience.
Topics: Adolescent; Afibrinogenemia; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Female; Fibrinogen; Hemorrhage; Humans; Male; Plasma; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Thrombosis | 2014 |
D-dimer and fibrinogen/fibrin degradation products.
Topics: Blood Coagulation Tests; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Thrombosis | 2013 |
C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.
Topics: Animals; Blood Platelets; Bone Marrow Cells; Fibrinogen; Hemorrhage; Humans; Integrin beta3; Lentivirus; Megakaryocytes; Mice; Mutation; P-Selectin; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Conformation; Syndrome; Thrombasthenia; Thrombosis | 2013 |
Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
Topics: Adult; alpha-2-Antiplasmin; Biosensing Techniques; Fibrinogen; Fibrinolysin; Fibrinolysis; Gold; Humans; Limit of Detection; Nanoparticles; Plasminogen; Thrombin; Thrombosis; Urokinase-Type Plasminogen Activator; Young Adult | 2013 |
Fabrication and in vivo thrombogenicity testing of nitric oxide generating artificial lungs.
Topics: Animals; Artificial Organs; Blood Cell Count; Blood Platelets; Copper; Fibrinogen; Hemodynamics; Lung; Nitric Oxide; Rabbits; Regional Blood Flow; S-Nitrosothiols; Thrombosis; Time Factors; Tissue Engineering | 2013 |
Correlation of fibrinogen-like protein 2 with progression of acute pancreatitis in rats.
Topics: Acute Disease; Animals; Biomarkers; Disease Models, Animal; Fibrinogen; Leukocytes, Mononuclear; Male; Pancreas; Pancreatitis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Severity of Illness Index; Taurocholic Acid; Thrombosis; Time Factors; Up-Regulation | 2013 |
Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.
Topics: Diabetes Mellitus, Type 1; Enzyme Activation; Fibrinogen; Fibrinolysin; Fibrinolysis; Glycosylation; Humans; Mucoproteins; Plasminogen; Protein Binding; Protein Processing, Post-Translational; Thrombosis | 2013 |
Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions.
Topics: Adult; Aged; Blood Coagulation; Blood Flow Velocity; Blood Specimen Collection; Cardiac Surgical Procedures; Coronary Artery Bypass; Diffusion Chambers, Culture; Female; Fibrinogen; Hemodilution; Hemorheology; Hemostatics; Humans; Lab-On-A-Chip Devices; Male; Microscopy, Confocal; Microscopy, Video; Middle Aged; Thrombelastography; Thrombosis; Young Adult | 2013 |
Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Drug Monitoring; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lower Extremity; Male; Middle Aged; Minnesota; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis; Young Adult | 2013 |
Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
Topics: Animals; Blood Coagulation Factors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Factor VIIa; Fibrinogen; Hemorrhage; Male; Pyrazoles; Pyridones; Rabbits; Recombinant Proteins; Thrombosis | 2013 |
Pharmacokinetics and thrombolytic effects of the recombinant tissue-type plasminogen activator in horses.
Topics: Animals; Area Under Curve; Female; Fibrinogen; Fibrinolytic Agents; Half-Life; Horses; Infusions, Intravenous; Male; Partial Thromboplastin Time; Prothrombin Time; Thrombin Time; Thrombosis; Tissue Plasminogen Activator | 2013 |
Successful living-related kidney transplantation in a boy with inherited dysfibrinogenemia.
Topics: Afibrinogenemia; Blood Coagulation Tests; Child; Fibrinogen; Hemorrhage; Humans; Kidney Diseases; Kidney Transplantation; Living Donors; Male; Mutation; Phenotype; Thrombosis; Treatment Outcome | 2013 |
The role of hemostatic mechanisms in the development of thrombosis in Behcet's disease: an analysis by modified rotation thromboelastogram (ROTEM).
Topics: Adolescent; Adult; Behcet Syndrome; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Prothrombin Time; Rotation; Spondylitis, Ankylosing; Thrombelastography; Thrombosis; Young Adult | 2013 |
Effects of fibrinogen concentrate after shock/resuscitation: a comparison between in vivo microvascular clot formation and thromboelastometry*.
Topics: Animals; Cricetinae; Fibrinogen; Hemodynamics; Hemostasis; Hydroxyethyl Starch Derivatives; Male; Random Allocation; Resuscitation; Shock, Hemorrhagic; Thrombelastography; Thrombosis | 2013 |
[Use of rFVIIa in intractable hemorrhage in patients on central veno-arterial ECMO].
Topics: Adult; Blood Transfusion; Drug Resistance; Extracorporeal Membrane Oxygenation; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Infant; Lactic Acid; Male; Middle Aged; Platelet Count; Recombinant Proteins; Retrospective Studies; Survival Analysis; Thrombosis; Ventilator Weaning | 2013 |
Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.
Topics: Blood Coagulation; Blood Platelets; Blotting, Western; Female; Fibrin; Fibrinogen; Flow Cytometry; Humans; Microscopy, Confocal; Oligopeptides; Phosphatidylserines; Platelet Aggregation; Polymerization; Thrombasthenia; Thrombosis; Thrombospondins; Transglutaminases | 2013 |
Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Child; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysin; Fibrinolysis; Genetic Association Studies; Humans; Male; Middle Aged; Pedigree; Peptide Fragments; Phenotype; Polymorphism, Genetic; Protein Structure, Tertiary; Sequence Deletion; Thrombosis; Young Adult | 2013 |
Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Cardiovascular Diseases; Cross-Sectional Studies; Diastole; Echocardiography, Doppler; Essential Hypertension; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Failure; Hemostasis; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Myocardium; Plasminogen Activator Inhibitor 1; Prothrombin; Risk Factors; Thrombosis; Tissue Plasminogen Activator; Young Adult | 2013 |
Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism.
Topics: Adult; C-Reactive Protein; Colitis, Ulcerative; Crohn Disease; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Permeability; Prognosis; Risk Factors; Survival Rate; Thrombosis; Young Adult | 2013 |
Multiple sites on Streptococcus gordonii surface protein PadA bind to platelet GPIIbIIIa.
Topics: Amino Acid Motifs; Bacterial Proteins; Binding Sites; Blood Platelets; Carrier Proteins; Cell Degranulation; Cells, Cultured; Endocarditis; Fibrinogen; Humans; Membrane Proteins; Mutagenesis, Site-Directed; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Proteomics; Signal Transduction; Streptococcus gordonii; Thrombosis | 2013 |
Visualization of fibrinogen-dependent thrombus formation*.
Topics: Animals; Fibrinogen; Hydroxyethyl Starch Derivatives; Male; Resuscitation; Shock, Hemorrhagic; Thrombosis | 2013 |
Gene-centric association signals for haemostasis and thrombosis traits identified with the HumanCVD BeadChip.
Topics: Adaptor Proteins, Signal Transducing; Apolipoprotein A-V; Apolipoproteins A; Blood Platelets; Blood Viscosity; Carrier Proteins; Cell Count; DNA Mutational Analysis; Factor VII; Fibrinogen; G-Protein-Coupled Receptor Kinase 5; Genetic Association Studies; Hemostasis; Humans; Macrophage Colony-Stimulating Factor; Membrane Transport Proteins; Microarray Analysis; Microspheres; Phenotype; Polymorphism, Single Nucleotide; Quantitative Trait, Heritable; Thrombosis | 2013 |
Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure.
Topics: Afibrinogenemia; Case-Control Studies; Cohort Studies; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hypertension, Pulmonary; Microscopy, Confocal; Models, Molecular; Protein Conformation; Thrombosis | 2013 |
[Effect of xuebijing oral effervescent tablet on endotoxin induced fever and disseminated intravascular coagulation rabbit model].
Topics: Administration, Oral; Animals; Blood Coagulation; Body Temperature; Disseminated Intravascular Coagulation; Drugs, Chinese Herbal; Ear Auricle; Endotoxins; Female; Fever; Fibrinogen; Male; Microcirculation; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Prothrombin Time; Rabbits; Tablets; Thrombosis | 2013 |
Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis.
Topics: Adolescent; Adult; Animals; Female; Fibrinogen; Ginsenosides; Humans; Male; MAP Kinase Signaling System; Mice; Platelet Activation; Platelet Aggregation; Signal Transduction; Thrombosis; Young Adult | 2014 |
Imaging of thrombosis and microcirculation in mouse lungs of initial melanoma metastasis with in vivo cryotechnique.
Topics: Animals; Blood Coagulation; Blood Platelets; Cell Line, Tumor; Fibrinogen; Freezing; Glutathione; Lung; Lung Neoplasms; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microcirculation; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activation; Platelet Aggregation; Quantum Dots; src-Family Kinases; Thrombosis | 2014 |
Purification and characterization of a novel fibrinolytic α chymotrypsin like serine metalloprotease from the edible mushroom, Lyophyllum shimeji.
Topics: Agaricales; Amino Acid Sequence; Chromatography, Gel; Chymotrypsin; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Fibrinolysis; Hydrogen-Ion Concentration; Metalloproteases; Molecular Weight; Serine; Temperature; Thrombosis | 2014 |
Fibrinogen Dusart presenting as recurrent thromboses in the hepatic portal system.
Topics: Adult; Afibrinogenemia; Diagnosis, Differential; Fibrinogen; Hepatitis C; Humans; Male; Portal System; Thrombosis | 2014 |
Dok-2 adaptor protein regulates the shear-dependent adhesive function of platelet integrin αIIbβ3 in mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Blood Platelets; Calcium; Cell Membrane; Fibrinogen; Hemorheology; Humans; Immobilized Proteins; Mice; Mice, Inbred C57BL; Phosphatidylinositol Phosphates; Phosphoproteins; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Shear Strength; Thrombosis; Time Factors | 2014 |
Cyclophilin A is an important mediator of platelet function by regulating integrin αIIbβ3 bidirectional signalling.
Topics: Animals; Blood Platelets; Cell Adhesion; Cells, Cultured; Chlorides; Cyclophilin A; Cytoskeleton; Ferric Compounds; Fibrinogen; Hemorrhage; Mesenteric Arteries; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Reactive Oxygen Species; Signal Transduction; Thrombin; Thrombosis | 2014 |
Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Catheter Ablation; Creatine Kinase, MB Form; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Injuries; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; Troponin T | 2014 |
Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Component Transfusion; Blood Platelets; Female; Fibrin Clot Lysis Time; Fibrinogen; Humans; Injury Severity Score; Linear Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Resuscitation; Risk Assessment; Sampling Studies; Survival Rate; Thrombelastography; Thrombin Time; Thrombosis; Trauma Centers; Wounds and Injuries; Young Adult | 2014 |
Interaction of platelets with poly(vinylidene fluoride-co-hexafluoropropylene) electrospun surfaces.
Topics: Adsorption; Biocompatible Materials; Blood Platelets; Blood Proteins; Fibrinogen; Humans; Platelet Adhesiveness; Polyvinyls; Surface Properties; Thrombosis | 2014 |
A novel fibrin(ogen)olytic trypsin-like protease from Chinese oak silkworm (Antheraea pernyi): purification and characterization.
Topics: Amino Acid Sequence; Animals; Arginine; China; DNA, Complementary; Electrophoresis, Polyacrylamide Gel; Esterases; Fibrin; Fibrinogen; Fibrinolysis; Insect Proteins; Kinetics; Mice; Molecular Sequence Data; Moths; Peptide Hydrolases; Phylogeny; Sequence Analysis, DNA; Sequence Analysis, Protein; Sequence Homology, Amino Acid; Substrate Specificity; Thrombosis; Trypsin | 2014 |
[Effects of raloxifene combined with conjugated equine estrogen on prothrombotic state in ovariectomized rats].
Topics: Animals; Antithrombin III; Disease Models, Animal; Estrogens, Conjugated (USP); Female; Fibrinogen; Fibrinolysis; Ovariectomy; Plasminogen Activator Inhibitor 1; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Factors; Selective Estrogen Receptor Modulators; Thrombosis | 2013 |
Effects of riboflavin and ultraviolet light treatment on platelet thrombus formation on collagen via integrin αIIbβ3 activation.
Topics: Blood Platelets; Collagen; Fibrinogen; Humans; Manganese; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Plateletpheresis; Protein Binding; Riboflavin; Thrombosis; Ultraviolet Rays | 2014 |
Branch retinal vein occlusion in an asymptomatic adult with cystic fibrosis.
Topics: Adult; Blood Pressure; Cystic Fibrosis; Fibrinogen; Humans; Intraocular Pressure; Male; Retinal Vein Occlusion; Thrombosis; Visual Acuity | 2014 |
Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice.
Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Fibrinogen; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Mannose-Binding Lectin; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Pipecolic Acids; Reperfusion Injury; Sulfonamides; Thrombosis | 2014 |
DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score.
Topics: Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemostasis; Humans; Pregnancy; Prothrombin Time; Retrospective Studies; Thrombosis | 2014 |
Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement.
Topics: Adult; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Blood Coagulation; Blood Coagulation Tests; C-Reactive Protein; Factor VIII; Factor Xa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fondaparinux; Hip Joint; Humans; Male; Middle Aged; Polysaccharides; Thrombin; Thromboplastin; Thrombosis | 2014 |
Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas.
Topics: Animals; Astrocytoma; Biomarkers; Dog Diseases; Dogs; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gene Expression; Glioma; Immunohistochemistry; Oligodendroglioma; Spain; Thromboplastin; Thrombosis | 2014 |
Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease.
Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Early Diagnosis; Female; Fibrinogen; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mexico; Middle Aged; Overweight; Prediabetic State; Risk Factors; Thrombosis; Vasculitis | 2014 |
A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrinogen; Humans; Maze Learning; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Fluorescence; Molecular Structure; Motor Activity; Protein Binding; Pyrazoles; Pyrimidines; Small Molecule Libraries; Thrombosis; Time-Lapse Imaging | 2014 |
Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Blood Platelets; Blotting, Western; Cell Membrane; Cells, Cultured; Disease Models, Animal; Endothelium; Fibrin; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Platelet Activation; Thrombosis | 2014 |
Coagulation management with factor concentrates in liver transplantation: a single-center experience.
Topics: Adult; Algorithms; Blood Coagulation; Blood Coagulation Factors; Blood Component Transfusion; Female; Fibrinogen; Humans; Ischemia; Liver Diseases; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Thrombelastography; Thrombosis; Transfusion Reaction; Ultrasonography, Doppler | 2014 |
Prevention effect of orally active heparin conjugate on cancer-associated thrombosis.
Topics: Administration, Oral; Animals; Anticoagulants; Deoxycholic Acid; Factor Xa; Fibrinogen; Heparin Antagonists; Heparin, Low-Molecular-Weight; Humans; Hyperthermia, Induced; Male; Mice, Inbred ICR; Neoplasms; Protamines; Rats, Sprague-Dawley; Thrombosis | 2014 |
A rabbit model of spontaneous thrombosis induced by lipopolysaccharide.
Topics: Animals; C-Reactive Protein; Disease Models, Animal; Fibrinogen; Lipids; Lipopolysaccharides; Male; Platelet Count; Rabbits; Thrombosis; Tomography, Optical Coherence | 2014 |
The significance of F139V mutation on thrombotic events in compound heterozygous and homozygous protein C deficiency.
Topics: Adult; Alleles; Base Sequence; Exons; Factor V; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heterozygote; Homozygote; Humans; Male; Molecular Sequence Data; Mutation; Partial Thromboplastin Time; Pedigree; Protein C; Protein C Deficiency; Prothrombin Time; Sequence Analysis, DNA; Thrombin Time; Thrombosis | 2014 |
The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.
Topics: Animals; Antithrombins; Arteries; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Inflammation; Male; Mice; Middle Aged; Protein Isoforms; Thrombin; Thrombosis | 2014 |
Alzheimer's disease: Aβ-fibrinogen interaction inhibitor improves cognition in AD.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition Disorders; Fibrinogen; Humans; Pyrazoles; Pyrimidines; Small Molecule Libraries; Thrombosis | 2014 |
Starase: A bi-functional fibrinolytic protease from hepatic caeca of Asterina pectinifera displays antithrombotic potential.
Topics: Amino Acid Sequence; Animals; Asterina; Collagen Type VII; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Mice; Plasminogen; Serine Proteases; Substrate Specificity; Thrombolytic Therapy; Thrombosis | 2014 |
Single administration of p2TA (AB103), a CD28 antagonist peptide, prevents inflammatory and thrombotic reactions and protects against gastrointestinal injury in total-body irradiated mice.
Topics: Amino Acid Sequence; Animals; Antigens, Differentiation; CD28 Antigens; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Fibrinogen; Gamma Rays; Gastrointestinal Tract; Immunohistochemistry; Inflammation; Interleukin-6; Jejunum; Macrophages; Male; Mice, Inbred BALB C; Mice, Inbred Strains; Peptides; Radiation Injuries, Experimental; Radiation-Protective Agents; Thrombosis; Whole-Body Irradiation | 2014 |
A fibrin-specific monoclonal antibody from a designed phage display library inhibits clot formation and localizes to tumors in vivo.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Blood Coagulation; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Immunoglobulin G; Mice; Molecular Sequence Data; Mutation; Neoplasm Transplantation; Neoplasms; Peptide Library; Protein Binding; Protein Structure, Tertiary; Sequence Homology, Amino Acid; Surface Plasmon Resonance; Thrombosis | 2014 |
Value of serum fibrinogen levels in the assessment of mechanical prosthetic valve thrombosis.
Topics: Adult; Anticoagulants; Biomarkers; Case-Control Studies; Echocardiography, Transesophageal; Female; Fibrinogen; Heart Atria; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; Risk Factors; Thrombosis; Up-Regulation; Ventricular Function, Left | 2014 |
Plasma fibronectin supports hemostasis and regulates thrombosis.
Topics: Animals; Blood Coagulation; Blood Platelets; Female; Fibrin; Fibrinogen; Fibronectins; Hemostasis; Homeostasis; Humans; Male; Mice; Mice, Knockout; Mice, Transgenic; Microscopy, Confocal; Microscopy, Electron, Scanning; Thrombosis; Treatment Outcome | 2014 |
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carcinoma, Squamous Cell; Cecal Neoplasms; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Fibrinogen; Fibrinolysis; Fluorouracil; Heart Diseases; Hemorrhage; Humans; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Multiple Organ Failure; Neoplasms, Multiple Primary; Organoplatinum Compounds; Postoperative Complications; Thrombosis; Tranexamic Acid; Vulvar Neoplasms | 2014 |
Evaluation of antithrombotic activity of thrombin DNA aptamers by a murine thrombosis model.
Topics: Animals; Anticoagulants; Antithrombins; Aptamers, Nucleotide; Blood Coagulation; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinogen; Fibrinolytic Agents; G-Quadruplexes; Hirudins; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Recombinant Proteins; Thrombin; Thrombosis | 2014 |
Platelet mechanosensing of substrate stiffness during clot formation mediates adhesion, spreading, and activation.
Topics: Acrylic Resins; Blood Coagulation; Blood Platelets; Cell Movement; Cellular Microenvironment; Fibrin; Fibrinogen; Humans; Immobilized Proteins; Mechanotransduction, Cellular; Microscopy, Confocal; P-Selectin; Phosphatidylserines; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; rac1 GTP-Binding Protein; Stress, Mechanical; Thrombosis | 2014 |
Endocannabinoids control platelet activation and limit aggregate formation under flow.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acids; Blood Platelets; Calcium; Cannabis; Collagen; Dronabinol; Endocannabinoids; Fibrinogen; Humans; Integrin beta3; Intracellular Signaling Peptides and Proteins; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Polyunsaturated Alkamides; Protein-Tyrosine Kinases; Receptor, Cannabinoid, CB2; Receptor, PAR-1; Signal Transduction; Syk Kinase; Thrombosis | 2014 |
Purification and characterization of a fibrinolytic enzyme from Petasites japonicus.
Topics: Amides; Amino Acid Sequence; Animals; Anticoagulants; Antithrombins; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Fibrinolysis; Humans; Male; Mice, Inbred ICR; Molecular Sequence Data; Petasites; Sequence Analysis, Protein; Serine Proteases; Thrombosis | 2015 |
Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 1; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hyperglycemia; Male; Microcirculation; Middle Aged; Nephelometry and Turbidimetry; Permeability; Risk Factors; Thrombin; Thrombosis; Young Adult | 2015 |
The β isoform of the catalytic subunit of protein phosphatase 2B restrains platelet function by suppressing outside-in αII b β3 integrin signaling.
Topics: Animals; Blood Platelets; Calcineurin; Carotid Arteries; Catalytic Domain; Cell Adhesion; Chlorides; Female; Ferric Compounds; Fibrinogen; Flow Cytometry; HEK293 Cells; Humans; Male; Mice; Mice, Transgenic; Phenotype; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Isoforms; Signal Transduction; Thrombosis | 2014 |
A comparison of fibrinogen measurement using TEG(®) functional fibrinogen and Clauss in cardiac surgery patients.
Topics: Anticoagulants; Blood Coagulation; Cardiac Surgical Procedures; Fibrinogen; Heparin; Humans; Platelet Count; Point-of-Care Systems; Protamines; Regression Analysis; Thrombelastography; Thrombosis | 2015 |
The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment-naïve, asymptomatic HIV-infected individuals.
Topics: Adult; Antigens, CD; Asymptomatic Diseases; Biomarkers; Blood Coagulation; Blood Platelets; Case-Control Studies; CD4 Lymphocyte Count; Cross-Sectional Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; HIV Infections; HIV-1; Humans; Immunity, Innate; Inflammation; Male; Mean Platelet Volume; Middle Aged; Platelet Activation; Platelet Count; T-Lymphocytes; Thrombosis; Viral Load | 2015 |
The balance of pro- and anticoagulant processes underlying thrombin generation.
Topics: alpha-Macroglobulins; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Computational Biology; Computer Simulation; Enoxaparin; Factor Xa Inhibitors; Fibrinogen; Humans; Models, Biological; Prothrombin; Reproducibility of Results; Rivaroxaban; Thrombin; Thrombosis; Time Factors | 2015 |
Coronary thrombus composition: links with inflammation, platelet and endothelial markers.
Topics: Acute Disease; Aged; Blood Coagulation; Blood Platelets; Coronary Vessels; Endothelial Cells; Endothelium, Vascular; Female; Fibrin; Fibrinogen; Humans; Inflammation; Male; Microscopy, Electron, Scanning; Middle Aged; Neutrophils; P-Selectin; Percutaneous Coronary Intervention; Plasminogen Activator Inhibitor 1; Platelet Activation; Prospective Studies; Thrombosis; Treatment Outcome | 2014 |
Spirulan from blue-green algae inhibits fibrin and blood clots: its potent antithrombotic effects.
Topics: Animals; Blood Coagulation; Cyanobacteria; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Mice; Polysaccharides; Thrombosis | 2015 |
[Hypercoagulable state in patients with multiple myeloma].
Topics: Blood Coagulation Tests; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Multiple Myeloma; Thalidomide; Thrombomodulin; Thrombosis | 2015 |
flg2 as a potential biomarker of acute cerebral ischemic-reperfusion injury.
Topics: Animals; Biomarkers; Chemokine CCL2; Cytokines; Fibrinogen; Gene Expression Regulation; Inflammation; Interleukin-1beta; Interleukin-8; Macrophages; Male; Microcirculation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptor, Fibroblast Growth Factor, Type 3; Reperfusion Injury; RNA, Messenger; Thrombosis; Tumor Necrosis Factor-alpha | 2015 |
Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Cardiovascular Diseases; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Hypertension; Inflammation; Inflammation Mediators; Lipids; Male; Middle Aged; Prognosis; Thrombosis | 2015 |
L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Antithrombins; Asparaginase; Child; Child, Preschool; Febrile Neutropenia; Female; Fibrinogen; Humans; Infant; Male; Mannose-Binding Lectin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombosis | 2015 |
International survey on D-dimer test reporting: a call for standardization.
Topics: Blood Chemical Analysis; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; International Cooperation; Reproducibility of Results; Surveys and Questionnaires; Thrombosis; United States; Venous Thromboembolism | 2015 |
Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.
Topics: Animals; Antithrombins; Biomarkers; Blood Coagulation; Blood Coagulation Disorders; Disease Models, Animal; Doxorubicin; Elasticity; Fibrinogen; Hemostasis; Hypoalbuminemia; Male; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Serum Albumin; Severity of Illness Index; Thrombin; Thrombosis | 2015 |
Experimental and imaging techniques for examining fibrin clot structures in normal and diseased states.
Topics: Anemia, Sickle Cell; Blood Chemical Analysis; Factor XIIIa; Fibrin; Fibrinogen; Fibrinolysis; Humans; Microscopy, Confocal; Myocardial Infarction; Myocardial Ischemia; Stroke; Thrombin; Thrombosis | 2015 |
Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and fibrinogen Mumbai mutation.
Topics: Adult; Afibrinogenemia; Diagnosis, Differential; Exons; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Hepatic Veins; Homozygote; Humans; Mutation, Missense; Portal Vein; Sequence Analysis, DNA; Splenic Vein; Thrombosis | 2015 |
The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study.
Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Cohort Studies; Elasticity; Female; Fibrinogen; Fibrinolytic Agents; Fractals; Humans; Male; Middle Aged; Prospective Studies; Stroke; Thrombosis; Tissue Plasminogen Activator; Whole Blood Coagulation Time | 2015 |
Biochemical characterization of a new glycosylated protease from Euphorbia cf. lactea latex.
Topics: Amino Acid Sequence; Electrophoresis, Polyacrylamide Gel; Euphorbia; Fibrinogen; Fibrinolytic Agents; Glycosylation; Humans; Hydrogen-Ion Concentration; Kinetics; Latex; Mercaptoethanol; Molecular Weight; Plant Proteins; Proline; Serine Proteases; Serine Proteinase Inhibitors; Stress, Physiological; Temperature; Thrombosis | 2015 |
LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa.
Topics: Animals; Bleeding Time; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Fibrinolytic Agents; Male; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Rabbits; Rats, Sprague-Dawley; Snake Venoms; Sulfonamides; Thrombosis; Tryptophan | 2015 |
[Features of coagulative blood potential disorder in acute constitutional inflammatory response of septic tubo-ovarian formations].
Topics: Adult; Blood Coagulation; Cytokines; Female; Fibrinogen; Humans; Oxidative Stress; Prospective Studies; Reproductive Tract Infections; Suppuration; Systemic Inflammatory Response Syndrome; Thromboplastin; Thrombosis | 2014 |
Pharmacological actions of nobiletin in the modulation of platelet function.
Topics: Animals; Blood Coagulation Tests; Blood Platelets; Calcium; Cells, Cultured; Cyclic GMP; Fibrinogen; Flavones; Humans; Mice, Inbred C57BL; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Proto-Oncogene Proteins c-akt; Thrombosis | 2015 |
Altered plasma fibrin clot properties in essential thrombocythemia.
Topics: Adult; Aged; Biomarkers; Blood Platelets; C-Reactive Protein; Case-Control Studies; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Humans; Janus Kinase 2; Male; Middle Aged; Nephelometry and Turbidimetry; P-Selectin; Plasminogen Activator Inhibitor 1; Platelet Activation; Platelet Count; Platelet Factor 4; Thrombocythemia, Essential; Thrombosis; Tissue Plasminogen Activator | 2016 |
Preventive Effect of Aspirin Eugenol Ester on Thrombosis in κ-Carrageenan-Induced Rat Tail Thrombosis Model.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Carrageenan; Disease Models, Animal; Erythrocyte Count; Erythrocytes; Eugenol; Fibrinogen; Hemoglobins; Male; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin Time; Rats; Rats, Wistar; Thrombosis | 2015 |
The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions.
Topics: Blood Platelets; Collagen; Dinoprostone; Fibrinogen; Humans; In Vitro Techniques; Platelet Adhesiveness; Platelet Aggregation; Receptors, Prostaglandin E, EP3 Subtype; Sulfonamides; Thrombosis | 2015 |
Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin αIIbβ3 and Lyn Kinase.
Topics: Animals; Antigen-Antibody Complex; Autoimmune Diseases; Blood Platelets; Cell Line; CHO Cells; Cricetulus; Fibrinogen; Humans; Immunoglobulin G; Mice; Mice, Inbred C57BL; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein-Tyrosine Kinases; Receptors, IgG; Signal Transduction; src-Family Kinases; Thrombosis | 2015 |
Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus.
Topics: Adamantane; Administration, Oral; Animals; Biomarkers; Diabetes Mellitus, Experimental; Disease Progression; Drug Therapy, Combination; Fibrinogen; Hypoglycemic Agents; Male; Nitriles; Pioglitazone; Platelet Count; Pyrrolidines; Rats; Rats, Sprague-Dawley; Streptozocin; Thiazolidinediones; Thrombosis; Vildagliptin | 2015 |
Assessment of coagulation profile by thromboelastometry in adult patients with cyanotic congenital heart disease.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Cyanosis; Female; Fibrinogen; Fibrinolysis; Heart Diseases; Hemorrhage; Hemostatic Techniques; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Care; Prothrombin Time; Thrombelastography; Thrombosis; Warfarin; Young Adult | 2016 |
Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Topics: Arterial Occlusive Diseases; Biomarkers; Catheterization, Peripheral; Down-Regulation; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Punctures; Retrospective Studies; Risk Assessment; Risk Factors; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2015 |
Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.
Topics: Antibodies, Monoclonal; Blood Platelets; Coagulants; Collagen; Fibrin; Fibrinogen; Hemostasis; Hemostatics; Humans; Microscopy, Confocal; Platelet Adhesiveness; Shear Strength; Thrombin; Thrombosis | 2015 |
Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations.
Topics: Adult; Anticoagulants; Blood Platelets; Dabigatran; Disseminated Intravascular Coagulation; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Platelet Count; Thrombosis; Vascular Malformations | 2016 |
Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
Topics: Aminopyridines; Animals; Benzamides; Blood Platelets; Cardiovascular Diseases; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Extracellular Traps; Fibrinogen; Humans; Leukocytes; Macrophage-1 Antigen; Mice; Microscopy, Confocal; Monocytes; Neutrophils; P-Selectin; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Phosphorylation; Platelet Adhesiveness; Pulmonary Disease, Chronic Obstructive; Risk; Thromboplastin; Thrombosis | 2016 |
Elevated fibrinogen and lowered homocysteine-vitamin determinants and their association with left atrial thrombus in patients with rheumatic mitral stenosis.
Topics: Adult; Biomarkers; Blood Platelets; Cross-Sectional Studies; Female; Fibrinogen; Folic Acid; Heart Atria; Homocysteine; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Stenosis; Platelet Aggregation; Rheumatic Heart Disease; Thrombosis; Ultrasonography; Vitamin B 12 | 2015 |
Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions.
Topics: Animals; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Fibrinogen; Humans; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Microscopy; Microscopy, Confocal; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Recombinant Proteins; Shear Strength; Stress, Mechanical; Thrombosis; Tissue Inhibitor of Metalloproteinase-2; von Willebrand Factor | 2016 |
Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; C-Reactive Protein; Case-Control Studies; Churg-Strauss Syndrome; Eosinophilia; Female; Fibrin; Fibrin Clot Lysis Time; Fibrinogen; Fibrinolysis; Granulomatosis with Polyangiitis; Humans; Male; Middle Aged; Thrombin; Thrombosis; Young Adult | 2015 |
Exome Sequencing and Clot Lysis Experiments Demonstrate the R458C Mutation of the Alpha Chain of Fibrinogen to be Associated with Impaired Fibrinolysis in a Family with Thrombophilia.
Topics: Blood Coagulation; Blood Coagulation Tests; Exome; Family Health; Female; Fibrin; Fibrinogen; Humans; Male; Mutation; Pedigree; Sequence Analysis, DNA; Thrombin; Thrombophilia; Thrombosis; Venous Thromboembolism | 2016 |
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet Disease.
Topics: Behcet Syndrome; Female; Fibrinogen; Humans; Male; Neutrophil Activation; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Thrombosis | 2016 |
Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.
Topics: Adult; Aged; Antithrombins; Biomarkers; C-Reactive Protein; Case-Control Studies; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Kidney; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index; Thrombosis; von Willebrand Factor | 2016 |
Thromboembolic events in patients with severe inherited fibrinogen deficiency.
Topics: Adult; Afibrinogenemia; Fibrinogen; Hemorrhage; Humans; Middle Aged; Retrospective Studies; Thromboembolism; Thrombosis | 2016 |
Hypertensive Crisis and Left Ventricular Thrombi after an Upper Respiratory Infection during the Long-term Use of Oral Contraceptives.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Contraceptives, Oral; Echocardiography; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Ventricles; Heparin; Humans; Hypertension; Respiratory Tract Infections; Thrombosis; Treatment Outcome; Warfarin | 2016 |
Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice.
Topics: Animals; Bleeding Time; Carotid Artery Thrombosis; Clot Retraction; DNA-Binding Proteins; Fibrinogen; Hemostasis; Humans; Mice; Mice, 129 Strain; Mice, Knockout; P-Selectin; Phospholipase C gamma; Phosphoproteins; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; RNA-Binding Proteins; Signal Transduction; Thrombosis | 2016 |
Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice.
Topics: Animals; Blood Platelets; Calcium; Disease Models, Animal; Fibrinogen; Hemostasis; Hydroxyindoleacetic Acid; Melatonin; Mice; Mice, Knockout; Phosphoric Monoester Hydrolases; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Stroke; Thrombosis | 2016 |
Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Coagulants; Factor XIII; Female; Fibrin; Fibrinogen; Fibrosis; Healthy Volunteers; Hemostasis; Hemostatics; Humans; Male; Malondialdehyde; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Oxygen; Permeability; Thrombosis | 2016 |
Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.
Topics: Amino Acid Sequence; Factor XIIIa; Fibrinogen; Glutamine; Humans; Lysine; Mutagenesis, Site-Directed; Mutation, Missense; Nuclear Magnetic Resonance, Biomolecular; Point Mutation; Protein Binding; Protein Conformation; Recombinant Fusion Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Thrombosis | 2016 |
Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation.
Topics: Animals; Blood Platelets; C-Reactive Protein; Collagen; Fibrinogen; Hemostasis; Mice; Mice, Inbred C57BL; P-Selectin; Platelet Aggregation; Protein Interaction Maps; Serum Amyloid P-Component; Thrombosis | 2016 |
Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling.
Topics: Animals; Antimicrobial Cationic Peptides; Blood Platelets; Cathelicidins; Female; Fibrinogen; Gene Expression Regulation; Humans; Male; P-Selectin; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; src-Family Kinases; Thrombosis | 2016 |
A coupled chemo-fluidic computational model for thrombogenesis in infarcted left ventricles.
Topics: Blood Coagulation; Blood Flow Velocity; Blood Platelets; Computer Simulation; Fibrinogen; Heart Aneurysm; Heart Ventricles; Hemodynamics; Humans; Hydrodynamics; Models, Cardiovascular; Platelet Activation; Regional Blood Flow; ST Elevation Myocardial Infarction; Thrombosis; Time Factors; Tomography, X-Ray Computed | 2016 |
Dynamic and quantitative assessment of blood coagulation using optical coherence elastography.
Topics: Animals; Blood Coagulation; Elasticity Imaging Techniques; Fibrinogen; Humans; Phantoms, Imaging; Swine; Thrombosis; Tomography, Optical Coherence | 2016 |
Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury.
Topics: Adult; Blood Coagulation; Female; Fibrin; Fibrinogen; Hemorrhage; Humans; Male; Methionine; Middle Aged; Oxidative Stress; Thrombosis; Wounds and Injuries | 2016 |
Computational Study of Thrombus Formation and Clotting Factor Effects under Venous Flow Conditions.
Topics: Blood Circulation; Blood Coagulation; Blood Platelets; Fibrin; Fibrinogen; Models, Biological; Nonlinear Dynamics; Thrombosis; Veins | 2016 |
Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.
Topics: 3' Untranslated Regions; Aged; Binding Sites; Cell Line; Diabetes Mellitus; Endothelial Cells; Female; Fibrinogen; Gene Expression Regulation; Genes, Reporter; Hemostasis; Humans; Hypoglycemic Agents; Male; MicroRNAs; Middle Aged; Monocytes; RNA Interference; Thromboplastin; Thrombosis; Time Factors; Transfection; Vascular Cell Adhesion Molecule-1 | 2016 |
Novel assay for prothrombotic polyphosphates in plasma reveals their correlation with obesity.
Topics: Cross-Sectional Studies; Factor VIII; Fibrinogen; Humans; Male; Middle Aged; Obesity; Polyphosphates; Thrombosis | 2016 |
Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
Topics: Adult; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Blood Coagulation Factors; Brain Ischemia; Case-Control Studies; Comorbidity; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Foramen Ovale, Patent; Heart Diseases; Humans; Ischemic Attack, Transient; Male; Middle Aged; Migraine Disorders; Platelet Count; Smoking; Stroke Volume; Thrombin; Thrombophilia; Thrombosis | 2016 |
Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Topics: Afibrinogenemia; DNA Mutational Analysis; Family Health; Female; Fibrinogen; Fibrinogens, Abnormal; Genotype; Hemorrhage; Humans; Middle Aged; Mutation, Missense; Pedigree; Thrombosis; Tunisia | 2016 |
Revisiting the mechanism of coagulation factor XIII activation and regulation from a structure/functional perspective.
Topics: Binding Sites; Calcium; Factor XIII; Fibrin; Fibrinogen; Humans; Protein Subunits; Thrombin; Thrombosis | 2016 |
Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
Topics: Animals; Antithrombins; Blood Coagulation; Blood Platelets; Coagulants; Factor V; Factor VIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Therapy; Hemophilia A; Hemostasis; Humans; Leukocytes; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phenotype; Platelet Activation; Thrombin; Thrombosis | 2017 |
Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity.
Topics: ADAMTS13 Protein; Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysin; HEK293 Cells; Humans; Microscopy, Confocal; Protein Conformation; Proteolysis; Purpura, Thrombotic Thrombocytopenic; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Tandem Mass Spectrometry; Thrombosis | 2016 |
Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII: reply.
Topics: Antifibrinolytic Agents; Factor XIII; Fibrin; Fibrinogen; Humans; Thrombosis | 2017 |
Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII: comment.
Topics: Antifibrinolytic Agents; Factor XIII; Fibrin; Fibrinogen; Humans; Thrombosis | 2017 |
Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets.
Topics: Animals; Blood Platelets; Calcium Signaling; Chenodeoxycholic Acid; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Genotype; Hemostasis; Humans; Isoxazoles; Ligands; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cytoplasmic and Nuclear; Thrombosis; Time Factors | 2016 |
A novel mutation in exon 2 of FGB caused by c.221G>T
Topics: Adult; Afibrinogenemia; Computer Simulation; Consanguinity; Exons; Female; Fibrinogen; Humans; Male; Middle Aged; Mutation, Missense; Nuclear Family; Point Mutation; Thrombosis | 2017 |
Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Topics: Adult; Body Mass Index; Factor XIII; Female; Fibrinogen; Humans; Introns; Male; Middle Aged; Polymorphism, Single Nucleotide; Smoking; Thrombosis; Young Adult | 2016 |
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Topics: Aged; Blood Coagulation Tests; Diabetes Mellitus, Type 2; Female; Fibrin; Fibrinogen; Fibrinolysis; Genetic Association Studies; Genotype; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Phenotype; Polymorphism, Genetic; Protein Conformation; Risk Assessment; Risk Factors; Scotland; Structure-Activity Relationship; Thrombosis | 2017 |
On societal and hemostatic changes.
Topics: Biomedical Research; Diabetes Mellitus; Factor XIII; Fibrinogen; Genetic Variation; Hemostasis; Humans; Politics; Thrombosis | 2016 |
Exploring hemostatic and thrombolytic potential of heynein - A cysteine protease from Ervatamia heyneana latex.
Topics: Adult; Animals; Apocynaceae; Cysteine Proteases; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Hemostasis; Hemostatics; Humans; Latex; Male; Mice; Plant Bark; Plant Extracts; Thrombosis; Young Adult | 2017 |
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2016 |
Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.
Topics: Aged; Anticoagulants; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Carboxypeptidase B2; Carotid Arteries; Carotid Stenosis; Endarterectomy; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immunohistochemistry; Inflammation; Macrophages; Male; Middle Aged; Myocytes, Smooth Muscle; Pilot Projects; Plaque, Atherosclerotic; Plasminogen Activator Inhibitor 1; Platelet Glycoprotein GPIb-IX Complex; Thrombin; Thrombosis; von Willebrand Factor | 2017 |
Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
Topics: Blood Coagulation; Elasticity; Factor XIII; Fibrin; Fibrinogen; Humans; Microscopy, Electron, Scanning; Nephelometry and Turbidimetry; Nonlinear Dynamics; Protein Conformation; Recombinant Proteins; Rheology; Scattering, Small Angle; Structure-Activity Relationship; Thrombosis; X-Ray Diffraction | 2017 |
Immobilization of heparin/poly-l-lysine microspheres on medical grade high nitrogen nickel-free austenitic stainless steel surface to improve the biocompatibility and suppress thrombosis.
Topics: Animals; Antioxidants; Biocompatible Materials; Blood Platelets; Cell Count; Cell Death; Cell Proliferation; Cell Shape; Dental Alloys; Dopamine; Fibrinogen; Hemolysis; Heparin; Human Umbilical Vein Endothelial Cells; Humans; Microspheres; Nickel; Nitric Oxide; Nitrogen; Partial Thromboplastin Time; Particle Size; Platelet Adhesiveness; Polylysine; Prothrombin Time; Rabbits; Stainless Steel; Static Electricity; Surface Properties; Thrombosis | 2017 |
Water-Pipe Smoke Exposure-Induced Circulatory Disturbances in Mice, and the Influence of Betaine Supplementation Thereon.
Topics: Administration, Oral; Animals; Antioxidants; Betaine; Blood Platelets; Cytochromes c; Fibrinogen; Gene Expression; Interleukin-6; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Oxidative Stress; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Primary Cell Culture; Prothrombin Time; Smoking; Superoxide Dismutase; Thrombocytopenia; Thrombosis; Tumor Necrosis Factor-alpha | 2017 |
Silencing of Anticoagulant Protein C Evokes Low-Incident but Spontaneous Atherothrombosis in Apolipoprotein E-Deficient Mice-Brief Report.
Topics: Animals; Antithrombin III; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Coagulation; Diet, Western; Disease Models, Animal; Female; Fibrinogen; Genetic Predisposition to Disease; Liver; Mice, Inbred C57BL; Mice, Knockout; Peptide Hydrolases; Phenotype; Plaque, Atherosclerotic; Protein C; RNA Interference; Thrombosis | 2017 |
Whole blood rotation thrombelastometry in subjects undergoing vitamin K antagonist treatment: hypo- or hypercoagulable profiles?
Topics: Aged; Area Under Curve; Blood Coagulation; Blood Coagulation Tests; Chemistry, Clinical; Female; Fibrinogen; Humans; Male; Middle Aged; Thrombelastography; Thrombosis; Vitamin K | 2008 |
The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury.
Topics: Angioplasty, Balloon, Coronary; Animals; Cell Proliferation; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thrombosis; Tunica Intima | 2008 |
Eosinophilia and first-line coagulation testing.
Topics: Adult; Aged; Blood Coagulation Tests; Eosinophilia; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Retrospective Studies; Thrombosis | 2009 |
Thrombolysis effect of a novel targeted microbubble with low-frequency ultrasound in vivo.
Topics: Acute Disease; Angiography; Animals; Carotid Artery, Common; Disease Models, Animal; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Microbubbles; Partial Thromboplastin Time; Prothrombin Time; Rabbits; Thrombolytic Therapy; Thrombosis; Ultrasonography, Interventional | 2008 |
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Antithrombins; Asparaginase; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Thrombosis; Treatment Outcome | 2008 |
Acoustic determination of performance and equivalence of plasminogen activators.
Topics: Acoustics; Biosensing Techniques; Caseins; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Metalloendopeptidases; Plasminogen; Plasminogen Activators; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator | 2008 |
Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.
Topics: Adolescent; Adult; Fibrin; Fibrinogen; Humans; Microscopy, Immunoelectron; Middle Aged; Nitrogen; Oxidative Stress; Protein Processing, Post-Translational; Protein Structure, Tertiary; Risk Factors; Thrombosis; Tyrosine | 2008 |
Fibrinogen index in thromboembolism.
Topics: Blood; Embolism; Fibrinogen; Humans; Thrombosis | 1947 |
Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.
Topics: Cell Membrane; Cells, Cultured; Factor Va; Factor Xa; Fibrin; Fibrinogen; Fibroblasts; Humans; In Vitro Techniques; Integrins; Microscopy, Confocal; Microscopy, Electron, Transmission; Oligopeptides; Prothrombin; Thrombin; Thrombosis | 2008 |
Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma' chain sequence.
Topics: Animals; Binding Sites; Factor V; Fibrinogen; Humans; Mice; Mice, Transgenic; Platelet Aggregation Inhibitors; Recombinant Fusion Proteins; Risk; Thrombin; Thrombosis | 2009 |
Blood compatibility evaluation of elastic gelatin gel from salmon collagen.
Topics: Animals; Blood Platelets; Collagen; Elasticity; Fibrinogen; Gelatin; Gels; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Platelet Adhesiveness; Rats; Salmon; Surface Properties; Thrombosis; Tissue Engineering | 2008 |
Antithrombotic effects of targeting alphaIIbbeta3 signaling in platelets.
Topics: Animals; Blood Platelets; Fibrinogen; Gene Knock-In Techniques; Hemorrhage; Hemostasis; Mice; Mice, Mutant Strains; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Structure, Tertiary; Signal Transduction; src-Family Kinases; Thrombosis | 2009 |
Surface characterization of biopolyurethanes based on cellulose derivatives.
Topics: Adsorption; Biocompatible Materials; Biopolymers; Cellulose; Fibrinogen; Humans; In Vitro Techniques; Materials Testing; Microscopy, Electron, Scanning; Molecular Weight; Polyurethanes; Surface Properties; Surface Tension; Thermodynamics; Thrombosis; Water | 2009 |
Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.
Topics: Animals; Fibrinogen; Fibronectins; In Vitro Techniques; Integrases; Mesenteric Arteries; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; Solubility; Thrombosis; von Willebrand Factor | 2009 |
Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke.
Topics: Adolescent; Adult; Alleles; Case-Control Studies; Female; Fibrinogen; Genetic Variation; Genotype; Humans; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Risk; Stroke; Thrombosis | 2009 |
Retinal pathology of pediatric cerebral malaria in Malawi.
Topics: Amyloid beta-Peptides; Axons; Blood-Retinal Barrier; Child; Fibrinogen; Fundus Oculi; Glial Fibrillary Acidic Protein; Gliosis; Humans; Immunohistochemistry; Macula Lutea; Malaria, Cerebral; Malawi; Retina; Retinal Hemorrhage; Retinal Vessels; Thrombosis | 2009 |
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
Topics: Adult; Antiphospholipid Syndrome; Case-Control Studies; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Leucine; Male; Odds Ratio; Polymorphism, Genetic; Protein Subunits; Risk Assessment; Risk Factors; Thrombosis; Up-Regulation; Valine | 2009 |
Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces.
Topics: Angioplasty, Balloon, Coronary; Carbon Compounds, Inorganic; Chromium Alloys; Fibrin; Fibrinogen; Humans; Magnesium; Materials Testing; Platelet Adhesiveness; Prosthesis Design; Reproducibility of Results; Silicon Compounds; Stainless Steel; Stents; Surface Properties; Thrombosis | 2009 |
The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis.
Topics: Animals; Antigens, Surface; Blood Platelets; Cell Adhesion; Cells, Cultured; Fibrinogen; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 3; Receptors, IgG; Signal Transduction; Thrombosis | 2009 |
Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: potential triggers for atherothrombotic events.
Topics: Atherosclerosis; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammation; Male; Respiratory Tract Infections; Seasons; Thrombosis | 2009 |
Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice.
Topics: Animals; Apolipoproteins E; Blood Coagulation; Carotid Arteries; Carotid Artery Diseases; Constriction; Cytokines; Dietary Fats; Disease Models, Animal; Fibrinogen; Fibrosis; Hemodynamics; Inflammation; Injections, Intraperitoneal; Lipopolysaccharides; Macrophages; Male; Matrix Metalloproteinases; Mice; Mice, Knockout; Norepinephrine; Rupture; Stress, Psychological; Thrombosis | 2009 |
Severe spontaneous arterial thrombotic manifestations in patients with inherited hypo- and afibrinogenemia.
Topics: Adult; Afibrinogenemia; Amputation, Surgical; Angiography; Female; Fibrinogen; Foot; Humans; Middle Aged; Renal Artery; Thrombosis; Tibial Arteries; Treatment Outcome | 2009 |
A novel anti-platelet aggregation tripeptide from Agkistrodon acutus venom: isolation and characterization.
Topics: Agkistrodon; Animals; Chromatography, Ion Exchange; Crotalid Venoms; Female; Fibrinogen; Humans; In Vitro Techniques; Integrin beta3; Magnetic Resonance Spectroscopy; Male; Mice; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Rabbits; Thrombosis | 2009 |
Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).
Topics: Arterial Occlusive Diseases; Blood Coagulation Disorders, Inherited; Blood Coagulation Tests; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Testing; Hand Injuries; Hemorrhage; Heterozygote; Humans; Menorrhagia; Middle Aged; Molecular Weight; Mutation; Pedigree; Phenotype; Postpartum Hemorrhage; Thrombosis | 2009 |
Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
Topics: Abortion, Habitual; Abruptio Placentae; Adult; Afibrinogenemia; Enoxaparin; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Humans; Infant, Newborn; Phenotype; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, First; Prothrombin Time; Puerperal Disorders; Retrospective Studies; Thrombin Time; Thromboembolism; Thrombosis | 2009 |
Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel alphaIIb-specific alphaIIbbeta3 antagonist.
Topics: Amino Acid Sequence; Animals; Blood Platelets; Carotid Artery Injuries; Fibrinogen; Fibrinolytic Agents; Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Molecular Sequence Data; Molecular Structure; Muscle, Skeletal; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Rats; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Species Specificity; Thrombosis | 2009 |
Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Factor V; Family Health; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Infant; Male; Thromboembolism; Thrombosis; Venous Thrombosis | 2009 |
Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; Carrier Proteins; Child; Child, Preschool; Cohort Studies; Creatinine; Family; Female; Fibrinogen; Genome-Wide Association Study; Genome, Human; Homocysteine; Humans; Infant; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Spain; Thrombosis | 2009 |
Simulation of thrombus formation in shear flows using Lattice Boltzmann Method.
Topics: Blood Flow Velocity; Computer Simulation; Equipment Design; Fibrinogen; Heart-Assist Devices; Hemorheology; Humans; Surface Tension; Thrombosis | 2009 |
CIB1 deficiency results in impaired thrombosis: the potential role of CIB1 in outside-in signaling through integrin alpha IIb beta 3.
Topics: Animals; Blood Platelets; Calcium-Binding Proteins; Cell Shape; Fibrinogen; Hemostasis; Mice; Mice, Knockout; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction; Thrombosis | 2009 |
Targeted venous occlusion using pulsed high-intensity focused ultrasound.
Topics: Animals; Blood Coagulation; Contrast Media; Ear; Endothelium, Vascular; Fibrinogen; High-Intensity Focused Ultrasound Ablation; Histocytochemistry; Rabbits; Thrombosis; Ultrasonography | 2010 |
Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
Topics: Adult; Blood Coagulation; Coagulation Protein Disorders; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Mutation; Platelet Aggregation; Pulmonary Embolism; Thrombosis | 2009 |
Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation.
Topics: Artificial Cells; Blood Platelets; Fibrinogen; Hemorrhage; Humans; Lactic Acid; Nanostructures; Oligopeptides; Platelet Activation; Platelet Aggregation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Silicon Dioxide; Thrombocytopenia; Thrombosis | 2009 |
Study on the changes of thrombosis-associated factors in patients with coronary heart disease of turbidity-phlegm blocking syndrome.
Topics: Case-Control Studies; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Thrombosis; von Willebrand Factor | 2009 |
Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation.
Topics: Animals; Blood Platelets; Bone Marrow Cells; Carotid Artery Injuries; Female; Fibrinogen; Flow Cytometry; Humans; Male; Megakaryocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Confocal; Mutation; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoprotein IIb; Thrombosis; von Willebrand Diseases; von Willebrand Factor | 2009 |
Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation.
Topics: Adult; Blood Coagulation; Blood Platelets; Fibrin; Fibrinogen; Humans; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Nephelometry and Turbidimetry; Risk Factors; Smoking; Thrombelastography; Thrombosis | 2010 |
The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase.
Topics: Adolescent; Asparaginase; British Columbia; Central Nervous System; Child; Child, Preschool; Costs and Cost Analysis; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Infant; Male; Nova Scotia; Outcome Assessment, Health Care; Plasma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Sex Factors; Thrombosis | 2009 |
Coagulation alterations in treating arrhythmias with radiofrequency ablation.
Topics: Adult; Aged; Arrhythmias, Cardiac; Catheter Ablation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Postoperative Complications; Risk Factors; Thrombosis; Time Factors | 2009 |
Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Protein Carbonylation; Protein Multimerization; Thrombin; Thrombosis; Tyrosine | 2010 |
Purification and characterization of a novel fibrinolytic enzyme from the polychaete, Neanthes japonica (Iznka).
Topics: Ammonium Sulfate; Animals; Annelida; Biotechnology; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hydrogen-Ion Concentration; Isoelectric Point; Peptide Hydrolases; Polychaeta; Serine Proteases; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Temperature; Thrombosis | 2010 |
Improved biocompatibility of thrombo-resistant iron-polysaccharides multilayer coatings on nitinols.
Topics: Adsorption; Albumins; Alloys; Animals; Cell Adhesion; Cell Line; Cell Proliferation; Coated Materials, Biocompatible; Endothelial Cells; Fibrinogen; Humans; Iron; Leukocytes, Mononuclear; Materials Testing; Neutrophils; Polysaccharides; Surface Properties; Sus scrofa; Thrombosis | 2010 |
Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects.
Topics: Abortion, Spontaneous; Adolescent; Adult; Afibrinogenemia; Aged; Aged, 80 and over; Amino Acid Substitution; Arterial Occlusive Diseases; Blood Coagulation Tests; Child; DNA Mutational Analysis; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Mutation, Missense; Point Mutation; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Hematologic; Protein Structure, Quaternary; Protein Subunits; Purpura; Sequence Deletion; Structure-Activity Relationship; Thrombosis; Young Adult | 2010 |
Microbial production of 2,3-butanediol by a mutagenized strain of Serratia marcescens H30.
Topics: Butylene Glycols; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hydrogen-Ion Concentration; Isoelectric Focusing; Molecular Weight; Mutagenesis; Peptide Hydrolases; Serine Proteases; Serratia marcescens; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Temperature; Thrombosis | 2010 |
Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
Topics: Acute Disease; Aged; Blood Coagulation Tests; Family; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Intracranial Thrombosis; Ischemia; Male; Middle Aged; Permeability; Stroke; Thrombosis | 2010 |
High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.
Topics: Adult; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; HIV Infections; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Lipoproteins, HDL; Male; Middle Aged; Thrombosis | 2010 |
Role for ADAP in shear flow-induced platelet mechanotransduction.
Topics: Actins; Adaptor Proteins, Signal Transducing; Animals; Blood Platelets; Carotid Arteries; Cell Adhesion Molecules; Cell Movement; Cytoskeleton; Fibrinogen; Hemorheology; Intracellular Space; Mechanotransduction, Cellular; Mice; Microfilament Proteins; Phosphoproteins; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Transport; Proto-Oncogene Proteins c-vav; Stress, Mechanical; Thrombosis | 2010 |
Mlck1a is expressed in zebrafish thrombocytes and is an essential component of thrombus formation.
Topics: Animals; Animals, Genetically Modified; Blood Platelets; Cell Shape; Disease Models, Animal; Fibrinogen; Gene Expression Profiling; Gene Expression Regulation, Developmental; Gene Expression Regulation, Enzymologic; Gene Knockdown Techniques; Myosin-Light-Chain Kinase; Oligonucleotide Array Sequence Analysis; Platelet Adhesiveness; Platelet Membrane Glycoprotein IIb; Recombinant Fusion Proteins; RNA, Messenger; Thrombosis; Zebrafish; Zebrafish Proteins | 2010 |
The catalytic subunit of protein phosphatase 1 gamma regulates thrombin-induced murine platelet alpha(IIb)beta(3) function.
Topics: Animals; Blood Platelets; Catalytic Domain; Disease Models, Animal; Fibrinogen; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Isoenzymes; Mice; Phosphoserine; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Phosphatase 1; Proto-Oncogene Proteins c-akt; Receptors, Thrombin; Secretory Vesicles; Signal Transduction; Thrombin; Thrombosis | 2009 |
Proteolytic resistance conferred to fibrinogen by von Willebrand factor.
Topics: Blood Coagulation; Cell Adhesion; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Kinetics; Peptide Hydrolases; Protein Binding; Thrombosis; von Willebrand Factor | 2010 |
Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.
Topics: Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Factor VII; Female; Fibrinogen; Humans; Logistic Models; London; Macular Degeneration; Male; Peptide Fragments; Prothrombin; Risk Factors; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2010 |
A mathematical model of evolving mechanical properties of intraluminal thrombus.
Topics: Collagen Type I; Collagen Type III; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Kinetics; Models, Biological; Stress, Mechanical; Thrombosis | 2009 |
Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Cohort Studies; Factor V; Factor VIII; Female; Fibrinogen; Humans; Hypertension, Pulmonary; Male; Middle Aged; Polymorphism, Genetic; Protein S; Pulmonary Embolism; Retrospective Studies; Risk Factors; Thrombosis; von Willebrand Factor; Young Adult | 2010 |
Association of thrombotic and fibrinolytic factors with severity of culprit lesion in patients with acute coronary syndromes without ST elevation.
Topics: Acute Coronary Syndrome; Antithrombin III; Biomarkers; Coronary Stenosis; Electrocardiography; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Peptide Fragments; Peptide Hydrolases; Prothrombin; Thrombosis | 2010 |
The culture of tissue cells in clots formed from purified bovine fibrinogen and thrombin.
Topics: Animals; Cattle; Fibrinogen; Thrombin; Thrombosis; Tissues | 1947 |
A fibrinogen-thrombin clot useful in tissue culture.
Topics: Fibrinogen; Hemostatics; Humans; Thrombin; Thrombosis; Tissue Culture Techniques | 1947 |
Intermittent fibrinogenesis and recurrent thrombosis.
Topics: Blood; Fibrinogen; Humans; Thrombosis | 1946 |
Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow.
Topics: Biophysics; Blood Platelets; Cell Membrane; Computer Simulation; Fibrin; Fibrinogen; Gels; Humans; Microfluidics; Microscopy, Electron, Scanning; Polymers; Stress, Mechanical; Thrombin; Thrombosis | 2010 |
Coagulopathies and thrombosis: usual and unusual causes and associations, part III.
Topics: ADAM Proteins; ADAMTS13 Protein; Animals; Blood Coagulation Disorders; Factor XIII; Fibrinogen; Hemophilia A; Humans; Influenza A virus; Influenza, Human; Kidney Diseases; Obesity; Orthomyxoviridae Infections; Purpura, Thrombotic Thrombocytopenic; Swine; Thrombosis; von Willebrand Factor; Wine | 2010 |
Enhanced platelet reactivity and thrombosis in Apoe-/- mice exposed to cigarette smoke is attenuated by P2Y12 antagonism.
Topics: Adenosine Monophosphate; Animals; Apolipoproteins E; Blood Platelets; Chlorides; Female; Ferric Compounds; Fibrinogen; Gene Deletion; Mice; Mice, Inbred C57BL; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Tobacco Smoke Pollution | 2010 |
Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles.
Topics: Administration, Inhalation; Animals; Biological Transport; Carbon; Fibrinogen; Inflammation; Liver; Mice; Mice, Inbred C57BL; Microcirculation; Nanoparticles; Platelet Adhesiveness; Thrombosis; Tissue Distribution | 2010 |
Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
Topics: Adult; Age Factors; Behcet Syndrome; Blood Sedimentation; Blood Viscosity; C-Reactive Protein; Endothelium, Vascular; Erythrocyte Deformability; Female; Fibrinogen; Humans; Male; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Thrombosis; Young Adult | 2010 |
Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
Topics: Adult; Aged; Blood Coagulation Tests; Cardiovascular Diseases; Case-Control Studies; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Inflammation; Male; Middle Aged; Permeability; Plasminogen Activator Inhibitor 1; Thrombosis; Tissue Plasminogen Activator; Young Adult | 2010 |
Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Family Health; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Ohio; Plasminogen Activator Inhibitor 1; Risk Factors; Severity of Illness Index; Sleep Apnea Syndromes; Thrombosis; Up-Regulation | 2010 |
Prevalence of the fibrinogen beta-chain, angiotensin-converting enzyme and plasminogen activator inhibitor-1 polymorphisms in Costa Rican young adults with thrombotic disease.
Topics: Adolescent; Adult; Alleles; Case-Control Studies; Costa Rica; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prevalence; Retrospective Studies; Risk Factors; Smoking; Thrombosis | 2010 |
Coexisting dysfibrinogenemia (gamma Arg275His) and FV Leiden associated with thrombosis (Fibrinogen Crete).
Topics: Adolescent; Adult; Afibrinogenemia; Factor V; Female; Fibrinogen; Greece; Humans; Male; Pedigree; Point Mutation; Thrombosis | 2010 |
Simple surface modification of a titanium alloy with silanated zwitterionic phosphorylcholine or sulfobetaine modifiers to reduce thrombogenicity.
Topics: Adsorption; Alloys; Animals; Betaine; Biocompatible Materials; Fibrinogen; Methacrylates; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Phosphorylcholine; Photoelectron Spectroscopy; Platelet Activation; Sheep; Silanes; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermodynamics; Thrombosis; Titanium | 2010 |
Mechanism and clinical significance of the prothrombotic state in patients with essential hypertension.
Topics: Aged; Biomarkers; Blood Coagulation; Blood Pressure; Case-Control Studies; Chi-Square Distribution; China; Endothelium, Vascular; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; P-Selectin; Plasminogen Activator Inhibitor 1; Platelet Activation; Severity of Illness Index; Thrombophilia; Thrombosis; Vasodilation | 2010 |
Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
Topics: Adult; Afibrinogenemia; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorheology; Heterozygote; Humans; Male; Middle Aged; Point Mutation; Thrombosis | 2010 |
Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype.
Topics: Animals; ARNTL Transcription Factors; Biological Clocks; Cell Line; Fibrinogen; Gene Expression Regulation; Humans; Liver; Male; Mice; Mice, Knockout; Phenotype; Platelet Aggregation; Risk Factors; RNA, Messenger; Serpin E2; Thrombosis; Time Factors; von Willebrand Factor | 2011 |
Childhood body mass index and adult pro-inflammatory and pro-thrombotic risk factors: data from the New Delhi birth cohort.
Topics: Adiposity; Adolescent; Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Child; Cohort Studies; Female; Fibrinogen; Humans; India; Inflammation; Male; Plasminogen Activator Inhibitor 1; Risk Factors; Surveys and Questionnaires; Thrombosis | 2011 |
A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Biomarkers; Case-Control Studies; Female; Fibrinogen; Humans; Male; Middle Aged; P-Selectin; Prognosis; Risk Factors; Thrombophilia; Thrombosis; von Willebrand Factor | 2011 |
A new fibrinolytic enzyme (55 kDa) from Allium tuberosum: purification, characterization, and comparison.
Topics: Chive; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Discovery; Ferrous Compounds; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hydrogen-Ion Concentration; Hydrolysis; Isoelectric Point; Isoenzymes; Leupeptins; Molecular Weight; Oligopeptides; Plant Components, Aerial; Plant Proteins; Substrate Specificity; Temperature; Thrombolytic Therapy; Thrombosis | 2010 |
Some observations on the blood-clotting mechanism; the role of fibrinogen and platelets, with reference to a case of congenital afibrinogenaemia.
Topics: Afibrinogenemia; Blood; Blood Coagulation; Blood Platelets; Coagulants; Fibrinogen; Hemostatics; Humans; Thrombosis | 1946 |
Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol.
Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Bone Marrow Transplantation; Chlorides; Cholesterol, Dietary; Cholesterol, HDL; Disease Models, Animal; Ferric Compounds; Fibrinogen; Mice; Mice, Knockout; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Scavenger Receptors, Class B; Thrombocytopenia; Thrombosis; Time Factors; Up-Regulation | 2011 |
Expression and significance of fgl2 prothrombinase in cardiac microvascular endothelial cells of rats with type 2 diabetes.
Topics: Animals; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelial Cells; Fibrinogen; Male; Microvessels; Myocardial Ischemia; Rats; Rats, Sprague-Dawley; Thromboplastin; Thrombosis; Tumor Necrosis Factor-alpha | 2010 |
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Calcium; Dinoprostone; Dose-Response Relationship, Drug; Fibrinogen; Fibrinolytic Agents; Flow Cytometry; Humans; Methyl Ethers; Naphthalenes; P-Selectin; Phenylbutyrates; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Prostaglandin E, EP4 Subtype; Thrombosis | 2010 |
Obesity and thrombotic risk.
Topics: Adipose Tissue; Adult; Diet, Fat-Restricted; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Obesity; Risk Factors; Thrombosis; Triglycerides; Weight Loss | 2010 |
Sequential binding of αVβ3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophils.
Topics: Animals; Blood Flow Velocity; CD11b Antigen; CD18 Antigens; Cell Adhesion; Cell Communication; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Inflammation Mediators; Integrin alphaVbeta3; Intercellular Adhesion Molecule-1; Melanoma; Mice; Neutrophil Infiltration; Thrombosis | 2011 |
Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cholecystectomy; Cytarabine; Etoposide; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gallbladder; Heparin, Low-Molecular-Weight; Humans; Idarubicin; Infarction; Kidney; Lebanon; Leukemia, Myeloid, Acute; Male; Protein C; Protein C Deficiency; Remission Induction; Splenectomy; Splenic Infarction; Thrombosis; Tretinoin | 2011 |
Coagulation factor VIII activity in diabetic patients.
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Factor VIII; Fibrinogen; Humans; Risk Factors; Thrombosis | 2011 |
Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation.
Topics: Blood Coagulation; Blood Coagulation Tests; Factor XI; Factor XIa; Factor XII; Factor XIIa; Fibrinogen; Humans; Kallikreins; Prekallikrein; Proteins; Thrombosis; Zinc | 2011 |
Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Topics: alpha-2-Antiplasmin; Antifibrinolytic Agents; Blood Coagulation Tests; Carbon Monoxide; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Organometallic Compounds; Plasma; Thrombelastography; Thromboplastin; Thrombosis; Tissue Plasminogen Activator | 2011 |
Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.
Topics: Animals; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal; Drug Resistance; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation; Risk Factors; Saphenous Vein; Thrombolytic Therapy; Thrombosis | 2011 |
Correlations between abdominal circumference and the breakage resistance of the fibrin clot in patients with diabetes mellitus type 2.
Topics: Aged; Brain Ischemia; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Obesity, Abdominal; Platelet Activation; Thrombophilia; Thrombosis; Time; Waist Circumference | 2010 |
Fibrinogen clot induced by gold-nanoparticle in vitro.
Topics: Fibrinogen; Gold; Humans; Light; Metal Nanoparticles; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Particle Size; Protein Binding; Scattering, Radiation; Spectrophotometry, Ultraviolet; Thrombosis | 2011 |
Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
Topics: Blood Coagulation; Carbon Monoxide; Fibrinogen; Heme; Humans; Kinetics; Organometallic Compounds; Plasma; Tandem Mass Spectrometry; Thrombelastography; Thrombosis | 2011 |
Investigation of the potential effects of metformin on atherothrombotic risk factors in hyperlipidemic rats.
Topics: Animals; Antioxidants; Aorta; Atherosclerosis; Blood Coagulation; Body Weight; Carotid Arteries; Cholesterol, HDL; Cholesterol, LDL; Eating; Female; Fibrinogen; Hyperlipidemias; Lipid Peroxidation; Male; Metformin; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; Risk Factors; Thrombosis | 2011 |
Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Phenotype; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Thrombelastography; Thrombocytopenia; Thrombosis; von Willebrand Factor; Young Adult | 2011 |
Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target.
Topics: Adenosine Diphosphate; Analysis of Variance; Animals; Antigens, CD; Apyrase; Blood Platelets; Fibrinogen; Fibrinolytic Agents; Humans; Hydrolysis; Hypothermia, Induced; Leukopenia; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; P-Selectin; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Recombinant Proteins; Thrombocytopenia; Thrombosis; von Willebrand Factor | 2011 |
Diabetic ketoasidosis is associated with prothrombotic tendency in children.
Topics: Adolescent; Child; Child, Preschool; Diabetic Ketoacidosis; Factor VIII; Female; Fibrinogen; Fibrinolysis; Humans; Male; Partial Thromboplastin Time; Protein C; Thrombosis | 2011 |
Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications.
Topics: Adolescent; Adult; Child; Diagnosis, Differential; Early Diagnosis; Female; Fibrinogen; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemostasis; Humans; Male; Middle Aged; Opportunistic Infections; Plasminogen Activator Inhibitor 1; Prospective Studies; Protein C; Thrombosis; Time Factors; Tissue Plasminogen Activator; Transplantation, Homologous; Young Adult | 2011 |
Progression of the prothrombotic state in aging Bmal1-deficient mice.
Topics: Aging; Aging, Premature; Animals; ARNTL Transcription Factors; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Fibrinogen; Male; Mice; Mice, Knockout; Platelet Count; Prothrombin Time; Thrombomodulin; Thrombosis; von Willebrand Factor | 2011 |
Atherothrombotic risk factors & premature coronary heart disease in India: a case-control study.
Topics: Adult; Atherosclerosis; Blood Pressure; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Eating; Female; Fibrinogen; Homocysteine; Humans; India; Logistic Models; Male; Middle Aged; Platelet Count; Risk Factors; Smoking; Thrombosis; Triglycerides | 2011 |
Targeted long-term venous occlusion using pulsed high-intensity focused ultrasound combined with a pro-inflammatory agent.
Topics: Animals; Aprotinin; Cyanoacrylates; Esophageal and Gastric Varices; Ethanol; Fibrinogen; Fluorocarbons; High-Intensity Focused Ultrasound Ablation; Rabbits; Sodium Morrhuate; Thrombosis; Ultrasonography | 2011 |
Effects of the Ala379Val polymorphism of lipoprotein-associated phospholipase A2 on thrombosis and inflammation in hypertensive patients.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Alanine; Fibrinogen; Gene Frequency; Genotype; Heterozygote; Humans; Hypertension; Inflammation; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Thrombosis; Valine | 2011 |
Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs.
Topics: Abdominal Fat; Absorptiometry, Photon; Adult; Blood Coagulation; Blood Coagulation Factors; Body Composition; Body Mass Index; C-Reactive Protein; Factor IX; Factor XI; Factor XII; Fasting; Fatty Liver; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Glucose Clamp Technique; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Obesity; Plasminogen Activator Inhibitor 1; Thrombosis; Twins, Monozygotic | 2012 |
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
Topics: Aged; Angioplasty; Cardiovascular Diseases; Factor V; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Intermittent Claudication; Ischemia; Leg; Lupus Coagulation Inhibitor; Male; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Stents; Thrombophilia; Thrombosis | 2011 |
Risk factors for early hemorrhagic and thrombotic complications after kidney transplantation.
Topics: Adolescent; Adult; Aged; Antithrombin III; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Hematoma; Hemostasis; Humans; International Normalized Ratio; Kidney Transplantation; Male; Middle Aged; Partial Thromboplastin Time; Postoperative Complications; Postoperative Hemorrhage; Risk Factors; Thrombosis; Young Adult | 2011 |
Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients.
Topics: Adolescent; Adult; Antithrombins; Child; Child, Preschool; Factor VIII; Female; Fibrinogen; Graft Survival; Hepatic Artery; Humans; Infant; Kaplan-Meier Estimate; Liver Transplantation; Male; Middle Aged; Portal Vein; Proportional Hazards Models; Prospective Studies; Protein C; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis; Young Adult | 2011 |
The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function.
Topics: Adenosine Triphosphate; Animals; Antibodies; Blood Platelets; Calcium; Disease Models, Animal; Enzyme Inhibitors; Fibrinogen; Humans; Mice; Mice, Inbred C57BL; Platelet Aggregation; Protein Disulfide-Isomerases; Secretory Vesicles; Thrombosis; Time Factors | 2012 |
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.
Topics: Complement C3; Complement Factor H; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Plasma; Thrombosis | 2012 |
Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa.
Topics: alpha-Defensins; Amyloid; Antithrombins; Apoptosis; Blood Platelets; Caspase 3; Cell Degranulation; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Flow Cytometry; Humans; Inflammation; Integrin alpha2; Integrin beta3; Membrane Potential, Mitochondrial; Microscopy, Confocal; Neutrophil Activation; Neutrophils; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Serpins; Thrombosis; Thrombospondin 1; Time Factors | 2012 |
Utility of clot formation and lysis assay to monitor global coagulation state of patients with severe acute pancreatitis.
Topics: Adult; Aged; Blood Coagulation Tests; Diagnosis, Computer-Assisted; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Monitoring, Physiologic; Pancreatitis; Plasminogen; Severity of Illness Index; Systemic Inflammatory Response Syndrome; Thrombophilia; Thrombosis | 2012 |
β-arrestin-1 participates in thrombosis and regulates integrin aIIbβ3 signalling without affecting P2Y receptors desensitisation and function.
Topics: Animals; Arrestins; beta-Arrestin 1; beta-Arrestin 2; beta-Arrestins; Blood Platelets; Calcium; Carotid Arteries; Cell Adhesion; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Hemorrhage; Mesenteric Arteries; Mice; Mice, Transgenic; Microscopy, Electron, Scanning; P-Selectin; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2Y; Signal Transduction; Thrombosis | 2012 |
Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity.
Topics: Area Under Curve; Case-Control Studies; Collagen; Factor IX; Factor V; Factor VIII; Factor XI; Factor XII; Female; Fibrinogen; Humans; Male; Partial Thromboplastin Time; Phospholipids; Protein Binding; Spectrometry, Fluorescence; Thrombin; Thromboplastin; Thrombosis; von Willebrand Factor | 2012 |
Antithrombin-independent effects of heparins on fibrin clot nanostructure.
Topics: Blood Coagulation; Fibrin; Fibrinogen; Fibrinolytic Agents; Heparin; Humans; Spectrophotometry; Thrombin; Thrombosis | 2012 |
Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
Topics: alpha 1-Antitrypsin; Animals; Antithrombins; Carotid Artery Injuries; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxemia; Endotoxins; Factor Xa; Factor Xa Inhibitors; Factor XIa; Factor XIIa; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Injections, Intravenous; Kinetics; Leukocyte Elastase; Mice; Mutation; NG-Nitroarginine Methyl Ester; Recombinant Fusion Proteins; Thrombin; Thrombosis | 2012 |
Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
Topics: Adult; Blood Coagulation; Cross-Sectional Studies; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperthyroidism; Male; Plasminogen Activator Inhibitor 1; Risk; Thrombosis; Thyroid Function Tests; Thyroid Gland | 2012 |
Functional fibrinogen to platelet ratio using thromboelastography as a predictive parameter for thrombotic complications following free tissue transfer surgery: a preliminary study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Decision Support Techniques; Female; Fibrinogen; Free Tissue Flaps; Humans; Intraoperative Complications; Male; Middle Aged; Plastic Surgery Procedures; Platelet Count; Postoperative Complications; Preoperative Care; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Thrombelastography; Thrombosis | 2012 |
Inflammatory and prothrombotic states in obese children of European descent.
Topics: Adipose Tissue; Adolescent; Atherosclerosis; Blood Coagulation Disorders; Child; Cross-Sectional Studies; Cytokines; Europe; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Interleukin-5; Male; Obesity; Prothrombin Time; Switzerland; Thrombin; Thrombosis; White People | 2012 |
Thrombosis in rare bleeding disorders.
Topics: Blood Coagulation Disorders, Inherited; Factor VII Deficiency; Factor XI Deficiency; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Rare Diseases; Thrombosis | 2012 |
Streptococcus gordonii FSS2 Challisin affects fibrin clot formation by digestion of the αC region and cleavage of the N -terminal region of the Bβ chains of fibrinogen.
Topics: Amino Acid Sequence; Bacterial Proteins; Blood Coagulation; Coagulants; Endocarditis; Fibrin; Fibrinogen; Humans; Molecular Sequence Data; Peptide Fragments; Proline; Protein Binding; Protein Structure, Tertiary; Serine Proteases; Streptococcus gordonii; Substrate Specificity; Thrombosis; Virulence Factors | 2012 |
Multiple gene polymorphisms predisposing to the prothrombotic state in an adolescent with acute myocardial infarction.
Topics: Adolescent; Anticoagulants; Aspirin; Cholesterol Ester Transfer Proteins; Clopidogrel; Coronary Angiography; Electrocardiography; Fibrinogen; Genetic Predisposition to Disease; Heparin; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Thrombosis; Ticlopidine | 2012 |
A prothrombotic state is associated with early arterial damage in hypertensive patients.
Topics: Aged; Arteries; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Male; Middle Aged; Thrombosis | 2012 |
Vitreoretinal traction in impending branch retinal vein occlusion: a pathogenetic role?
Topics: Adult; Blood Pressure; Female; Fibrinogen; Fluorescein; Fundus Oculi; Heterozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Optic Nerve; Plasminogen Activator Inhibitor 1; Retina; Retinal Detachment; Retinal Vein Occlusion; Retinal Vessels; Thrombosis; Tomography, Optical Coherence | 2012 |
Distinct and overlapping functional roles of Src family kinases in mouse platelets.
Topics: Animals; Blood Platelets; Carrier Proteins; Cell Shape; Disease Models, Animal; Fibrinogen; Mice; Mice, Knockout; Mutation; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Signal Transduction; src-Family Kinases; Thrombosis; Time Factors | 2012 |
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Topics: Animals; Arterial Occlusive Diseases; Blood Coagulation; Blood Gas Analysis; Blood Platelets; Blood Pressure; Boranes; Carbon Monoxide; Carbonates; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Green Fluorescent Proteins; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Organometallic Compounds; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Solubility; Thrombosis; Time Factors; Venous Thrombosis; Water | 2012 |
[Gene-determined hemocoagulation disease as a cause of ischemic stroke in children].
Topics: Alleles; Blood Coagulation Disorders; Child; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Integrin alpha2; Male; Mutation; Plasminogen Activator Inhibitor 1; Stroke; Thrombosis | 2011 |
Plasmin-driven fibrinolysis facilitates skin tumor growth in a gender-dependent manner.
Topics: Animals; Extracellular Matrix; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Gene Expression Regulation, Neoplastic; Humans; Laminin; Male; Mice; Mice, Knockout; Neoplasms, Experimental; Ovariectomy; Sex Factors; Skin Neoplasms; Thrombosis | 2012 |
BF066, a novel dual target antiplatelet agent without significant bleeding.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenine; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Arterioles; Chlorides; Collagen; Ferric Compounds; Fibrinogen; Hemorrhage; Humans; Immobilized Proteins; Mice; Mice, Inbred C57BL; Oligopeptides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Adenosine A2A; Thrombin; Thrombosis | 2012 |
Biological variation in tPA-induced plasma clot lysis time.
Topics: Adult; Aged; Air Pollution; Analysis of Variance; Biomarkers; C-Reactive Protein; Female; Fibrin Clot Lysis Time; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Prothrombin Time; Reference Values; Risk Factors; Thrombin; Thrombosis; Tissue Plasminogen Activator; Young Adult | 2012 |
Titania nanotube arrays as interfaces for blood-contacting implantable devices: a study evaluating the nanotopography-associated activation and expression of blood plasma components.
Topics: Biocompatible Materials; Blood Cells; Blood Platelets; Cell Adhesion; Fibrinogen; Humans; Leukocytes; Nanotubes; Platelet Adhesiveness; Platelet Factor 4; Prostheses and Implants; Thrombosis; Titanium | 2012 |
Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron.
Topics: Adult; Biomarkers; Female; Fibrin; Fibrinogen; Humans; Hydroxyl Radical; Iron; Male; Middle Aged; Solubility; Thrombosis; Young Adult | 2012 |
Mechanisms of microthrombosis and microcirculatory constriction after experimental subarachnoid hemorrhage.
Topics: Analysis of Variance; Animals; Constriction, Pathologic; Disease Models, Animal; Fibrinogen; In Situ Nick-End Labeling; Male; Mice; Microcirculation; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microvessels; Neurons; Nitric Oxide; Subarachnoid Hemorrhage; Thrombosis | 2013 |
A rare case of intracerebral hemorrhage complicating heparin-induced thrombocytopenia with thrombosis: a clinical dilemma ameliorated by novel use of plasmapheresis.
Topics: Aged; Cerebral Hemorrhage; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Male; Plasmapheresis; Platelet Count; Thrombocytopenia; Thrombosis; Venous Thrombosis | 2012 |
Resolving two-dimensional kinetics of the integrin αIIbβ3-fibrinogen interactions using binding-unbinding correlation spectroscopy.
Topics: Blood Platelets; Fibrinogen; Hemostasis; Humans; Kinetics; Models, Biological; Models, Chemical; Multiprotein Complexes; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 2012 |
Embolic middle cerebral artery occlusion model using thrombin and fibrinogen composed clots in rat.
Topics: Animals; Anticoagulants; Disease Models, Animal; Fibrinogen; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Sprague-Dawley; Thrombin; Thrombosis; Tissue Plasminogen Activator | 2012 |
Chemico-physical characterisation and in vivo biocompatibility assessment of DLC-coated coronary stents.
Topics: Acute Coronary Syndrome; Adsorption; Albumins; Animals; Biocompatible Materials; Blood Platelets; Carbon; Cell Proliferation; Chemistry, Physical; Coated Materials, Biocompatible; Electrons; Endothelial Cells; Fibrinogen; Inflammation; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Spectrum Analysis, Raman; Stents; Surface Properties; Swine; Thrombosis; Time Factors | 2013 |
Heterogeneity of platelet functional alterations in patients with filamin A mutations.
Topics: Blood Platelets; Blotting, Western; Cell Shape; Collagen; Contractile Proteins; Crotalid Venoms; Cytoskeleton; Dose-Response Relationship, Drug; Female; Fibrinogen; Filamins; Genetic Predisposition to Disease; Heterozygote; Humans; Lectins, C-Type; Microfilament Proteins; Muscular Dystrophies; Mutation; Phenotype; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Signal Transduction; Thrombocytopenia; Thrombosis; von Willebrand Factor | 2013 |
The dilemma of inherited dysfibrinogenemia during pregnancy.
Topics: Afibrinogenemia; Anticoagulants; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Live Birth; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis; Young Adult | 2012 |
Systemic effects induced by the venom of the snake Bothrops caribbaeus in a murine model.
Topics: Animals; Bothrops; Coagulants; Crotalid Venoms; Disease Models, Animal; Edetic Acid; Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Lectins, C-Type; Longevity; Lung Diseases; Male; Metalloproteases; Mice; Platelet Aggregation; Species Specificity; Thrombocytopenia; Thrombosis | 2013 |
Oxidation inhibits iron-induced blood coagulation.
Topics: Adult; Blood Coagulation; Chlorides; Female; Ferric Compounds; Fibrin; Fibrinogen; Humans; Hydrogen Peroxide; Hydroxyl Radical; Methylene Blue; Microscopy, Electron, Scanning; Oxidants; Oxidation-Reduction; Sodium Selenite; Thrombosis; Young Adult | 2013 |
Parameters predicting complications in flap surgery.
Topics: Activated Protein C Resistance; Blood Coagulation Tests; C-Reactive Protein; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Forecasting; Free Tissue Flaps; Hematologic Tests; Hemorrhagic Disorders; Humans; Male; Necrosis; Plastic Surgery Procedures; Platelet Function Tests; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Reoperation; Skin Transplantation; Surgical Flaps; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2013 |
Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Arteries; Blood Platelets; Cytoplasmic Granules; Exocytosis; Fibrinogen; Flavonols; Humans; Mice; P-Selectin; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Quercetin; Quinacrine; Regional Blood Flow; Thrombosis | 2013 |
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.
Topics: Animals; Arterioles; Blood Platelets; Fibrin; Fibrinogen; Hemostasis; Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Transgenic; Platelet Aggregation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, IgG; Receptors, Immunologic; Signal Transduction; Thrombosis; Tyrosine; Veins | 2013 |
[Evaluation of the blood coagulation system after surgeries on abdominal aortic aneurysms].
Topics: Anticoagulants; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Prognosis; Solubility; Thrombosis | 2012 |
Platelet and fibrinogen turnover at the exposed subendothelium measured over 1 year after a balloon catheter de-endothelializing injury to the rabbit aorta: thrombotic eruption at the late re-endothelialization stage.
Topics: Animals; Aorta, Thoracic; Catheterization; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Fibrinogen; Hemostasis; Immunohistochemistry; Platelet Adhesiveness; Platelet Count; Rabbits; Radioimmunoassay; Reperfusion Injury; Sensitivity and Specificity; Thrombosis; Tunica Intima | 2002 |
Factors contributing to individual propensity for arterial thrombosis.
Topics: Animals; Aorta, Abdominal; Aortic Diseases; Blood Platelets; Female; Fibrinogen; In Vitro Techniques; Lymphocyte Count; Lymphocytes; Microcirculation; Platelet Count; Regional Blood Flow; Reproducibility of Results; Risk Factors; Swine; Thrombosis | 2002 |
Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome.
Topics: Animals; Cell Degranulation; Enzyme Inhibitors; Fibrinogen; Hemolytic-Uremic Syndrome; Kidney Glomerulus; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activation; Shiga Toxin 2; Thrombosis; Urea | 2002 |
Von Willebrand factor, fibrinogen and other risk factors of thrombosis in patients with a history of cerebrovascular ischemic stroke and their children.
Topics: Adult; Age Distribution; Analysis of Variance; Biomarkers; Blood Chemical Analysis; Blood Pressure Determination; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Incidence; Male; Middle Aged; Predictive Value of Tests; Probability; Reference Values; Risk Factors; Sensitivity and Specificity; Sex Distribution; Statistics, Nonparametric; Stroke; Thrombosis; von Willebrand Factor | 2002 |
Role of microthrombus formation in the development of ischemia/reperfusion-induced liver injury in rats.
Topics: Animals; Chemokine CXCL1; Chemokines; Chemokines, CXC; Chemotactic Factors; Clinical Enzyme Tests; Fibrin; Fibrinogen; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Intercellular Signaling Peptides and Proteins; Interleukin-3; Kinetics; Liver; Male; Plasminogen Activator Inhibitor 1; Proteins; Rats; Rats, Wistar; Recombinant Fusion Proteins; Recombinant Proteins; Reperfusion Injury; Thrombosis; Tumor Necrosis Factor-alpha | 2002 |
Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow.
Topics: Afibrinogenemia; Case-Control Studies; Collagen; Fibrinogen; Heart Diseases; Humans; Kinetics; Microscopy, Video; Perfusion; Platelet Adhesiveness; Stress, Mechanical; Thrombosis; von Willebrand Diseases; von Willebrand Factor | 2002 |
Induction of platelet thrombi by bacteria and antibodies.
Topics: Adult; Antibodies, Bacterial; Antigens, Bacterial; Antigens, CD; Bacterial Outer Membrane Proteins; Blood Platelets; Carrier Proteins; Fibrinogen; Humans; Immunoglobulin G; Models, Biological; Platelet Activation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Receptors, IgG; Staphylococcus aureus; Streptococcus pyogenes; Thrombosis; Virulence | 2002 |
Atherothrombotic risk factors in subjects with a family history of stroke.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Male; Medical Records; Metabolic Syndrome; Middle Aged; Risk Factors; Stroke; Thrombosis; von Willebrand Factor | 2002 |
Influence of plasminogen deficiency on the contribution of polymorphonuclear leucocytes to fibrin/ogenolysis: studies in plasminogen knock-out mice.
Topics: Animals; Fibrin; Fibrinogen; Genotype; Histocytochemistry; Iodine Radioisotopes; Kinetics; Mice; Mice, Knockout; Neutrophils; Peptide Hydrolases; Plasminogen; Thrombosis | 2002 |
Blockade of platelet GPIIB-IIIA (Integrin alphaII(b)beta(3)) in flowing human blood leads to passivation of prothrombotic surfaces.
Topics: Adenosine Diphosphate; Collagen; Fibrinogen; Hemorheology; Humans; Integrin alpha2beta1; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Thrombosis | 2002 |
Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: studies in an ex vivo perfusion chamber model.
Topics: Blood Platelets; Collagen Type III; Diffusion Chambers, Culture; Female; Fibrin; Fibrinogen; Heterozygote; Humans; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombasthenia; Thrombosis; von Willebrand Factor | 2002 |
Thrombus formation with rehydrated, lyophilized platelets.
Topics: Blood Platelets; Blood Preservation; Cell Degranulation; Fibrin; Fibrinogen; Fibrinolysis; Freeze Drying; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Protein Binding; Thrombosis | 2002 |
Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents.
Topics: Animals; Anticoagulants; Base Sequence; Binding Sites; DNA; Endothelium, Vascular; Female; Fibrinogen; Fluoroscopy; Humans; Iodine Radioisotopes; Isotope Labeling; Jugular Veins; Ligands; Molecular Sequence Data; Oligonucleotides; Plasma; Protein Binding; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Serine Endopeptidases; Thrombin; Thrombosis | 2003 |
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematologic Neoplasms; Hemorrhage; Humans; Infections; Interleukin-1; Interleukin-6; International Normalized Ratio; Male; Middle Aged; Multiple Organ Failure; Neoplasms; Peptide Hydrolases; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Count; Prognosis; Thrombomodulin; Thromboplastin; Thrombosis; Tissue Plasminogen Activator | 2003 |
Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population.
Topics: Adult; Cyprus; Factor V; Female; Fibrinogen; Gene Frequency; Humans; Integrin beta3; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Plasminogen Activator Inhibitor 1; Polymorphism, Single Nucleotide; Prothrombin; Serine Proteinase Inhibitors; Thrombosis | 2002 |
[Aprotinin -- an allogeneic transfusion sparing drug].
Topics: Adult; Aged; Aprotinin; Blood Loss, Surgical; Blood Transfusion, Autologous; Female; Fibrinogen; Hemostatics; Humans; Male; Middle Aged; Postoperative Complications; Risk; Thrombosis | 2003 |
Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.
Topics: Adult; Blood Platelets; Cathepsin G; Cathepsins; Cell Adhesion; Fibrin; Fibrinogen; Hemodynamics; Humans; Microscopy, Fluorescence; Microscopy, Video; Models, Biological; Neutrophils; Pancreatic Elastase; Perfusion; Phospholipids; Protein Structure, Tertiary; Serine Endopeptidases; Thrombin; Thromboplastin; Thrombosis; Time Factors | 2003 |
The efficacy of two antivenoms against the venom of North American snakes.
Topics: Animals; Antivenins; Biological Assay; Blood Coagulation; Crotalid Venoms; Fibrinogen; Hemorrhage; Horses; Immunoglobulin Fab Fragments; Lethal Dose 50; Neutralization Tests; North America; Rabbits; Sheep; Species Specificity; Thrombosis | 2003 |
Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.
Topics: Aged; Atrial Fibrillation; Biomarkers; Case-Control Studies; Cohort Studies; Comorbidity; Disease Susceptibility; Female; Fibrinogen; Humans; Male; Netherlands; Odds Ratio; P-Selectin; Predictive Value of Tests; Risk Factors; Sex Distribution; Sex Factors; Thrombosis; von Willebrand Factor | 2003 |
Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Topics: Aged; Antithrombin III; Biomarkers; Blood Coagulation Disorders; Coronary Artery Bypass; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombosis; Time Factors | 2003 |
Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice.
Topics: Animals; Bacterial Proteins; Chronic Disease; Disease Models, Animal; Embolism; Erythrocyte Count; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Lasers; Leukocyte Count; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Platelet Aggregation; Platelet Count; Polymerase Chain Reaction; Thrombosis | 2002 |
Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots.
Topics: Algorithms; Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Microscopy, Confocal; Plasminogen; Thrombin; Thrombosis; Time Factors | 2003 |
Hemocompatibility of titanium oxide films.
Topics: Adsorption; Animals; Blood Platelets; Coated Materials, Biocompatible; Dogs; Fibrinogen; Heart Valve Prosthesis; Histocompatibility; Humans; Materials Testing; Molecular Conformation; Platelet Activation; Platelet Adhesiveness; Prosthesis Design; Surface Properties; Thrombosis; Titanium | 2003 |
Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Topics: Antithrombin III; Biomarkers; Disseminated Intravascular Coagulation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Latex Fixation Tests; Peptide Hydrolases; Plasma; Protein Binding; Risk Factors; Solubility; Thrombosis | 2003 |
Comparative effects of diet and simvastatin on markers of thrombogenicity in patients with coronary artery disease.
Topics: Anticholesteremic Agents; Antineoplastic Agents; Apolipoproteins; Biomarkers; C-Reactive Protein; Coronary Disease; Female; Fibrinogen; Hemostatics; Humans; Hyperlipidemias; Lipoproteins; Male; Matrix Metalloproteinase 9; Middle Aged; Placebo Effect; Protease Inhibitors; Simvastatin; Thromboplastin; Thrombosis; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha | 2003 |
Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients.
Topics: Acute-Phase Proteins; Adult; Arteriosclerosis; Autoantibodies; Biomarkers; Female; Fibrinogen; Fibronectins; Folic Acid; Homocysteine; Humans; Lipoproteins, LDL; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Psoriasis; Thrombosis; Tissue Plasminogen Activator; Vitamin B 12 | 2003 |
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.
Topics: Adult; Animals; Disease Susceptibility; Female; Fibrinogen; Hemorrhage; Hepatitis, Chronic; Hepatitis, Viral, Animal; Hepatitis, Viral, Human; Humans; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Middle Aged; RNA, Messenger; Thrombosis | 2003 |
Two novel fibrinogen variants found in patients with pulmonary embolism and their families.
Topics: Adult; Base Sequence; Case-Control Studies; Codon, Terminator; DNA Mutational Analysis; Family Health; Female; Fibrinogen; Frameshift Mutation; Genetic Variation; Humans; Male; Point Mutation; Pregnancy; Pulmonary Embolism; Thrombosis | 2003 |
Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
Topics: Animals; Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Homocysteine; Hyperhomocysteinemia; In Vitro Techniques; Microscopy, Electron, Scanning; Rabbits; Thrombosis | 2003 |
Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
Topics: Animals; Batroxobin; Carboxypeptidase B2; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Humans; Injections, Intravenous; Iodine Radioisotopes; Lung Diseases; Male; Rats; Thrombosis | 2003 |
The determination of plasma fibrinogen by the clot-weight method.
Topics: Fibrin; Fibrinogen; Humans; Plasma; Thrombosis | 1952 |
[Fibrinogen B and prethrombotic state].
Topics: Blood Coagulation; Female; Fibrin; Fibrinogen; Hemostatics; Humans; Thrombosis | 1952 |
[Microscopic modifications of the fibrinous clot in relation to the plasma modifications; variations in the thrombin-fibrinogen reaction].
Topics: Blood Coagulation; Fibrinogen; Humans; Plasma; Thrombin; Thrombosis | 1952 |
[Fibrinogen B: its diagnostic and prognostic value in obstetrics gynecology].
Topics: Female; Fibrinogen; Genital Diseases, Female; Gynecology; Hemostatics; Humans; Obstetrics; Pregnancy; Prognosis; Thrombosis | 1953 |
Intravascular clotting and afibrinogenemia, the presumptive lethal factors in the syndrome of amniotic fluid embolism.
Topics: Afibrinogenemia; Amniotic Fluid; Antigens, Bacterial; Bacterial Toxins; Blood Coagulation; Embolism, Amniotic Fluid; Female; Fibrinogen; Humans; Pregnancy; Pulmonary Embolism; Thrombosis | 1953 |
Carcinoma of the body of the pancreas with fibrin thrombosis and fibrinogenopenia.
Topics: Carcinoma; Fibrin; Fibrinogen; Humans; Pancreas; Pancreatic Neoplasms; Thrombosis | 1953 |
[Clinical value of the Lyons test in patients subjected to surgical intervention].
Topics: Coagulants; Fibrinogen; Hemostatics; Humans; Thrombosis | 1953 |
Clot density method of fibrinogen determination in some pediatric conditions.
Topics: Blood Coagulation; Child; Fibrinogen; Hematologic Diseases; Pediatrics; Thrombosis | 1953 |
[Role of blood fibrinogen in the prevention of postoperative phlebitis and pulmonary embolism].
Topics: Coagulants; Fibrinogen; Humans; Phlebitis; Pulmonary Embolism; Thrombosis | 1953 |
[Significance of fibrinogen B and its role in postoperative venous thrombosis].
Topics: Coagulants; Fibrinogen; Hemostatics; Humans; Thrombosis; Venous Thrombosis | 1953 |
The effects of tyrosinase on certain components of the blood clotting system.
Topics: Blood Coagulation; Coagulants; Fibrinogen; Hemostatics; Humans; Monophenol Monooxygenase; Oxidoreductases; Thrombosis | 1954 |
Quantitative method for the in vivo testing of fibrinolytic agents: effect of intravenous trypsin on radioactive thrombi and emboli.
Topics: Embolism; Fibrin; Fibrinogen; Fibrinolytic Agents; Humans; Thrombosis; Trypsin | 1956 |
Fibrinemboli of the lungs with afibrinogenemia after cesarean section, without the presence of amniotic epithelial squames.
Topics: Afibrinogenemia; Amnion; Cesarean Section; Female; Fibrinogen; Humans; Medical Records; Pregnancy; Pulmonary Embolism; Thrombosis | 1956 |
Amniotic fluid embolism, afibrinogenemia, and disseminated fibrin thrombosis; case report and review of the literature.
Topics: Afibrinogenemia; Amniotic Fluid; Embolism; Embolism, Amniotic Fluid; Female; Fibrin; Fibrinogen; Humans; Pregnancy; Pregnancy Complications; Thrombosis | 1957 |
Postoperative hypofibrinogenemia: diffuse intravascular thrombosis after fibrinogen administration.
Topics: Afibrinogenemia; Fibrinogen; Hemostatics; Humans; Medical Records; Postoperative Period; Thrombosis | 1957 |
[Experiences with fibrinogen B reaction].
Topics: Fibrinogen; Hemostatics; Humans; Thrombosis | 1957 |
[Fibrinogen, fibrin-formation and its clinical importance].
Topics: Arteriosclerosis; Coagulants; Fibrin; Fibrinogen; Hemostatics; Humans; Rheumatic Diseases; Thrombosis | 1957 |
[Significant blood factors for solidity of the thrombus; at the same time a contribution to the problem of unspecific stimulation of hemostasis by transfusions].
Topics: Blood Platelets; Blood Transfusion; Fibrinogen; Hemorrhagic Disorders; Hemostasis; Humans; Platelet Transfusion; Thrombosis | 1957 |
Alterations in the blood coagulation system induced by bacterial endotoxin. I. In vivo (generalized Shwartzman reaction).
Topics: Animals; Blood Coagulation; Endotoxins; Fibrinogen; Hypersensitivity; Rabbits; Shwartzman Phenomenon; Thrombocytopenia; Thromboplastin; Thrombosis | 1958 |
The effect of fibrinogen concentration on susceptibility of clots to in vitro clot lysis with plasmin.
Topics: Blood Coagulation; Fibrinogen; Fibrinolysin; Humans; In Vitro Techniques; Thrombosis | 1958 |
In vivo fibrinolytic effect of various proteolytic enzymes: quantitative tests employing iodine 131-labeled clots.
Topics: Blood Coagulation; Endopeptidases; Fibrinogen; Humans; Iodine; Peptide Hydrolases; Thrombosis | 1959 |
Postoperative thrombosis and plasma fibrinolytic activity. A comparative study in Africans, Indians, and whites.
Topics: Coagulants; Fibrinogen; Fibrinolysis; Humans; Pulmonary Embolism; Surgical Procedures, Operative; Thrombolytic Therapy; Thrombosis | 1961 |
Effect of increased fibrinogen concentration on the lysis of in vivo thrombi.
Topics: Fibrinogen; Thrombosis | 1960 |
External measurement of fibrinogen uptake in experimental venous thrombosis and other local pathological states.
Topics: Autoradiography; Coagulants; Fibrinogen; Humans; Iodine; Iodine Radioisotopes; Thrombosis; Venous Thrombosis | 1962 |
Sialic acid in fibrinogen and 'vulcanization' of the fibrin clot.
Topics: Fibrin; Fibrinogen; N-Acetylneuraminic Acid; Neuraminic Acids; Peptide Hydrolases; Thrombosis | 1963 |
Clinical and pathological studies: thrombolytic activity and related phenomena.
Topics: Coagulants; Deoxyribonuclease I; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Streptodornase and Streptokinase; Streptokinase; Thrombosis | 1961 |
An investigation of the possible role of platelet fibrinogen in thrombi formation.
Topics: Blood Platelets; Coagulants; Fibrinogen; Humans; Thrombosis | 1963 |
[THE USE OF HYDROXYCHLOROQUINE IN THE TREATMENT OF VASCULAR DISEASES].
Topics: Arteriosclerosis; Arteritis; Blood Proteins; Cholesterol; Coronary Disease; Fibrinogen; Humans; Hydroxychloroquine; Intracranial Embolism; Intracranial Embolism and Thrombosis; Lipoproteins; Thrombophlebitis; Thrombosis | 1963 |
STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD FOR OBTAINING A THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
Topics: Deoxyribonuclease I; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Geriatrics; Intracranial Embolism; Intracranial Embolism and Thrombosis; Myocardial Infarction; Streptodornase and Streptokinase; Streptokinase; Thromboembolism; Thrombosis | 1963 |
PHYSIOLOGY AND PATHOLOGY OF BLOOD COAGULATION. A REVIEW OF THE LITERATURE OF 1962.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinogen; Fibrinolysis; Humans; Physiology; Prothrombin; Thrombosis | 1963 |
CONTROL MECHANISMS IN BLOOD FLUIDITY: ROLE OF ADENOSINE TRIPHOSPHATE.
Topics: Adenosine Triphosphate; Aging; Arteriosclerosis; Blood Coagulation; Coagulants; Diphosphates; Fibrinogen; Geriatrics; Humans; Thrombin; Thromboplastin; Thrombosis | 1963 |
[IMMUNOHISTOCHEMICAL DEMONSTRATION OF THROMBOCYTE ANTIGENS].
Topics: Animals; Antigens; Blood Platelets; Blood Proteins; Fibrinogen; Fluorescent Antibody Technique; Guinea Pigs; Histocytochemistry; Rabbits; Research; Thrombosis | 1963 |
[ON BLOOD COAGULATION DISORDERS FOLLOWING BRAIN INJURY AND BRAIN SURGERY].
Topics: Blood Coagulation Disorders; Brain; Brain Injuries; Cerebral Hemorrhage; Enzyme Inhibitors; Fibrinogen; Heparin; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Kallikreins; Neurosurgery; Postoperative Complications; Thrombosis | 1963 |
[COAGULATION RESEARCH AND ITS CLINICAL SIGNIFICANCE].
Topics: Anticoagulants; Blood Coagulation; Coagulants; Electrons; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Microscopy; Microscopy, Electron; Physiology; Thrombosis | 1963 |
CELLULAR SITE OF FIBRINOGEN SYNTHESIS.
Topics: Animals; Dogs; Fibrinogen; Fluorescent Antibody Technique; Hemostatics; Liver; Metabolism; Pregnancy; Pregnancy, Animal; Prothrombin; Research; Thrombosis | 1964 |
EXPERIMENTAL STUDIES OF THE INTRAVASCULAR DISSEMINATION OF ASCITIC V2 CARCINOMA CELLS IN THE RABBIT, WITH SPECIAL REFERENCE TO FIBRINOGEN AND FIBRINOLYTIC AGENTS.
Topics: Animals; Autoradiography; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Humans; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Rabbits; Research; Thrombosis | 1964 |
[TEST FOR THE PRESENCE OF COLD-SENSITIVE FIBRINOGEN B, THE THROMBOTEST AND SOME OTHER COAGULATION METHODS].
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Cold Temperature; Fibrinogen; Humans; Prothrombin Time; Thrombosis | 1963 |
A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
Topics: Antibodies; Biomedical Technology; Blood Coagulation; Deoxyribonuclease I; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Indicators and Reagents; Medical Laboratory Science; Plasminogen; Plasminogen Activators; Streptodornase and Streptokinase; Streptokinase; Thrombin; Thrombosis | 1964 |
[FIBRINOGEN CONTENT OF MATERNAL BLOOD AND CORD BLOOD].
Topics: Afibrinogenemia; Blood Coagulation; Blood Coagulation Disorders; Female; Fetal Blood; Fibrinogen; Fibrinolysis; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Thrombosis; Umbilical Cord | 1964 |
STUDIES ON THE THROMBOLYTIC ACTIVITY OF A PROTEASE FROM ASPERGILLUS ORYZAE.
Topics: Animals; Anticoagulants; Aspergillus; Aspergillus oryzae; Blood Coagulation; Blood Pressure; Blood Proteins; Body Temperature; Cats; Endopeptidases; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Peptide Hydrolases; Pharmacology; Rabbits; Research; Thrombosis; Toxicology | 1964 |
ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE.
Topics: Angiography; Anticoagulants; Blood Coagulation Disorders; Cerebral Hemorrhage; Deoxyribonuclease I; Drug Therapy; Fibrinogen; Heparin; Intracranial Embolism; Intracranial Embolism and Thrombosis; Streptodornase and Streptokinase; Streptokinase; Stroke; Thrombosis; Toxicology; Warfarin | 1964 |
EFFECT OF GLYCEROL ON THE RESISTANCE OF BLOOD AND PLASMA CLOTS TO THE ACTION OF PROTEOLYTIC ENZYMES.
Topics: Deoxyribonuclease I; Endopeptidases; Fibrinogen; Fibrinolysis; Glycerol; Papain; Peptide Hydrolases; Plasma; Research; Streptodornase and Streptokinase; Streptokinase; Thrombelastography; Thrombosis; Trypsin | 1964 |
ANTIFIBRINOLYTIC TREATMENT WITH EPSILON-AMINOCAPROIC ACID IN CONNECTION WITH PROSTATECTOMY.
Topics: Aminocaproates; Aminocaproic Acid; Drug Therapy; Embolism; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Geriatrics; Hemorrhage; Humans; Male; Postoperative Complications; Prostatectomy; Prothrombin; Thromboplastin; Thrombosis; Toxicology | 1964 |
ARE THROMBOLYTIC AGENTS MORE EFFECTIVE IF GIVEN NEAR THE THROMBUS?
Topics: Animals; Deoxyribonuclease I; Dogs; Embolism; Femoral Artery; Fibrinogen; Fibrinolytic Agents; Iliac Artery; Infusions, Parenteral; Injections, Intravenous; Iodine Isotopes; Jugular Veins; Pulmonary Artery; Pulmonary Embolism; Research; Streptodornase and Streptokinase; Streptokinase; Thrombosis; Venae Cavae | 1964 |
TURNOVER AND DISTRIBUTION OF 131-IODINE-LABELLED HUMAN FIBRINOGEN.
Topics: Arteriosclerosis; Blood Coagulation Tests; Coronary Disease; Diabetes Mellitus; Fibrinogen; Geriatrics; Humans; Intervertebral Disc Displacement; Iodine; Iodine Isotopes; Liver Cirrhosis; Lung Neoplasms; Metabolism; Radiometry; Thrombophlebitis; Thrombosis | 1964 |
EXPERIMENTAL STUDIES ON THE PRODUCTION AND PREVENTION OF CEREBRAL INFARCTION IN DOGS.
Topics: Animals; Anticoagulants; Brain Diseases; Carbon; Cerebral Hemorrhage; Cerebral Infarction; Deoxyribonuclease I; Dogs; Fibrinogen; Hematoma; Hypoxia, Brain; Infarction; Intracranial Embolism; Intracranial Embolism and Thrombosis; Pharmacology; Research; Streptodornase and Streptokinase; Streptokinase; Thrombin; Thrombosis | 1964 |
[CHANGES IN THE BLOOD COAGULATION SYSTEM IN RABBITS, RATS AND DOGS IN SUDDEN DEATH].
Topics: Asphyxia; Blood Coagulation; Blood Coagulation Tests; Death, Sudden; Dogs; Fibrinogen; Heart; Pathology; Rabbits; Rats; Research; Thrombosis; Wounds and Injuries | 1964 |
CURRENT STATUS OF THROMBOLYTIC THERAPY.
Topics: Antibodies; Deoxyribonuclease I; Drug Therapy; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemorrhagic Disorders; Niacin; Physiology; Plasminogen; Pyrogens; Streptodornase and Streptokinase; Streptokinase; Thrombolytic Therapy; Thrombosis; Toxicology | 1964 |
[DIAGNOSTIC VALUE OF THE DETERMINATION OF BLOOD FIBRINOGEN IN MYOCARDIAL INFARCTION AND ARTERIAL THROMBOSIS].
Topics: Cardiovascular Diseases; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Thrombosis | 1964 |
INTRAVASCULAR COAGULATION, THE SHWARTZMAN REACTION AND THE PATHOGENESIS OF T.T.P.
Topics: Blood Coagulation; Blood Vessels; Fibrin; Fibrinogen; Humans; Hyalin; Pathology; Purpura; Purpura, Thrombotic Thrombocytopenic; Shwartzman Phenomenon; Thrombocytopenia; Thrombosis | 1964 |
SOLUBILITY OF FIBRIN CLOTS IN SOLUTIONS OF HEPARIN.
Topics: Blood Coagulation; Chemical Phenomena; Chemistry; Fibrin; Fibrinogen; Fibrinolysis; Heparin; Humans; Pharmacology; Research; Solubility; Solutions; Thrombin; Thrombosis | 1964 |
[ANTICOAGULANT THERAPY IN PEDIATRICS].
Topics: Anemia; Anemia, Hemolytic; Anticoagulants; Child; Drug Therapy; Fibrinogen; Humans; Infant; Pediatrics; Purpura; Purpura, Thrombotic Thrombocytopenic; Thrombocytopenia; Thrombosis; Uremia; Waterhouse-Friderichsen Syndrome | 1964 |
ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR.
Topics: Blood Coagulation Tests; Deoxyribonuclease I; Drug Therapy; Embolism; Fibrinogen; Fibrinolysis; Humans; Plasminogen; Streptodornase and Streptokinase; Streptokinase; Thrombosis; Trypsin; Trypsin Inhibitors | 1964 |
THE PLATELET-FIBRIN RELATIONSHIP IN HUMAN BLOOD CLOTS: AN ULTRASTRUCTURAL STUDY UTILIZING FERRITIN-CONJUGATED ANTI-HUMAN FIBRINOGEN ANTIBODY.
Topics: Antibodies; Blood Coagulation; Blood Platelets; Cyanates; Electrons; Ferritins; Fibrin; Fibrinogen; Hemostatics; Humans; Microscopy; Microscopy, Electron; Research; Thrombosis | 1965 |
FIBROGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. II. RENAL LESIONS INDUCED BY INTRAVENOUS INJECTION OF M PROTEIN INTO MICE AND RATS.
Topics: Animals; Antibodies; Antibodies, Anti-Idiotypic; Antigen-Antibody Reactions; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carrier Proteins; Fibrinogen; Fluorescent Antibody Technique; Glomerulonephritis; Injections, Intravenous; Kidney; Kidney Glomerulus; Mice; Myeloma Proteins; Pathology; Proteinuria; Rats; Research; Streptococcus; Thrombosis; Toxicology | 1965 |
EFFECT OF FIBRIN AND FIBRINOGEN PROTEOLYSIS PRODUCTS ON CLOT PHYSICAL PROPERTIES.
Topics: Biophysical Phenomena; Biophysics; Blood Coagulation Disorders; Blood Platelets; Fibrin; Fibrinogen; Humans; Immunoelectrophoresis; Peptides; Polymers; Proteolysis; Research; Spectrophotometry; Thrombelastography; Thrombosis | 1965 |
PLASMA FIBRINOLYTIC ACTIVITY FOLLOWING RECENT MYOCARDIAL AND CEREBRAL INFARCTION.
Topics: Cerebral Infarction; Fibrinogen; Fibrinolysis; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Myocardial Infarction; Stroke; Thrombolytic Therapy; Thrombosis | 1965 |
The clot density determination of fibrinogen in rheumatic fever.
Topics: Fibrinogen; Humans; Rheumatic Fever; Thrombosis | 1955 |
Clot density determination of fibrinogen in experimental myocardial infarction.
Topics: Coagulants; Fibrinogen; Hemostatics; Myocardial Infarction; Thrombosis | 1955 |
Detection of venous thrombosis with 131 I-labelled fibrinogen in the rabbit.
Topics: Animals; Fibrinogen; Rabbits; Radiometry; Thrombosis; Venous Thrombosis | 1960 |
[Easy method of determining plasma fibrinogen by means of clot density].
Topics: Fibrinogen; Humans; Plasma; Thrombosis | 1962 |
Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study.
Topics: Aged; Albuminuria; Arteriosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertrophy, Left Ventricular; Incidence; Indians, North American; Inflammation; Male; Middle Aged; Prevalence; Risk Factors; Thrombosis | 2003 |
Genetics of fibrin clot structure: a twin study.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Coronary Vessels; Diseases in Twins; Environment; Factor XIII; Female; Fibrin; Fibrinogen; Humans; Middle Aged; Multivariate Analysis; Phenotype; Thrombosis; Time Factors; Twins, Dizygotic; Twins, Monozygotic | 2004 |
Primary failure of arteriovenous fistulae in auto-immune disease.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Catheters, Indwelling; Child; Female; Fibrinogen; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis; Vasculitis | 2003 |
The study of the sterilization effect of gamma ray irradiation of immobilized collagen polypropylene nonwoven fabric surfaces.
Topics: Biocompatible Materials; Blood Platelets; Cell Adhesion; Collagen Type III; Cross-Linking Reagents; Erythrocytes; Fibrinogen; Gamma Rays; Humans; Polypropylenes; Sterilization; Surface Properties; Thrombosis | 2003 |
Cause-effect relation between hyperfibrinogenemia and vascular disease.
Topics: Animals; Carotid Arteries; Chlorides; Cross-Linking Reagents; Dimerization; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ferric Compounds; Fibrinogen; Mice; Mice, Transgenic; Protein Binding; Thrombin; Thrombosis; Vascular Diseases | 2004 |
Pharmacokinetics of pulse-sprayed recombinant tissue plasminogen activator for deep venous thrombosis.
Topics: alpha-2-Antiplasmin; Drug Administration Schedule; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Plasminogen; Recombinant Proteins; Thrombosis; Tissue Plasminogen Activator | 2003 |
[Direct and indirect effects of epoietin alpha in an experimental model of thrombosis and bleeding in the rabbit].
Topics: Animals; Bleeding Time; Blood Pressure; Body Temperature; Carotid Arteries; Erythrocyte Transfusion; Erythropoietin; Fibrinogen; Heart Rate; Hemobilia; Hemorrhage; Partial Thromboplastin Time; Platelet Aggregation; Rabbits; Recombinant Proteins; Regional Blood Flow; Thrombosis | 2003 |
Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species.
Topics: Blood Coagulation; Coronary Artery Disease; Fibrin; Fibrinogen; Humans; Microscopy, Electron, Scanning; Protein Processing, Post-Translational; Reactive Nitrogen Species; Thrombosis | 2004 |
Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2.
Topics: Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Fibrinogen; Mice; Platelet Activation; Platelet Aggregation; Protein Isoforms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; RNA, Messenger; Thrombosis | 2004 |
Relationship of fibrinogen B to thromboembolic phenomena.
Topics: Blood Coagulation; Coagulants; Embolism; Fibrinogen; Humans; Thrombosis | 1951 |
Retraction of clots formed from purified fibrinogen.
Topics: Fibrinogen; Humans; Plasma; Thrombosis | 1951 |
Effect of physical variables on adhesion in clots formed from fibrinogen and thrombin.
Topics: Blood Coagulation; Fibrinogen; Hemostatics; Humans; Thrombin; Thrombosis | 1952 |
Thrombin binding to GPIbalpha induces integrin alphaIIbbeta3 dependent platelet adhesion to fibrin in ex vivo flowing whole blood.
Topics: Acetates; Anticoagulants; Blood; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Membrane Glycoproteins; Membrane Proteins; Oligopeptides; Peptide Fragments; Perfusion; Platelet Adhesiveness; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Thrombin; Thrombosis; Tyrosine | 2004 |
Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; beta-Thromboglobulin; Factor XI; Female; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Phosphorylation; Platelet Activation; Thrombosis; Venous Thrombosis | 2004 |
A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury.
Topics: Acute Disease; Animals; Carotid Artery Injuries; Cells, Cultured; Cricetinae; Disease Models, Animal; Enzyme Precursors; Fibrinogen; Kidney; Mice; Mice, Mutant Strains; Mutagenesis; Platelet Activation; Protein C; Prothrombin; Recombinant Proteins; Thrombin; Thrombomodulin; Thrombosis | 2004 |
Embolization itself stimulates thrombus propagation in pulmonary embolism.
Topics: Ancrod; Animals; Anticoagulants; Dogs; Fibrinogen; Fibrinopeptide B; Heparin; Humans; Male; Pulmonary Embolism; Thromboembolism; Thrombosis | 2004 |
Synthesis and thrombolytic activity of carboline-3-carboxylic acid modified metabolites of Ala-Arg-Pro-Ala-Lys.
Topics: Animals; Carbolines; Fibrinogen; Fibrinolytic Agents; Male; Peptides; Rabbits; Rats; Rats, Wistar; Thrombin; Thrombosis | 2004 |
Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection.
Topics: Acute Disease; Amino Acid Sequence; Animals; Cell Membrane; Cells, Cultured; Chromosome Mapping; Cloning, Molecular; Endothelium, Vascular; Enzyme Activation; Fibrinogen; Graft Rejection; Heart Transplantation; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Papio; Prothrombin; Rats; Recombinant Proteins; Swine; Thrombin; Thrombosis; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 2004 |
Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events.
Topics: Abciximab; Analysis of Variance; Antibodies, Monoclonal; Arterial Occlusive Diseases; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Peripheral Vascular Diseases; Recombinant Proteins; Retrospective Studies; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome | 2004 |
Techniques to examine platelet adhesive interactions under flow.
Topics: Animals; Biological Assay; Blood Platelets; Cell Adhesion; Collagen Type I; Fibrinogen; Humans; Microscopy, Confocal; Thrombosis; von Willebrand Factor | 2004 |
Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Topics: Adult; Behcet Syndrome; Blood Viscosity; Body Mass Index; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Lipids; Male; Middle Aged; Reference Values; Risk Factors; Thrombosis | 2004 |
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.
Topics: Animals; Blood Platelets; Cell Survival; Fibrin; Fibrinogen; GTP-Binding Protein alpha Subunits, Gq-G11; Killer Cells, Natural; Lung; Mice; Mice, Knockout; Neoplasm Metastasis; Neoplasms; Platelet Activation; Thrombosis | 2005 |
The value of the fibrinogen-B test in intravascular thrombosis in surgical subjects.
Topics: Blood; Fibrinogen; Hemostatics; Humans; Thrombosis | 1950 |
The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.
Topics: Angioplasty; Animals; Arteries; Aspirin; Blood Coagulation Factors; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; International Normalized Ratio; Platelet Adhesiveness; Swine; Thrombosis; Vitamin K; Warfarin | 2004 |
Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease.
Topics: Aged; Biomarkers; C-Reactive Protein; Cholesterol; Cross-Sectional Studies; Disability Evaluation; Female; Fibrinogen; Geriatric Assessment; Humans; Inflammation; Male; Peripheral Vascular Diseases; Serum Amyloid A Protein; Statistics, Nonparametric; Thrombosis; Walking | 2004 |
Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Agents; Asparaginase; Fibrinogen; Humans; Medical Records; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Thrombosis | 2004 |
[Effect of the extract from Peristrophe roxburghiana on hemorheology in rats].
Topics: Acanthaceae; Animals; Blood Viscosity; Disease Models, Animal; Drugs, Chinese Herbal; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Male; Phototherapy; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Thrombosis | 2002 |
Plasma thrombosis markers following cerebral infarction in African Americans.
Topics: Antithrombin III; Biomarkers; Black or African American; Cerebral Infarction; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Prothrombin; Recurrence; Thrombosis | 2005 |
[A study of human annexin V derivative: its effects of anticoagulation and antithrombosis].
Topics: Animals; Annexin A5; Anticoagulants; Blood Coagulation; Disease Models, Animal; Fibrinogen; Humans; Injections, Intravenous; Male; Partial Thromboplastin Time; Prothrombin Time; Rabbits; Random Allocation; Thrombin Time; Thrombosis | 2004 |
Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.
Topics: Aged; Biomarkers; C-Reactive Protein; Creatinine; Factor VII; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Hemoglobins; Humans; Leukocyte Count; Linear Models; Longitudinal Studies; Male; Predictive Value of Tests; Prospective Studies; Renal Insufficiency; Serum Albumin; Thrombosis | 2004 |
Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
Topics: Biomarkers; Blood Specimen Collection; Coronary Disease; Europe; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation Mediators; Male; Middle Aged; Risk Factors; Thrombosis; von Willebrand Factor | 2005 |
Thrombolytic activity of BB-10153, a thrombin-activatable plasminogen.
Topics: alpha-2-Antiplasmin; Animals; Bleeding Time; Dogs; Fibrinogen; Fibrinolytic Agents; Male; Mutagenesis, Site-Directed; Plasminogen; Plasminogen Activators; Rabbits; Risk; Risk Factors; Thrombin; Thrombosis; Time Factors | 2005 |
No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors.
Topics: Blood Platelets; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; DNA; Factor V; Factor VII; Factor XIII; Family Health; Fibrinogen; Humans; Integrin alpha2beta1; Integrin beta3; Myocardial Infarction; Odds Ratio; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Prothrombin; Risk; Risk Factors; Thrombosis | 2005 |
Role of p38 mitogen-activated protein kinase in thrombus formation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alleles; Animals; Blood Coagulation; Blood Platelets; Chlorides; Ferric Compounds; Fibrinogen; Heterozygote; Homozygote; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Placenta; Platelet Adhesiveness; Protein Binding; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Thrombosis; Thromboxane A2; Time Factors; Vasoconstrictor Agents | 2004 |
Inflammation-sensitive proteins and erythrocyte aggregation in atherothrombosis.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Cell Adhesion; Ceruloplasmin; Cholesterol; Cross-Sectional Studies; Diabetic Angiopathies; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Immunoglobulins; Male; Middle Aged; Thrombosis | 2005 |
High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Topics: Aged; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Circadian Rhythm; Coronary Artery Disease; Coronary Thrombosis; Endothelium, Vascular; Female; Fibrinogen; Heart Rate; Humans; Male; Middle Aged; Multivariate Analysis; P-Selectin; Platelet Activation; Risk Factors; Thrombosis; von Willebrand Factor | 2005 |
[Study on function of decoction for invigorating the kidney and improving blood circulation on rabbits blood stasis model].
Topics: Animals; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Kidney; Liver; Lung; Male; Medicine, Chinese Traditional; Plants, Medicinal; Plasminogen Inactivators; Rabbits; Random Allocation; Thrombosis; Tissue Plasminogen Activator | 2004 |
Inflammation in patients with lupus anticoagulant and implications for thrombosis.
Topics: Adult; Biomarkers; C-Reactive Protein; Factor VIII; Female; Fibrinogen; Humans; Inflammation; Lupus Coagulation Inhibitor; Male; Middle Aged; Risk Factors; Thrombosis | 2005 |
A genome search for genetic determinants that influence plasma fibrinogen levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fibrinogen; Gene Expression Profiling; Genetic Predisposition to Disease; Genomics; Haplotypes; Humans; Infant; Linkage Disequilibrium; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Thrombosis | 2005 |
Hyperfibrinogenemia alone does not affect the patency of microvascular anastomosis: clinical experience and animal study.
Topics: Adult; Aged; Anastomosis, Surgical; Animals; Female; Fibrinogen; Flow Cytometry; Head and Neck Neoplasms; Humans; Male; Microsurgery; Middle Aged; Plastic Surgery Procedures; Platelet Aggregation; Rats; Rats, Inbred Lew; Thrombosis | 2005 |
Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Bone Marrow Transplantation; Carotid Artery Injuries; Carotid Artery Thrombosis; Disease Models, Animal; Factor V; Fibrinogen; Homozygote; Mice; Mice, Mutant Strains; Photochemistry; Thrombin; Thrombosis | 2005 |
Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
Topics: Annexin A5; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; Factor VII; Factor VIIa; Factor X; Fibrinogen; Hemostasis; Humans; Microscopy, Fluorescence; Perfusion; Phosphatidylserines; Phospholipids; Platelet Adhesiveness; Platelet Count; Protein Binding; Prothrombin; Recombinant Proteins; Signal Transduction; Thrombin; Thrombocytopenia; Thrombosis; Time Factors | 2005 |
Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus as an antiplatelet agent in vivo.
Topics: Animals; Anticoagulants; Bacterial Proteins; Bleeding Time; Blood Platelets; Dose-Response Relationship, Drug; Female; Fibrinogen; Glutathione Transferase; Mice; Mice, Inbred BALB C; Platelet Aggregation Inhibitors; Protein Binding; Recombinant Proteins; Staphylococcus aureus; Thrombosis; Time Factors; Wound Healing | 2005 |
Comparison of colchicine, dapsone, triamcinolone, and diphenhydramine therapy for the treatment of brown recluse spider envenomation: a double-blind, controlled study in a rabbit model.
Topics: Animals; Blood Coagulation Factors; Colchicine; Dapsone; Diphenhydramine; Fibrinogen; Phosphoric Diester Hydrolases; Rabbits; Spider Bites; Spider Venoms; Thrombosis; Time Factors; Triamcinolone | 2005 |
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis | 2005 |
An indium:calcium phosphate colloid that specifically targets fibrin.
Topics: Biocompatible Materials; Calcium Phosphates; Colloids; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Humans; Hydrogen-Ion Concentration; Indium; Indium Radioisotopes; Inflammation; Phosphates; Protein Binding; Protein Isoforms; Thrombin; Thrombosis; Time Factors | 2005 |
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Blood Coagulation; Complement C3; Complement C5; Complement C9; Complement System Proteins; Endothelium, Vascular; Escherichia coli; Female; Fibrinogen; Glycoproteins; Humans; Immunoglobulin G; Inflammation; Lipopolysaccharides; Male; Microscopy, Fluorescence; Protein Structure, Tertiary; Rats; Rats, Wistar; Thrombosis; Time Factors; Venous Thrombosis | 2005 |
Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin.
Topics: Animals; Antibodies, Monoclonal; Blood Coagulation Factors; Cell Separation; Disease Progression; Endothelium, Vascular; Endotoxins; Escherichia coli; Fibrin; Fibrinogen; Flow Cytometry; Hemostasis; Hemostatics; Lipopolysaccharides; Mice; Mice, Transgenic; Promoter Regions, Genetic; Protein C; Receptor, TIE-2; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Sepsis; Thrombin; Thrombosis; Time Factors; Transgenes | 2005 |
[The effect of bamboo leaves extract on hemorheology of normal rats].
Topics: Animals; Blood Sedimentation; Blood Viscosity; Cholesterol; Drugs, Chinese Herbal; Erythrocyte Aggregation; Fibrinogen; Hematocrit; Hemorheology; Mice; Plant Leaves; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Sasa; Thrombosis | 2005 |
Mechanism of antithrombotic effect of heparin and antithrombin in balloon-injured arteries.
Topics: Angiography; Animals; Antithrombins; Arginine; Arteries; Catheterization; Dogs; Fibrinogen; Fibrinolytic Agents; Heparin; Iliac Artery; Microscopy, Fluorescence; Partial Thromboplastin Time; Pipecolic Acids; Prothrombin Time; Sulfonamides; Thrombosis | 2005 |
Blood compatibility of thermoplastic polyurethane membrane immobilized with water-soluble chitosan/dextran sulfate.
Topics: Acrylic Resins; Adsorption; Animals; Blood Coagulation; Blood Group Antigens; Blood Platelets; Cell Proliferation; Cell Survival; Chitosan; Dextran Sulfate; Dose-Response Relationship, Drug; Fibrinogen; Fibroblasts; Glucose; Humans; Hydrogen-Ion Concentration; Macromolecular Substances; Mice; Models, Chemical; Ozone; Plastics; Platelet Adhesiveness; Polyurethanes; Spectrometry, X-Ray Emission; Surface Properties; Tetrazolium Salts; Thiazoles; Thrombosis; Time Factors; Water | 2005 |
The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
Topics: Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Fibrinolysis; Humans; Microscopy, Confocal; Microscopy, Electron, Scanning; Peptide Fragments; Recombinant Proteins; Thrombosis | 2005 |
In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex.
Topics: Animals; Anticoagulants; Antithrombins; Blood Coagulation; Catheterization; Coated Materials, Biocompatible; Ethylene Oxide; Fibrin; Fibrinogen; Heparin; Humans; Male; Materials Testing; Oxygen; Polyethylene Glycols; Polyurethanes; Rabbits; Surface Properties; Thrombosis | 2005 |
Endothelial cell activation by IL-1beta in the presence of fibrinogen requires alphavbeta3.
Topics: Antibodies, Monoclonal; Cells, Cultured; Drug Interactions; Endothelium, Vascular; Fibrinogen; Humans; Integrin alphaVbeta3; Interleukin-1; Nitric Oxide; Nitric Oxide Synthase Type III; Receptors, Fibrinogen; Receptors, Interleukin-1; Thrombosis; Umbilical Veins | 2005 |
Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families.
Topics: Age of Onset; Atherosclerosis; Family Health; Female; Fibrinogen; Genetic Markers; Genotype; Homocysteine; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Pedigree; Risk Factors; Thrombosis | 2005 |
Fibrinogen contains cryptic PAI-1 binding sites that are exposed on binding to solid surfaces or limited proteolysis.
Topics: Adsorption; Binding Sites; Fibrin; Fibrinogen; Fibrinolysin; Gene Library; Humans; Peptide Fragments; Plasminogen Activator Inhibitor 1; Protein Structure, Tertiary; Surface Plasmon Resonance; Thrombosis; Two-Hybrid System Techniques; Vitronectin | 2005 |
A model system to assess key vascular responses to biomaterials.
Topics: Alloys; Aorta; Binding, Competitive; Biocompatible Materials; Blood Platelets; Cell Adhesion; Cell Movement; Chromium Alloys; Cobalt; Endothelial Cells; Endothelium, Vascular; Fibrinogen; Humans; Materials Testing; Monocytes; Polyhydroxyethyl Methacrylate; Polytetrafluoroethylene; Polyurethanes; Reproducibility of Results; Thrombosis | 2005 |
Genetic risk factors for arterial thrombosis and inflammation.
Topics: Arteries; Factor V; Factor VIII; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Hemostasis; Humans; Inflammation; Myocardial Infarction; Risk Factors; Stroke; Thrombosis | 2005 |
Erythrocyte aggregation in Behçet's disease determined with the Sefam and Myrenne aggregometer. Lack of association with thrombosis and uveitis.
Topics: Adult; Behcet Syndrome; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Male; Middle Aged; Predictive Value of Tests; Thrombosis; Triglycerides; Uveitis | 2005 |
Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering.
Topics: Animals; Blood Platelets; Cholesterol, Dietary; Endothelium, Vascular; Female; Fibrinogen; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunohistochemistry; Platelet Aggregation; Pravastatin; rhoA GTP-Binding Protein; Risk; Swine; Thrombosis | 2005 |
Genetic influence on thrombotic risk markers in the elderly--a Danish twin study.
Topics: Aged; Aged, 80 and over; Aging; Carboxypeptidase B2; Denmark; Environment; Factor VII; Female; Fibrinogen; Hemostasis; Humans; Male; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; Thrombosis; Twins, Dizygotic; Twins, Monozygotic | 2006 |
Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk.
Topics: Adult; C-Reactive Protein; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Heart Diseases; Humans; Hyperlipidemias; Hypertension; Inflammation Mediators; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Periodontitis; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Smoking; Thrombosis; Tissue Plasminogen Activator; Tooth Extraction | 2006 |
The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite.
Topics: Adsorption; Antithrombin III; Blood Platelets; Cell Adhesion; Cells, Cultured; Elasticity; Factor Xa Inhibitors; Fibrinogen; Humans; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molecular Structure; Nanostructures; Organosilicon Compounds; Thrombosis; Water | 2006 |
More on: Pathogenic antibodies to coagulation factors. Part II: Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor.
Topics: Abortion, Habitual; Autoantibodies; Blood Coagulation Factors; Factor IX; Factor V; Factor XII; Factor XIII; Female; Fibrinogen; Humans; Male; Protein C; Prothrombin; Thrombin; Thrombosis; von Willebrand Factor | 2006 |
Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Topics: Amino Acid Sequence; Blood Coagulation; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lysine; Models, Biological; Molecular Sequence Data; Plasminogen; Protein Binding; Radiation-Protective Agents; Structure-Activity Relationship; Thrombosis; Tissue Plasminogen Activator | 2006 |
Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Calcium; Cell Shape; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Femoral Artery; Fibrinogen; Fibrinolytic Agents; GTP-Binding Protein alpha Subunits, Gq-G11; Ligation; Macaca fascicularis; P-Selectin; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Regional Blood Flow; Stress, Mechanical; Thrombosis | 2006 |
Gender differences in the expression of erythrocyte aggregation in relation to B beta-fibrinogen gene polymorphisms in apparently healthy individuals.
Topics: Aged; Atherosclerosis; Erythrocyte Aggregation; Female; Fibrinogen; Gene Frequency; Humans; Male; Polymorphism, Genetic; Risk Factors; Sex Factors; Thrombosis | 2006 |
Hypofibrinogenaemia resulting from novel single nucleotide deletion at codon Bbeta58 (3404del A) associated with thrombotic stroke in infancy.
Topics: Adolescent; Adult; Afibrinogenemia; Amino Acid Sequence; Base Sequence; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Male; Molecular Sequence Data; Point Mutation; Stroke; Thrombosis | 2006 |
Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk.
Topics: Aged; Base Sequence; Blood Proteins; Cardiovascular Diseases; Chromosome Mapping; Factor VII; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Variation; Haplotypes; Hemostatics; Humans; Linkage Disequilibrium; Male; Middle Aged; Molecular Sequence Data; Multigene Family; Plasminogen Activators; Polymorphism, Single Nucleotide; Thrombosis | 2006 |
COX-2 protects against thrombosis of the retinal vasculature in a mouse model of proliferative retinopathy.
Topics: Animals; Animals, Newborn; Blood Platelets; Cell Nucleus; Cyclooxygenase 1; Cyclooxygenase 2; Endothelial Cells; Fibrinogen; Immunohistochemistry; Lectins; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxygen; Prostaglandins; Regional Blood Flow; Retina; Retinal Diseases; Retinal Vessels; Staining and Labeling; Thrombosis; Vitreous Body | 2006 |
[Study on the function of decoction for invigorating the kidney and improving blood circulation to thrombosis on rabbit blood stasis model].
Topics: Animals; Blood Viscosity; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Male; Plants, Medicinal; Plasminogen Inactivators; Rabbits; Random Allocation; Thrombosis; Tissue Plasminogen Activator | 2006 |
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Topics: Amino Acid Motifs; Animals; Antibodies; Bleeding Time; Blood Platelets; Carotid Artery Diseases; Chlorides; Complementarity Determining Regions; Eptifibatide; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Humans; Mice; Mice, Inbred C57BL; Molecular Conformation; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 2006 |
Carbon monoxide-induced early thrombolysis contributes to heme oxygenase-1-mediated inhibition of neointimal growth after vascular injury in hypercholesterolemic mice.
Topics: Animals; Apolipoproteins E; Carbon Monoxide; Carotid Artery, Common; Fibrin; Fibrinogen; Heme Oxygenase-1; Hypercholesterolemia; Inflammation; Male; Mice; Muscle Development; Muscle, Smooth, Vascular; Plasminogen Activator Inhibitor 1; Thrombosis; Transduction, Genetic | 2006 |
Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans.
Topics: Aged; Biomarkers; Female; Fibrinogen; Glycation End Products, Advanced; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Thrombosis | 2006 |
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Blood Coagulation Factors; Case-Control Studies; Cohort Studies; Death; Female; Fibrinogen; Humans; Longitudinal Studies; Male; Netherlands; P-Selectin; Proportional Hazards Models; Risk Factors; Stroke; Thrombophilia; Thrombosis; von Willebrand Factor | 2006 |
Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo.
Topics: Animals; Blood Platelets; Calcium; Fibrinogen; Hirudins; In Vitro Techniques; Integrin beta3; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Platelet Aggregation; Thrombin; Thrombosis; von Willebrand Factor | 2006 |
Antiadhesive effect of fibrinogen: a safeguard for thrombus stability.
Topics: Cell Adhesion; Cell Line; Fibrin; Fibrinogen; Humans; Integrins; Leukocytes; Neutrophils; Thrombosis | 2007 |
Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Humans; Immunoassay; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Thrombosis | 2006 |
Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Black or African American; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibrin; Fibrinogen; Haplotypes; Humans; Linear Models; Male; Microcirculation; Middle Aged; Polymorphism, Genetic; Purpura, Thrombotic Thrombocytopenic; Reference Values; Syndrome; Thrombosis; White People | 2007 |
Radiolabeled and near-infrared fluorescent fibrinogen derivatives create a system for the identification and repair of obscure gastrointestinal bleeding.
Topics: Animals; Blood Coagulation; Fibrinogen; Fluorescent Dyes; Gastrointestinal Hemorrhage; Iodine Radioisotopes; Mice; Occult Blood; Rabbits; Spectrometry, Fluorescence; Swine; Thrombosis | 2006 |
Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis.
Topics: Adult; Anticoagulants; Enoxaparin; Factor VIII; Fibrinogen; Fibrinogens, Abnormal; Graft Survival; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Thrombosis | 2007 |
Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization.
Topics: Actins; Adenosine Diphosphate; Blood Platelets; Calcium; Calcium Signaling; Cytoskeleton; Extracellular Matrix; Fibrinogen; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Myosin Light Chains; p38 Mitogen-Activated Protein Kinases; Peptides; Phosphorylation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Receptor, PAR-1; Receptors, Thrombin; Thrombin; Thrombosis | 2007 |
Plasma-deposited tetraglyme surfaces greatly reduce total blood protein adsorption, contact activation, platelet adhesion, platelet procoagulant activity, and in vitro thrombus deposition.
Topics: Adsorption; Blood Coagulation Factors; Blood Platelets; Catheterization; Ethylene Glycols; Fibrinogen; Humans; Platelet Adhesiveness; Surface Plasmon Resonance; Surface Properties; Thrombin; Thrombosis; Time Factors; von Willebrand Factor | 2007 |
Heart rate and microinflammation in men: a relevant atherothrombotic link.
Topics: Adult; Age Factors; Atherosclerosis; Biomarkers; Body Mass Index; C-Reactive Protein; Exercise; Fibrinogen; Heart Rate; Humans; Inflammation; Leukocyte Count; Linear Models; Lipids; Male; Middle Aged; Neutrophils; Risk Factors; Thrombosis | 2007 |
Influence of red blood cell concentration on the initiation time of blood coagulation: risk of thrombus formation in pregnant females with anemia.
Topics: Adult; Anemia; Blood Viscosity; Erythrocyte Count; Erythrocyte Deformability; Female; Fibrinogen; Hemorheology; Hemorrhage; Humans; Partial Thromboplastin Time; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Prothrombin Time; Risk Factors; Thrombophilia; Thrombosis | 2007 |
Exercise training-induced changes in coagulation factors in older adults.
Topics: Aged; Exercise; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Prothrombin; Thrombosis; United States | 2007 |
A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221-550) inhibits platelet-plug formation in mice.
Topics: Animals; Blood Platelets; Coagulants; Coagulase; Dose-Response Relationship, Drug; Fibrinogen; Male; Mice; Mice, Inbred ICR; Platelet Aggregation; Protein Binding; Staphylococcus aureus; Thrombosis | 2007 |
Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
Topics: Adolescent; Adult; Alleles; Cohort Studies; Cross-Sectional Studies; Epistasis, Genetic; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Kidney Glomerulus; Logistic Models; Lupus Nephritis; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Thrombosis | 2007 |
Influence of two different regimens of concomitant treatment with asparaginase and dexamethasone on hemostasis in childhood acute lymphoblastic leukemia.
Topics: Adrenal Cortex Hormones; Asparaginase; Coagulants; Combined Modality Therapy; Dexamethasone; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Thrombosis; Time Factors | 2007 |
The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Biomarkers; Epitope Mapping; Epitopes; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Hybridomas; Mice; Mice, Inbred BALB C; Solubility; Thrombin; Thrombosis | 2007 |
Fibrinogen controls human platelet fibronectin internalization and cell-surface retention.
Topics: Adult; Blood Coagulation Disorders; Blood Platelets; Cell Membrane; Consanguinity; Factor VIII; Fibrinogen; Fibronectins; Flow Cytometry; Hemostasis; Humans; Male; Platelet Activation; Platelet Aggregation; Thrombosis | 2007 |
Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
Topics: Age of Onset; Child; Complement Factor H; Female; Fibrinogen; Genetic Predisposition to Disease; Hemolytic-Uremic Syndrome; Humans; Infant; Kidney Transplantation; Male; Membrane Cofactor Protein; Plasma; Point Mutation; Postoperative Complications; Prognosis; Risk Factors; Thrombosis; Treatment Outcome | 2007 |
The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation.
Topics: Amino Acid Substitution; Anemia; Animals; Blood Platelets; Chlorides; Contractile Proteins; Ferric Compounds; Fibrinogen; Filamins; Hemorrhage; Homozygote; Mice; Mice, Transgenic; Microfilament Proteins; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Protein Binding; Protein Structure, Tertiary; Pulmonary Embolism; Talin; Thrombosis | 2007 |
Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation.
Topics: Animals; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Carrier Proteins; Fibrinogen; Humans; Immunoglobulin G; Monocytes; Neutrophils; Platelet Activation; Streptococcal Infections; Streptococcus pyogenes; Thrombosis | 2007 |
Heritability of platelet function in families with premature coronary artery disease.
Topics: Adult; Blood Platelets; Coronary Artery Disease; Family Health; Female; Fibrinogen; Genotype; Humans; Male; Middle Aged; Platelet Aggregation; Polymorphism, Genetic; Thrombosis; Thromboxane B2; von Willebrand Factor | 2007 |
A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Topics: Administration, Oral; Animals; Aorta; Aspirin; Bleeding Time; Blood Coagulation; Clopidogrel; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Naphthalenes; Platelet Activation; Platelet Aggregation Inhibitors; Propionates; Prosthesis Design; Receptors, Thromboxane A2, Prostaglandin H2; Stainless Steel; Stents; Swine; Thrombosis; Ticlopidine; Time Factors | 2007 |
Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
Topics: Animals; Anticoagulants; Blood Coagulation; Disease Models, Animal; Dose-Response Relationship, Drug; Factor VIII; Fibrinogen; Male; Papio; Partial Thromboplastin Time; Peptide Fragments; Prothrombin Time; Thrombin; Thrombosis | 2007 |
Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Europe; Female; Fibrinogen; Fibrinolysis; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Metabolic Syndrome; Middle Aged; Nephelometry and Turbidimetry; Pedigree; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis; Time Factors | 2007 |
Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.
Topics: Adenosine Triphosphate; Animals; beta-Thromboglobulin; Blood Platelets; Chlorides; Ferric Compounds; Fibrinogen; Hematopoietic Stem Cells; Mast Cells; Megakaryocytes; Mice; Mice, Knockout; Neutrophils; Noxae; Oligopeptides; P-Selectin; Platelet Aggregation; Platelet Factor 4; Platelet Membrane Glycoprotein IIb; Proteoglycans; Receptors, Thrombin; Secretory Vesicles; Serotonin; T-Lymphocytes, Cytotoxic; Thrombin; Thrombosis; Vesicular Transport Proteins | 2008 |
Clinical evaluation of two tests for incipient thrombosis; prothrombin activity and fibrinogen B of Lyons.
Topics: Blood Coagulation Tests; Fibrinogen; Hemostatics; Humans; Prothrombin; Thrombosis | 1949 |
Central venous catheter-related thrombosis after replacement therapy for intracranial bleeding in a patient with afibrinogenaemia.
Topics: Adult; Afibrinogenemia; Anticoagulants; Catheterization, Central Venous; Female; Fibrinogen; Humans; Intracranial Hemorrhages; Thrombosis; Treatment Outcome | 2008 |
Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor.
Topics: Animals; Blood Platelets; Computer Simulation; Fibrinogen; Humans; Models, Cardiovascular; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Pulsatile Flow; Stress, Mechanical; Thrombosis; Time Factors; von Willebrand Factor | 2008 |
Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury.
Topics: Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Blood Pressure; Carotid Arteries; Cattle; Contractile Proteins; Extracellular Matrix Proteins; Fibrinogen; Fibronectins; Humans; Immunohistochemistry; Injections; Mice; Mice, Inbred C57BL; Platelet Function Tests; Protein Binding; Recombinant Proteins; RNA Splicing Factors; Surface Plasmon Resonance; Thrombosis; von Willebrand Factor | 2008 |
Segmented poly(esterurethane urea)s from novel urea-diol chain extenders: synthesis, characterization and in vitro biological properties.
Topics: Adsorption; Adult; Animals; Calorimetry, Differential Scanning; Cell Death; CHO Cells; Cricetinae; Cricetulus; Fibrinogen; Humans; Kinetics; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Microscopy, Fluorescence; P-Selectin; Platelet Adhesiveness; Polyurethanes; Serum Albumin; Spectroscopy, Fourier Transform Infrared; Surface Plasmon Resonance; Thrombosis; Urea | 2008 |
Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes.
Topics: Adult; Afibrinogenemia; Codon, Nonsense; Consanguinity; Fibrinogen; Homozygote; Humans; Male; Pedigree; Polymorphism, Single Nucleotide; Thrombosis | 2008 |
EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
Topics: Contrast Media; Fibrin; Fibrinogen; Gadolinium; Heterocyclic Compounds; Humans; Kinetics; Magnetic Resonance Angiography; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Peptides; Protein Binding; Substrate Specificity; Thermodynamics; Thrombosis | 2008 |
Bothrops protease A, a unique highly glycosylated serine proteinase, is a potent, specific fibrinogenolytic agent.
Topics: Animals; Fibrinogen; Fibrinolytic Agents; Glycosylation; Humans; In Vitro Techniques; Male; Rats; Rats, Wistar; Serine Endopeptidases; Serine Proteinase Inhibitors; Snake Venoms; Substrate Specificity; Thrombosis | 2008 |
Platelets in haemostasis and thrombosis.
Topics: Blood Coagulation; Blood Platelets; Fibrinogen; Hemorrhage; Humans; Thrombin; Thrombosis | 1967 |
Factors influencing the lysis of artificial thrombi by urokinase.
Topics: Acetates; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; In Vitro Techniques; Plasminogen; Thrombosis | 1967 |
Fibrinolytic activity in the clinical crisis of sickle-cell anaemia.
Topics: Anemia, Sickle Cell; Child; Fibrinogen; Fibrinolysis; Humans; Thrombosis | 1967 |
The problem of intravascular fibrinolytic reaction.
Topics: Blood Coagulation Disorders; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Thrombosis | 1967 |
Intravascular coagulation with generalized Shwartzman reaction induced by a heparin-like anticoagulant (Liquoid).
Topics: Animals; Anticoagulants; Blood Coagulation; Fibrinogen; Injections, Intravenous; Kidney Cortex Necrosis; Rats; Shwartzman Phenomenon; Thrombocytopenia; Thrombosis; Warfarin | 1967 |
Coagulation and fibrinolytic studies during pregnancy.
Topics: Antifibrinolytic Agents; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Contraceptives, Oral; Embolism; Factor IX; Factor V; Female; Fibrinogen; Fibrinolysis; Humans; Postpartum Period; Pregnancy; Prothrombin Time; Thrombosis | 1967 |
Coagulation and fibrinolytic studies during use of gestagens.
Topics: Adult; Blood Circulation; Blood Coagulation; Blood Platelets; Contraceptives, Oral; Embolism; Endometriosis; Female; Fibrinogen; Fibrinolysis; Hemophilia A; Humans; Pregnancy; Progestins; Thrombosis | 1967 |
[Significance of the laboratory diagnosis of hypercoagulability].
Topics: Blood Coagulation Tests; Cardiovascular Diseases; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Neoplasms; Partial Thromboplastin Time; Platelet Count; Postoperative Complications; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis | 1984 |
[Hypofibrinolysis and thrombophilia].
Topics: Adult; Blood Coagulation Tests; Deamino Arginine Vasopressin; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Prognosis; Thrombophlebitis; Thrombosis | 1984 |
[Thrombophilic states in late gestosis].
Topics: Antithrombin III Deficiency; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hematocrit; Hemostasis; Humans; Platelet Count; Pre-Eclampsia; Pregnancy; Prostaglandins; Thrombosis | 1984 |
[Substitution of antithrombin III by synthetic thrombin inhibitors].
Topics: Animals; Antithrombin III; Antithrombin III Deficiency; Arginine; Carbon Tetrachloride Poisoning; Fibrinogen; Heparin; Phenylpyruvic Acids; Pipecolic Acids; Platelet Count; Rats; Sulfonamides; Thrombin; Thrombosis | 1984 |
[Continuous measurement of lysis of radioactively marked fibrin clots].
Topics: Animals; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Iodine Radioisotopes; Models, Cardiovascular; Rabbits; Radionuclide Imaging; Thrombin; Thrombosis | 1984 |
Expression of the platelet procoagulant activity in vivo in thrombus formation in an extracorporeal shunt in the rat.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Coagulation; Blood Platelets; Cyclic AMP; Fibrinogen; Heparin; Rats; Thrombosis; Warfarin | 1984 |
Requirements for thromboresistance of surface-heparinized materials.
Topics: Adsorption; Animals; Blood Platelets; Dogs; Endothelium; Fibrinogen; Fibrinopeptide A; Glutaral; Heparin; Humans; Platelet Count; Polysaccharides; Surface Properties; Thrombin; Thrombosis | 1983 |
Blood viscosity in proliferative diabetic retinopathy and complicated retinal vein thrombosis.
Topics: Aged; Blood Viscosity; Diabetic Retinopathy; Fibrinogen; Hematocrit; Humans; Middle Aged; Neovascularization, Pathologic; Retinal Vein; Thrombosis | 1983 |
An abnormal fibrinogen (Copenhagen II) with increased sialic acid content associated with thrombotic tendency and normal liver function.
Topics: Adult; alpha-Macroglobulins; Fibrinogen; Fibrinogens, Abnormal; Haptoglobins; Humans; Male; N-Acetylneuraminic Acid; Nephrotic Syndrome; Renal Veins; Sialic Acids; Thrombosis; Warfarin | 1984 |
The biology of thrombosis.
Topics: Blood Coagulation; Blood Platelets; Fibrin; Fibrinogen; Fibrinolysin; Humans; Platelet Adhesiveness; Thrombin; Thrombosis | 1982 |
[Thrombosis and diabetic angiopathy].
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Coagulation Factors; Blood Platelets; Diabetic Angiopathies; Fibrinogen; Fibrinolysis; Humans; Platelet Aggregation; Thrombosis | 1982 |
Application of a synthetic serine protease inhibitor in the treatment of DIC.
Topics: Animals; Chemical Phenomena; Chemistry; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysin; Fibrinolysis; Gabexate; Guanidines; Humans; In Vitro Techniques; Protease Inhibitors; Rats; Rats, Inbred Strains; Thrombin; Thrombosis | 1983 |
[Clinical significance of fibrinopeptide A in surgery].
Topics: Adult; Aged; beta-Thromboglobulin; Cardiopulmonary Bypass; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Radioimmunoassay; Stomach Neoplasms; Thrombosis | 1984 |
Hemostasis: the balance concept of procoagulant and inhibitor systems and use of the serial thrombin time (STT).
Topics: Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemophilia A; Hemostasis; Homeostasis; Humans; Phosphatidylethanolamines; Phosphatidylserines; Thrombin Time; Thrombosis | 1984 |
Temporary ischaemia induced by degradable starch microspheres. Possible thrombogenic effects in vivo and in vitro.
Topics: Animals; Cats; Factor VIII; Fibrinogen; Intestine, Small; Ischemia; Male; Mesenteric Arteries; Microspheres; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; Starch; Thrombosis | 1981 |
[Morphology of thrombolysis as affected by a plasmakinase preparation].
Topics: Animals; Blood Coagulation; Fibrinogen; Fibrinolysis; In Vitro Techniques; Male; Microscopy, Electron; Peptide Hydrolases; Phosphotransferases; Plasminogen Activators; Rats; Thrombelastography; Thrombosis; Time Factors | 1982 |
Acquired neutrophil myeloperoxidase deficiency: an indicator of subclinical activation of blood coagulation?
Topics: Adolescent; Adult; Aged; Blood Coagulation; Child; Child, Preschool; Diabetes Mellitus; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutrophils; Peroxidase; Peroxidases; Thrombosis | 1983 |
Bulk-heparinized catheters do not generate fibrinopeptide A in an ex-vivo test in dogs.
Topics: Animals; Biocompatible Materials; Catheters, Indwelling; Dogs; Fibrinogen; Fibrinopeptide A; Heparin; Surface Properties; Thrombosis | 1983 |
Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A.
Topics: Blood Coagulation Tests; Cardiovascular Diseases; Evaluation Studies as Topic; Fibrinogen; Fibrinopeptide A; Humans; Immunoenzyme Techniques; Neoplasms; Radioimmunoassay; Reference Values; Thrombosis | 1984 |
Comprehensive study of haemostasis in nephrotic syndrome.
Topics: Adult; Antithrombin III; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Nephrotic Syndrome; Platelet Adhesiveness; Serum Albumin; Thrombosis | 1983 |
Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during L-asparaginase therapy.
Topics: Acute Disease; Adolescent; Adult; Antithrombin III; Antithrombin III Deficiency; Asparaginase; Female; Fibrinogen; Humans; Leukemia, Lymphoid; Male; Middle Aged; Prospective Studies; Pulmonary Embolism; Thrombosis | 1983 |
Blood viscosity and haemostasis in the nephrotic syndrome.
Topics: Adult; Blood Viscosity; Creatinine; Factor VIII; Female; Fibrinogen; Hematocrit; Hemostasis; Humans; Male; Nephrotic Syndrome; Proteinuria; Serum Globulins; Thrombosis | 1983 |
The lupus anticoagulant.
Topics: Blood Coagulation Factors; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Phospholipids; Prothrombin; Prothrombin Time; Thrombosis | 1984 |
Arterial graft maturation: the duration of thrombotic activity in Dacron aortobifemoral grafts measured by platelet and fibrinogen kinetics.
Topics: Aged; Aorta; Arterial Occlusive Diseases; Blood Platelets; Blood Vessel Prosthesis; Female; Femoral Artery; Fibrinogen; Humans; Kinetics; Male; Middle Aged; Polyethylene Terephthalates; Thrombosis; Time Factors | 1981 |
Relative proteolysis of the fibrinogen B beta chain by thrombin and plasmin as a determinant of thrombosis.
Topics: Fibrinogen; Fibrinolysin; Thrombin; Thrombosis | 1981 |
The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
Topics: Animals; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Plasminogen; Rabbits; Streptokinase; Swine; Thrombosis; Vena Cava, Inferior | 1981 |
[First contact between blood and the arterial prosthesis. Study of the retention of the blood elements].
Topics: Biocompatible Materials; Bioprosthesis; Blood Platelets; Blood Vessel Prosthesis; Fibrin; Fibrinogen; Humans; Microscopy, Electron; Polyesters; Polytetrafluoroethylene; Thrombosis; Umbilical Veins | 1984 |
Fibrinopeptide A in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism.
Topics: Blood Preservation; Fibrinogen; Fibrinopeptide A; Humans; Pulmonary Embolism; Specimen Handling; Thrombophlebitis; Thrombosis | 1984 |
[Thrombus formation with special reference to the substrates, fibrinogen and its related substances].
Topics: alpha-2-Antiplasmin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Humans; Plasminogen; Thrombosis | 1984 |
[Thrombophilic diatheses as hemostasis disorders in acute psychoses].
Topics: Acute Disease; Adult; Female; Fibrinogen; Hematocrit; Hemostasis; Humans; Middle Aged; Partial Thromboplastin Time; Platelet Count; Psychomotor Agitation; Psychotic Disorders; Pulmonary Embolism; Schizophrenia; Schizophrenia, Paranoid; Thrombophlebitis; Thrombosis | 1984 |
Effect of silastic tubing wall thickness on ex vivo thrombus formation in a series shunt.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Compliance; Dogs; Fibrinogen; Platelet Aggregation; Rheology; Silicone Elastomers; Thrombosis | 1984 |
Bound and circulating heparin in an ECMO system thrombogenicity versus functionality.
Topics: Animals; Biocompatible Materials; Extracorporeal Circulation; Female; Fibrinogen; Heparin; Humans; Male; Oxygenators, Membrane; Quaternary Ammonium Compounds; Rabbits; Sheep; Thrombosis | 1984 |
Protective effects of thromboxane A2 synthetase inhibitors on endotoxin shock.
Topics: Animals; Fibrinogen; Glucuronidase; Kidney; Male; Methacrylates; Oxidoreductases; Platelet Count; Rats; Rats, Inbred Strains; Shock, Septic; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1983 |
The endo-endothelial fibrin lining. A historical account.
Topics: Basement Membrane; Blood Coagulation; Capillaries; Capillary Fragility; Capillary Permeability; Elasticity; Endothelium; Fibrin; Fibrinogen; Fibrinolysis; Hematology; Homeostasis; Terminology as Topic; Thrombosis | 1983 |
The physiological significance of the endoendothelial fibrin lining (EEFL) as the critical interface in the 'vessel-blood organ' and the importance of in vivo 'fibrinogenin formation' in health and disease.
Topics: Basement Membrane; Blood Vessels; Calcium; Capillaries; Capillary Permeability; Endothelium; Fibrin; Fibrinogen; Fibrinolysis; Gels; Homeostasis; Permeability; Surface Properties; Thrombosis; Vascular Diseases | 1983 |
Comparative studies on thrombin inhibitors in experimental microthrombosis.
Topics: 4-Aminobenzoic Acid; Animals; Arginine; Dipeptides; Female; Fibrinogen; Hirudins; Kinetics; Lung; Male; Microcirculation; para-Aminobenzoates; Piperidines; Rats; Rats, Inbred Strains; Thrombin; Thrombosis | 1983 |
Evaluation of fibrin sealing for cardiovascular surgery.
Topics: Animals; Aortic Valve; Blood Platelets; Cardiovascular Surgical Procedures; Cell Survival; Dogs; Drug Combinations; Drug Evaluation, Preclinical; Factor XIII; Fibrin; Fibrin Tissue Adhesive; Fibrinogen; Fibronectins; Heart Valve Prosthesis; Hemostatics; Thrombin; Thrombosis; Time Factors; Tissue Adhesives | 1984 |
Stroke in two young siblings with congenital dysfibrinogenemia.
Topics: Adult; Aorta, Abdominal; Blood Coagulation Disorders; Carotid Artery Thrombosis; Carotid Artery, Internal; Cerebrovascular Disorders; Female; Fibrinogen; Humans; Male; Thrombosis | 1983 |
Some aspects of the molecular pathology of thrombosis and haemorrhage.
Topics: Blood Coagulation; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Models, Biological; Molecular Conformation; Thrombosis | 1984 |
[Effect of emotional stress on the system of hemostasis in patients with coronary arteriosclerosis].
Topics: Adult; Blood Coagulation; Coronary Disease; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Stress, Psychological; Thrombosis | 1984 |
[Hematoma and thrombosis prevention after hip surgery].
Topics: Dihydroergotamine; Female; Fibrinogen; Hematoma; Heparin; Hip Prosthesis; Humans; Iodine Radioisotopes; Male; Middle Aged; Thrombosis; Time Factors | 1984 |
The systemic fibrinolytic effect of low-dose intraarterial streptokinase: observations in 12 patients. Work in progress.
Topics: Adult; Aged; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Radiography; Streptokinase; Thrombin Time; Thrombosis; Time Factors | 1984 |
Use of noninvasive laboratory testing in the prediction of thrombosis in the nephrotic syndrome.
Topics: alpha-2-Antiplasmin; Antithrombin III; Creatinine; Female; Fibrinogen; Hematocrit; Humans; Male; Nephrotic Syndrome; Plasminogen; Risk; Thrombosis | 1984 |
Endotoxin-induced disseminated intravascular coagulation in vitamin E deficient rats.
Topics: Animals; Blood Cell Count; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrinogen; Kidney Glomerulus; Rats; Rats, Inbred Strains; Thrombosis; Vitamin E; Vitamin E Deficiency | 1984 |
Plasma fibronectin and resistance to thrombosis during sepsis.
Topics: Albumins; Animals; Endotoxins; Escherichia coli; Escherichia coli Infections; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Immune Sera; Male; Rats; Rats, Inbred Strains; Sepsis; Thrombosis; Time Factors | 1982 |
Effect of urokinase on fibrinolysis and fibrinogenolysis.
Topics: Animals; Dogs; Endopeptidases; Fibrinogen; Fibrinolysis; Pulmonary Embolism; Rabbits; Thrombosis; Urokinase-Type Plasminogen Activator | 1982 |
A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models.
Topics: Animals; Blood Coagulation Tests; Factor IX; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Male; Partial Thromboplastin Time; Platelet Count; Rabbits; Thrombosis | 1980 |
Hypoxic radioprotection by temporary intestinal ischemia: degradable starch microsphere embolization in the cat.
Topics: Animals; Blood Flow Velocity; Cats; Embolization, Therapeutic; Factor VIII; Female; Fibrinogen; Intestine, Small; Ischemia; Male; Mesenteric Vascular Occlusion; Microspheres; Oxygen; Platelet Count; Radiation Protection; Radiation Tolerance; Starch; Thrombosis | 1981 |
Monoclonal cryoglobulin of IgG (lambda) type interacting with transferrin.
Topics: Cryoglobulins; Edetic Acid; Fibrinogen; Humans; Immunoelectrophoresis; Immunoglobulin lambda-Chains; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Temperature; Thrombosis; Transferrin | 1981 |
Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency.
Topics: Animals; Antithrombin III; Dog Diseases; Dogs; Factor VIII; Female; Fibrinogen; Male; Nephrotic Syndrome; Partial Thromboplastin Time; Prothrombin Time; Pulmonary Embolism; Thrombosis | 1982 |
Physicochemical characterization and in vivo blood tolerability of cast and extruded Biomer.
Topics: Animals; Biocompatible Materials; Blood Platelets; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Dogs; Fibrinogen; Microscopy, Electron, Scanning; Polyurethanes; Spectrophotometry, Infrared; Stress, Mechanical; Surface Properties; Thrombosis | 1983 |
Relationship of triglyceride levels to thrombosis in patients with coronary artery disease.
Topics: Adult; Aged; Anticoagulants; Antithrombin III; Blood Coagulation Disorders; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Thromboplastin; Thrombosis; Triglycerides | 1983 |
Clinical and laboratory management of pulmonary embolism.
Topics: Anticoagulants; Blood Cell Count; Diagnosis, Differential; Electrocardiography; Fibrinogen; Humans; Iodine Radioisotopes; Lung; Myocardial Infarction; Physical Examination; Platelet Count; Plethysmography, Impedance; Pneumonia; Pulmonary Embolism; Radionuclide Imaging; Thrombosis; Ultrasonography | 1983 |
Red blood cell aggregation in nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Blood Sedimentation; Blood Viscosity; Erythrocyte Aggregation; Erythrocyte Indices; Female; Fibrinogen; Humans; Male; Middle Aged; Nephrotic Syndrome; Rheology; Thrombosis | 1983 |
The detection of fibrinogen (or FgDP)-protamine sulphate complex in vitro and in the circulating blood.
Topics: Animals; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoelectrophoresis, Two-Dimensional; In Vitro Techniques; Partial Thromboplastin Time; Protamines; Rabbits; Thrombosis | 1983 |
[Monitoring of post-operative prevention of thrombosis by low dosage heparin with the radioactive iodine fibrinogen test (author's transl)].
Topics: Adult; Aged; Austria; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Middle Aged; Postoperative Complications; Prospective Studies; Thrombosis | 1981 |
[Intravascular coagulation in paroxysmal nocturnal hemoglobinuria].
Topics: Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Hemoglobinuria, Paroxysmal; Humans; Kallikreins; Kinins; Platelet Aggregation; Thrombosis | 1981 |
[The radiofibrinogen test and the fibrinsplit product test in the diagnosis of deep veinous thrombophlebitis during radiotherapy. A contribution to the evaluation for silent acute thrombophlebitis (author's transl)].
Topics: Aged; Brachytherapy; Cobalt Radioisotopes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Middle Aged; Radioisotope Teletherapy; Thrombosis; Uterine Cervical Neoplasms; Uterine Neoplasms | 1982 |
[Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Topics: Adult; Animals; Blood Coagulation; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Radioimmunoassay; Swine; Thrombosis | 1982 |
Recanalization of an acutely occluded aortocoronary bypass by intragraft fibrinolysis.
Topics: Acute Disease; Coronary Angiography; Coronary Artery Bypass; Coronary Vessels; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Streptokinase; Thrombosis | 1980 |
A personal perspective on hemostasis and thrombosis (1937-1981).
Topics: Amino Acid Sequence; Animals; Antithrombin III; Blood Coagulation; Blood Platelets; Factor V; Factor X; Fibrinogen; Hemostasis; History, 20th Century; Humans; Plasminogen; Prothrombin; Research; Thrombin; Thrombosis | 1981 |
Severe thrombocytopenia delays but does not prevent the occlusion of an arterial prosthesis in rats.
Topics: Animals; Blood Platelets; Blood Vessel Prosthesis; Fibrinogen; Immune Sera; Leukocyte Count; Male; Partial Thromboplastin Time; Platelet Count; Rats; Thrombocytopenia; Thrombosis | 1981 |
[The postphlebitic syndrome of the lower extremities].
Topics: Age Factors; Eczema; Edema; Fibrinogen; Humans; Leg Ulcer; Ligation; Obesity; Phlebography; Radionuclide Imaging; Thrombophlebitis; Thrombosis; Ultrasonics; Varicose Veins; Veins; Venous Insufficiency | 1982 |
Hemorheological and biochemical parameters in the "fatty" rat.
Topics: Animals; Arteriosclerosis; Blood Glucose; Blood Viscosity; Cholesterol; Female; Fibrinogen; Genotype; Male; Rats; Rats, Mutant Strains; Rheology; Thrombosis; Triglycerides | 1982 |
Detection of hypercoagulability by the measurement of the dynamic loss modulus of clotting blood.
Topics: Adult; Aged; Biophysical Phenomena; Biophysics; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Humans; Male; Middle Aged; Thrombophlebitis; Thrombosis | 1982 |
67 Ga-labeled human fibrinogen: a new promising thrombus imaging agent.
Topics: Animals; Deferoxamine; Femoral Vein; Fibrinogen; Gallium Radioisotopes; Humans; Male; Mice; Rabbits; Radionuclide Imaging; Thrombosis | 1982 |
An ex vivo narrow-slit flow device for evaluation of blood-material interactions.
Topics: Animals; Blood Flow Velocity; Dogs; Fibrinogen; Platelet Adhesiveness; Polymers; Polyvinyl Chloride; Silicone Elastomers; Thrombosis | 1982 |
A new nonthrombogenic surface.
Topics: Adsorption; Animals; Biocompatible Materials; Blood Coagulation; Fibrinogen; Heparin; Humans; Platelet Count; Polymers; Rabbits; Thrombosis | 1982 |
Intensive plasma exchange--effects on haemostasis.
Topics: Adult; Aged; Blood Coagulation Factors; Blood Coagulation Tests; Blood Flow Velocity; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Plasma Exchange; Plasma Volume; Platelet Aggregation; Platelet Count; Thrombosis | 1982 |
Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fraction.
Topics: Animals; Antithrombins; Dose-Response Relationship, Drug; Factor X; Fibrinogen; Heparin; Molecular Weight; Partial Thromboplastin Time; Prothrombin Time; Rabbits; Thrombosis | 1982 |
Platelet and fibrinogen kinetics in canine tumors.
Topics: Adenocarcinoma; Animals; Blood Platelets; Dog Diseases; Dogs; Fibrinogen; Kinetics; Neoplasm Metastasis; Neoplasms; Platelet Count; Sarcoma; Thrombocytopenia; Thrombosis; Time Factors | 1981 |
Pseudointima in expanded polytetrafluoroethylene graft implanted in the inferior vena cava of normal and defibrinogenated dogs.
Topics: Animals; Artificial Organs; Batroxobin; Dogs; Dose-Response Relationship, Drug; Fibrinogen; Microscopy, Electron; Polytetrafluoroethylene; Thrombosis; Time Factors; Vena Cava, Inferior | 1981 |
Dysbaric osteonecrosis: a consequence of intravascular bubble formation, endothelial damage, and platelet thrombosis.
Topics: Animals; Blood Platelet Disorders; Blood Platelets; Diving; Embolism, Air; Endothelium; Fibrinogen; Fibrinolytic Agents; Hemostasis; Humans; Kinetics; Male; Osteonecrosis; Plasminogen; Pressure; Swine; Thrombosis; Time Factors | 1981 |
[Changes of fibrinogen concentration and their prognostic value in acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Female; Fibrinogen; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk; Thrombosis | 1981 |
The thrombolytic activity of streptokinase in the rabbit.
Topics: Animals; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Plasminogen; Rabbits; Streptokinase; Thrombosis; Vena Cava, Inferior | 1981 |
Pseudoendothelium formation in expanded polytetrafluoroethylene grafts implanted in the inferior vena cava of normal and defibrinogenated dogs.
Topics: Animals; Blood Vessel Prosthesis; Dogs; Endothelium; Fibrinogen; Graft Survival; Polytetrafluoroethylene; Thrombosis; Time Factors; Vena Cava, Inferior | 1981 |
Direct comparison of biomaterials and endothelium in an ex vivo shunt.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Biocompatible Materials; Blood Vessels; Dogs; Endothelium; Evaluation Studies as Topic; Fibrinogen; Male; Platelet Adhesiveness; Thrombosis | 1981 |
[A discussion on the etiology and clinical significance of hyperfibrinogenemia (author's transl)].
Topics: Adult; Aged; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Leukemia; Male; Middle Aged; Thrombosis | 1981 |
Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.
Topics: Adolescent; Adult; Arteriosclerosis; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Platelet Aggregation; Thrombosis; Triglycerides | 1980 |
Characterization of bromine-77-labeled proteins prepared using bromoperoxidase.
Topics: Animals; Chemical Phenomena; Chemistry; Dogs; Fibrinogen; Hydrogen-Ion Concentration; Isotope Labeling; Peroxidases; Radioisotopes; Serum Albumin; Thrombosis | 1980 |
Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs.
Topics: Animals; Blood Pressure; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrinogen; Hirudins; Male; Myocardial Contraction; Platelet Count; Swine; Thrombosis | 1980 |
Platelet changes after placement of aortic prostheses in dogs. II. Impaired surface-induced arterial thrombosis.
Topics: Animals; Aorta; Arterial Occlusive Diseases; Arteries; Aspirin; Blood Coagulation; Blood Platelets; Dogs; Female; Fibrinogen; Heparin; Leukocyte Count; Male; Partial Thromboplastin Time; Platelet Count; Prostheses and Implants; Prothrombin Time; Thrombosis; Time Factors | 1981 |
[Investigation of the process of thrombus formation by nuclear medicine (author's transl)].
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Postoperative Complications; Thrombosis | 1980 |
Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis.
Topics: Animals; Antibodies, Monoclonal; Fibrinogen; Fibrinolytic Agents; Hemodynamics; Heparin; Macaca mulatta; Male; Mice; P-Selectin; Streptokinase; Thrombosis | 1995 |
Increase in fibrinogenemia in the postoperative period of open-heart surgery.
Topics: Acute-Phase Proteins; Coronary Artery Bypass; Female; Fibrinogen; Fibrinolysis; Heart Valve Prosthesis; Hemostasis; Humans; Male; Middle Aged; Platelet Count; Postoperative Complications; Postoperative Period; Thrombosis | 1993 |
Effect of dextran and enoxaparin on early ePTFE graft thrombogenicity in sheep.
Topics: Animals; Blood Vessel Prosthesis; Carotid Artery, Common; Dextrans; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Female; Fibrinogen; Graft Occlusion, Vascular; Male; Platelet Adhesiveness; Polygeline; Polytetrafluoroethylene; Radionuclide Imaging; Random Allocation; Sheep; Sodium Chloride; Thrombosis; Vascular Patency | 1995 |
Alterations in coagulation and fibrinolysis after surgery for aortic aneurysm.
Topics: Aged; alpha-2-Antiplasmin; alpha-Macroglobulins; Antifibrinolytic Agents; Antithrombin III; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Dissection; Blood Coagulation Tests; Cardiopulmonary Bypass; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Middle Aged; Peptide Hydrolases; Postoperative Complications; Reference Values; Risk Factors; Thrombosis | 1995 |
[Effects of lyophilized royal jelly on experimental hyperlipidemia and thrombosis].
Topics: Animals; Bees; Cholesterol; Cholesterol, HDL; Erythrocyte Deformability; Fatty Acids; Fibrinogen; Hyperlipidemias; Insect Hormones; Male; Rats; Rats, Sprague-Dawley; Thrombosis | 1995 |
The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis.
Topics: Binding Sites; Biopolymers; Calcium-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Fluorescence Polarization; Hemostasis; Humans; Protein Binding; Thrombosis | 1995 |
Fibrin polymerization defect in HIV-infected patients--evidence for a critical role of albumin in the prolongation of thrombin and reptilase clotting times.
Topics: Adult; Aged; Biopolymers; Disease Susceptibility; Female; Fibrin; Fibrinogen; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; Serum Albumin; Severity of Illness Index; Thrombin Time; Thrombosis | 1995 |
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
Topics: Aneurysm; Arteriosclerosis; Coronary Artery Disease; Extracellular Matrix; Extracellular Matrix Proteins; Fibrinogen; Hematoma; Humans; Lipids; Lipoproteins; Macrophages; Muscle, Smooth, Vascular; Thrombosis | 1995 |
Activation of human platelets by cocaine.
Topics: Blood Platelets; Cell Adhesion Molecules; Cocaine; Fibrinogen; Flow Cytometry; Humans; In Vitro Techniques; P-Selectin; Platelet Activation; Platelet Membrane Glycoproteins; Thrombosis | 1993 |
A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
Topics: alpha-2-Antiplasmin; Animals; Disease Models, Animal; Femoral Artery; Fibrinogen; Fibrinolysin; Guinea Pigs; Infusions, Intravenous; Male; Metalloendopeptidases; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1993 |
Differential thrombogenicity of artery and vein: the role of von Willebrand factor.
Topics: Animals; Arteries; Fibrinogen; Humans; Immunohistochemistry; In Vitro Techniques; Platelet Adhesiveness; Swine; Thrombosis; Veins; von Willebrand Factor | 1995 |
Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass.
Topics: Aged; Antifibrinolytic Agents; Antithrombins; Cardiopulmonary Bypass; Case-Control Studies; Chemical Precipitation; Cold Temperature; Equipment Failure; Factor VII; Factor VIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hot Temperature; Humans; Male; Middle Aged; Oxygenators, Membrane; Protein S; Thrombosis; von Willebrand Factor | 1995 |
Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis.
Topics: Aged; Factor V; Fibrinogen; Hemorrhage; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Partial Thromboplastin Time; Platelet Transfusion; Prothrombin Time; Reference Values; Thrombosis | 1995 |
Evaluation of the effects of esophageal varicosclerosants on local vascular occlusion and systemic blood coagulation.
Topics: Animals; Arteries; Blood Coagulation; Ear, External; Female; Fibrinogen; Ischemia; Kidney; Liver; Lung; Necrosis; Platelet Count; Prothrombin Time; Rabbits; Sclerosing Solutions; Sclerotherapy; Spleen; Thrombosis; Veins | 1995 |
SC-54684A: an orally active inhibitor of platelet aggregation.
Topics: Administration, Oral; Animals; Benzamides; Benzamidines; Biological Availability; Carbon Radioisotopes; Dogs; Fibrinogen; Humans; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Binding; Sensitivity and Specificity; Thrombosis | 1995 |
beta-Amyloid protein induces platelet aggregation and supports platelet adhesion.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Binding Sites; Fibrinogen; Humans; In Vitro Techniques; Macromolecular Substances; Membrane Glycoproteins; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Platelet Adhesiveness; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Thrombosis; Thrombospondins | 1994 |
Thrombelastographic patterns following abdominal aortic surgery.
Topics: Aged; Aged, 80 and over; Analgesia, Epidural; Anesthesia, General; Antithrombin III; Aorta, Abdominal; Aspirin; Blood Coagulation; Blood Loss, Surgical; Blood Transfusion; Factor VIII; Fibrinogen; Fluid Therapy; Humans; Middle Aged; Platelet Count; Thrombelastography; Thrombosis | 1994 |
Fibrin-specific fibrinolysis induced by recombinant staphylokinase.
Topics: Animals; Chromatography, Ion Exchange; Fibrin; Fibrinogen; Fibrinolysis; Humans; Iodine Radioisotopes; Jugular Veins; Male; Metalloendopeptidases; Plasminogen; Rabbits; Recombinant Proteins; Thrombosis; Tissue Plasminogen Activator | 1994 |
Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Coronary Thrombosis; Disease Models, Animal; Fibrinogen; Histamine; Rabbits; Thrombosis; Viper Venoms | 1995 |
Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Carbon Dioxide; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Forced Expiratory Volume; Heparin; Humans; Injections, Subcutaneous; Lung Diseases, Obstructive; Male; Oxygen; Partial Pressure; Peptide Fragments; Prothrombin; Smoking; Thrombin; Thrombosis | 1994 |
Antithrombotic effects of thrombolytic agents in a platelet-rich femoral vein thrombosis model in the hamster.
Topics: Animals; Blood Platelets; Cricetinae; Dose-Response Relationship, Drug; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Plasminogen Activators; Thrombosis; Time Factors | 1995 |
The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
Topics: Adsorption; Blood Coagulation Tests; Factor V; Factor VIII; Feedback; Fibrin; Fibrinogen; Humans; Platelet Activation; Reference Values; Thrombin; Thrombosis | 1994 |
Sex differences in platelet adherence to subendothelium: relationship to platelet function tests and hematologic variables.
Topics: Adult; Bleeding Time; Blood Platelets; Endothelium, Vascular; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Sex Factors; Thrombosis; Umbilical Arteries | 1995 |
Effect of geometric taper on thrombosis in vascular prostheses: an ex vivo study.
Topics: Animals; Blood Platelets; Blood Vessel Prosthesis; Blood Viscosity; Dogs; Fibrinogen; Indium Radioisotopes; Iodine Radioisotopes; Polyurethanes; Prosthesis Design; Surface Properties; Thrombosis | 1994 |
Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy.
Topics: Animals; Aspirin; Fibrinogen; Heparin; Hirudin Therapy; Partial Thromboplastin Time; Swine; Thrombin; Thrombosis | 1994 |
Evaluation of sensitivity and specificity of six D-dimer latex assays.
Topics: Enzyme-Linked Immunosorbent Assay; Evaluation Studies as Topic; Fibrin; Fibrinogen; Humans; Latex; Reagent Kits, Diagnostic; Sensitivity and Specificity; Thrombosis | 1994 |
Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation.
Topics: Blood Coagulation; Fibrin; Fibrinogen; Gels; Humans; Microscopy, Confocal; Thrombin; Thrombosis | 1994 |
Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets.
Topics: Animals; Aorta; Constriction, Pathologic; Coronary Thrombosis; Fibrinogen; Hemorheology; Models, Cardiovascular; Platelet Adhesiveness; Swine; Thrombosis; Time Factors; Tunica Media | 1994 |
[Changes in hemocoagulation during thrombolytic therapy of acute myocardial infarct in relation to risks of thrombotic complications].
Topics: Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Risk Factors; Thrombolytic Therapy; Thrombosis | 1994 |
Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.
Topics: Antibodies; Antibodies, Monoclonal; Blood Platelets; Cell Membrane; Cells, Cultured; Endothelium, Vascular; Fibrinogen; Humans; Immunoglobulin G; Immunohistochemistry; Ligands; Microscopy, Immunoelectron; Platelet Adhesiveness; Platelet Membrane Glycoproteins; Thrombosis; Umbilical Veins | 1994 |
Sensitivity of the fibrinogen clotting time: an in vitro test of potential thrombogenicity.
Topics: Antithrombin III; Benzamidines; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Fibrinogen; Heparin; Hirudins; Humans; Phenylalanine; Piperidines; Reproducibility of Results; Temperature; Thrombin; Thrombosis | 1994 |
Ultrasound accelerates urokinase-induced thrombolysis and reperfusion.
Topics: Analysis of Variance; Combined Modality Therapy; Fibrinogen; Humans; In Vitro Techniques; Models, Cardiovascular; Models, Structural; Myocardial Reperfusion; Plasminogen; Random Allocation; Temperature; Thrombolytic Therapy; Thrombosis; Time Factors; Ultrasonic Therapy; Urokinase-Type Plasminogen Activator | 1994 |
Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
Topics: Aerobiosis; Antithrombin III; Apolipoproteins; Apoprotein(a); Blood Coagulation; Diet; Dietary Carbohydrates; Factor VII; Factor X; Fibrinogen; Fibrinolysis; Humans; Lipoprotein(a); Male; Middle Aged; Oxygen Consumption; Physical Fitness; Plasminogen Activator Inhibitor 1; Thrombosis; Tissue Plasminogen Activator | 1994 |
[Antithrombotic and antiplatelet effects of rosmarinic acid, a water-soluble component isolated from radix Salviae miltiorrhizae (danshen)].
Topics: Animals; Blood Coagulation Tests; Cinnamates; Depsides; Female; Fibrinogen; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Rosmarinic Acid; Thrombosis; Venae Cavae | 1993 |
[Diagnostic tests of blood platelets in patients with platelet disorders].
Topics: Blood Platelets; Fibrinogen; Humans; Membrane Glycoproteins; Platelet Activation; Platelet Count; Thrombosis | 1993 |
Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis.
Topics: Animals; Arthropod Proteins; Bleeding Time; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Fibrinogen; Fibrinolytic Agents; Heparin; Intercellular Signaling Peptides and Proteins; Jugular Veins; Partial Thromboplastin Time; Peptides; Rabbits; Recombinant Proteins; Thrombosis; Ticks | 1993 |
Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting.
Topics: Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Humans; Macromolecular Substances; Peptide Fragments; Sequence Homology, Amino Acid; Thrombosis | 1993 |
The uptake of platelets, fibrinogen and leucocytes in ePTFE vascular grafts in relation to blood flow--an experimental study in sheep.
Topics: Animals; Blood Flow Velocity; Blood Platelets; Blood Vessel Prosthesis; Carotid Artery, Common; Female; Fibrinogen; Graft Occlusion, Vascular; Leukocytes; Male; Polytetrafluoroethylene; Radionuclide Imaging; Regional Blood Flow; Sheep; Thrombosis | 1993 |
Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
Topics: Adenosine Diphosphate; Adolescent; Adult; Angiotensin III; Arachidonic Acid; Biopsy; Blood Coagulation Factors; Blood Platelets; Collagen; Endothelium, Vascular; Erythrocyte Deformability; Extracellular Matrix; Female; Fibrin; Fibrinogen; Humans; In Vitro Techniques; Kidney; Male; Microscopy, Electron, Scanning; Middle Aged; Muscle, Smooth, Vascular; Nephrotic Syndrome; Platelet Adhesiveness; Platelet Aggregation; Thrombosis; Umbilical Arteries | 1994 |
Cold-induced increases in erythrocyte count, plasma cholesterol and plasma fibrinogen of elderly people without a comparable rise in protein C or factor X.
Topics: Adult; Aged; Aging; Body Temperature; Cholesterol; Cold Temperature; Erythrocyte Count; Factor X; Female; Fibrinogen; Humans; Male; Protein C; Thrombosis | 1994 |
Disordered hemostasis in extrahepatic portal hypertension.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Portal Vein; Thrombosis | 1993 |
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Platelets; Factor V; Factor VII; Fibrin; Fibrinogen; Fibrinopeptide A; Male; Papio; Partial Thromboplastin Time; Polyethylene Terephthalates; Protein C; Thrombin; Thrombosis | 1993 |
Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia.
Topics: Adult; Aged; Biopsy; Cryoglobulinemia; Cryoglobulins; Female; Fibrinogen; Fibrinogens, Abnormal; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Skin Ulcer; Stanozolol; Thrombosis | 1993 |
Combined effects of urokinase and heparin on PTT values during thrombolytic therapy.
Topics: Aged; Drug Therapy, Combination; Female; Fibrinogen; Hematoma; Hemorrhage; Heparin; Humans; Male; Middle Aged; Partial Thromboplastin Time; Retrospective Studies; Thrombolytic Therapy; Thrombosis; Urokinase-Type Plasminogen Activator | 1993 |
Scintigraphic methods for detecting vascular thrombus.
Topics: Antibodies, Monoclonal; Blood Platelets; Fibrin; Fibrinogen; Humans; Indium Radioisotopes; Peptides; Radioimmunodetection; Thrombosis | 1993 |
Fulminant cerebral infarctions with membranous nephropathy.
Topics: Adult; Cerebral Angiography; Cerebral Arteries; Cerebral Infarction; Female; Fibrinogen; Glomerulonephritis, Membranous; Humans; Ischemia; Protein S; Thrombosis | 1993 |
The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits.
Topics: Animals; Annexin A5; Blood Coagulation; Fibrin; Fibrinogen; Heparin; Jugular Veins; Rabbits; Thrombin; Thrombosis | 1993 |
Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.
Topics: Adult; Base Sequence; Blood Coagulation Disorders; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Gene Amplification; Humans; Immunoblotting; Male; Microscopy, Electron; Molecular Sequence Data; Mutation; Platelet Membrane Glycoproteins; Protein Binding; Sequence Analysis, DNA; Structure-Activity Relationship; Sulfhydryl Compounds; Thrombosis; Thrombospondins | 1993 |
Recombinant pro-urokinase requires heparin for optimal clot lysis and restoration of blood flow in a canine femoral artery thrombosis model.
Topics: alpha-2-Antiplasmin; Animals; Dogs; Drug Synergism; Femoral Artery; Fibrinogen; Heparin; Hindlimb; Male; Partial Thromboplastin Time; Plasminogen; Recombinant Proteins; Thrombolytic Therapy; Thrombosis; Urokinase-Type Plasminogen Activator | 1993 |
Assessments of thrombogenicity by three in vitro techniques. Student Research Award in the Undergraduate, Master Candidate, or Health Science Degree Candidate Category, 21st annual meeting of the Society for Biomaterials, San Francisco, CA, March 18-22, 1
Topics: Awards and Prizes; Biocompatible Materials; Blood; Blood Vessel Prosthesis; Fibrinogen; Fibrinopeptide A; Heparin; Humans; In Vitro Techniques; Polyethylene Glycols; Polytetrafluoroethylene; Stress, Mechanical; Thrombin; Thrombosis; Time Factors; Viscosity | 1995 |
A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
Topics: Acetates; Amino Acid Sequence; Antibodies, Monoclonal; Cross-Linking Reagents; Factor XIII; Fibrin; Fibrinogen; Humans; Molecular Sequence Data; Peptide Fragments; Solubility; Thrombosis; Urea | 1995 |
Platelet activation and thrombosis: studies in a patient with essential thrombocythemia.
Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Blood Platelets; Disease Susceptibility; Female; Fibrinogen; Flow Cytometry; Humans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Portal Vein; Receptors, Purinergic P2; Splenic Vein; Thrombocythemia, Essential; Thrombosis; Ticlopidine | 1996 |
Pooled patient samples as reference material for D-Dimer.
Topics: Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Reference Values; Thrombosis | 1995 |
Thrombolytic therapy for acute deep venous thrombosis: how much is enough?
Topics: Acute Disease; Femoral Vein; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorheology; Hemorrhage; Humans; Iliac Vein; Injections, Intravenous; Monitoring, Physiologic; Partial Thromboplastin Time; Popliteal Vein; Prospective Studies; Remission Induction; Streptokinase; Thrombin Time; Thrombolytic Therapy; Thrombophlebitis; Thrombosis; Time Factors; Ultrasonography, Doppler, Duplex; Urokinase-Type Plasminogen Activator | 1996 |
Platelet-derived microparticles associate with fibrin during thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Biomarkers; Blood Coagulation; Blood Platelets; Calcimycin; Calcium; Collagen; Fibrin; Fibrinogen; Humans; Ionophores; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Molecular Sequence Data; Oligopeptides; P-Selectin; Perfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Thrombosis; von Willebrand Factor | 1996 |
Thrombotic vascular risk factors in inflammatory bowel disease.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Factor VII; Female; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Risk Factors; Smoking; Thrombosis; Triglycerides | 1996 |
Arterial thrombosis enhanced by an acute phase response.
Topics: Acute-Phase Reaction; Animals; Fibrinogen; Male; Rats; Rats, Sprague-Dawley; Thrombosis; Time Factors; Turpentine | 1996 |
Fish oil may be an antidote for the cardiovascular risk of smoking.
Topics: Antidotes; Arrhythmias, Cardiac; Arteriosclerosis; Blood Viscosity; Cardiovascular Diseases; Fibrinogen; Fish Oils; Humans; Models, Biological; Nicotine; Risk Factors; Smoking; Thrombosis; Vasoconstriction | 1996 |
Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
Topics: Adult; Aged; Biomarkers; Female; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Pregnancy; Protein C; Protein S; Thrombosis | 1996 |
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.
Topics: Animals; Anticoagulants; Electric Stimulation; Factor Xa Inhibitors; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Ligation; Male; Oligosaccharides; Rabbits; Rats; Rats, Wistar; Thrombin; Thromboplastin; Thrombosis; Tissue Plasminogen Activator; Venae Cavae | 1996 |
Sensitivity of experimental venous and arterial thrombosis and bleeding to ancrod-induced defibrinogenation.
Topics: Ancrod; Animals; Blood Flow Velocity; Carotid Arteries; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Male; Rats; Rats, Sprague-Dawley; Thrombosis; Vena Cava, Inferior | 1996 |
Monoclonal antibody directed to a fibrinogen A alpha #529-539 epitope inhibits alpha-chain crosslinking by transglutaminases.
Topics: Animals; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Cyanogen Bromide; Epitope Mapping; Fibrinogen; Macromolecular Substances; Mice; Mice, Inbred BALB C; Peptide Fragments; Peptide Mapping; Thrombosis; Transglutaminases | 1996 |
Thrombotic markers during myocardial infarction.
Topics: Adult; Biomarkers; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Thrombosis | 1995 |
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.
Topics: Adult; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Leukocyte Count; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Thrombosis | 1996 |
Preincubation of Dacron grafts with recombinant tissue factor pathway inhibitor decreases their thrombogenicity in vivo.
Topics: Animals; Blood Platelets; Blood Vessel Prosthesis; Drug Evaluation, Preclinical; Femoral Artery; Fibrinogen; Fibrinolytic Agents; Indium Radioisotopes; Lipoproteins; Platelet Transfusion; Polyethylene Terephthalates; Radionuclide Imaging; Recombinant Proteins; Swine; Thrombosis | 1996 |
Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions.
Topics: CD18 Antigens; Cell Adhesion; Endothelium, Vascular; Extracellular Matrix; Fibrin; Fibrinogen; Hemorheology; Humans; Macrophage-1 Antigen; Neutrophils; Platelet Adhesiveness; Surface Properties; Thrombosis | 1997 |
Non-traditional risk factors for atherosclerosis in high risk children.
Topics: Adolescent; Adult; Arteriosclerosis; Autonomic Nervous System Diseases; Case-Control Studies; Child; Electrocardiography, Ambulatory; Female; Fibrinogen; Humans; Hyperinsulinism; Hyperlipoproteinemias; Hypertrophy, Left Ventricular; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombosis | 1996 |
Antithrombotic effect in vivo of thrombotic substances adsorbed on a platinum surface.
Topics: Adenosine Diphosphate; Adsorption; Albumins; Animals; Arachidonic Acid; Biocompatible Materials; Catheterization; Collagen; Female; Fibrinogen; Male; Platelet Activation; Platinum; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Surface Properties; Thrombin; Thrombosis; Venae Cavae | 1996 |
Fibrinogen and leukocyte activation-the keys to understanding prosthetic valve thrombosis?
Topics: Aged; Colitis, Ulcerative; Diabetes Complications; Female; Fibrinogen; Heart Valve Prosthesis; Humans; Hypertriglyceridemia; Leukocytes; Obesity; Thrombosis | 1997 |
Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Aged; Blood Coagulation; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Thrombosis | 1997 |
Acute thrombogenicity of intact and injured natural blood conduits versus synthetic conduits: neutrophil, platelet, and fibrin(ogen) adsorption under various shear-rate conditions.
Topics: Adsorption; Animals; Arteries; Bioprosthesis; Blood Platelets; Blood Vessel Prosthesis; Endothelium, Vascular; Fibrinogen; Microscopy, Electron, Scanning; Neutrophils; Polytetrafluoroethylene; Rheology; Surface Properties; Swine; Thrombosis | 1997 |
Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Platelets; Femoral Artery; Femoral Vein; Fibrin; Fibrinogen; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Papio; Recombinant Proteins; Thrombin; Thrombosis | 1997 |
Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography.
Topics: Adolescent; Adult; Aged; Antithrombin III; Autoantigens; Blood Coagulation Disorders; Cholangitis, Sclerosing; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Male; Middle Aged; Phenotype; Platelet Count; Protein C; Protein S; Prothrombin Time; Risk Factors; Thrombelastography; Thrombosis | 1997 |
Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery.
Topics: Actins; Angioplasty, Balloon; Animals; Carotid Arteries; Fibrinogen; Immunohistochemistry; Male; Muscle, Smooth, Vascular; Platelet Endothelial Cell Adhesion Molecule-1; Rabbits; Thrombosis; Time Factors; Tunica Intima; von Willebrand Factor | 1997 |
Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.
Topics: Animals; Fibrin; Fibrinogen; Hypoxia; Lung; Mice; Monocytes; Neutrophils; Thromboplastin; Thrombosis | 1997 |
Hemostatic profile in nephrotic syndrome.
Topics: Antithrombin III; Blood Coagulation; Case-Control Studies; Child; Child, Preschool; Drug Resistance; Female; Fibrinogen; Hemostasis; Humans; Infant; Kidney; Liver; Male; Nephrotic Syndrome; Partial Thromboplastin Time; Protein C; Protein S; Proteinuria; Prothrombin Time; Remission Induction; Renal Veins; Serum Albumin; Steroids; Thrombin Time; Thrombocytosis; Thromboembolism; Thrombosis; Ultrasonography; Vena Cava, Inferior | 1996 |
Erythropoietin potentiates thrombus development in a canine arterio-venous shunt model.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Platelets; Dogs; Erythrocyte Count; Erythropoietin; Fibrin; Fibrinogen; Humans; Platelet Count; Recombinant Proteins; Thrombosis; Time Factors | 1997 |
Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
Topics: alpha-Macroglobulins; Animals; Biomarkers; Cell Line; Dogs; Drug Administration Schedule; Femoral Artery; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemostasis; Hot Temperature; Infusions, Intravenous; Injections, Intravenous; Male; Mice; Plasmacytoma; Plasminogen; Recombinant Proteins; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1997 |
Experimental studies on three types of heparin-coated cardiopulmonary bypass circuits.
Topics: Anticoagulants; Antithrombin III; Binding Sites; Biocompatible Materials; Cardiopulmonary Bypass; Complement C3a; Complement C4a; Fibrinogen; Heparin; Humans; In Vitro Techniques; Peptide Hydrolases; Platelet Count; Thioguanine; Thrombosis | 1997 |
Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.
Topics: Adult; Aged; Aging; Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Estrogen Replacement Therapy; Factor IX; Factor VII; Female; Fibrinogen; Health Surveys; Humans; Male; Middle Aged; Protein C; Protein S; Reference Values; Scotland; Sex Characteristics; Thrombosis | 1997 |
Surface studies of albumin immobilized onto PE and PVC films.
Topics: Acrylates; Adsorption; Animals; Binding Sites; Biocompatible Materials; Blood Coagulation; Blood Platelets; Cattle; Drug Carriers; Fibrinogen; Humans; In Vitro Techniques; Microscopy, Electron, Scanning; Molecular Weight; Platelet Activation; Platelet Adhesiveness; Polyethylenes; Polyvinyl Chloride; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared; Thrombosis | 1997 |
Platelet activation in flowing blood passing growing arterial thrombi.
Topics: Adult; Antigens, CD; Blood Coagulation; Blood Flow Velocity; Blood Platelets; Cell Degranulation; Exocytosis; Fibrinogen; Humans; Immunologic Techniques; Lysosomes; Male; Models, Biological; P-Selectin; Platelet Activation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Rheology; Tetraspanin 30; Thrombosis | 1997 |
Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
Topics: Antioxidants; Ascorbic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Peptide Fragments; Predictive Value of Tests; Protein Precursors; Prothrombin; Reference Values; Regression Analysis; Risk Factors; Thrombosis; Uric Acid; Vitamin A; Vitamin E | 1997 |
The in vitro and in vivo pharmacological profiles of a platelet glycoprotein IIb/IIIa antagonist, NSL-9403.
Topics: Adenosine Diphosphate; Animals; Bleeding Time; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Femoral Artery; Fibrinogen; Humans; Male; Mice; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Embolism; Thrombosis | 1997 |
Disseminated intravascular coagulation in chickens inoculated with Erysipelothrix rhusiopathiae.
Topics: Animals; Blood Coagulation; Chickens; Disseminated Intravascular Coagulation; Erysipelothrix; Erysipelothrix Infections; Fibrinogen; Injections, Intramuscular; Kidney Diseases; Liver Diseases; Lung Diseases; Partial Thromboplastin Time; Prothrombin Time; Thrombosis | 1997 |
Effects of long-term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation.
Topics: Anemia; Antithrombin III; Blood Coagulation; Catheters, Indwelling; Complement C4b; Erythropoietin; Female; Fibrinogen; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Partial Thromboplastin Time; Plasminogen; Protein C; Protein S; Prothrombin Time; Recombinant Proteins; Renal Dialysis; Thrombosis; Treatment Outcome | 1997 |
Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis.
Topics: Adolescent; Adult; Aged; Antibodies, Anticardiolipin; beta-Thromboglobulin; Blood Platelets; Blood Proteins; Blotting, Western; Complement C3; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Phosphates; Phosphorylation; Platelet Activation; Protein Kinases; Thrombosis; Vitronectin | 1997 |
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
Topics: Adult; Aged; Black People; Blood Pressure; Blood Viscosity; Cross-Sectional Studies; Echocardiography; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemoglobins; Hemorheology; Humans; Hypertension; Hypertrophy, Left Ventricular; India; Lipoprotein(a); Male; Middle Aged; Myocardial Ischemia; P-Selectin; Plasminogen Inactivators; Racial Groups; Risk Factors; Thrombosis; von Willebrand Factor; White People | 1997 |
Electrospray ionisation mass spectrometry facilitates detection of fibrinogen (Bbeta 14 Arg --> Cys) mutation in a family with thrombosis.
Topics: Adult; Amino Acid Substitution; Arginine; Catalysis; Cysteine; Family Health; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Glycoproteins; Heterozygote; Humans; Mass Spectrometry; Molecular Weight; Mutation; Point Mutation; Polymerase Chain Reaction; Sequence Analysis; Thrombin; Thrombosis | 1997 |
Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions.
Topics: Blood Circulation; Fibrinogen; Humans; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; von Willebrand Factor | 1998 |
Inhibitory effect of piracetam on platelet-rich thrombus formation in an animal model.
Topics: Animals; Bleeding Time; Cricetinae; Disease Models, Animal; Fibrinogen; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Piracetam; Platelet Aggregation Inhibitors; Platelet Count; Protein Binding; Rats; Thrombosis | 1998 |
Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli.
Topics: Animals; Binding Sites; Blood Coagulation; Capillaries; Escherichia coli Infections; Factor VIIa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-6; Interleukin-8; Interleukins; Kidney Glomerulus; Kinetics; Papio; Platelet Count; Thrombosis; Tumor Necrosis Factor-alpha | 1998 |
Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits.
Topics: Animals; Disease Models, Animal; Endotoxins; Fibrinogen; Hematocrit; Hemoglobins; Leukocyte Count; Meningococcal Infections; Platelet Count; Protein C; Prothrombin; Rabbits; Shock, Septic; Survival; Thrombosis | 1998 |
The differential involvement of von Willebrand factor, fibrinogen and fibronectin in acute experimental thrombosis in rat cerebral and mesenteric microvessels.
Topics: Adhesiveness; Animals; Antibodies; Arterioles; Binding, Competitive; Brain; Collagen; Endothelium, Vascular; Erythrocytes; Fibrinogen; Fibronectins; Male; Mesentery; Microcirculation; Microscopy, Electron; Platelet Aggregation; Rats; Rats, Wistar; Stress, Mechanical; Thrombosis; Venules; von Willebrand Factor | 1997 |
Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation.
Topics: Adult; Arteriosclerosis; Biomarkers; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heart Transplantation; Hemostasis; Humans; Male; Middle Aged; Risk Factors; Thrombosis | 1997 |
Blood rheology in patients with native heart valve disease and after valve replacement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Viscosity; Echocardiography; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Postoperative Complications; Thrombosis | 1998 |
Thrombogenicity of heparin and non-heparin bound arterial prostheses: an in vitro evaluation.
Topics: Anticoagulants; Arteries; Biocompatible Materials; Blood Coagulation; Blood Vessel Prosthesis; Equipment Failure; Evaluation Studies as Topic; Fibrin; Fibrinogen; Graft Occlusion, Vascular; Heparin; Humans; In Vitro Techniques; Materials Testing; Microscopy, Electron, Scanning; Polyethylene Terephthalates; Polytetrafluoroethylene; Reference Values; Surface Properties; Thrombosis | 1998 |
Fibrinogen as a factor of thrombosis: experimental study.
Topics: Adenosine Diphosphate; Animals; Disease Models, Animal; Fibrinogen; Humans; In Vitro Techniques; Male; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Risk Factors; Thromboembolism; Thrombophlebitis; Thrombosis | 1998 |
Docosahexaenoic acid inhibits blood viscosity in stroke-prone spontaneously hypertensive rats.
Topics: Aging; Animals; Antihypertensive Agents; Blood Pressure; Blood Viscosity; Cerebrovascular Disorders; Docosahexaenoic Acids; Fibrinogen; Hematocrit; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thrombosis | 1998 |
Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot study.
Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Case-Control Studies; Female; Fibrinogen; Flow Cytometry; Fluorescent Dyes; Graft Survival; Humans; In Vitro Techniques; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Quinacrine; Thrombosis; Transplantation Conditioning | 1998 |
Platelet thrombus formation in microvessels of young spontaneously hypertensive rats.
Topics: Analysis of Variance; Animals; Blood Pressure; Blood Viscosity; Fibrinogen; Fibronectins; Hypertension; Male; Microcirculation; Platelet Adhesiveness; Rats; Rats, Inbred SHR; Thrombosis; von Willebrand Factor | 1998 |
Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol.
Topics: Adsorption; Biocompatible Materials; Collagen; Fibrinogen; Heart Diseases; Humans; Isocyanates; Platelet Adhesiveness; Polyethylene Glycols; Polyethylene Terephthalates; Proteins; Thrombosis | 1998 |
Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
Topics: Albumins; Animals; Blood Platelets; Blood Substitutes; Capsules; Disease Models, Animal; Fibrinogen; Hemorrhage; Humans; Rabbits; Thrombocytopenia; Thrombosis; Time Factors | 1999 |
Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol.
Topics: Adsorption; Blood Proteins; Blood Vessel Prosthesis; Coated Materials, Biocompatible; Collagen; Fibrinogen; Humans; Isocyanates; Platelet Adhesiveness; Polyethylene Glycols; Polyethylene Terephthalates; Thrombosis | 1999 |
Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis.
Topics: Animals; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fibrinogen; Fibrinolytic Agents; Male; Platelet Count; Rats; Rats, Wistar; Thrombosis; Venous Thrombosis | 1999 |
Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
Topics: Adolescent; Adult; Blood Coagulation; Cholesterol, LDL; Contraceptives, Oral, Combined; Down-Regulation; Factor VIIa; Female; Fibrinogen; Fibrinolytic Agents; Humans; Lipoproteins; Middle Aged; Peptide Fragments; Protein Precursors; Prothrombin; Thrombosis; von Willebrand Factor | 1999 |
Thrombus deposition on polyurethanes designed for biomedical applications.
Topics: Animals; Blood Platelets; Dogs; Fibrinogen; Materials Testing; Polyurethanes; Spectrum Analysis; Surface Properties; Thrombosis | 1992 |
Introducers and protective sleeves may increase thrombogenicity of pulmonary artery catheters.
Topics: Animals; Catheterization, Swan-Ganz; Chlorocebus aethiops; Equipment Design; Female; Femoral Vein; Fibrinogen; Hematocrit; Incidence; Macaca mulatta; Male; Microscopy, Electron; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Surface Properties; Thrombosis; Venous Cutdown | 1999 |
Thrombogenic factors and recurrent coronary events.
Topics: Adult; Aged; Factor VII; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Insulin; Lipids; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Prospective Studies; Recurrence; Risk Factors; Thrombosis; von Willebrand Factor | 1999 |
Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding.
Topics: Adult; Blood Platelets; Female; Fibrinogen; Flow Cytometry; Genotype; Heterozygote; Homozygote; Humans; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Risk Factors; Thrombosis | 1999 |
Surface-dependent conformations of human fibrinogen observed by atomic force microscopy under aqueous conditions.
Topics: Computer Simulation; Fibrinogen; Hemostasis; Humans; Image Processing, Computer-Assisted; In Vitro Techniques; Microscopy, Atomic Force; Models, Molecular; Protein Conformation; Surface Properties; Thrombosis; Water | 1999 |
Relation between atrial coagulation activity and levels of coagulation markers in peripheral samples.
Topics: Atrial Fibrillation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Atria; Humans; Mitral Valve Stenosis; Predictive Value of Tests; Thrombin; Thrombosis | 1999 |
Surface-immobilized biomolecules on albumin modified porcine pericardium for preventing thrombosis and calcification.
Topics: Albumins; Alprostadil; Animals; Biocompatible Materials; Calcinosis; Cardiomyopathies; Culture Techniques; Enzyme-Linked Immunosorbent Assay; Epoprostenol; Fibrinogen; Heparin; Humans; Materials Testing; Pericardium; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Probability; Surface Properties; Swine; Thrombosis | 1999 |
Left ventricular hypertrophy and its regression: the prothrombic state in hypertension may be involved in its pathophysiology and altered by therapy.
Topics: Blood Viscosity; Fibrinogen; Humans; Hypertension; Hypertrophy, Left Ventricular; Thrombosis | 1999 |
Fradafiban. BIBU 52, BIBU 52 ZW.
Topics: Animals; Biphenyl Compounds; Callithrix; Fibrinogen; Guinea Pigs; Humans; In Vitro Techniques; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Swine; Thrombosis | 1999 |
Surface modification with PEO-containing triblock copolymer for improved biocompatibility: in vitro and ex vivo studies.
Topics: Adsorption; Animals; Arteriovenous Shunt, Surgical; Biocompatible Materials; Carotid Arteries; Chemical Phenomena; Chemistry, Physical; Coated Materials, Biocompatible; Dimethylpolysiloxanes; Dogs; Epoxy Compounds; Fibrinogen; Gamma Rays; Glass; Jugular Veins; Materials Testing; Molecular Weight; Platelet Adhesiveness; Polyethylene; Polyethylenes; Polymers; Polytetrafluoroethylene; Silicones; Surface Properties; Thrombosis | 1999 |
Increased adsorption of high molecular weight kininogen to heparin-coated artificial surfaces and correlation to hemocompatibility.
Topics: Adsorption; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Heparin; Histocompatibility; Humans; Kininogen, High-Molecular-Weight; Thrombosis | 1999 |
Soluble fibrin species in arterial thrombi.
Topics: Aged; Antibodies, Monoclonal; Arteries; Blotting, Western; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Molecular Weight; Oxidation-Reduction; Protein Structure, Quaternary; Solubility; Thrombosis | 2000 |
Fibrinogen Bbeta14 Arg-->Cys: further evidence for a role in thrombosis.
Topics: Adult; Arginine; Cysteine; Female; Fibrinogen; Humans; Male; Point Mutation; Thrombosis | 1999 |
Adjuvant effect of antibodies against von Willebrand Factor, fibrinogen, and fibronectin on staphylokinase-induced thrombolysis as measured using mural thrombi formed in rat mesenteric venules.
Topics: Adjuvants, Immunologic; Animals; Blood Pressure; Fibrinogen; Fibrinolytic Agents; Fibronectins; Heart Diseases; Immune Sera; Immunoglobulin G; Male; Mesenteric Veins; Metalloendopeptidases; Plasminogen Activators; Rats; Rats, Wistar; Thrombolytic Therapy; Thrombosis; von Willebrand Factor | 2000 |
Inhibition of platelet thrombosis using an activated protein C-loaded stent: in vitro and in vivo results.
Topics: Adsorption; Animals; Catheterization; Disease Models, Animal; Fibrin; Fibrinogen; Humans; Iliac Artery; In Vitro Techniques; Kinetics; Partial Thromboplastin Time; Platelet Aggregation; Protein C; Rabbits; Stents; Thrombosis | 2000 |
Thrombophilic factors in patients with Syndrome X.
Topics: Activated Protein C Resistance; Antithrombin III; Blood Coagulation Factors; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Male; Microvascular Angina; Middle Aged; Plasminogen; Plasminogen Activator Inhibitor 1; Protein C; Protein S; Risk Factors; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2000 |
Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant?
Topics: Acute-Phase Proteins; Adolescent; Adult; Aging; Blood Sedimentation; C-Reactive Protein; Female; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Thrombosis | 2000 |
Elevation of plasma fibrinogen in silent myocardial ischaemia.
Topics: Adult; Arteriosclerosis; Case-Control Studies; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Risk Factors; Thrombosis | 1999 |
Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury.
Topics: Adenosine Diphosphate; Animals; Arteries; Blood Coagulation Tests; Blood Flow Velocity; Collagen; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hematologic Tests; Heparin; Heparin, Low-Molecular-Weight; Perfusion; Platelet Aggregation; Platelet Function Tests; Swine; Thrombosis | 2000 |
Fibrinogen bellingham: a gamma-chain R275C substitution and a beta-promoter polymorphism in a thrombotic member of an asymptomatic family.
Topics: Adult; Aged; Alleles; Amino Acid Substitution; Female; Fibrinogen; Humans; Male; Middle Aged; Pedigree; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Thrombosis | 2000 |
Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.
Topics: Afibrinogenemia; Animals; Arterioles; Blood Platelets; Female; Fibrinogen; Fibronectins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Adhesiveness; Platelet Aggregation; Thrombosis; von Willebrand Diseases; von Willebrand Factor | 2000 |
Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters.
Topics: Animals; Arteriosclerosis; Diet, Atherogenic; Ferritins; Fibrinogen; Hematocrit; Hemostasis; Hypercholesterolemia; Leukocyte Count; Rabbits; Risk Factors; Thrombomodulin; Thrombosis; Triglycerides; Tunica Intima; von Willebrand Factor | 2000 |
Dietary fish oil reduces microvascular thrombosis in a porcine experimental model.
Topics: Animals; Bleeding Time; Dietary Fats, Unsaturated; Disease Models, Animal; Fatty Acids, Omega-3; Fibrinogen; Fish Oils; Microcirculation; Platelet Count; Reperfusion Injury; Swine; Thrombosis; Thromboxane B2 | 2000 |
Quality assessment of heparin coatings by their binding capacities of coagulation and complement enzymes.
Topics: Adsorption; Anticoagulants; Antithrombin III; Antithrombins; beta-Thromboglobulin; Blood Coagulation Factors; Coated Materials, Biocompatible; Complement Activation; Complement C1 Inactivator Proteins; Complement C3; Complement System Proteins; Cysteine Proteinase Inhibitors; Fibrinogen; Granulocytes; Heparin; Humans; Kininogens; Leukocyte Elastase; Materials Testing; Peptide Fragments; Peptide Hydrolases; Platelet Activation; Protein Binding; Prothrombin; Sensitivity and Specificity; Solubility; Statistics, Nonparametric; Thrombin; Thrombosis | 2000 |
Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Disease Models, Animal; Fibrinogen; Lasers; Male; Partial Thromboplastin Time; Platelet Aggregation; Rats; Rats, Wistar; Thrombosis | 2000 |
Is avoidance of air contact necessary for the in vitro evaluation of thrombogenicity in mechanical circulatory assist devices?
Topics: Air; Anticoagulants; Assisted Circulation; Blood; Blood Coagulation; Equipment Design; Factor VIII; Factor XII; Fibrinogen; Hematocrit; Hemoglobins; Heparin; Humans; Platelet Count; Reproducibility of Results; Thrombosis; Thromboxane B2; Whole Blood Coagulation Time | 2000 |
Anti-human von willebrand factor monoclonal antibody AJvW-2 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs.
Topics: Angioplasty, Balloon; Animals; Antibodies, Monoclonal; Carotid Artery Injuries; Cell Division; Cells, Cultured; Fibrinogen; Guinea Pigs; Immunohistochemistry; Male; Models, Animal; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Thrombosis; Time Factors; Tunica Intima; von Willebrand Factor | 2000 |
Activation of thrombosis and fibrinolysis following brain infarction.
Topics: Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Brain Infarction; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinopeptide A; Humans; Male; Risk Factors; Thrombin; Thrombosis | 2000 |
The incidence of thrombovenous and thromboembolic complications in kidney transplant patients with recurrent glomerulonephritis is dependent on the occurrence of severe proteinuria.
Topics: Adult; Antithrombins; Female; Fibrinogen; Glomerulonephritis; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Proteinuria; Recurrence; Thromboembolism; Thrombosis; Transplantation, Homologous | 2000 |
Target organ damage and the prothrombotic state in hypertension.
Topics: Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Fibrinogen; Humans; Hypertension; Thrombosis | 2000 |
Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality.
Topics: Animals; Bacterial Infections; Biomarkers; Blood Coagulation Disorders; Bone Marrow; Bone Marrow Diseases; Disease Susceptibility; Drug Evaluation, Preclinical; Endotoxemia; Fibrinogen; Fibrinolysis; Hemorrhage; Immunologic Deficiency Syndromes; Leukocyte Count; Male; Mice; Mice, Inbred C57BL; Neutrophils; Platelet Activation; Platelet Count; Radiation Injuries, Experimental; Recombinant Proteins; RNA, Messenger; Thrombopoietin; Thrombosis; Whole-Body Irradiation | 2001 |
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice.
Topics: Animals; Antibodies, Monoclonal; Bleeding Time; Blood Platelets; C-Reactive Protein; Collagen; Fibrinogen; Integrins; Mice; Platelet Membrane Glycoproteins; Receptors, Collagen; Thrombosis | 2001 |
Endothelial cell protein C receptor plays an important role in protein C activation in vivo.
Topics: Animals; Antibodies, Monoclonal; Anticoagulants; Blood Coagulation Factors; Cattle; Enzyme Activation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Papio; Partial Thromboplastin Time; Protein C; Receptors, Cell Surface; Thrombin; Thrombosis; Time Factors | 2001 |
In vitro and in vivo studies of PEO-grafted blood-contacting cardiovascular prostheses.
Topics: Adsorption; Animals; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Coated Materials, Biocompatible; Dogs; Fibrinogen; Heart Valve Prosthesis; Platelet Activation; Polyethylene Glycols; Prostheses and Implants; Stents; Surface Properties; Swine; Thrombosis | 2000 |
Antithrombogenic polymer alloy composed of 2-methacryloyloxyethyl phosphorylcholine polymer and segmented polyurethane.
Topics: Adsorption; Animals; Arteries; Blood Vessel Prosthesis; Fibrinogen; Fibrinolytic Agents; Methacrylates; Models, Animal; Phosphorylcholine; Platelet Adhesiveness; Polymers; Polyurethanes; Rabbits; Surface Properties; Thrombosis | 2000 |
Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
Topics: Animals; Bandages; Blood Coagulation Disorders; Blood Pressure; Combined Modality Therapy; Disease Models, Animal; Drug Evaluation, Preclinical; Exchange Transfusion, Whole Blood; Factor VII; Factor VIIa; Fibrinogen; Hemorrhage; Hypothermia, Induced; Isotonic Solutions; Liver; Partial Thromboplastin Time; Prothrombin Time; Random Allocation; Recombinant Proteins; Resuscitation; Ringer's Lactate; Single-Blind Method; Survival Analysis; Swine; Thrombosis; Time Factors; Wounds and Injuries | 2001 |
A new model for in vitro clot formation that considers the mode of the fibrin(ogen) contacts to platelets and the arrangement of the platelet cytoskeleton.
Topics: Blood Platelets; Cytoskeleton; Fibrin; Fibrinogen; Humans; In Vitro Techniques; Models, Biological; Myosins; Platelet Aggregation; Thrombosis | 2001 |
Fibrinogen: a vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cells.
Topics: Arteriosclerosis; Endothelium, Vascular; Fibrinogen; Fibrinolysis; Hepatocytes; Humans; Oncostatin M; Peptides; Risk Factors; Thrombosis | 2001 |
[Disseminated intravessel blood coagulation in blood vessel trauma].
Topics: Adolescent; Adult; Aged; Blood Coagulation; Blood Vessels; Fibrinogen; Humans; Immunodiffusion; Middle Aged; Thrombosis | 2001 |
Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Hemorrhage; Humans; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasms; Thrombocytopenia; Thrombosis | 2001 |
Activation of coagulation and fibrinolysis in microsurgical reconstructions in the lower extremities.
Topics: Adult; Aged; Analysis of Variance; Blood Coagulation; C-Reactive Protein; Dalteparin; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Heparin, Low-Molecular-Weight; Humans; Male; Microsurgery; Middle Aged; Plasminogen Activator Inhibitor 1; Reoperation; Statistics, Nonparametric; Surgical Flaps; Thrombin; Thrombosis; Treatment Outcome | 2001 |
Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonist.
Topics: Animals; Biological Availability; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrinogen; Guinea Pigs; Humans; Inhibitory Concentration 50; Nipecotic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Pyridines; Rats; Thrombosis | 2001 |
Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Cholesterol; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Recurrence; Risk Factors; Stents; Thrombosis | 2000 |
Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
Topics: Acute-Phase Proteins; alpha-2-Antiplasmin; Antifibrinolytic Agents; Arteriosclerosis; Blood Coagulation; Blood Preservation; Blood Proteins; C-Reactive Protein; Cryopreservation; Factor VII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Inflammation Mediators; Least-Squares Analysis; Plasminogen Activator Inhibitor 1; Protein C; Protein Denaturation; Protein S; Reproducibility of Results; Risk Factors; Thrombosis; Time Factors; Tissue Plasminogen Activator | 2001 |
Fluorinated surface-modifying macromolecules: modulating adhesive protein and platelet interactions on a polyether-urethane.
Topics: Adsorption; Biocompatible Materials; Blood Platelets; Blood Proteins; Blotting, Western; Chromium Radioisotopes; Fibrinogen; Fibronectins; Fluorocarbon Polymers; Humans; Immunoassay; In Vitro Techniques; Microscopy, Electron, Scanning; Platelet Adhesiveness; Polyurethanes; Protein Binding; Surface Properties; Thrombosis; Vitronectin | 2002 |
[Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
Topics: Adolescent; Adult; Alleles; Capillaries; Confidence Intervals; Female; Fibrinogen; Gene Dosage; Humans; Kidney Glomerulus; Lupus Nephritis; Male; Middle Aged; Odds Ratio; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Thrombosis | 2002 |
[The significance of thrombosis after experimental pulmonary thromboembolism].
Topics: Animals; Disease Models, Animal; Endothelins; Female; Fibrinogen; Lung; Male; Prothrombin Time; Pulmonary Embolism; Rabbits; Thrombosis; Thromboxane A2 | 2001 |
[Indicators of plaque stability].
Topics: Acute Disease; Adult; Angina, Unstable; C-Reactive Protein; Chest Pain; Clinical Trials as Topic; Coronary Angiography; Electrocardiography; Fibrinogen; Humans; Interleukin-6; Magnetic Resonance Angiography; Myocardial Infarction; Myocardial Ischemia; Prognosis; Risk Assessment; Risk Factors; Syndrome; Thrombolytic Therapy; Thrombosis; Time Factors; Tomography, X-Ray Computed; Troponin T; Tumor Necrosis Factor-alpha | 2002 |
Antithrombogenic investigation of surface energy and optical bandgap and hemocompatibility mechanism of Ti(Ta(+5))O2 thin films.
Topics: Animals; Biocompatible Materials; Blood; Blood Platelets; Dogs; Fibrinogen; Mathematics; Rabbits; Solvents; Surface Properties; Tantalum; Thrombosis; Titanium | 2002 |
Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model.
Topics: Animals; Antibodies; Arteriosclerosis; Contrast Media; Dogs; Echocardiography; Fibrinogen; Heart Diseases; Heart Ventricles; Injections, Intravenous; Kinetics; Liposomes; Microscopy, Fluorescence; Observer Variation; Pericardium; Thorax; Thrombosis | 2002 |
Elevated fibrinogen and homocysteine levels enhance the risk of mortality in patients from a high-risk preventive cardiology clinic.
Topics: Aged; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Heart Diseases; Homocysteine; Humans; Longitudinal Studies; Male; Middle Aged; Prevalence; Regression Analysis; Risk Factors; Thrombosis | 2002 |
Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model.
Topics: Alloys; Animals; Biocompatible Materials; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Fibrinogen; Humans; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Platelet Adhesiveness; Stainless Steel; Stents; Surface Properties; Swine; Thrombosis | 2002 |
[Pathohysiological and biochemical aspects of the diagnosis of thrombosis].
Topics: Blood Coagulation; Blood Flow Velocity; Calcium; Factor XII; Fibrin; Fibrinogen; Fibrinolysis; Humans; Phospholipids; Platelet Aggregation; Prothrombin; Thrombin; Thrombosis | 1975 |
[Experimental studies on the prethrombotic state].
Topics: Animals; Blood Coagulation; Diet, Atherogenic; Epinephrine; Fibrinogen; Fibrinolysis; Heparin; Humans; Injections, Intravenous; Linoleic Acids; Lung; Norepinephrine; Plasminogen; Rats; Stress, Psychological; Thrombin; Thrombosis; Vitamin A | 1975 |
[Nuclear medical thrombosis diagnosis, current state and developmental trends].
Topics: Chromium Radioisotopes; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Leukocytes; Radiometry; Serum Albumin, Radio-Iodinated; Streptokinase; Thrombosis | 1975 |
[Changes in the content of finbrinolysis activating and inhibiting factors and of fibrinogen in patients with thrombosis and prethrombotic conditions].
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Plasminogen Activators; Thrombosis | 1975 |
[Conditions leading to the rise of hypocoagulability in thromboses].
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Thrombelastography; Thrombosis | 1975 |
[The limits of laboratory diagnosis in the detection of thrombosis susceptibility].
Topics: Aged; Clinical Laboratory Techniques; Coumarins; Femoral Neck Fractures; Fibrinogen; Fracture Fixation, Internal; Humans; Iodine Radioisotopes; Pulmonary Embolism; Thrombosis | 1975 |
Thrombotic side-effects of lower-limb phlebography.
Topics: Adult; Contrast Media; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Phlebography; Thromboembolism; Thrombophlebitis; Thrombosis | 1976 |
Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis.
Topics: Animals; Anticoagulants; Disseminated Intravascular Coagulation; Dogs; Epitopes; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Heparin; Humans; Radioimmunoassay; Thrombin; Thromboembolism; Thrombosis | 1976 |
[Fibrinolytic therapy in DIC in children].
Topics: Child; Child, Preschool; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Infant; Infant, Newborn; Peritoneal Dialysis; Prognosis; Renal Veins; Shock, Septic; Streptokinase; Thrombosis; Uremia | 1977 |
Transient in vivo protein adsorption onto polymeric biomaterials.
Topics: Adsorption; Animals; Biocompatible Materials; Blood Proteins; Dogs; Fibrinogen; gamma-Globulins; Heparin; Intubation; Polymers; Polyurethanes; Polyvinyl Chloride; Serum Albumin; Silicone Elastomers; Thrombosis | 1979 |
Role of endothelium in sequestration of lipoprotein and firbrinogen in aortic lesions, thrombi, and graft pseudo-intimas.
Topics: Aged; Aorta; Aortic Diseases; Blood Vessel Prosthesis; Cholesterol; Endothelium; Female; Fibrin; Fibrinogen; Humans; Lipoproteins, LDL; Male; Middle Aged; Thrombosis | 1979 |
Treatment of deep vein thrombosis with streptokinase.
Topics: Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Drug Therapy, Combination; Female; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Plasminogen; Prothrombin Time; Pulmonary Embolism; Streptokinase; Thrombophlebitis; Thrombosis; Time Factors; Venous Insufficiency | 1975 |
Soluble fibrin complex production and proteolysis during ancrod therapy.
Topics: Ancrod; Blood Coagulation; Endopeptidases; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Isoantigens; Thrombosis | 1975 |
Regulation of the thrombin time in cirrhosis.
Topics: Antithrombin III; Antithrombins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Humans; Liver Cirrhosis; Plasminogen; Prothrombin Time; Thrombin; Thromboplastin; Thrombosis; Time Factors | 1976 |
Coagulation, oestrogen and the menopause.
Topics: Aging; Antithrombins; Blood Circulation; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Blood Vessels; Estrogens; Factor X; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Menopause; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1977 |
Vein surgery during defibrinogenation.
Topics: Animals; Batroxobin; Blood Vessel Prosthesis; Dogs; Femoral Vein; Fibrinogen; Injections, Intravenous; Injections, Subcutaneous; Peptide Hydrolases; Polyethylene Terephthalates; Postoperative Complications; Thrombosis; Time Factors | 1978 |
[Isotope methods in the radiological diagnosis of venous disease. II. Indications and accuracy (author's transl)].
Topics: Acute Disease; Diagnosis, Differential; Fibrinogen; Humans; Iodine Radioisotopes; Phlebography; Pulmonary Embolism; Radionuclide Imaging; Risk; Thrombosis; Veins | 1979 |
[Fibrin (ogen) Split products of nephropathies].
Topics: Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Glomerulonephritis; Graft vs Host Reaction; Hemolytic-Uremic Syndrome; Humans; Immunoelectrophoresis; Infant; Kidney Diseases; Kidney Transplantation; Molecular Weight; Pre-Eclampsia; Pregnancy; Prognosis; Thrombosis; Transplantation, Homologous; Urinary Tract Infections | 1975 |
Simple, sensitive method for measuring plasmin and plasminogen activity in plasma.
Topics: Enzyme Activation; Female; Fibrinogen; Fibrinolysin; Humans; Hydrogen-Ion Concentration; Kinetics; Liver Diseases; Male; Neoplasms; Plasminogen; Pregnancy; Pregnancy Trimester, First; Spectrophotometry; Streptokinase; Thrombosis | 1975 |
Highly iodinated fibrinogen: a new thrombus-localizing agent.
Topics: Animals; Dogs; Electrolysis; Fibrinogen; Hydrogen-Ion Concentration; Iodine Radioisotopes; Isotope Labeling; Methods; Molecular Weight; Radionuclide Imaging; Thrombosis | 1975 |
Microvascular anastomosis using a blood product sealant-adhesive.
Topics: Animals; Blood Platelets; Cattle; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Microcirculation; Postoperative Complications; Rats; Suture Techniques; Thrombin; Thrombosis; Time Factors | 1977 |
A modified [125I]fibrinogen technique for thrombus detection in the whole leg.
Topics: Adult; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Methods; Posture; Radioisotope Dilution Technique; Thrombophlebitis; Thrombosis | 1979 |
Thromboxane B2 and fibrinopeptide A levels in platelet consumption and thrombosis.
Topics: Cardiopulmonary Bypass; Fibrinogen; Fibrinopeptide A; Humans; Platelet Activation; Radioimmunoassay; Thrombosis; Thromboxane B2 | 1978 |
Guide wire thrombogenicity measured by fibrinopeptide A radioimmunoassay.
Topics: Angiography; Animals; Dogs; Female; Fibrinogen; Fibrinopeptide A; Heparin; Male; Polytetrafluoroethylene; Quaternary Ammonium Compounds; Radioimmunoassay; Stainless Steel; Thrombosis | 1977 |
Plasma administration to defibrinogenated dogs during extracorporeal circulation.
Topics: Animals; Batroxobin; Blood Transfusion; Dogs; Extracorporeal Circulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Filtration; Hemoperfusion; Oxygen; Peptide Hydrolases; Plasma; Surface Properties; Thrombosis | 1979 |
Heparin monitoring and thrombosis.
Topics: Blood Coagulation; Factor VIII; Fibrinogen; Heparin; Thrombin; Thromboplastin; Thrombosis | 1979 |
Protection of pregnant mice with phospholipase C and with Arvin against foetal death induced by bacterial lipopolysaccharide.
Topics: Ancrod; Animals; Female; Fetal Death; Fibrinogen; Lipopolysaccharides; Mice; Phospholipases; Placenta; Pregnancy; Thrombosis | 1979 |
Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses.
Topics: Aged; Animals; Arteries; Blood Cell Count; Blood Platelets; Cattle; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Platelet Aggregation; Serotonin; Thrombocytopenia; Thrombosis | 1979 |
The behavior of three different types of materials in vitro and in the dynamic physiological environment: review and analyses of critical parameters.
Topics: Acrylamides; Adsorption; Biocompatible Materials; Blood; Blood Proteins; Fibrinogen; Gels; Humans; In Vitro Techniques; Polyesters; Polymers; Polyurethanes; Surface Properties; Thromboembolism; Thrombosis | 1979 |
Estimation of thrombus formation by labeling of platelets, red cells and fibrinogen in experimental thrombosis.
Topics: Animals; Arteries; Blood Coagulation; Blood Flow Velocity; Blood Platelets; Chromium Radioisotopes; Erythrocytes; Fibrinogen; Fibrinolytic Agents; Iodine Radioisotopes; Iron Radioisotopes; Rabbits; Thrombophlebitis; Thrombosis | 1979 |
Problem of abnormal hemostasis in liver disease.
Topics: Acute Disease; Blood Coagulation Factors; Chronic Disease; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Hemostasis; Hepatic Encephalopathy; Hepatitis, Alcoholic; Humans; Thrombocytopenia; Thrombosis | 1979 |
Snake venoms and haemostasis: some suggested mechanisms of action.
Topics: Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Snake Venoms; Thrombosis | 1979 |
The effect of dextran on the platelet distribution and lysability of ex vivo thrombi in dogs.
Topics: Animals; Blood Platelets; Dextrans; Dogs; Factor VIII; Factor XIII; Fibrinogen; Hematocrit; Thrombosis | 1979 |
[Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Iodine Radioisotopes; Neoplasms; Radioimmunoassay; Thrombosis | 1979 |
Detection of thrombin-induced fibrinogen derivatives in thrombotic states.
Topics: Blood Coagulation; Chromatography, Affinity; Disseminated Intravascular Coagulation; Electrophoresis, Disc; Fibrin; Fibrinogen; Humans; Thrombin; Thrombosis | 1977 |
Problems of resistant thrombolysis and early recurrent thrombosis in streptokinase therapy.
Topics: Anticoagulants; Femoral Vein; Fibrinogen; Fibrinolysis; Humans; Iliac Vein; Plasminogen; Recurrence; Streptokinase; Thromboembolism; Thrombophlebitis; Thrombosis | 1978 |
Localization of injury in arteries by I-125 fibrinogen uptake.
Topics: Animals; Dogs; Endothelium; Femoral Artery; Fibrinogen; Glucose; Iodine Radioisotopes; Ischemia; Microscopy, Electron, Scanning; Perfusion; Thrombosis; Wound Healing | 1978 |
[Autologous 131J-tagged human fibrinogen for early detection of venous thrombosis (preparation, biological and in vivo properties) (author's transl)].
Topics: Blood Coagulation Tests; Fibrinogen; Humans; Iodine Radioisotopes; Thrombosis; Time Factors | 1978 |
[Thrombotic arterial and venous obstructions under ancrod (Arwin) therapy (author's transl)].
Topics: Adult; Ancrod; Arterial Occlusive Diseases; Female; Femoral Artery; Fibrinogen; Humans; Leg; Male; Middle Aged; Popliteal Artery; Thrombophlebitis; Thrombosis | 1978 |
Sensitization to the generalized Shwartzman reaction by catechol-O-methyltransferase inhibitors.
Topics: Animals; Blood Coagulation; Blood Platelets; Catechol O-Methyltransferase Inhibitors; Endotoxins; Factor XII; Fibrinogen; Fibrinolysis; Male; Pargyline; Phenelzine; Pyrogallol; Rabbits; Rats; Shwartzman Phenomenon; Thrombosis; Tropolone | 1978 |
[Prophylactic action of complex heparin-urea and adrenaline--heparin-fibrinogen compounds in thrombogenesis imitation in animals].
Topics: Animals; Drug Combinations; Drug Evaluation, Preclinical; Epinephrine; Fibrinogen; Heparin; Male; Rats; Thrombosis; Time Factors; Urea | 1978 |
99mTc-fibrinogen as a thrombus-imaging agent.
Topics: Animals; Fibrinogen; Rabbits; Radionuclide Imaging; Technetium; Thrombosis | 1978 |
Thrombus formation in the artificial kidney. Platelet and fibrin(ogen) content of experimental thrombi detected by radioisotope technique.
Topics: Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Chromium Radioisotopes; Fibrin; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Kidneys, Artificial; Thrombosis | 1978 |
The in-vivo behavior of electrolytically radioiodinated fibrinogen.
Topics: Animals; Dogs; Fibrinogen; Half-Life; Iodine Radioisotopes; Isotope Labeling; Kinetics; Rabbits; Radionuclide Imaging; Saphenous Vein; Thrombosis | 1978 |
Platelet function, factor VIII, fibrinogen, and fibrinolysis in Nigerians and Europeans in relation to atheroma and thrombosis.
Topics: Arteriosclerosis; Blood Cell Count; Blood Platelets; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Nigeria; Platelet Aggregation; Thrombosis | 1978 |
Coagulation studies in long-term survivors after renal allograft transplantation.
Topics: Adolescent; Adult; Aged; Antithrombins; Blood Coagulation Factors; Factor VIII; Fatty Acids, Nonesterified; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Thromboplastin; Thrombosis; Transplantation, Homologous | 1976 |
A method for characterising serum fibrinogen and fibrin degradation products.
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunologic Techniques; Thrombosis | 1976 |
[Acute thrombophlebitis of the saphenous veins as a problem of emergency surgery].
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fibrinogen; Humans; Ligation; Male; Middle Aged; Radioisotope Dilution Technique; Saphenous Vein; Thrombosis | 1976 |
Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.
Topics: Albuminuria; Amyloidosis; Chromatography; Fibrin; Fibrinogen; Filtration; Glomerular Filtration Rate; Glomerulonephritis; Humans; Hypersensitivity; Hypertension, Malignant; Immunodiffusion; Immunoglobulin G; Lupus Erythematosus, Systemic; Molecular Weight; Nephrotic Syndrome; Proteinuria; Purpura; Thrombosis; Transferrin | 1975 |
Enhancement of blood coagulation by soluble fibrin complexes.
Topics: Blood Coagulation; Chromatography, Gel; Colorimetry; Fibrin; Fibrinogen; Heparin; Humans; Immunoassay; Immunodiffusion; Macromolecular Substances; Male; Solubility; Thrombin; Thrombosis; Time Factors | 1975 |
A nonhuman primate vascular shunt model for thrombus generation.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Cells; Fibrin Fibrinogen Degradation Products; Fibrinogen; Haplorhini; Leukocyte Count; Macaca mulatta; Models, Biological; Polystyrenes; Postoperative Complications; Silicone Elastomers; Thromboplastin; Thrombosis; Time Factors | 1976 |
Protection of rats by phospholipase C from Bacillus cereus against the effects of intravenous infusions of purified tissue thromboplastin.
Topics: Animals; Bacillus cereus; Blood Cell Count; Blood Coagulation Factors; Blood Platelets; Fibrin; Fibrinogen; Injections, Intravenous; Male; Phospholipases; Pulmonary Circulation; Rats; Thromboplastin; Thrombosis; Time Factors | 1976 |
Evaluation of 125I-fibrinogen test for venous thrombosis in patients with hip fractures: comparison between isotope scanning and necropsy findings.
Topics: Autopsy; Evaluation Studies as Topic; Femoral Vein; Fibrinogen; Fractures, Bone; Hip Injuries; Humans; Iodine Radioisotopes; Radionuclide Imaging; Saphenous Vein; Thrombosis | 1977 |
In vitro stability and in vivo clearance of fibrinogen or serum albumin labeled with 77Br, 131I, or 125I by direct or indirect synthetic methods.
Topics: Acylation; Animals; Bromine; Chloride Peroxidase; Dogs; Drug Stability; Fibrinogen; Hydrolysis; Iodine Radioisotopes; Methods; Propionates; Rabbits; Radioisotopes; Serum Albumin; Thrombosis | 1977 |
[Mode of action and control of "low dose heparin" (author's transl)].
Topics: Arterial Occlusive Diseases; Blood Coagulation Tests; Fibrinogen; Half-Life; Heparin; Humans; Iodine Radioisotopes; Thrombin; Thrombosis | 1977 |
Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
Topics: Adenosine Diphosphate; Adult; Behcet Syndrome; Blood Coagulation; Blood Platelets; Factor VIII; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Factor 4; Thrombosis | 1977 |
SDS polyacrylamide gel characterization of serum FDP produced in response to ancrod and streptokinase/plasminogen infusion in man.
Topics: Ancrod; Arterial Occlusive Diseases; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoelectrophoresis; Plasminogen; Streptokinase; Thrombosis | 1977 |
[Diagnosis of thromboembolic diseases].
Topics: Aortic Aneurysm; Arterial Occlusive Diseases; Diagnosis, Differential; Embolism; Erysipelas; Fibrinogen; Humans; Myocardial Infarction; Phlebography; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thrombosis; Ultrasonography | 1977 |
The problem of thromboembolic disease.
Topics: Blood Coagulation; Blood Platelets; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Radionuclide Imaging; Thromboembolism; Thrombophlebitis; Thrombosis | 1977 |
Diagnosis of deep vein thrombosis and pulmonary embolism.
Topics: Fibrinogen; Humans; Lung; Pulmonary Embolism; Radiography; Radionuclide Imaging; Thrombophlebitis; Thrombosis; Ultrasonography | 1977 |
Blood viscosity factors in severe nondiabetic and diabetic retinopathy.
Topics: Blood Viscosity; Cholesterol; Diabetic Retinopathy; Erythrocyte Aggregation; Erythrocytes; Female; Fibrinogen; Humans; Hypertension; Male; Retinal Diseases; Thrombosis | 1977 |
Dietary fatty acids and arterial thrombosis: effects and mechanism of action with special reference to linoleic acid.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Blood Coagulation; Blood Platelets; Cholesterol; Collagen; Dietary Fats; Fatty Acids; Fibrinogen; Humans; Linoleic Acids; Platelet Aggregation; Prostaglandin Endoperoxides; Rats; Thrombin; Thrombosis | 1977 |
Coagulation abnormalities in patients with arterial, venous, and combined arterial and venous thromboses.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Blood Coagulation Disorders; Factor IX; Factor VIII; Factor XI; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Thrombophlebitis; Thrombosis | 1977 |
[Prevention of experimental thrombogenesis with secondary adrenaline-heparin-fibrinogen complex].
Topics: Animals; Drug Evaluation; Drug Therapy, Combination; Epinephrine; Fibrinogen; Fibrinolysis; Heparin; Male; Rats; Thrombosis | 1977 |
In vivo assessment of anticoagulation.
Topics: Adult; Anticoagulants; Blood Coagulation; Femoral Artery; Femoral Vein; Fibrinogen; Half-Life; Heparin; Humans; Iliac Vein; Iodine Radioisotopes; Isotope Labeling; Male; Middle Aged; Thrombosis | 1977 |
Change of the molecular mass of fibrinogen in circulating blood, as an index of the hypercoagulable states.
Topics: Adult; Aged; Antigens; Blood Protein Disorders; Cold Temperature; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Leukemia; Liver Cirrhosis; Male; Thrombosis | 1976 |
New aspects of blood clotting and thrombosis; investigations with the method of rheosimulation.
Topics: Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Factor XIII; Fibrinogen; Humans; In Vitro Techniques; Rheology; Thrombosis | 1976 |
Polymolecular layers of fibrinogen systems and the genesis of thrombosis.
Topics: Blood Coagulation; Fibrinogen; Polymers; Rheology; Thrombosis | 1976 |
Kinetics of fibrinogen and platelet adherence to biomaterials.
Topics: Adhesiveness; Adsorption; Binding Sites; Biocompatible Materials; Blood Proteins; Fibrinogen; Humans; Kinetics; Platelet Adhesiveness; Polyvinyl Chloride; Thrombosis | 1976 |
Kinetics of thrombus formation.
Topics: Animals; Blood Platelets; Diffusion; Dogs; Fibrinogen; Kinetics; Models, Biological; Thrombosis | 1976 |
Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog.
Topics: Ancrod; Animals; Disease Models, Animal; Dogs; Endarterectomy; Endopeptidases; Femoral Artery; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Thrombosis; Wound Healing | 1976 |
Phlebography and radionuclide clot localization in the lower extremities.
Topics: Contrast Media; Fibrinogen; Humans; Iliac Vein; Iodine Radioisotopes; Leg; Phlebography; Popliteal Vein; Technetium; Thrombophlebitis; Thrombosis; Vena Cava, Inferior | 1976 |
A comparison of the sulphite and thrombin methods for measuring fibrinogen concentration of plasma from patients undergoing thrombolytic therapy.
Topics: Evaluation Studies as Topic; Fibrinogen; Humans; Methods; Plasminogen; Streptokinase; Sulfites; Thrombin; Thrombosis; Time Factors | 1976 |
Experience of extensive vascular surgery on defibrase-defibrinogenated patients.
Topics: Adolescent; Adult; Batroxobin; Blood Platelets; Female; Femoral Vein; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Iliac Vein; Infusions, Parenteral; Male; Middle Aged; Peptide Hydrolases; Thrombosis; Time Factors; Vascular Surgical Procedures | 1976 |
[A prospective study on the occurrence of postoperative thrombosis of leg-veins and the possible influence of aescin in its prevention (author's transl)].
Topics: Adolescent; Adult; Blood Coagulation Tests; Child; Drug Evaluation; Escin; Female; Fibrinogen; Humans; Middle Aged; Postoperative Complications; Saponins; Thrombosis | 1976 |
[Intravascular disorders of microcirculation and microthrombus formation in patients with chronic ischemic disease of the heart].
Topics: Adult; Blood Coagulation; Coronary Disease; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Heparin; Humans; Hypertension; Kallikreins; Kininogens; Male; Microcirculation; Middle Aged; Myocardial Infarction; Thrombosis | 1976 |
Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology.
Topics: Ancrod; Blood Coagulation Tests; Blood Viscosity; Endopeptidases; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Plasminogen; Rheology; Serum Albumin; Serum Globulins; Streptokinase; Thrombosis; Time Factors | 1976 |
[Determination of the rate of microthrombosis in experimentally induced disseminated intravascular coagulation (DIC)].
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Iodine Radioisotopes; Rats; Thrombosis | 1976 |
[Thrombolytic activity of terrilytin and its effect on the coagulating system of the blood].
Topics: Amylases; Animals; Blood Coagulation; Dogs; Drug Combinations; Drug Interactions; Femoral Vein; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; In Vitro Techniques; Peptide Hydrolases; Phosphates; Thrombosis | 1976 |
[Detection of arterial thrombosis with 125I-fibrinogen (proceedings)].
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Thrombosis | 1976 |
[The influence of increased clotting reactions as shown by thrombosis formation in the immediate postoperative period on aortic valve prothesis (author's transl)].
Topics: Aortic Valve; Blood Cell Count; Blood Coagulation; Blood Platelets; Extracorporeal Circulation; Factor V; Fibrinogen; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Prothrombin; Thromboplastin; Thrombosis; Time Factors | 1975 |
[Absorption of fibrinogen I-125 in the hepatosplenic form of schistosomiasis mansoni].
Topics: Adolescent; Adult; Blood Coagulation Tests; Female; Fibrinogen; Humans; Iodine Radioisotopes; Liver; Male; Middle Aged; Schistosoma mansoni; Schistosomiasis; Spleen; Thrombosis | 1976 |
Induction of disseminated intravascular coagulation by endotoxin and saline loading in rats II. Fibrin deposition and removal.
Topics: Animals; Disseminated Intravascular Coagulation; Endotoxins; Escherichia coli; Female; Fibrin; Fibrinogen; Fibrinolysis; Iodine Radioisotopes; Kidney; Liver; Lung; Mononuclear Phagocyte System; Phagocytosis; Rats; Saline Solution, Hypertonic; Spleen; Thrombosis; Time Factors | 1975 |
Endothelial injury induced by thrombin or thrombi.
Topics: Adenosine Diphosphate; Animals; Aorta; Arteriosclerosis; Elastic Tissue; Endothelium; Fibrin; Fibrinogen; Male; Microscopy, Electron; Microscopy, Phase-Contrast; Platelet Aggregation; Rabbits; Sonication; Thrombin; Thrombosis; Tissue Extracts | 1975 |
Glomerular microcapillary thrombosis demonstrated by the new technique of immunocathodoluminescence.
Topics: Animals; Antigen-Antibody Complex; Disease Models, Animal; Female; Fibrinogen; Fluorescent Antibody Technique; Kidney Glomerulus; Microcirculation; Rats; Shwartzman Phenomenon; Thrombosis | 1975 |
Changes in fibrinogen levels, platelet counts, clotting times and fibrinolytic activity in relation to thrombosis in contagious bovine pleuropneumonia.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Proteins; Cattle; Cattle Diseases; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematocrit; Hemoglobins; Lung; Mycoplasma Infections; Mycoplasma mycoides; Pleuropneumonia, Contagious; Prothrombin Time; Thrombin; Thromboplastin; Thrombosis | 1975 |
Incidence of early post-operative iliofemoral thrombosis.
Topics: Female; Femoral Vein; Fibrinogen; Humans; Iliac Vein; Iodine Radioisotopes; Male; Phlebography; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis; Thrombosis; Ultrasonics | 1975 |
The effect of defibrase on arterial thrombus formation.
Topics: Animals; Arteries; Blood Platelets; Computers; Electric Stimulation; Enzymes; Fibrinogen; Hemolysin Proteins; Injections, Intravenous; Rats; Snake Venoms; Thrombosis | 1975 |
Absence of intravascular coagulation in the hemolytic-uremic syndrome.
Topics: Anuria; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Blood Pressure; Blood Urea Nitrogen; Carbon Radioisotopes; Child; Child, Preschool; Creatinine; Disseminated Intravascular Coagulation; Factor V; Factor VIII; Female; Fibrin; Fibrinogen; Hematuria; Hemoglobins; Hemolytic-Uremic Syndrome; Heparin; Humans; Infant; Male; Proteinuria; Prothrombin Time; Thromboplastin; Thrombosis | 1975 |
Heparin is an anionic hydrated anticoagulant.
Topics: Anions; Anticoagulants; Blood Coagulation; Coagulants; Colloids; Fibrinogen; Heparin; Humans; Thrombosis; Water | 1975 |
Letter: Preparation of 125 I-fibrinogen.
Topics: Animals; Dogs; Fibrinogen; Humans; Iodine Radioisotopes; Isotope Labeling; Thrombosis | 1975 |
The effect of dextran on the lysability of ex vivo thrombi.
Topics: Cholecystectomy; Dextrans; Female; Fibrinogen; Fibrinolytic Agents; Humans; Immunoelectrophoresis; In Vitro Techniques; Iodine Radioisotopes; Male; Thrombosis; Time Factors | 1975 |
Possible pathway for formation of fibrin degradation products during ancrod therapy.
Topics: Ancrod; Blood Coagulation Disorders; Endopeptidases; Fibrin; Fibrinogen; Humans; Solubility; Thrombosis | 1975 |
[Characteristics of hemocoagulation in different periods of the development of a venous intravascular thrombus].
Topics: Animals; Blood Coagulation; Blood Platelets; Femoral Vein; Fibrinogen; Fibrinolysis; Heparin; Rabbits; Thrombocytopenia; Thrombosis; Time Factors | 1975 |
Decision theory in the prevention of thrombo-embolism after myocardial infarction.
Topics: Aged; Decision Making; Fibrinogen; Heparin; Humans; Mathematics; Middle Aged; Myocardial Infarction; Probability; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thrombosis | 1975 |
Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Chorionic Gonadotropin; Estrogens; Factor V; Female; Fibrinogen; Fibrinolysis; Gonadotropins; Gonadotropins, Pituitary; Humans; Infertility, Female; Meigs Syndrome; Menotropins; Progestins; Thromboplastin; Thrombosis; Time Factors | 1975 |
[The place of complementary examinations in the study of a leg ulcer].
Topics: Angiography; Arteriosclerosis; Arteriosclerosis Obliterans; Diabetic Angiopathies; Fibrinogen; Humans; Leg Ulcer; Phlebitis; Phlebography; Thrombosis; Ultrasonography; Varicose Ulcer | 1975 |
Radioiodinated soluble canine fibrin. Preparation and evaluation as a thrombus localizing agent in the dog.
Topics: Animals; Coronary Disease; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Fibrin; Fibrinogen; Half-Life; Iodine Radioisotopes; Isotope Labeling; Solubility; Thrombophlebitis; Thrombosis | 1975 |
[Clinical aspects of the use of labelled fibrinogen].
Topics: Acute Disease; Diagnosis, Differential; Fibrinogen; Humans; Isotope Labeling; Leg; Postoperative Complications; Thrombophlebitis; Thrombosis; Veins | 1975 |
[A case of consumption coagulopathy due to atrial giant thrombus. Detection of thrombus by scintillation camera using fibrinogen labelled with 125I, 131I and warfarin-aspirin combination therapy (author's transl)].
Topics: Aspirin; Coronary Disease; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Fibrinogen; Heart Atria; Humans; Iodine Radioisotopes; Middle Aged; Radionuclide Imaging; Thrombosis; Warfarin | 1975 |
Editorial: Disseminated intravascular coagulation--a color of different horses.
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Thromboplastin; Thrombosis | 1975 |
In vivo production of soluble complexes containing fibrinogen-fibrin related antigen during ancrod therapy.
Topics: Adult; Aged; Ancrod; Antigen-Antibody Complex; Blood Coagulation; Endopeptidases; Female; Fibrin; Fibrinogen; Humans; Male; Middle Aged; Thrombosis | 1975 |
The pathogenesis of Vaccinia virus toxicity. I. The role of virus-platelet interaction.
Topics: Afibrinogenemia; Animals; Antibodies, Viral; Antiviral Agents; Ascitic Fluid; Blood Platelets; Erythrocyte Aggregation; Fibrinogen; Heparin; Lung; Mice; Propiolactone; Rabbits; Thrombocytopenia; Thromboplastin; Thrombosis; Trypsin Inhibitor, Bowman-Birk Soybean; Vaccinia virus | 1975 |
Studies in experimental animals on disseminated intravascular coagulation (DIC).
Topics: Aminobenzoates; Animals; Antifibrinolytic Agents; Blood Cell Count; Blood Platelets; Blood Vessels; Disease Models, Animal; Disseminated Intravascular Coagulation; Endothelium; Fibrin; Fibrinogen; Hemoglobins; Hemolysis; Lung; Lung Volume Measurements; Male; Pulmonary Edema; Rats; Respiration; Thrombin; Thrombosis | 1975 |
The effect of ecarin- defibrinating enzyme isolated from Echis carinatus - on experimental arterial thrombosis.
Topics: Animals; Blood Coagulation Tests; Carotid Artery Diseases; Endopeptidases; Fibrin; Fibrinogen; Fibrinolytic Agents; Injections, Intravenous; Prothrombin; Rats; Snake Venoms; Thrombosis | 1975 |
Use of fibrinopeptide A measurements in the diagnosis and management of thrombosis.
Topics: Fibrinogen; Fibrinopeptide A; Humans; Pulmonary Embolism; Thrombophlebitis; Thrombosis | 1975 |
[Heparin-urea complex and its biological properties].
Topics: Animals; Autonomic Nervous System; Chlorpromazine; Drug Combinations; Fibrinogen; Fibrinolysis; Heparin; Injections, Intravenous; Male; Rats; Thrombosis; Time Factors; Urea | 1975 |
Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood.
Topics: Amino Acid Sequence; Batroxobin; Fibrinogen; Fibrinopeptide A; Humans; Immune Sera; Protein Binding; Radioimmunoassay; Retinal Diseases; Retinal Vessels; Thrombophlebitis; Thrombosis; Tyrosine | 1975 |
Arterial thrombosis in scleroderma.
Topics: Adult; Amputation, Surgical; Arteries; Fibrinogen; Gangrene; Hand; Humans; Infarction; Intestines; Leg; Middle Aged; Scleroderma, Systemic; Telangiectasis; Thrombosis | 1975 |
[Symposium on the blood coagulation and fibrinolysis. (4) Predisposition to chronic thrombi formation and blood coagulation (author's transl)].
Topics: Adult; Aged; Animals; Dogs; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Rabbits; Thrombosis | 1975 |
[Trends in the nuclear-medical diagnosis of thrombosis].
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Methods; Radionuclide Imaging; Technetium; Thrombosis | 1976 |
Preparation and use of 123I-labeled highly iodinated fibrinogen for imaging deep-vein thrombi.
Topics: Animals; Dogs; Femoral Vein; Fibrinogen; Iodine Radioisotopes; Isotope Labeling; Radionuclide Imaging; Thrombophlebitis; Thrombosis | 1976 |
Adhesion of platelets to artificial surfaces: effect of red cells.
Topics: Animals; Biocompatible Materials; Blood Platelets; Collagen; Erythrocytes; Fibrinogen; Glass; In Vitro Techniques; Platelet Adhesiveness; Polystyrenes; Polyurethanes; Swine; Thrombosis; Time Factors | 1976 |
[Formation of left ventricular thrombus in acute myocardial infarction: significance of the determination of fibrinogen, of products of fibrinogen degradation, and of plasminogen].
Topics: Aged; Female; Fibrinogen; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Prospective Studies; Thrombosis | 1992 |
Antithrombotic efficacy of low-molecular-weight heparin in deep arterial injury.
Topics: Animals; Arterial Occlusive Diseases; Arteries; Blood Coagulation Tests; Blood Platelets; Fibrinogen; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Swine; Thrombosis | 1992 |
Partial characterization of an autoantibody recognizing the secondary binding site(s) of thrombin in a patient with recurrent spontaneous arterial thrombosis.
Topics: Adult; Antithrombin III; Arteries; Autoantibodies; Binding Sites, Antibody; Female; Fibrinogen; Heparin Cofactor II; Humans; Protein Binding; Receptors, Cell Surface; Receptors, Thrombin; Recurrence; Thrombin; Thrombin Time; Thrombosis | 1992 |
Genetic factors determining thrombosis and fibrinolysis.
Topics: Factor VIII; Fibrinogen; Fibrinolysis; Humans; Male; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Thrombosis | 1992 |
The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
Topics: Angina Pectoris; beta-Thromboglobulin; Blood Coagulation Tests; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Plasminogen Inactivators; Platelet Factor 4; Risk Factors; Thrombosis; Tissue Plasminogen Activator | 1992 |
Vampire bat salivary plasminogen activator promotes rapid and sustained reperfusion without concomitant systemic plasminogen activation in a canine model of arterial thrombosis.
Topics: alpha-Macroglobulins; Animals; Arterial Occlusive Diseases; Chiroptera; Dogs; Enzymes; Female; Femoral Artery; Fibrin; Fibrinogen; Fibrinolysin; Male; Plasminogen; Plasminogen Activators; Recurrence; Reperfusion; Salivary Glands; Thrombosis; Tissue Plasminogen Activator | 1992 |
[Detection of circulating activated platelets by anti-GMP-140 monoclonal antibodies].
Topics: Antibodies, Monoclonal; Binding Sites; Fibrinogen; Humans; P-Selectin; Platelet Activation; Platelet Membrane Glycoproteins; Thrombosis | 1992 |
Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Child; Cyclophosphamide; Daunorubicin; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Thrombin; Thrombosis; Vincristine | 1992 |
Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
Topics: alpha-2-Antiplasmin; Animals; Chiroptera; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; In Vitro Techniques; Male; Plasminogen; Plasminogen Activators; Recombinant Proteins; Streptokinase; Thrombosis; Tissue Plasminogen Activator | 1992 |
Increased platelet, but unaltered fibrinogen, accumulation in experimental thrombi in alloxan-induced diabetic rabbits.
Topics: Alloxan; Animals; Aorta; Blood Glucose; Blood Platelets; Catheters, Indwelling; Cholesterol; Diabetes Mellitus, Experimental; Fibrinogen; Microscopy, Electron; Microscopy, Electron, Scanning; Rabbits; Thrombosis | 1992 |
Maintenance of patency after vascular trauma by topical irrigation with a peptide homologous to the carboxy-terminus of the fibrinogen gamma chain.
Topics: Administration, Topical; Amino Acid Sequence; Animals; Blood Coagulation; Blood Vessels; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinogen; Male; Molecular Sequence Data; Peptides; Rats; Rats, Sprague-Dawley; Thrombosis; Vascular Patency; Wounds and Injuries | 1992 |
Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
Topics: Adult; Fetal Blood; Fibrin; Fibrinogen; Humans; Infant, Newborn; Iodine Radioisotopes; Plasminogen; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator | 1992 |
Increased lipid binding to thrombi in coronary artery disease. Findings in patients without premedication in native (not anticoagulated) test systems.
Topics: Blood Coagulation; Blood Platelets; Coronary Disease; Female; Fibrinogen; Humans; Lipid Metabolism; Male; Thrombosis | 1992 |
Physiologic alteration of fibrinogen levels: influence upon patency of microvenous anastomoses.
Topics: Anastomosis, Surgical; Ancrod; Animals; Blood Coagulation; Femoral Vein; Fibrinogen; Male; Microsurgery; Partial Thromboplastin Time; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Thrombosis; Turpentine; Vascular Patency | 1992 |
Bioregulatory roles for fibrin(ogen) on blood coagulation.
Topics: Blood Coagulation; Fibrin; Fibrinogen; Humans; In Vitro Techniques; Models, Biological; Thrombin; Thrombosis | 1992 |
Interaction of platelets with subendothelium in rats treated with PCA-4230, a new antithrombotic agent. Effect of PCA-4230 on experimental thrombosis.
Topics: Animals; Blood Platelets; Carotid Arteries; Dihydropyridines; Fibrinogen; Fibrinolytic Agents; Male; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Thrombosis; Thromboxane B2; Ticlopidine | 1992 |
An in vitro evaluation of the effect of laser irradiation on the thrombogenicity of thrombus.
Topics: Animals; Antithrombin III; Dogs; Fibrinogen; In Vitro Techniques; Lasers; Peptide Hydrolases; Thrombosis | 1992 |
[Physical mechanisms of solid-protein interactions in the interface between amorphous silicon carbide and fibrinogen].
Topics: Biocompatible Materials; Carbon; Carbon Compounds, Inorganic; Fibrinogen; Humans; Materials Testing; Silicon; Silicon Compounds; Surface Properties; Thrombosis | 1992 |
Non-vitamin K-dependent clotting factors during oral anticoagulant treatment.
Topics: Administration, Oral; Anticoagulants; Factor V; Factor XIII; Fibrinogen; Gene Expression Regulation; Hemorrhagic Disorders; Humans; Postoperative Complications; Thromboembolism; Thrombosis; von Willebrand Factor | 1992 |
Anti D dimer monoclonal antibodies: a possible scintigraphic agent for immunodetection of thrombi.
Topics: Animals; Fibrinogen; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Rabbits; Radioimmunodetection; Thrombosis | 1992 |
Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
Topics: Animals; Female; Fibrin; Fibrinogen; Fibrinopeptide A; Heparin; Hirudin Therapy; Hirudins; Humans; Jugular Veins; Kinetics; Male; Partial Thromboplastin Time; Rabbits; Recombinant Proteins; Thrombin Time; Thrombosis | 1992 |
A new bioactive molecule for improving vascular graft patency: exploratory trials in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Bacterial Proteins; Blood Platelets; Blood Vessel Prosthesis; Dogs; Fibrinogen; Glycopeptides; Microscopy, Electron, Scanning; Myxococcus xanthus; Thrombosis; Thromboxane A2; Vascular Patency | 1992 |
Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: evidence of a prothrombotic state.
Topics: Albumins; Alloxan; Animals; Antithrombin III; Aorta; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Fibrinogen; Iodine Radioisotopes; Male; Rabbits; Serum Albumin; Stereoisomerism; Thrombosis; Time Factors | 1992 |
Effect of varying fibrinogen and hematocrit concentrations on magnetic resonance relaxation times of thrombus.
Topics: Adult; Analysis of Variance; Cell Separation; Dose-Response Relationship, Drug; Erythrocytes; Fibrinogen; Hematocrit; Humans; In Vitro Techniques; Magnetic Resonance Imaging; Male; Reference Values; Thrombosis; Time Factors | 1992 |
Non-thrombogenicity by novel surface modification methods.
Topics: Anticoagulants; Antithrombin III; Biocompatible Materials; Fibrinogen; Heparin; Hydrolysis; Models, Theoretical; Polymers; Surface Properties; Thrombin; Thrombosis | 1992 |
Delivery of passivating proteins to sutures during passage through the vessel wall reduces subsequent platelet deposition by blocking fibrinogen adsorption.
Topics: Adsorption; Albumins; Arteries; Aspirin; Blood Platelets; Blotting, Western; Fibrinogen; Hemoglobins; Humans; Microscopy, Electron, Scanning; Placenta; Suture Techniques; Sutures; Thrombosis; Vascular Surgical Procedures | 1992 |
Development of a new dynamic method for quantitative evaluation of in vitro hemocompatibility of biomedical materials.
Topics: Acrylic Resins; Biocompatible Materials; Blood Cells; Cell Adhesion; Cellulose; Fibrinogen; Glass; Humans; Leukocytes; Materials Testing; Platelet Adhesiveness; Polymers; Rheology; Silicones; Thrombosis | 1992 |
Fibrinolysis and fibrinogenolysis in patients with thrombotic disease.
Topics: Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Thrombosis | 1992 |
The efficacy of heparin in the treatment of common brown snake (Pseudonaja textilis) envenomation.
Topics: Animals; Blood Coagulation Disorders; Blood Pressure; Cardiac Output; Central Venous Pressure; Dogs; Elapid Venoms; Electrocardiography; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Rate; Hemorrhage; Heparin; Prothrombin Time; Stroke Volume; Thrombocytopenia; Thrombosis; Vascular Resistance | 1992 |
Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysis.
Topics: Drug Interactions; Fibrinogen; Heparin; Heparin, Low-Molecular-Weight; Humans; Iodine Radioisotopes; Radioimmunoassay; Thrombosis; Tissue Plasminogen Activator | 1991 |
Fibrinogen-immobilized urokinase demonstrates increased thrombolytic activity in animal experiments.
Topics: alpha-Macroglobulins; Animals; Dogs; Enzymes, Immobilized; Fibrinogen; Fibrinolysin; Kinetics; Plasminogen; Thrombosis; Urokinase-Type Plasminogen Activator | 1990 |
Hypercoagulopathy induced by chemotherapy in a patient with lung cancer. A possible role for a factor with thrombosis-inducing activity (TIA).
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Lung Neoplasms; Male; Organoplatinum Compounds; Platelet Count; Tegafur; Thrombosis; Vindesine | 1992 |
Thrombosis-inducing activity in plasma of patients with acute respiratory tract infection disappears after treatment.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Animals; Biological Assay; Blood Sedimentation; C-Reactive Protein; Ceftizoxime; Escherichia coli Infections; Fibrinogen; Humans; Male; Mice; Mice, Inbred BALB C; Middle Aged; Pneumonia; Rabbits; Respiratory Tract Infections; Thrombosis | 1991 |
Thrombin-inhibitory capacity of the injured vessel wall.
Topics: Angioplasty, Balloon; Animals; Aorta; Endothelium, Vascular; Female; Fibrinogen; In Vitro Techniques; Male; Rabbits; Thrombin; Thrombosis | 1991 |
Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Hemostasis; Male; Papio; Protein C; Regional Blood Flow; Thrombosis; Urokinase-Type Plasminogen Activator | 1991 |
Appearance of thrombosis-inducing activity in the plasma of patients undergoing pulmonary resection.
Topics: Aged; Animals; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Middle Aged; Platelet Count; Pneumonectomy; Postoperative Period; Thrombosis; Tumor Necrosis Factor-alpha | 1991 |
Hirudin as anticoagulant in experimental hemodialysis.
Topics: Animals; Anticoagulants; Blood Loss, Surgical; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Female; Fibrinogen; Hirudin Therapy; Hirudins; Male; Nephrectomy; Platelet Count; Recombinant Proteins; Renal Dialysis; Thrombosis | 1991 |
Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbits.
Topics: alpha-2-Antiplasmin; Animals; Drug Synergism; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Hirudin Therapy; Iliac Artery; Rabbits; Recombinant Proteins; Recurrence; Thrombin; Thrombolytic Therapy; Thrombosis | 1991 |
Low-dose intermittent heparin therapy decreases plasma fibrinogen levels.
Topics: Coronary Disease; Depression, Chemical; Dietary Fats; Fibrinogen; Heparin; Humans; Injections, Subcutaneous; Interleukin-1; Thrombosis | 1991 |
Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodies.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Immunoenzyme Techniques; Liver Cirrhosis; Male; Middle Aged; Plasma; Thrombosis | 1991 |
International Scientific Symposium on Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis. August 30-September 1, 1989, Taipei, Taiwan, Republic of China.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Fibrinogen; Fibrinolysis; Humans; Thrombosis | 1990 |
Fibrinogen A alpha and gamma-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease.
Topics: Arteriosclerosis; Biomarkers; Electrophoresis, Agar Gel; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Humans; Immunoelectrophoresis; Thrombophlebitis; Thrombosis; Transglutaminases | 1990 |
Blood rheology after cardiac valve replacement with mechanical prostheses or bioprostheses.
Topics: Bioprosthesis; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Graft Occlusion, Vascular; Heart Valve Prosthesis; Hematocrit; Humans; Male; Middle Aged; Platelet Aggregation; Thrombosis | 1991 |
Thrombotic vasculopathy associated with cryofibrinogenemia.
Topics: Arterioles; Cryoglobulinemia; Cryoglobulins; Fibrinogen; Fibrinogens, Abnormal; Humans; Male; Middle Aged; Skin; Skin Diseases; Thrombosis | 1991 |
Mesangiolysis: an important glomerular lesion in thrombotic microangiopathy.
Topics: Adult; Aged; Anemia, Hemolytic; Biopsy; Female; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Glomerular Mesangium; Humans; Kidney Diseases; Male; Middle Aged; Thrombosis | 1991 |
Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy.
Topics: Bleeding Time; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Tests; Hemorrhage; Humans; Myocardial Infarction; Platelet Function Tests; Streptokinase; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1990 |
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
Topics: Abortion, Habitual; Adult; Autoantibodies; Blood Coagulation Factors; Cardiolipins; Complement C3; Complement C4; Female; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Male; Middle Aged; Plasminogen Inactivators; Pregnancy; Prospective Studies; Thrombosis; Tissue Plasminogen Activator | 1990 |
A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
Topics: Buffers; Catalysis; Fibrin; Fibrinogen; Fibrinolysis; Humans; Kinetics; Models, Biological; Nephelometry and Turbidimetry; Peptide Fragments; Plasminogen; Reference Standards; Reproducibility of Results; Thrombosis; Tissue Plasminogen Activator | 1990 |
[Peri- and postoperative use of low molecular weight heparin in peripheral vascular surgery].
Topics: Aged; Anesthesia, Epidural; Blood Coagulation Tests; Blood Vessel Prosthesis; Femoral Artery; Fibrinogen; Hematocrit; Heparin, Low-Molecular-Weight; Humans; Intraoperative Care; Pilot Projects; Platelet Count; Popliteal Artery; Postoperative Care; Thrombosis | 1990 |
Pathological and immunohistochemical features of graft liver antibody-mediated rejection.
Topics: Complement C1; Complement C3; Fibrinogen; Graft Rejection; Humans; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Liver Transplantation; Necrosis; Thrombosis | 1990 |
[Studies on the pathogenesis of hypercoagulability in patients with arterial thrombosis and malignancy].
Topics: Aged; Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Female; Fibrinogen; Humans; Male; Middle Aged; Monocytes; Neoplasms; Peptide Hydrolases; Thrombosis | 1990 |
Protective effects of ONO-3307, a new synthetic protease inhibitor against experimental disseminated intravascular coagulation in rats.
Topics: Animals; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Guanidines; Kidney Glomerulus; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Rats; Rats, Inbred Strains; Serine Proteinase Inhibitors; Thrombosis | 1990 |
Streptokinase treatment for femoral artery thrombosis after arterial cardiac catheterisation in infants and children.
Topics: Cardiac Catheterization; Catheterization; Child; Child, Preschool; Femoral Artery; Fibrinogen; Humans; Infant; Streptokinase; Thrombin Time; Thrombolytic Therapy; Thrombosis | 1990 |
[Disorders of thrombin interaction with the blood vessel wall and its inactivation by antithrombin III in experimental nephrotic syndrome].
Topics: Animals; Antithrombin III; Blood Vessels; Electrophoresis; Fibrinogen; Glomerulonephritis; Half-Life; Iodine Radioisotopes; Nephrotic Syndrome; Rats; Thrombin; Thrombosis | 1990 |
Fibrinogen and platelet deposition in PTFE grafts.
Topics: Animals; Blood Vessel Prosthesis; Dogs; Fibrinogen; Platelet Adhesiveness; Prostheses and Implants; Thrombosis | 1990 |
Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
Topics: Adult; Aged; Anemia; Blood Viscosity; Erythrocyte Aggregation; Erythropoietin; Female; Fibrinogen; Hematocrit; Humans; Hypertension; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Rheology; Thrombosis | 1990 |
Prevention of thrombosis and rethrombosis. New approaches.
Topics: Animals; Antithrombins; Cardiology; Fibrinogen; Humans; Platelet Aggregation Inhibitors; Protein C; Recombinant Proteins; Recurrence; Thrombosis; Thromboxane A2 | 1990 |
Effects of fibrinogen and fibrin on the migration of vascular smooth muscle cells in vitro.
Topics: Animals; Arteriosclerosis; Cattle; Cell Movement; Cells, Cultured; Chemotaxis; Fibrin; Fibrinogen; Muscle, Smooth, Vascular; Thrombosis | 1990 |
Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Hypertension, Pulmonary; Lung Diseases; Plasminogen Inactivators; Prospective Studies; Thrombosis | 1990 |
[Evaluation of thrombus scintigraphy using 67Ga-deferoxamine-dialdehydestarch-fibrinogen in patients with internal A-V shunt].
Topics: Adolescent; Adult; Arteriovenous Shunt, Surgical; Deferoxamine; Female; Fibrinogen; Gallium Radioisotopes; Humans; Kidney Failure, Chronic; Male; Middle Aged; Radionuclide Imaging; Starch; Thrombosis | 1990 |
[Disorders of fibrinogen metabolism in thoracic and abdominal injuries].
Topics: Abdominal Injuries; Adolescent; Adult; Aged; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Thoracic Injuries; Thrombosis | 1990 |
Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.
Topics: Animals; Carotid Arteries; Carotid Artery Injuries; Catheterization; Dose-Response Relationship, Drug; Female; Fibrinogen; Heparin; Hirudins; Male; Microscopy, Electron, Scanning; Partial Thromboplastin Time; Placebos; Platelet Aggregation; Swine; Thrombin; Thrombosis | 1990 |
High susceptibility to ADP-induced thrombus formation in mast cell-deficient W/Wv mice.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Epitopes; Fibrinogen; Humans; Male; Mast Cells; Mesenteric Veins; Mice; Mice, Mutant Strains; Platelet Aggregation; Platelet Count; Thrombosis | 1985 |
[Drug preparations of immobilized enzymes with enhanced affinity for the site of action].
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Chymotrypsin; Dextrans; Drug Evaluation, Preclinical; Enzymes, Immobilized; Fibrin; Fibrinogen; Fibrinolytic Agents; In Vitro Techniques; Magnetics; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
Rheological importance of acute-phase reactants.
Topics: Acute-Phase Proteins; Blood Proteins; Bone Marrow Cells; Fibrinogen; Humans; Interleukin-1; Leukocytes; Rheology; Thrombosis; Vascular Diseases | 1986 |
Impaired fibrinolysis and protein C increase after cadaver kidney transplantation.
Topics: Adult; alpha 1-Antitrypsin; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Cadaver; Cyclosporins; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Glycoproteins; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Plasmapheresis; Plasminogen; Postoperative Complications; Protein C; Thrombosis | 1986 |
Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
Topics: Aged; alpha-2-Antiplasmin; Drug Combinations; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Plasminogen; Streptokinase; Thrombosis | 1986 |
[Thrombolytic therapy with urokinase--indications and results].
Topics: Coronary Artery Bypass; Factor XIII; Fibrinogen; Fibrinolysis; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Risk; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
[30 years of thrombolytic therapy].
Topics: Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Streptokinase; Thrombosis | 1986 |
[Status of fibrinolysis in systemic lupus erythematosus].
Topics: Adult; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Lupus Erythematosus, Systemic; Male; Plasminogen; Serum Albumin; Thrombosis | 1986 |
[Laboratory control of fibrinolytic therapy].
Topics: Blood Coagulation Tests; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Plasminogen; Plasminogen Activators; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
Atherosclerosis in vascular grafts for peripheral vascular disease. Part 2. Synthetic arterial prostheses.
Topics: Adult; Aged; Aneurysm; Apolipoproteins B; Arteriosclerosis; Blood Vessel Prosthesis; Epitopes; Female; Fibrinogen; Follow-Up Studies; Graft Occlusion, Vascular; Histocytochemistry; Humans; Immunoenzyme Techniques; Male; Middle Aged; Polyethylene Terephthalates; Polytetrafluoroethylene; Thrombosis; Vascular Diseases | 1986 |
Defibrinogenation by batroxobin and acylated batroxobin in rats.
Topics: Acylation; Animals; Batroxobin; Benzamidines; Benzoates; Female; Fibrinogen; Fibrinolysis; Hydrogen-Ion Concentration; Male; Rats; Rats, Inbred Strains; Serine Endopeptidases; Thrombosis | 1988 |
Pharmacologic profiling of defibrotide in experimental models.
Topics: alpha-2-Antiplasmin; Animals; Fibrinogen; Fibrinolytic Agents; Humans; Polydeoxyribonucleotides; Primates; Rabbits; Thrombosis; Tissue Plasminogen Activator | 1988 |
Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: an angioscopic study.
Topics: Angiography; Animals; Arterial Occlusive Diseases; Batroxobin; Dogs; Drug Synergism; Female; Fibrinogen; Fibrinolytic Agents; Heparin; Male; Premedication; Serine Endopeptidases; Thrombosis; Tissue Plasminogen Activator | 1989 |
Two-year follow-up of changes in clinical chemistry in Singaporean Norplant-2 rod acceptors: haemostatic changes.
Topics: Blood Coagulation; Female; Fibrinogen; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Platelet Aggregation; Platelet Count; Singapore; Thrombosis | 1989 |
Thrombus age and tissue plasminogen activator mediated thrombolysis in rats.
Topics: Animals; Fibrinogen; Male; Rats; Rats, Inbred Strains; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator | 1989 |
Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor.
Topics: Angioplasty, Balloon; Animals; Carotid Arteries; Female; Fibrinogen; Heparin; Hirudin Therapy; Male; Platelet Aggregation; Recombinant Proteins; Swine; Thrombin; Thrombosis | 1989 |
[Fibrinogen and factor VII: 2 risk factors for arterial thrombosis].
Topics: Cardiovascular Diseases; Factor VII; Female; Fibrinogen; Humans; Male; Prospective Studies; Risk Factors; Thrombosis | 1989 |
Increased plasma fibrinopeptide A levels during attacks induced by hyperventilation in patients with coronary vasospastic angina.
Topics: Aged; beta-Thromboglobulin; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Female; Fibrinogen; Fibrinopeptide A; Heart Diseases; Humans; Hyperventilation; Male; Middle Aged; Thrombosis | 1989 |
Congenital severe protein C deficiency in adults.
Topics: Adolescent; Adult; Child; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Pedigree; Platelet Count; Protein C Deficiency; Thrombosis | 1989 |
Femoral artery recanalisation with percutaneous angioplasty and segmentally enclosed plasminogen activator.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Catheters, Indwelling; Combined Modality Therapy; Femoral Artery; Fibrinogen; Heparin; Humans; Middle Aged; Plasminogen Activators; Recombinant Proteins; Recurrence; Thrombosis; Time Factors; Vascular Patency | 1989 |
Arterial thrombosis associated with immune thrombocytopenia: presence of a platelet aggregating IgG synergistic with thrombin and adrenalin.
Topics: Blood Platelets; Epinephrine; Female; Fibrinogen; Humans; Immunoglobulin G; Middle Aged; Platelet Aggregation; Purpura, Thrombocytopenic; Thrombin; Thrombosis | 1989 |
[Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
Topics: Amino Acid Sequence; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Immunoassay; Molecular Sequence Data; Peptide Fragments; Reference Values; Thrombosis | 1989 |
An antifibrin monoclonal antibody useful in immunoscintigraphic detection of thrombi.
Topics: Abdomen; Animals; Antibodies, Monoclonal; Binding Sites, Antibody; Fibrin; Fibrinogen; Immunoenzyme Techniques; Jugular Veins; Male; Mice; Mice, Inbred BALB C; Rabbits; Radionuclide Imaging; Rats; Technetium; Thrombosis; Vena Cava, Inferior | 1989 |
Hemorheological parameters in patients with gynecologic malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Blood Sedimentation; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Genital Neoplasms, Female; Hematocrit; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Rheology; Serum Albumin; Serum Globulins; Thrombosis | 1989 |
Acute and chronic canine ex vivo blood interactions with NHLBI-DTB primary reference materials.
Topics: Animals; Biocompatible Materials; Blood Platelets; Dimethylpolysiloxanes; Dogs; Fibrinogen; Platelet Adhesiveness; Polyethylenes; Prostheses and Implants; Silicone Elastomers; Silicones; Surface Properties; Thrombosis; Time Factors | 1989 |
Presence of thrombosis-inducing activity in plasma from patients with lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Animals; Carcinoma, Squamous Cell; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Guinea Pigs; Humans; Lung Diseases; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Middle Aged; Platelet Count; Thrombosis | 1989 |
Thrombogenicity of canine free internal mammary artery autografts.
Topics: Animals; Aspirin; Blood Platelets; Coronary Artery Bypass; Dipyridamole; Dogs; Fibrinogen; Kinetics; Mammary Arteries; Thoracic Arteries; Thrombosis; Tissue Distribution; Vascular Patency | 1989 |
Streptokinase in the management of arterial thrombosis in infancy.
Topics: Arterial Occlusive Diseases; Child, Preschool; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Infant; Infant, Newborn; Male; Pulse; Streptokinase; Thrombosis | 1989 |
[Left ventricular thrombi detected by Ga-67-DFO-DAS-fibrinogen imaging and two-dimensional echocardiography].
Topics: Adult; Aged; Deferoxamine; Depth Perception; Echocardiography; Female; Fibrinogen; Gallium Radioisotopes; Heart Diseases; Humans; Male; Middle Aged; Radionuclide Imaging; Starch; Thrombosis | 1989 |
Impaired fibrinolysis in patients with thrombotic or haemostatic defects.
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Child; Child, Preschool; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen Inactivators; Platelet Activating Factor; Platelet Function Tests; Retrospective Studies; Thrombosis | 1989 |
Dynamic evaluation of clotting phenomena in vitro and perfluorochemical oxygen transport across a membrane-bound thrombus model.
Topics: Adult; Blood Substitutes; Fibrinogen; Fluorocarbons; Humans; In Vitro Techniques; Male; Micropore Filters; Microscopy, Electron, Scanning; Models, Biological; Oxygen; Platelet Count; Thrombosis | 1989 |
Extrinsic-pathway enzyme-linked coagulation assay (EP-ELCA). A clot-based alternative to prothrombin time for measurement of extrinsic pathway factors in plasma.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Factor V; Factor VII; Factor X; Fibrinogen; Heparin; Humans; Male; Peroxidase; Prothrombin; Prothrombin Time; Thrombosis; Vitamin K; Warfarin | 1988 |
Platelet aggregation, haematocrit, and fibrinogen.
Topics: Adenosine Diphosphate; Erythrocytes; Fibrinogen; Hematocrit; Humans; Platelet Aggregation; Thrombosis | 1985 |
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.
Topics: Afibrinogenemia; Antibodies, Monoclonal; Blood Platelets; Cell Adhesion; Dose-Response Relationship, Drug; Endothelium; Fibrinogen; Humans; Platelet Aggregation; Platelet Membrane Glycoproteins; Thrombosis | 1989 |
Induced clot lysis by mini-dose injection of streptokinase in non-perfused arterial segments of rabbits.
Topics: Animals; Aorta, Abdominal; Drug Administration Schedule; Fibrinogen; Fibrinolysis; Infusions, Intravenous; Injections, Intra-Arterial; Partial Thromboplastin Time; Rabbits; Streptokinase; Thrombosis | 1989 |
[Fibrinolytic treatment today].
Topics: Evaluation Studies as Topic; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Thrombosis; Urokinase-Type Plasminogen Activator | 1985 |
Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.
Topics: Aorta; Arteriosclerosis; Fibrin; Fibrinogen; Fibrinolysin; Fibrinopeptide A; Fibrinopeptide B; Humans; Thrombin; Thrombosis | 1987 |
Markers of thrombotic activity in arterial disease.
Topics: Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Vessel Prosthesis; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Prognosis; Radioimmunoassay; Thrombosis; Time Factors; Wound Healing | 1987 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
Fate of polyester arterial prostheses implanted as thoraco-abdominal by-passes in dogs: haematology, pathology, and biochemistry.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Blood Vessel Prosthesis; Dogs; Epoprostenol; Female; Fibrin; Fibrinogen; Hematologic Tests; Microscopy, Electron, Scanning; Polyethylene Terephthalates; Thrombosis; Thromboxane A2; Time Factors | 1988 |
Defective platelet-fibrinogen interaction in hereditary canine thrombopathia.
Topics: Adenine Nucleotides; Animals; Blood Platelets; Calcimycin; Cell Adhesion; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Fibrinogen; Glycoproteins; Immunoelectrophoresis; Male; Membrane Proteins; Microscopy, Electron; Platelet Aggregation; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Serotonin; Thrombosis | 1986 |
Disseminated intravascular coagulation (DIC) induced by liquoid (polyanetholsulfonate) in the rat. V. Effects on circulating fibronectin.
Topics: Animals; Benzenesulfonates; Disseminated Intravascular Coagulation; Fibrinogen; Fibronectins; Kidney; Lung; Male; Polyanetholesulfonate; Rats; Rats, Inbred Strains; Thrombosis | 1986 |
Vasoactive agents and production of thrombosis during intravascular coagulation. 3. Comparative effects of catecholamines.
Topics: Animals; Blood Platelets; Blood Pressure; Capillaries; Catecholamines; Disseminated Intravascular Coagulation; Dopamine; Endotoxins; Female; Fibrinogen; Kidney Glomerulus; Male; Pregnancy; Propranolol; Rabbits; Rats; Receptors, Adrenergic, beta; Shwartzman Phenomenon; Thrombin; Thrombosis | 1987 |
Intra-operative activation of coagulation--a stimulus to thrombosis mediated by vasopressin?
Topics: Blood Coagulation; Factor VIII; Fibrinogen; Hemostasis; Humans; Plasminogen Activators; Postoperative Complications; Thrombosis; Vasopressins | 1986 |
Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.
Topics: Ancrod; Animals; Dogs; Fibrinogen; Heparin; Thrombosis; Tissue Plasminogen Activator | 1986 |
Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions.
Topics: Adult; Aged; Female; Fibrinogen; Graft Occlusion, Vascular; Humans; Leg; Male; Middle Aged; Recombinant Proteins; Thrombosis; Time Factors; Tissue Plasminogen Activator | 1986 |
Major abdominal surgery on a patient with factor XII deficiency and lupus anticoagulant: no postoperative DVT as judged by the fibrinogen uptake test.
Topics: Aged; Blood Coagulation Factors; Factor XII Deficiency; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Male; Postoperative Complications; Thrombosis; Tissue Plasminogen Activator | 1987 |
Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant.
Topics: Blood Coagulation Factors; Complement C3; Fibrinogen; Fluorescent Antibody Technique; Gangrene; Humans; Immunoglobulin M; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Skin; Skin Ulcer; Thrombophlebitis; Thrombosis | 1988 |
Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene.
Topics: Amino Acid Sequence; Base Sequence; Cyanogen Bromide; DNA; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysin; Fibrinopeptide A; Fibrinopeptide B; Humans; Molecular Weight; Pedigree; Thrombosis | 1985 |
Fibrinogenolysis and fibrinolysis in normal volunteers and patients with thrombosis after infusion of urokinase.
Topics: alpha-2-Antiplasmin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinopeptide B; Humans; Plasminogen; Protease Inhibitors; Thrombosis; Urokinase-Type Plasminogen Activator | 1985 |
A model system for the in vivo determination of the thrombolytic effect of plasminogen activators.
Topics: Animals; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Lung Diseases; Male; Plasminogen Activators; Rats; Rats, Inbred Strains; Thrombin; Thrombosis; Tumor Cells, Cultured | 1988 |
Anti-fibrin monoclonal antibodies for radioimmunodetection: preliminary assessment in a rat model system.
Topics: Animals; Antibodies, Monoclonal; Binding Sites, Antibody; Disease Models, Animal; Drug Implants; Female; Fibrin; Fibrinogen; Humans; Iodine Radioisotopes; Male; Radionuclide Imaging; Rats; Rats, Inbred F344; Thrombosis; Tissue Distribution | 1988 |
[Hemostatic tests for the diagnosis of thrombosis. Activated platelet].
Topics: Fibrinogen; Humans; Platelet Aggregation; Platelet Membrane Glycoproteins; Thrombosis | 1988 |
Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosis.
Topics: Animals; Animals, Newborn; Antithrombin III; Blood Coagulation Tests; Disease Models, Animal; Drug Interactions; Fibrinogen; Heparin; Swine; Thrombin; Thrombosis | 1988 |
Strain enhancement of elastic modulus in fine fibrin clots.
Topics: Biomechanical Phenomena; Elasticity; Fibrin; Fibrinogen; Humans; Thrombosis | 1988 |
[Detection of left ventricular thrombi after acute myocardial infarction using Ga-67-DFO-DAS-fibrinogen].
Topics: Adult; Deferoxamine; Echocardiography; Female; Fibrinogen; Gallium Radioisotopes; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Starch; Thrombosis | 1988 |
Oral contraceptives and the hemostatic system.
Topics: Adult; Antithrombins; Contraceptives, Oral; Female; Fibrinogen; Fibronectins; Hemostasis; Humans; Obesity; Thromboembolism; Thrombosis | 1988 |
Two-step targeting of urokinase to plasma clot provides efficient fibrinolysis.
Topics: Antibodies, Monoclonal; Fibrinogen; Fibrinolysis; Humans; Thrombosis; Urokinase-Type Plasminogen Activator | 1988 |
Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas.
Topics: Animals; Blood Coagulation; Cells, Cultured; Endothelium, Vascular; Fibrin; Fibrinogen; Fibrosarcoma; Mice; Mice, Inbred BALB C; Microscopy, Electron; Thrombosis; Tumor Necrosis Factor-alpha | 1988 |
A novel, stable high molecular weight urokinase: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Batroxobin; Drug Stability; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Molecular Weight; Thrombin; Thrombosis; Urokinase-Type Plasminogen Activator | 1987 |
The influence of preadsorbed canine von Willebrand factor, fibronectin and fibrinogen on ex vivo artificial surface-induced thrombosis.
Topics: Adsorption; Animals; Arteriovenous Shunt, Surgical; Blood Platelets; Disease Models, Animal; Dogs; Fibrinogen; Fibronectins; Microscopy, Electron, Scanning; Surface Properties; Thrombosis; von Willebrand Factor | 1986 |
Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.
Topics: Blood Coagulation; Electrophoresis, Agar Gel; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Myocardial Infarction; Polymers; Thrombosis; Time Factors | 1987 |
Intra-arterial thrombolytic therapy in peripheral vascular disease.
Topics: Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Prospective Studies; Pulmonary Embolism; Streptokinase; Thrombosis | 1987 |
Evaluation of a fully automated centrifugal analyzer for performance of hemostasis tests.
Topics: Antithrombin III; Autoanalysis; Centrifugation; Fibrinogen; Hemorrhage; Hemostasis; Humans; Light; Plasminogen; Scattering, Radiation; Thromboplastin; Thrombosis | 1987 |
[Biochemical bases of platelet activity in hemostasis and thrombogenesis. I].
Topics: Blood Platelets; Cell Membrane; Cytoskeletal Proteins; Fibrinogen; Hemostasis; Membrane Proteins; Platelet Aggregation; Thrombosis | 1987 |
[Thrombus scintigraphy with Ga-67 DFO-DAS-fibrinogen. II. Clinical applications of Ga-67 DFO-DAS-fibrinogen].
Topics: Adult; Aged; Deferoxamine; Female; Fibrinogen; Gallium Radioisotopes; Humans; Male; Middle Aged; Radionuclide Imaging; Starch; Thrombophlebitis; Thrombosis | 1987 |
Ex vivo interactions and surface property relationships of polyetherurethanes.
Topics: Animals; Arteriovenous Shunt, Surgical; Biocompatible Materials; Blood; Dogs; Evaluation Studies as Topic; Fibrinogen; In Vitro Techniques; Microscopy, Electron, Scanning; Platelet Adhesiveness; Polyurethanes; Solvents; Surface Properties; Thrombosis | 1986 |
Extraintracranial anastomosis performed by means of biological gluing materials: experimental and clinical study.
Topics: Adult; Aged; Animals; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Angiography; Cerebral Revascularization; Cerebrovascular Disorders; Female; Fibrinogen; Follow-Up Studies; Hemostatics; Humans; Ischemic Attack, Transient; Male; Middle Aged; Rabbits; Rats; Sutures; Thrombin; Thrombosis; Tissue Adhesives; Wound Healing | 1986 |
Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
Topics: Adult; Blood Coagulation Disorders; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinopeptide A; Fibrinopeptide B; Humans; Male; Pedigree; Platelet Aggregation; Thrombin; Thrombophlebitis; Thrombosis | 1986 |
Soluble fibrinogen derivatives generated by thrombin: affinity for elastin.
Topics: Animals; Arteriosclerosis; Calcium; Cattle; Citrates; Citric Acid; Dialysis; Elastin; Fibrinogen; Humans; In Vitro Techniques; Solubility; Thrombin; Thrombosis | 1986 |
The effect of fibrinogen sialic acid residues on ex vivo platelet deposition on biomaterials.
Topics: Animals; Biocompatible Materials; Dogs; Fibrinogen; Humans; In Vitro Techniques; Microscopy, Electron; N-Acetylneuraminic Acid; Platelet Adhesiveness; Polyvinyl Chloride; Sialic Acids; Thrombosis | 1986 |
Dynamics of the thrombolytic process under conditions of a constant magnetic field.
Topics: Animals; Female; Fibrinogen; Fibrinolysis; Iodine Radioisotopes; Kinetics; Magnetics; Male; Rabbits; Thrombosis; Time Factors | 1986 |
Acute thromboses of disc valve prostheses: fibrinolytic treatment-diagnosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiocardiography; Cineradiography; Echocardiography; Female; Fibrinogen; Heart Valve Prosthesis; Humans; Male; Middle Aged; Plasminogen; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
[Acute thrombosis at disc valve prostheses: fibrinolytic treatment-- Diagnosis].
Topics: Adult; Aged; Angiocardiography; Aortic Valve; Cineangiography; Echocardiography; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Stenosis; Prosthesis Design; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
Surface properties and blood compatibility of polyurethaneureas.
Topics: Animals; Biocompatible Materials; Blood; Blood Vessel Prosthesis; Dogs; Fibrinogen; Microscopy, Electron, Scanning; Platelet Adhesiveness; Polyurethanes; Surface Properties; Tensile Strength; Thermodynamics; Thrombosis | 1986 |
New surface treatments to prevent thrombosis during extracorporeal circulation.
Topics: Animals; Blood Coagulation; Extracorporeal Circulation; Fibrinogen; Heparin; Platelet Count; Rabbits; Surface Properties; Thrombosis; Time Factors | 1985 |
Importance of composition of the initial protein layer and platelet spreading in acute surface-induced thrombosis.
Topics: Adsorption; Animals; Blood Platelets; Blood Proteins; Dogs; Fibrinogen; Models, Biological; Platelet Adhesiveness; Polymers; Serum Albumin; Surface Properties; Thrombosis; Time Factors | 1985 |
Clearance characteristics of des-AA fibrin and des-AABB fibrin, and thrombus-related uptake of des-AABB fibrin as compared to fibrinogen.
Topics: Fibrin; Fibrinogen; Half-Life; Humans; Iodine Radioisotopes; Kinetics; Reference Values; Structure-Activity Relationship; Thrombosis | 1985 |
Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.
Topics: Adult; Ancrod; Female; Fibrinogen; Fibrinolysis; Glomerulonephritis; Glycoproteins; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Plasminogen Activators; Plasminogen Inactivators; Thrombosis | 1985 |
Influence of cyproheptadine on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs.
Topics: Animals; Cyproheptadine; Disseminated Intravascular Coagulation; Endotoxins; Escherichia coli; Female; Fibrin; Fibrinogen; Hemodynamics; Hemoglobins; Male; Platelet Count; Swine; Thrombosis; Weaning | 1985 |
[Significance of antithrombin III in clinical liver transplantations].
Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Ascites; Child; Child, Preschool; Female; Fibrinogen; Follow-Up Studies; Humans; Infant; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Proteinuria; Thrombosis | 1985 |
Protein/platelet interaction with an artificial surface: effect of vitamins and platelet inhibitors.
Topics: Adsorption; Amino Sugars; Animals; Aspirin; Blood Platelets; Blood Proteins; Cattle; Dipyridamole; Fibrinogen; In Vitro Techniques; Kinetics; Platelet Adhesiveness; Polycarboxylate Cement; Thrombosis; Vitamins | 1986 |
Hereditary dysfibrinogenemia.
Topics: Biopolymers; Blood Coagulation Disorders; Chemical Phenomena; Chemistry; Fibrin; Fibrinogen; Heterozygote; Humans; Protein Binding; Thrombin; Thrombosis; Wound Healing | 1985 |
[The thrombodensitogram: a photometric and dynamic study of the clot (the slow clotting test)].
Topics: Blood Coagulation Tests; Densitometry; Embolism; Fibrinogen; Humans; Platelet Adhesiveness; Platelet Count; Thrombelastography; Thrombin Time; Thrombosis; Whole Blood Coagulation Time | 1985 |
[Thrombosis and splenectomy. Preliminary note on the changes of various blood coagulation parameters 20 days after splenectomy. Experimental research].
Topics: Animals; Antithrombin III; Blood Coagulation; Fibrinogen; Male; Partial Thromboplastin Time; Prothrombin Time; Rats; Rats, Inbred Strains; Splenectomy; Thrombosis | 1985 |
The statistical analysis of distribution of blood deposits in arterial prostheses after short-term exposure to reduced blood flow in dogs: a computerized study using radioisotopes.
Topics: Animals; Aorta, Abdominal; Blood Platelets; Blood Vessel Prosthesis; Computers; Dogs; Fibrin; Fibrinogen; Graft Occlusion, Vascular; Indium; Iodine Radioisotopes; Platelet Aggregation; Radioisotopes; Regional Blood Flow; Thrombosis; Time Factors | 1985 |
Vasoactive agents and production of thrombosis during intravascular coagulation. 2. alpha-Adrenergic stimulation: effects and mechanisms.
Topics: Animals; Blood Platelets; Blood Pressure; Erythrocyte Aggregation; Fibrinogen; Granulocytes; Kidney Glomerulus; Male; Norepinephrine; Rabbits; Renal Circulation; Thrombin; Thrombosis | 1985 |
Streaming potential. An analysis of the test technique and its application to the study of thrombosis on implant materials.
Topics: Albumins; Blood Coagulation Factors; Blood Vessels; Colloids; Electrodes; Electrophysiology; Epoxy Resins; Fibrinogen; Fluorocarbon Polymers; gamma-Globulins; Heparin; Humans; Immune Sera; In Vitro Techniques; Protamines; Silicones; Thrombosis | 1970 |
[Thrombolytic effect of a protease from Aspergillus ocharaceus].
Topics: Animals; Anticoagulants; Aspergillus; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Dogs; Fibrinogen; Fibrinolysis; Mice; Mice, Inbred Strains; Peptide Hydrolases; Rabbits; Thrombin; Thrombosis | 1971 |
Non-Newtonian behavior of surface layers of human plasma protein systems and a new concept of the initiation of thrombosis.
Topics: Adsorption; Blood Proteins; Blood Vessels; Blood Viscosity; Fibrinogen; gamma-Globulins; Humans; Serum Albumin; Surface Properties; Thrombosis | 1971 |
Rate of fibrinogen turnover in thrombosis.
Topics: Age Factors; Analysis of Variance; Aspirin; Fibrin; Fibrinogen; Humans; Iodine Radioisotopes; Methods; Placebos; Postoperative Complications; Thrombosis; Time Factors | 1972 |
131 I-labelled-fibrinogen test: effect of 131 I-albumin.
Topics: Fibrinogen; Humans; Serum Albumin, Radio-Iodinated; Thrombosis | 1972 |
Incorporation of 125 I-labelled fibrinogen into coronary arterial thrombi in acute myocardial infarction in man.
Topics: Acute Disease; Aged; Arteries; Autopsy; Coronary Vessels; Dicumarol; Female; Fibrinogen; Heparin; Humans; Injections, Intravenous; Iodine Isotopes; Isotope Labeling; Male; Myocardial Infarction; Thrombosis; Time Factors | 1973 |
Long-term blood abnormalities in thrombosis.
Topics: Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Humans; Myocardial Infarction; Pulmonary Embolism; Thrombophlebitis; Thrombosis | 1973 |
Site of origin of venous thrombi.
Topics: Fibrinogen; Humans; Leg; Methods; Radioisotopes; Thrombophlebitis; Thrombosis | 1973 |
Hematologic, biochemical, and pathologic effects of intra-aortic balloon counterpulsation in the calf.
Topics: Alpha-Globulins; Animals; Aorta; Aspartate Aminotransferases; Beta-Globulins; Blood Cell Count; Blood Coagulation; Catheterization; Cattle; Creatinine; Electronics, Medical; Fibrinogen; gamma-Globulins; Hemoglobinometry; Infarction; Kidney; L-Lactate Dehydrogenase; Serum Albumin; Shock, Cardiogenic; Species Specificity; Thrombosis | 1973 |
[Thrombolysis in experimental shunt loops].
Topics: Angiography; Animals; Arteriovenous Shunt, Surgical; Aspergillus; Blood Coagulation Tests; Blood Platelets; Femoral Artery; Femoral Vein; Fibrinogen; Fibrinolysis; Peptide Hydrolases; Thrombosis; Transaminases | 1974 |
Letter: Fate of 125I-labelled fibrinogen.
Topics: Autopsy; Fibrinogen; Humans; Iodine Radioisotopes; Leukocyte Count; Leukocytes; Thrombophlebitis; Thrombosis | 1974 |
Endotoxin-induced intravascular coagulation and shock in dogs: the role of factor VII.
Topics: Animals; Autopsy; Blood Cell Count; Blood Coagulation Tests; Blood Pressure; Disseminated Intravascular Coagulation; Dogs; Endotoxins; Factor V; Factor VII; Factor VII Deficiency; Factor X; Fibrin; Fibrinogen; Plasminogen; Prothrombin; Shock, Septic; Staining and Labeling; Thrombosis | 1974 |
[Possibility of diagnosis of acute thrombosis by the symptoms of hypocoagulemia. Studies in vitro].
Topics: Blood Cell Count; Blood Platelets; Fibrinogen; Humans; In Vitro Techniques; Thrombelastography; Thrombosis | 1974 |
Editorial: Predisposition to thrombosis.
Topics: Animals; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Vessels; Fibrinogen; Fibrinolysis; Humans; Platelet Adhesiveness; Rats; Thrombophlebitis; Thrombosis; Veins | 1974 |
Fibrinogen and metastases.
Topics: Animals; Cell Line; Culture Media; Female; Fibrinogen; gamma-Glutamyltransferase; Humans; In Vitro Techniques; Lysine; Mitochondria; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Oxygen Consumption; Plasmacytoma; Pregnancy; Thrombin; Thrombosis; Wound Healing | 1974 |
[New data on the nature and function of the anticoagulation system].
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Physiological Phenomena; Blood Proteins; Chemoreceptor Cells; Enzymes; Fibrinogen; Fibrinolysin; Fibrinolysis; Heparin; Humans; Neurotransmitter Agents; Reflex; Stress, Psychological; Thrombin; Thromboplastin; Thrombosis | 1972 |
Intravascular haemolysis and disseminated intravascular coagulation.
Topics: Afibrinogenemia; Animals; Erythrocytes; Fibrin; Fibrinogen; Hemoglobinometry; Hemolysis; Iodine Isotopes; Iron Isotopes; Rabbits; Thrombosis | 1967 |
Detection of intracardiac thrombi using radio-iodinated antifibrinogen (RIAF) and precordial scanning: experimental and clinical studies.
Topics: Adult; Animals; Antibodies; Autoradiography; Chlormerodrin; Dogs; Fibrinogen; gamma-Globulins; Gastric Juice; Heart Aneurysm; Heart Atria; Heart Valve Diseases; Humans; Iodine Radioisotopes; Male; Myocardium; Radiometry; Sclerosing Solutions; Serum Albumin, Radio-Iodinated; Thrombosis | 1967 |
Therapeutic defibrination in the treatment of thrombotic disease.
Topics: Adult; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Humans; Immunoassay; Male; Middle Aged; Mitral Valve Stenosis; Myocardial Infarction; Plasminogen; Thrombophlebitis; Thrombosis; Urticaria; Venoms | 1968 |
Anticoagulant therapy with a purified fraction of Malayan pit viper venom.
Topics: Adolescent; Adult; Aged; Antivenins; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Thrombophlebitis; Thrombosis; Venoms | 1968 |
A new approach to anticoagulant therapy.
Topics: Anticoagulants; Fibrinogen; Humans; Myocardial Infarction; Thrombosis; Venoms | 1968 |
The paradox in therapeutic defibrination.
Topics: Animals; Blood Coagulation; Chemical Phenomena; Chemistry; Dogs; Female; Fibrinogen; Humans; Mice; Rabbits; Snake Bites; Thrombosis; Venoms | 1968 |
Platelet-surface reaction and thrombosis.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Carbon Isotopes; Endarterectomy; Extracorporeal Circulation; Femoral Artery; Fibrinogen; gamma-Globulins; Glass; Humans; In Vitro Techniques; Polymers; Popliteal Artery; Pulse; Rabbits; Serotonin; Serum Albumin; Sulfinpyrazone; Sulfur Isotopes; Surface Properties; Thrombosis; Transplantation, Autologous; Vascular Surgical Procedures | 1968 |
[On the problem of the thrombolytic effect of heparin and nicotinic acid].
Topics: Animals; Antithrombins; Cats; Femoral Artery; Fibrinogen; Fibrinolytic Agents; Heparin; Heparinoids; Injections, Intra-Arterial; Injections, Intravenous; Nicotinic Acids; Plasminogen; Thrombelastography; Thrombin; Thrombosis | 1968 |
Degos' disease (malignant papulosis). Report of three cases with clues to etiology.
Topics: Adult; Blood Protein Electrophoresis; Diagnosis, Differential; Female; Fibrinogen; Fluorescent Antibody Technique; gamma-Globulins; Gastrointestinal Diseases; Humans; Immunoelectrophoresis; Infarction; Intestinal Diseases; Intestines; Male; Polyarteritis Nodosa; Skin; Skin Diseases; Thrombosis | 1968 |
On the nature of hyaline microthrombi. A light microscopical, immunofluorescent and ultrastructural study.
Topics: Brain; Cerebral Arteries; Eosinophils; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Histocytochemistry; Humans; Hyalin; Kidney; Microscopy; Microscopy, Electron; Pituitary Gland; Staining and Labeling; Thrombosis | 1968 |
Changes in platelet behaviour during arvin therapy.
Topics: Adenine Nucleotides; Anticoagulants; Blood Platelets; Fibrinogen; Humans; Thrombophlebitis; Thrombosis; Venoms | 1969 |
Plasma-proteins and oral contraceptives.
Topics: Blood Coagulation Disorders; Blood Proteins; Cold Temperature; Contraceptives, Oral; Estrogens; Female; Fibrinogen; Humans; Immunoglobulin G; Macroglobulins; Pregnancy; Serum Albumin; Thrombosis; Transcortin | 1970 |
[Changes in the blood coagulation mechanism associated with kidney operations].
Topics: Blood Coagulation; Blood Coagulation Tests; Embolism; Factor VII; Female; Fibrinogen; Fibrinolysis; gamma-Globulins; Humans; Kidney Diseases; Male; Nephrectomy; Prothrombin; Prothrombin Time; Serum Globulins; Thromboembolism; Thrombosis | 1969 |
[The inhibition of thrombocyte aggregation in vitro and in vivo].
Topics: Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Blood Platelets; Dipyridamole; Fatty Acids, Essential; Fibrinogen; Fluorides; Gentisates; Humans; In Vitro Techniques; Iodoacetates; Nicotinic Acids; Papaverine; Phenylbutazone; Platelet Adhesiveness; Prostaglandins; Sodium; Thrombosis; Vasodilator Agents | 1969 |
[Platelet functions following dextran administration].
Topics: Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Dextrans; Embolism; Factor V; Factor VIII; Femoral Fractures; Fibrinogen; Fibrinolysis; Humans; Molecular Weight; Platelet Adhesiveness; Thrombosis | 1969 |
Detection of thrombosis with iodine-125 fibrinogen. Data reassessed.
Topics: Blood Coagulation Tests; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Methods; Postoperative Complications; Radionuclide Imaging; Thrombosis | 1970 |
[Role of the mesenchymal cells in the development of arteriosclerosis].
Topics: Age Factors; Animals; Aorta; Arteriosclerosis; Cell Division; Collagen; Connective Tissue; Connective Tissue Cells; Fibrinogen; Humans; Lipoproteins; Necrosis; Rabbits; Rats; Sulfates; Sulfur Isotopes; Thrombosis | 1973 |
Changes in antithrombin 3 levels following cessation of anticoagulant therapy.
Topics: Aged; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Depression, Chemical; Female; Fibrinogen; Humans; Immunodiffusion; Macroglobulins; Male; Middle Aged; Thrombosis; Warfarin | 1973 |
[Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
Topics: Age Factors; Aged; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Iodine Isotopes; Middle Aged; Myocardial Infarction; Prognosis; Thrombosis | 1973 |
[Degradation products of fibrinogen during thrombolysis].
Topics: Blood Coagulation; Fibrinogen; Humans; Immunodiffusion; Streptokinase; Thrombosis | 1973 |
Fibrinogen derivatives with a higher molecular weight than that of the parent molecule in cord vein plasma of newborns. I. Identification in single plasma samples.
Topics: Asphyxia Neonatorum; Blood; Blood Protein Electrophoresis; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Humans; Immunodiffusion; Infant, Newborn; Infant, Newborn, Diseases; Molecular Weight; Thrombosis; Umbilical Veins | 1973 |
The effect of anti-inflammatory drugs on the aggregation and adhesiveness of platelets, red cells and leukocytes.
Topics: Adenosine Diphosphate; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Antigen-Antibody Complex; Cell Adhesion; Chloroquine; Collagen; Dextrans; Edetic Acid; Endotoxins; Erythrocytes; Fibrinogen; Flufenamic Acid; Gelatin; Humans; In Vitro Techniques; Indomethacin; Leukocytes; Phenylbutazone; Phenylpropionates; Platelet Adhesiveness; Prednisolone; Rats; Thrombosis | 1972 |
The relationship between blood coagulation and thrombosis and atherosclerosis in man, monkeys and carnivores.
Topics: Animals; Antithrombins; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Carnivora; Cross Reactions; Factor X; Fibrin; Fibrinogen; Haplorhini; Humans; Phosphatidylethanolamines; Prothrombin Time; Species Specificity; Thrombin; Thromboplastin; Thrombosis | 1974 |
Homocystinemia. Vascular injury and arterial thrombosis.
Topics: Adolescent; Adult; Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Vessels; Dipyridamole; Disease Models, Animal; Endothelium; Female; Fibrinogen; Fibrinolysis; Haplorhini; Homocystine; Homocystinuria; Humans; Male; Papio; Plasminogen; Platelet Adhesiveness; Pyridoxine; Thrombosis | 1974 |
Properties of soluble fibrin polymers encountered in thrombotic states.
Topics: Animals; Blood Coagulation Tests; Chemical Precipitation; Chromatography, Gel; Cold Temperature; Fibrin; Fibrinogen; Heparin; Humans; Immunoassay; Immunodiffusion; Iodine Radioisotopes; Macromolecular Substances; Molecular Weight; Polymers; Pulmonary Embolism; Rabbits; Serum Globulins; Solubility; Thrombin; Thrombosis | 1973 |
Activation of thrombolysis by streptokinase in the cat.
Topics: Animals; Caseins; Cats; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; In Vitro Techniques; Peptide Hydrolases; Plasminogen; Serum Globulins; Streptokinase; Thrombosis | 1965 |
Effect of fibrinolysis on adhesion and aggregation of human platelets.
Topics: Adenine Nucleotides; Aged; Aminocaproates; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Collagen; Cyclohexanecarboxylic Acids; Factor VIII; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Middle Aged; Streptokinase; Suspensions; Thrombosis | 1968 |
Plasmatic and platelet anti-plasmins and anti-activators. 3. Results in normal people, in patients and in those with venous thrombosis.
Topics: Antifibrinolytic Agents; Blood Platelets; Blood Protein Electrophoresis; Enzymes; Fibrinogen; Fibrinolysin; Freezing; Humans; Liver Cirrhosis; Temperature; Thrombosis | 1969 |
[New approaches in the diagnosis of thrombosis and arteriosclerosis by the use of radioactive lytic and coagulating substances].
Topics: Animals; Arteriosclerosis; Blood Coagulation; Dogs; Fibrinogen; Fibrinolysin; Hemolysis; Iodine Radioisotopes; Rabbits; Streptokinase; Thrombosis | 1967 |
Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
Topics: Animals; Arthritis, Rheumatoid; Blood Coagulation Tests; Cats; Cattle; Chromatography, Gel; Electrophoresis; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Liver Cirrhosis; Methods; Prothrombin Time; Rabbits; Staphylococcus; Streptokinase; Thrombin; Thrombosis; Time Factors | 1970 |
A serum-induced defect in fibrin formation.
Topics: Animals; Blood; Blood Coagulation Disorders; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Humans; Male; Microscopy, Electron; Plasma; Rabbits; Serum Globulins; Spectrophotometry; Thrombelastography; Thrombin; Thrombosis | 1970 |
Experimental models of defibrination states.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelet Disorders; Blood Platelets; Coagulase; Disease Models, Animal; Dogs; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Mice; Rabbits; Rats; Streptodornase and Streptokinase; Thrombin; Thrombosis; Venoms | 1971 |
The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis.
Topics: Adult; Blood Vessels; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immune Sera; Immunodiffusion; Male; Menstruation; Middle Aged; Surgical Procedures, Operative; Thrombosis | 1972 |
Streptokinase as an adjunct to arterial surgery.
Topics: Adult; Aged; Angiography; Arterial Occlusive Diseases; Blood Coagulation Tests; Female; Femoral Artery; Fibrinogen; Fibrinolysin; Humans; Iliac Artery; Infusions, Parenteral; Male; Middle Aged; Popliteal Artery; Pulse; Streptokinase; Thrombosis; Time Factors | 1973 |
[Thrombosis and secondary fibrinolysis (author's transl)].
Topics: Adult; Animals; Dogs; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Thrombin; Thrombosis | 1973 |
Characterization of fibrin degradation products in patients on ancrod therapy: comparison with fibrinogen derivatives produced by plasmin.
Topics: Chromatography, Gel; Fibrin; Fibrinogen; Fibrinolysin; Humans; Immunodiffusion; Immunoelectrophoresis; Molecular Weight; Peptide Hydrolases; Thrombosis; Venoms | 1974 |
Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay into study of certain hypercoagulable states.
Topics: Adult; Antibodies; Antibodies, Anti-Idiotypic; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Platelet Disorders; Clot Retraction; Erythrocytes; Factor X; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Male; Plasminogen; Platelet Adhesiveness; Pulmonary Embolism; Stimulation, Chemical; Thrombin; Thrombophlebitis; Thrombosis | 1973 |
Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
Topics: Animals; Aprotinin; Blood Coagulation; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Fibrinolysin; Hirudins; Humans; Immunoassay; Immunodiffusion; Iodine Radioisotopes; Methods; Molecular Weight; Prothrombin Time; Rabbits; Thrombin; Thrombosis; Time Factors | 1973 |
[Value of various coagulation studies in the diagnosis of thromboses].
Topics: Blood Coagulation Tests; Disseminated Intravascular Coagulation; Evaluation Studies as Topic; Factor XIII; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Humans; Plasminogen; Postoperative Complications; Prothrombin; Thrombosis | 1974 |
Eosinophil mobilization during disseminated intravascular coagulation.
Topics: Adrenocorticotropic Hormone; Animals; Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Bone Marrow Examination; Cell Movement; Dogs; Eosinophils; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Humans; Photomicrography; Thrombin; Thrombosis | 1969 |
Interaction of angiotensin with disseminated intravascular coagulation: a possible mechanism in the genesis of acute renal failure.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Cell Count; Capillaries; Creatinine; Disseminated Intravascular Coagulation; Fibrinogen; Kidney; Kidney Cortex Necrosis; Kidney Glomerulus; Rabbits; Renin; Thrombin; Thrombosis | 1973 |
Modification of platelet function.
Topics: Animals; Antigen-Antibody Complex; Aspirin; Blood Coagulation; Blood Platelets; Calcium; Cell Movement; Cyclic AMP; Dipyridamole; Energy Transfer; Fibrinogen; Histamine H1 Antagonists; Humans; Platelet Adhesiveness; Prostaglandins; Rabbits; Thrombosis; Xanthines | 1972 |
Fibrinogen and its derivatives, hereditary and acquired abnormalities.
Topics: Blood Protein Disorders; Disseminated Intravascular Coagulation; Disulfides; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Fibrinolysis; Humans; Molecular Conformation; Molecular Weight; Peptide Fragments; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator; Venoms | 1974 |
Thrombus formation in the arterial and venous circulation in hypofibrinogenemic dogs.
Topics: Afibrinogenemia; Animals; Arteries; Blood Cell Count; Blood Circulation; Blood Platelets; Blood Vessel Prosthesis; Dogs; Erythrocyte Count; Female; Fibrinogen; Hematocrit; Hemostatics; Male; Peptide Hydrolases; Snake Venoms; Thrombosis; Veins | 1974 |
[Certain indicators of blood coagulation in acute occlusion of the mesenteric vessels in experimental studies].
Topics: Acute Disease; Animals; Blood Cell Count; Blood Coagulation; Dogs; Fibrinogen; Fibrinolysis; Hematocrit; Mesenteric Vascular Occlusion; Thrombocytopenia; Thrombosis | 1974 |
Incorporation of 131I-fibrinogen in a coronary artery thrombus, detected in vivo with a scintillation camera.
Topics: Animals; Cardiac Catheterization; Coronary Disease; Dogs; Electrocardiography; Electrodes; Fibrinogen; Heart Ventricles; Injections, Intravenous; Iodine Radioisotopes; Male; Scintillation Counting; Technetium; Thrombosis; Ventricular Fibrillation | 1974 |
[Platelets and vanous thrombosis].
Topics: Blood Coagulation Factors; Blood Platelet Disorders; Fibrinogen; Humans; Thrombin; Thrombophlebitis; Thrombosis | 1974 |
What factors determine thrombogenicity.
Topics: Blood Coagulation Factors; Blood Platelets; Factor XII; Fibrinogen; Platelet Adhesiveness; Surface Tension; Thrombosis | 1972 |
Some methods for in vitro estimation of the blood compatibility of biomaterials.
Topics: Animals; Biomedical Engineering; Blood Coagulation Tests; Blood Platelets; Cellulose; Fibrinogen; Fluorocarbon Polymers; Glass; Methylmethacrylates; Nylons; Platelet Adhesiveness; Polyethylenes; Prostheses and Implants; Silicone Elastomers; Thrombosis | 1972 |
Fibrin cross-linkage, thrombosis and pregnancy.
Topics: Blood Coagulation; Chemical Precipitation; Drug Stability; Factor XIII; Female; Fibrin; Fibrinogen; Humans; Light; Naphthols; Pregnancy; Pregnancy Complications; Solubility; Thrombosis; Time Factors; Urea | 1972 |
Our ancient heritage in blood clotting and some of its consequences.
Topics: Amino Acid Sequence; Amino Acids; Animals; Biological Evolution; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Contraceptives, Oral; Enzyme Activation; Enzyme Precursors; Factor XIII; Factor XIII Deficiency; Female; Fibrin; Fibrinogen; Glutamine; Humans; Neoplasms, Experimental; Peptides; Pregnancy; Thrombin; Thrombosis; Transferases | 1972 |
Effect of combined administration of EACA and heparin on thrombus weight and fibrinolysis. An experimental study.
Topics: Administration, Oral; Aminocaproates; Animals; Anticoagulants; Antifibrinolytic Agents; Aorta; Drug Synergism; Fibrinogen; Fibrinolysis; Heparin; Injections, Subcutaneous; Ligation; Male; Prothrombin Time; Rats; Thrombosis | 1973 |
Peripheral vascular disease today.
Topics: Angiography; Arterial Occlusive Diseases; Arteries; Arteriosclerosis Obliterans; Female; Fibrinogen; Fibrinolytic Agents; Foot Diseases; Heparin; Humans; Intermittent Claudication; Lymphedema; Male; Methods; Plethysmography, Impedance; Thrombosis; Ultrasonography; Vascular Diseases; Venous Insufficiency | 1973 |
Dynamic viscoelasticity of blood during clotting in health and disease.
Topics: Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Sedimentation; Blood Viscosity; Diabetes Mellitus; Elasticity; Female; Fibrinogen; Hematocrit; Humans; Infections; Leukemia, Myeloid; Male; Neoplasms; Polycythemia Vera; Rheology; Thrombosis | 1973 |
The action of atromid-s on lipids and other factors which may be involved in arterial thrombosis.
Topics: Administration, Oral; Animals; Blood Coagulation; Blood Platelets; Clofibrate; Fatty Acids, Nonesterified; Fibrinogen; Humans; Lipid Metabolism; Lipids; Platelet Adhesiveness; Rats; Thrombosis | 1972 |
[Diagnosis and treatment of obstetric thrombohemorrhagic syndrome].
Topics: Animals; Blood Coagulation; Female; Fibrinogen; Heparin; Humans; Placental Extracts; Postpartum Hemorrhage; Pregnancy; Rabbits; Syndrome; Thrombosis | 1974 |
[Immunofluorescence of neutrophil leukocytes as evidence of phagocytosis of fibrinogen, fibrin or their metabolites].
Topics: Fibrin; Fibrinogen; Fluorescent Antibody Technique; Humans; Neutrophils; Phagocytosis; Thrombosis | 1972 |
Renal allograft rejection in the rat studied with 125 I-fibrinogen.
Topics: Animals; Fibrin; Fibrinogen; Graft Rejection; Hydronephrosis; Iodine Isotopes; Kidney; Kidney Transplantation; Microscopy, Fluorescence; Rats; Rats, Inbred Strains; Renal Veins; Thrombosis; Transplantation Immunology; Transplantation, Homologous | 1972 |
The detection of fibrinogen degradation products (FDP) in serum and urine.
Topics: Chemical Phenomena; Chemistry; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Kidney Transplantation; Latex Fixation Tests; Thrombosis; Transplantation, Homologous | 1972 |
Tracheal aspiration and fiber optic bronchoscopy.
Topics: Adult; Fibrinogen; Graft Rejection; Humans; Iodine Radioisotopes; Kidney Transplantation; Thrombophlebitis; Thrombosis; Transplantation, Homologous | 1972 |
The use of 125 I-fibrinogen in the detection of renal allograft rejection. Rat model.
Topics: Acute Kidney Injury; Animals; Anuria; Fibrinogen; Graft Rejection; Hydronephrosis; Iodine Isotopes; Kidney; Kidney Transplantation; Rats; Rats, Inbred Strains; Renal Artery Obstruction; Thrombosis; Transplantation, Homologous | 1973 |
Detection of renal allograft rejection with (125I) fibrinogen.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Diagnosis, Differential; Disease Models, Animal; Fibrin; Fibrinogen; Graft Rejection; Hydronephrosis; Iodine Radioisotopes; Kidney Transplantation; Ligation; Protein Binding; Rabbits; Renal Artery Obstruction; Renal Veins; Thrombophlebitis; Thrombosis; Transplantation, Homologous | 1973 |
Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
Topics: ABO Blood-Group System; Blood Coagulation; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Diabetes Mellitus; Erythrocytes; Fibrinogen; Graft Rejection; Hematocrit; Hemophilia A; Humans; Hyperthyroidism; Kidney Failure, Chronic; Kidney Transplantation; Melanoma; Myocardial Infarction; Prognosis; Rheology; Serum Albumin; Thrombosis; Transplantation, Homologous | 1973 |
Production of the generalized Shwartzman reaction in rabbits by ancrod ('Arvin') infusion and endotoxin injection.
Topics: Analysis of Variance; Animals; Blood Cell Count; Blood Platelets; Capillaries; Endotoxins; Factor V; Female; Fibrin; Fibrinogen; Heparin; Kidney Glomerulus; Male; Prothrombin; Rabbits; Salmonella enteritidis; Shwartzman Phenomenon; Snakes; Thrombosis; Venoms | 1973 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin; Fibrinogen; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Iodine Radioisotopes; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Plasminogen; Proteinuria; Thrombosis; Transplantation, Homologous; Uremia; Warfarin | 1974 |
Analysis of platelet, red cell and fibrin content in experimental arterial and venous thrombi.
Topics: Animals; Blood Cell Count; Blood Platelets; Carotid Artery Thrombosis; Chromium Isotopes; Dogs; Erythrocytes; Female; Fibrin; Fibrinogen; Hematocrit; In Vitro Techniques; Iodine Isotopes; Iron Isotopes; Jugular Veins; Male; Microscopy, Phase-Contrast; Radiometry; Scintillation Counting; Thrombophlebitis; Thrombosis | 1974 |
[Contribution of morphology to the identification of fibrinogen derivatives].
Topics: Autopsy; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; In Vitro Techniques; Kupffer Cells; Phagocytosis; Thrombosis | 1974 |
A qualitative platelet defect in severe vitamin B 12 deficiency. Response, hyperresponse, and thrombosis after vitamin B 12 therapy.
Topics: Adenosine Diphosphate; Aged; Biological Assay; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelet Disorders; Collagen; Colorimetry; Epinephrine; Female; Fibrinogen; Folic Acid; Humans; Lacticaseibacillus casei; Male; Middle Aged; Platelet Adhesiveness; Prothrombin Time; Radioisotope Dilution Technique; Schilling Test; Thromboplastin; Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency | 1973 |
Coagulation changes induced by endotoxin and purified contact activation product.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Endotoxins; Factor V; Factor VIII; Female; Fibrinogen; Jugular Veins; Male; Rabbits; Shwartzman Phenomenon; Swine; Thrombelastography; Thrombosis | 1972 |
[Ovarian cancer with diffuse vascular thrombosis. Endocardial, arterial and venous involvement. Disseminated intravascular coagulation with cryofibrinogen].
Topics: Cerebrovascular Disorders; Cold Temperature; Cystadenocarcinoma; Diplopia; Disseminated Intravascular Coagulation; Edema; Encephalomalacia; Endocarditis; Female; Fibrinogen; Foot Diseases; Gangrene; Hemiplegia; Heparin; Humans; Ischemia; Middle Aged; Ovarian Neoplasms; Thrombophlebitis; Thrombosis; Vena Cava, Superior | 1972 |
Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature.
Topics: Adolescent; Adult; Aged; Alcoholism; Blood Protein Disorders; Cryoglobulins; Diabetes Mellitus; Female; Fibrinogen; Humans; Hypertension; Leukocyte Count; Male; Middle Aged; Neoplasms; Poisoning; Thromboembolism; Thrombosis; Trypsin Inhibitors; Wounds and Injuries | 1972 |
Fibrinolysis by protease of Aspergillus ochraceus.
Topics: Animals; Aorta, Abdominal; Aspergillus; Blood Cell Count; Blood Coagulation; Blood Platelets; Brachial Artery; Dogs; Endothelium; Fibrinogen; Fibrinolysis; Injections, Intravenous; Peptide Hydrolases; Rabbits; Thrombin; Thrombosis; Time Factors | 1972 |
Counterelectrophoresis test for molecules immunologically similar to fibrinogen.
Topics: Afibrinogenemia; Animals; Antibodies; Fibrin; Fibrinogen; Hemorrhage; Humans; Immune Sera; Immunoelectrophoresis; Rabbits; Thromboembolism; Thrombosis | 1972 |
Platelet and fibrinogen consumption in man.
Topics: Blood Cell Count; Blood Platelets; Catheterization; Cell Survival; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolytic Agents; Heart Valve Prosthesis; Hemolytic-Uremic Syndrome; Heparin; Humans; Inflammation; Neoplasms; Postoperative Complications; Purpura, Thrombotic Thrombocytopenic; Sepsis; Surgical Procedures, Operative; Thromboembolism; Thrombophlebitis; Thrombosis; Vascular Diseases | 1972 |
[An attempt to determine certain physical features of thrombus and its dynamic structure].
Topics: Animals; Blood Platelets; Clot Retraction; Elasticity; Fibrinogen; Hemostasis; Humans; Purpura, Thrombocytopenic; Rabbits; Rats; Surface Tension; Thrombelastography; Thrombosis | 1972 |
A serial dilution protamine sulphate test for detecting fibrin degradation products.
Topics: Adolescent; Adult; Buffers; Female; Fibrin; Fibrinogen; Heparin; Humans; Male; Middle Aged; Protamines; Pulmonary Embolism; Sulfates; Thromboembolism; Thrombophlebitis; Thrombosis; Tromethamine | 1973 |
Deep vein thrombosis in a Queensland hospital.
Topics: Adult; Age Factors; Aged; Australia; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Postoperative Complications; Thrombophlebitis; Thrombosis; Ultrasonics | 1973 |
Natural history of thrombophlebitis and its relationship to pulmonary embolism.
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Thrombophlebitis; Thrombosis | 1973 |
Relationship of fibrinolytic system to postoperative thrombotic phenomena.
Topics: Adult; Age Factors; Aged; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Postoperative Complications; Sex Factors; Thrombosis | 1973 |
The clinical significance of the plasminogen level.
Topics: Adolescent; Adult; Afibrinogenemia; Blood Coagulation Tests; Contraceptives, Oral; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Infections; Liver Cirrhosis; Male; Menstruation; Middle Aged; Myocardial Infarction; Neoplasms; Plasminogen; Sex Factors; Surgical Procedures, Operative; Thrombosis; Wounds and Injuries | 1973 |
Thrombogenic properties of vascular catheter materials in vivo. A device and objective method of comparing thrombus formation on vascular catheter materials.
Topics: Animals; Blood Platelets; Catheterization; Chromium Isotopes; Dogs; Erythrocyte Count; Erythrocytes; Fibrinogen; Hematocrit; Iodine Isotopes; Iron Isotopes; Methods; Polyethylenes; Polytetrafluoroethylene; Thrombosis | 1973 |
Review of knowledge obtained from the 125I-fibrinogen technique.
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Thrombosis | 1973 |
Intravascular coagulation: the cause of necrotic arachnidism.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Endothelium; Female; Fibrin; Fibrinogen; Hemorrhage; Injections, Intradermal; Microscopy, Electron; Necrosis; Prothrombin Time; Rabbits; Spider Bites; Spiders; Thrombosis; Time Factors; Venoms | 1973 |
Aspirin in the prevention of thrombosis.
Topics: Aspirin; Fibrinogen; Humans; Iodine Radioisotopes; Platelet Adhesiveness; Postoperative Complications; Thrombosis | 1973 |
Postoperative thromboembolism. A clinical study with 125I-fibrinogen and pulmonary scanning.
Topics: Adult; Age Factors; Aged; Aneurysm; Cholecystectomy; Diagnostic Errors; Femoral Artery; Fibrinogen; Humans; Iodine Radioisotopes; Leg; Middle Aged; Phlebography; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Thromboembolism; Thrombosis; Time Factors | 1973 |
Determination of fibrinogen in normal human plasma in the presence and absence of anticoagulants.
Topics: Blood Proteins; Chemical Precipitation; Fibrinogen; Heparin; Humans; Mercury; Methods; Potassium; Thiocyanates; Thrombin; Thrombosis | 1973 |
Coagulation studies in patients treated with defibrase.
Topics: Animals; Antithrombins; Factor V; Factor VIII; Factor X; Factor XII; Factor XIII; Fibrin; Fibrinogen; Humans; Immunoelectrophoresis; Macroglobulins; Peptide Hydrolases; Plasminogen; Prothrombin; Snakes; Thrombin; Thrombosis; Venoms | 1973 |
Fibrin-fibrinogin degradation products in cardiovascular surgery.
Topics: Adult; Aged; Agglutination Tests; Biodegradation, Environmental; Blood Coagulation Tests; Cardiac Surgical Procedures; Child; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Middle Aged; Protamines; Serologic Tests; Staphylococcus; Thrombosis; Time Factors | 1973 |
Decreased fibrinolysis in Behçet's disease.
Topics: Adult; Behcet Syndrome; Blood Coagulation; Factor VIII; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Thrombophlebitis; Thrombosis | 1973 |
Action of coagulation factors on experimental thrombogenesis and their changes after thrombosis.
Topics: Animals; Aspirin; Benzopyrans; Blood; Blood Cell Count; Blood Coagulation Factors; Blood Platelets; Fibrinogen; Hematocrit; Jugular Veins; Ketones; Male; Rats; Thrombosis | 1973 |
Protein interactions with materials as related to thromboresistance.
Topics: Adsorption; Binding Sites; Blood Proteins; Fibrinogen; Heparin; Microscopy, Electron; Minerals; Potassium; Surface Properties; Thrombosis | 1973 |
[The diagnostic use of labeled fibrinogen].
Topics: Angiography; Fibrinogen; Humans; Iodine Radioisotopes; Thrombophlebitis; Thrombosis | 1973 |
Fibrinogen derivatives with a higher molecular weight than that of the parent molecule in cord vein plasma of newborns. II. Further characterization from pooled plasma.
Topics: Asphyxia Neonatorum; Blood; Blood Protein Electrophoresis; Electrophoresis, Polyacrylamide Gel; Electrophoresis, Starch Gel; Fibrinogen; Humans; Infant, Newborn; Infant, Newborn, Diseases; Molecular Weight; Thrombin; Thrombosis; Umbilical Veins | 1973 |
Viscosity of blood in patients with myocardial infarction, haemophilia and thyroid diseases. Effect of fibrinogen, albumin and globulin.
Topics: Blood Coagulation; Blood Viscosity; Fibrinogen; Hemophilia A; Humans; Hyperthyroidism; Hypothyroidism; Myocardial Infarction; Serum Albumin; Serum Globulins; Stress, Mechanical; Thrombosis; Thyroid Diseases | 1973 |
[Valve of arachidonic acid in the prevention of depression of the anticoagulating system of the blood in animals on an atherogenic diet].
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Blood Coagulation; Diet, Atherogenic; Fibrinogen; Fibrinolysis; Male; Rats; Thrombosis | 1973 |
[The significance of blood coagulation in the pathogenesis of acute experimental pneumonias].
Topics: Acute Disease; Animals; Blood Coagulation; Drug Therapy, Combination; Factor V; Factor VII; Female; Fibrinogen; Fibrinolysis; Heparin; Male; Penicillin G Benzathine; Pneumonia, Pneumococcal; Prothrombin; Rabbits; Thrombin; Thrombosis | 1973 |
[Radio-fibrinogen test in venous thrombosis].
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Phlebography; Thrombophlebitis; Thrombosis | 1973 |
Thrombolytic therapy with streptokinase: a retrospective study.
Topics: Antibody Formation; Blood Coagulation Tests; Dose-Response Relationship, Drug; Fibrinogen; Humans; Plasminogen; Recurrence; Retrospective Studies; Streptokinase; Thrombophlebitis; Thrombosis; Time Factors | 1973 |
Fibrinogen responses following thrombosis.
Topics: Animals; Arteries; Blood; Dogs; Female; Fibrin; Fibrinogen; Fibrinolysis; Iodine Radioisotopes; Thrombosis; Veins | 1973 |
[Research on thrombogenesis in chronic obliterating arteriopathies of the extremities].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Blood Coagulation Disorders; Chronic Disease; Coronary Disease; Extremities; Female; Fibrinogen; Humans; Lipids; Lipoproteins; Male; Middle Aged; Platelet Adhesiveness; Smoking; Thromboangiitis Obliterans; Thrombosis | 1973 |
Gas transfer and thrombogenesis in an annular membrane oxygenator with active blood mixing.
Topics: Animals; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Carbon Dioxide; Cattle; Dogs; Electrocardiography; Extracorporeal Circulation; Fibrinogen; Heart Rate; Heart-Lung Machine; Hematocrit; Hemoglobins; Heparin; Hydrogen-Ion Concentration; Membranes, Artificial; Oxygen; Oxygenators, Membrane; Thrombosis | 1973 |
The role of coagulation in renal disease.
Topics: Acute Kidney Injury; Basement Membrane; Blood Coagulation Disorders; Diabetic Nephropathies; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Fibrinolysis; Glomerulonephritis; Hemagglutination Tests; Hemolytic-Uremic Syndrome; Humans; Ischemia; Kidney; Kidney Diseases; Male; Middle Aged; Pre-Eclampsia; Pregnancy; Thrombosis; Urokinase-Type Plasminogen Activator | 1973 |
Chronic intravascular coagulation: localized or generalized? With evidence for thrombus turnover.
Topics: Adult; Aged; Aneurysm; Aortic Aneurysm; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Platelets; Buttocks; Cell Survival; Chromium Radioisotopes; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Hemangioma; Humans; Iodine Radioisotopes; Middle Aged; Purpura, Thrombocytopenic; Skin Neoplasms; Syndrome; Thrombosis | 1973 |
Incorporation of radiolabelled fibrinogen into venous thrombi induced in dogs.
Topics: Animals; Dogs; Fibrinogen; Iodine Radioisotopes; Pulmonary Embolism; Pulmonary Veins; Serum Albumin, Radio-Iodinated; Thrombosis | 1974 |
Current thoughts on venous thromboembolism.
Topics: Anticoagulants; Blood Flow Velocity; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Radioisotopes; Leg; Pain; Phlebography; Plethysmography; Pulmonary Embolism; Radionuclide Imaging; Streptokinase; Thromboembolism; Thrombophlebitis; Thrombosis; Ultrasonography | 1974 |
Letter: Surface charge, protein adsorption, and thrombosis.
Topics: Adsorption; Blood Proteins; Fibrinogen; Platelet Adhesiveness; Surface Properties; Thrombosis | 1974 |
Thrombus formation in stainless steel tubes used as vascular implants in the dog.
Topics: Animals; Arteries; Blood Cell Count; Blood Platelets; Disease Models, Animal; Dogs; Erythrocyte Count; Fibrinogen; Hematocrit; Stainless Steel; Thrombosis; Time Factors; Veins | 1974 |
The behavior of isotope labelled blood proteins in thrombosis.
Topics: Animals; Blood Proteins; Chromatography, Affinity; Dogs; Electrophoresis, Polyacrylamide Gel; Embolism; Fibrin; Fibrinogen; Humans; Iodine Radioisotopes; Plasminogen; Serum Albumin, Radio-Iodinated; Sodium Dodecyl Sulfate; Thrombosis | 1974 |
Letter: Thrombosis and myocardial infarction.
Topics: Acidosis; Death, Sudden; Fibrinogen; Humans; Hypoxia; Myocardial Infarction; Thrombosis; Time Factors | 1974 |
Pharmacological fibrinolysis in diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Drug Interactions; Drug Therapy, Combination; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Humans; Male; Obesity; Phenformin; Thrombosis | 1974 |
[Coronary thrombosis in acute myocardial infarct, is it a primary or secondary phenomenon?].
Topics: Acute Disease; Aged; Autopsy; Coronary Disease; Electrocardiography; Female; Fibrinogen; Humans; Iodine Radioisotopes; Male; Myocardial Infarction; Necrosis; Thrombosis; Time Factors | 1974 |
Soluble fibrin complexes in experimental thrombotic states.
Topics: Animals; Blood; Blood Coagulation Disorders; Blood Coagulation Factors; Chromatography; Dextrans; Dogs; Fibrin; Fibrinogen; Hemostasis; Protamines; Solubility; Thrombosis | 1974 |
The possible use of 125I-labeled fibrinogen for the detection of mural thrombosis following myocardial infarction.
Topics: Aged; Autopsy; Cardiac Tamponade; Electrocardiography; Fibrinogen; Hemiplegia; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Infarction; Pericarditis; Thrombophlebitis; Thrombosis; Time Factors; Ventricular Fibrillation | 1974 |
Thrombus formation in the arterial and venous circulation in thrombocytopenic dogs.
Topics: Animals; Arteries; Blood Cell Count; Blood Platelets; Dogs; Erythrocytes; Female; Fibrin; Fibrinogen; Immune Sera; Iodine Radioisotopes; Male; Platelet Adhesiveness; Thrombocytopenia; Thrombophlebitis; Thrombosis; Veins | 1974 |
Influence of fibrinogen split products on platelets.
Topics: Animals; Blood Platelets; Dogs; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Immunoelectrophoresis; Microscopy, Electron; Microscopy, Phase-Contrast; Prothrombin; Thrombin; Thrombosis | 1967 |
Effects of Thorotrast upon the reactivity and intravascular disappearance rate of fibrinogen in the rabbit.
Topics: Animals; Anticoagulants; Blood Coagulation; Fibrinogen; Iodine Isotopes; Kidney Cortex Necrosis; Microscopy, Phase-Contrast; Rabbits; Thorium Dioxide; Thrombosis | 1968 |
Liver transplantation in man--IV, Haemorrhage and thrombosis.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Child, Preschool; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Thrombosis; Transplantation, Homologous | 1969 |
Induction of intravascular coagulation and renal cortical necrosis in rabbits by simultaneous injection of thorotrast and endotoxin.
Topics: Animals; Endotoxins; Escherichia coli; Fibrinogen; Injections, Intravenous; Kidney Cortex Necrosis; Rabbits; Thorium Dioxide; Thrombosis | 1969 |
Clearance of coagulation and fibrinolysis products by the reticuloendothelial system.
Topics: Animals; Biopsy; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Bone Marrow Examination; Dogs; Embolism; Endotoxins; Escherichia coli; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Fluorescent Antibody Technique; Liver; Microscopy, Electron; Mononuclear Phagocyte System; Neutrophils; Phagocytosis; Platelet Adhesiveness; Precipitin Tests; Protein Denaturation; Spleen; Streptokinase; Thrombin; Thrombosis; Zymosan | 1969 |
[Clinical experience in the diagnosis of thrombosis by use of 125 I-fibrinogen].
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Methods; Radioisotope Dilution Technique; Thrombosis | 1970 |
Thrombolytic therapy with streptokinase.
Topics: Embolism; Fibrinogen; History, 20th Century; Myocardial Infarction; Plasminogen; Prothrombin Time; Pulmonary Embolism; Streptokinase; Thromboembolism; Thrombophlebitis; Thrombosis | 1970 |
[Platelet hyperactivity associated with intravascular coagulation: experimental study in rabbits].
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Factor V; Fibrinogen; Graft Rejection; Kidney Transplantation; Methods; Rabbits; Thrombin; Thromboplastin; Thrombosis; Transplantation Immunology; Transplantation, Homologous | 1971 |
Separation and estimation split "products" of fibrinogen and fibrin in human serum.
Topics: Aminocaproates; Aprotinin; Cellulose; Chromatography; Chromatography, Gel; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Immunoelectrophoresis; Liver Diseases; Macroglobulins; Neoplasms; Plasminogen; Streptokinase; Thrombin; Thrombosis | 1967 |
Quantitation of circulating fibrinogen breakdown products in intravascular clotting.
Topics: Fibrinogen; Thrombosis | 1966 |
Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis.
Topics: Adrenal Glands; Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Endotoxins; Female; Fibrinogen; Haplorhini; Liver; Lung; Lymph Nodes; Male; Plague; Pneumonia; Sepsis; Spleen; Thrombosis; Yersinia pestis | 1968 |
A specific inhibitor of human clotting factor V.
Topics: Aged; Antibodies; Anticoagulants; Blood Coagulation Tests; Blood Transfusion; Electrophoresis; Factor V; Factor XI; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Immunodiffusion; Pulmonary Embolism; Thrombosis | 1968 |
Thrombosis and blood coagulation. A study by quantitative N-terminal amino acid analysis.
Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Autoanalysis; Binding Sites; Blood Coagulation; Cattle; Chemical Phenomena; Chemistry; Edetic Acid; Fibrin; Fibrinogen; Glycine; Humans; Immunoelectrophoresis; Models, Biological; Thrombin; Thrombosis; Tyrosine | 1970 |
Studies on pharmacological enhancement of blood fibrinolytic activity.
Topics: Aged; Arteriosclerosis; Clofibrate; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Immunodiffusion; Male; Metformin; Middle Aged; Plasminogen; Serum Globulins; Stimulation, Chemical; Testosterone; Thrombosis; Tolazamide | 1970 |
Coagulation studies in 45 cases of nephrotic syndrome without uremia.
Topics: Adolescent; Adult; Aged; Antigens; Antithrombins; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Child; Child, Preschool; Factor V; Factor VIII; Female; Fibrin; Fibrinogen; Hemiplegia; Humans; Immune Sera; Immunodiffusion; Male; Middle Aged; Nephrotic Syndrome; Phlebitis; Pulmonary Artery; Renal Veins; Thrombophlebitis; Thrombosis | 1970 |
The effect of intravascular and extravascular coagulation on serum fibrin degradation products in rats.
Topics: Animals; Antigens; Blood Coagulation; Disseminated Intravascular Coagulation; Erythrocytes; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Immune Sera; Immunodiffusion; Immunoelectrophoresis; Injections, Intravenous; Peptides; Pulmonary Embolism; Rats; Thrombin; Thrombosis; Venae Cavae | 1971 |
[Diagnosis of thrombosis with I 125 -labelled fibrinogen].
Topics: Aged; Female; Fibrinogen; Humans; Iodine Isotopes; Male; Middle Aged; Thrombosis | 1972 |
Development of blood-compatible elastomers. 3. Hematologic effects of Avcothane intra-aortic balloon pumps in cardiac patients.
Topics: Aorta, Thoracic; Assisted Circulation; Biocompatible Materials; Blood Coagulation; Blood Platelets; Erythrocyte Count; Fibrinogen; Hemodynamics; Hemoglobinometry; Humans; Leukocyte Count; Microscopy, Electron, Scanning; Polyurethanes; Silicone Elastomers; Thrombosis | 1972 |
[Consumption coagulopathies].
Topics: Aminobenzoates; Aminocaproates; Blood Coagulation Disorders; Blood Transfusion; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Heparin; Humans; Methylamines; Streptokinase; Thrombelastography; Thrombosis | 1972 |
Localization of ferritin-conjugated anti-fibrin-fibrinogen in platelet aggregates produced in vitro.
Topics: Adenosine Diphosphate; Antigen-Antibody Complex; Blood Platelets; Ferritins; Fibrinogen; Humans; Immunoelectrophoresis; In Vitro Techniques; Microscopy, Electron; Platelet Adhesiveness; Thrombosis | 1972 |
[Blood coagulation changes in splenic diseases].
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Dogs; Fibrinogen; Fibrinolysis; Heparin; Humans; Leukocyte Count; Liver Cirrhosis; Prothrombin; Spleen; Splenectomy; Splenic Diseases; Splenic Infarction; Splenic Rupture; Splenic Vein; Splenomegaly; Thrombosis; Time Factors; Tissue Extracts | 1972 |
[Diagnostics and therapy of hemolytic-hemorrhagic transfusion incidents].
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Factor V; Factor VIII; Factor XIII; Fibrinogen; Humans; Microcirculation; Prothrombin; Thromboplastin; Thrombosis; Toxins, Biological; Transfusion Reaction | 1972 |
Recurrent venous thrombosis and portal hypertension.
Topics: Adult; Blood Protein Disorders; Cold Temperature; Fibrinogen; Humans; Hypertension, Portal; Male; Recurrence; Syndrome; Thrombophlebitis; Thrombosis | 1972 |
[Biochemical diagnosis of thrombosis and thromboembolism of the pulmonary artery following pneumonectomy].
Topics: Adult; Blood Coagulation Tests; Fibrinogen; Humans; Lung Neoplasms; Middle Aged; Pneumonectomy; Postoperative Complications; Pulmonary Artery; Thromboembolism; Thrombosis | 1971 |
Hemangioma with thrombocytopenia and microangiopathic anemia (Kasabach-Merritt syndrome): an animal model.
Topics: Anemia; Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Cell Aggregation; Cell Survival; Disease Models, Animal; Fibrinogen; Hemangioma; Hematocrit; Heparin; Iodine Isotopes; Mice; Microscopy, Electron; Plasma Volume; Purpura, Thrombocytopenic; Skin Neoplasms; Thrombosis | 1971 |
[Early diagnosis of deep venons thromboses using radioisotope labelled human fibrinogen].
Topics: Adult; Aged; Fibrinogen; Hepatitis B; Humans; Iodine Radioisotopes; Middle Aged; Radionuclide Imaging; Thrombosis | 1971 |
[Evaluation of Doppler ultrasound].
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Methods; Thrombosis; Ultrasonography | 1971 |
[Blood coagulation analysis and pathologic-anatomical studies in cases of traumatic shock].
Topics: Adolescent; Adult; Aged; Autopsy; Blood Cell Count; Blood Coagulation; Blood Platelets; Child; Female; Fibrinogen; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Platelet Adhesiveness; Shock, Traumatic; Thrombosis | 1971 |
Blood hypercoagulability, thrombosis, and acute myocardial infarction.
Topics: Acute Disease; Blood Coagulation Disorders; Chromatography; Fibrin; Fibrinogen; Humans; Myocardial Infarction; Thrombosis | 1971 |
Blood rheological abnormalities complicating blood hypercoagulable-thrombotic states.
Topics: Blood Coagulation; Blood Viscosity; Chromatography; Fibrinogen; Humans; Myocardial Infarction; Rheology; Thrombosis | 1971 |
[Diagnosis of thrombosis with 125-I-labelled fibrinogen. Method and recent clinical results].
Topics: Female; Femoral Fractures; Fibrinogen; Humans; Iodine Radioisotopes; Male; Methods; Postoperative Complications; Thrombosis | 1971 |
Disseminated intravascular coagulation in experimental heatstroke.
Topics: Animals; Blood Coagulation Factors; Blood Platelets; Blood Vessels; Body Temperature; Disseminated Intravascular Coagulation; Dogs; Fibrinogen; Fibrinolysis; Heat Exhaustion; Hematocrit; Hemorrhage; Prothrombin Time; Thrombosis | 1971 |
Diabetes and atherosclerosis.
Topics: Adult; Age Factors; Aorta; Arteries; Arteriosclerosis; Autopsy; Cholesterol; Coronary Disease; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Fibrinogen; Humans; Insulin; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Platelet Adhesiveness; Sex Factors; Thrombosis; Triglycerides | 1971 |
[Cryofibrinogenemia].
Topics: Aged; Blood Coagulation Disorders; Cold Temperature; Edema; Female; Fibrinogen; Humans; Leg Ulcer; Male; Meniere Disease; Necrosis; Purpura; Thrombophlebitis; Thrombosis | 1971 |
[Coagulation changes following injection of a purified contact activation product].
Topics: Animals; Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Disseminated Intravascular Coagulation; Endotoxins; Factor V; Factor VIII; Factor XI; Female; Fibrinogen; Male; Rabbits; Salmonella typhi; Thrombelastography; Thrombosis | 1971 |
[Some indices of the blood coagulation system and thrombus-formation in patients with diabetes mellitus].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Factor XIII; Fibrinogen; Fibrinolysis; Heparin; Humans; Middle Aged; Prothrombin; Thrombelastography; Thrombin; Thrombosis | 1971 |
Disseminated intravascular coagulation.
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Blood Transfusion; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Shock; Surface-Active Agents; Surgical Procedures, Operative; Thrombosis; Venoms | 1971 |
Kasabach-Merritt syndrome: coagulo--analytical observations.
Topics: Adult; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Disseminated Intravascular Coagulation; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Hemangioma; Heparin; Humans; Male; Plasminogen; Platelet Adhesiveness; Postoperative Complications; Prothrombin; Purpura, Thrombocytopenic; Skin Neoplasms; Thrombelastography; Thrombosis | 1971 |
Examination of postoperative thrombosis by means of fibrinogen-I-125.
Topics: Female; Femoral Vein; Fibrinogen; Genital Diseases, Female; Hematoma; Humans; Iliac Vein; Iodine Isotopes; Methods; Pelvis; Phlebography; Postoperative Complications; Thrombosis | 1971 |
Studies on blood coagulation and fibrinolysis in conditions associated with an increased incidence of thrombosis. Methodological and clinical investigations.
Topics: Adult; Blood Coagulation; Contraceptives, Oral; Female; Fibrinogen; Fibrinolysis; Humans; Hydrogen-Ion Concentration; Methods; Plasminogen; Postpartum Period; Pregnancy; Surgical Procedures, Operative; Thrombosis; Time Factors | 1970 |
The significance of coagulative and thrombotic changes after haemorrhage and injury.
Topics: Acidosis; Animals; Autopsy; Blood Coagulation; Blood Coagulation Disorders; Blood Transfusion; Disseminated Intravascular Coagulation; Dogs; Fibrinogen; Hemolysis; Humans; Hypotension; Prothrombin Time; Shock, Hemorrhagic; Thrombosis; Vasomotor System; Wounds and Injuries | 1970 |
Thromboplastin-induced hypercoagulability and its prevention.
Topics: Animals; Antithrombin III; Aprotinin; Blood Coagulation Disorders; Dogs; Fibrinogen; In Vitro Techniques; Injections, Intravenous; Thromboplastin; Thrombosis | 1965 |
[Blood coagulation in rheumatic heart disease according to the data of a thromboelastographic study].
Topics: Blood Coagulation Disorders; Cardiovascular Diseases; Fibrinogen; Fibrinolysis; Heparin; Humans; Rheumatic Diseases; Rheumatic Heart Disease; Thrombelastography; Thrombosis | 1967 |
[Consumption coagulopathy].
Topics: Aminobenzoates; Aminocaproates; Aprotinin; Blood Coagulation Disorders; Dextrans; Fibrinogen; Fibrinolysis; Heparin; Humans; Microcirculation; Thrombelastography; Thrombosis | 1970 |
[The role of trypsin in the secondary manifestations of acute hemorrhagic pancreatitis].
Topics: Acute Disease; Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Disseminated Intravascular Coagulation; Fibrinogen; Gastrointestinal Hemorrhage; Injections, Intravenous; Kidney; Lung; Microscopy, Electron; Pancreatitis; Rabbits; Thrombosis; Trypsin | 1971 |
[Cancer, hypercoagulability and thrombosis].
Topics: Aprotinin; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Blood Transfusion; Factor VIII; Fibrinogen; Heparin; Humans; Neoplasms; Thrombosis | 1971 |
Infiltration and thrombosis in atherogenesis. A study using immunofluorescent techniques.
Topics: Animals; Arteriosclerosis; Blood Platelets; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Immune Sera; Rabbits; Thrombosis | 1967 |
Fine structure of the bond between platelets in artificial thrombi and in platelet aggregates induced by adenosine diphosphate.
Topics: Adenosine Triphosphate; Adult; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Blood Proteins; Cell Membrane; Factor V; Factor VIII; Factor XII; Fibrin; Fibrinogen; Humans; Methods; Microscopy, Electron; Platelet Adhesiveness; Thrombosis | 1969 |
[Role of erythrocytes in blood coagulation].
Topics: Anemia; Blood Coagulation; Blood Coagulation Factors; Erythrocytes; Fibrinogen; Humans; Hyperemia; Thrombosis | 1969 |
The turnover of fibrinogen in aortic surgery. An experimental study in dogs.
Topics: Animals; Aorta; Dogs; Fibrinogen; Hemostasis; Hypotension; Iodine Isotopes; Postoperative Complications; Thrombosis | 1969 |
[Blood coagulation in experimental shock].
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Blood Vessels; Blood Volume Determination; Dogs; Erythrocyte Count; Female; Fibrinogen; Fibrinolysis; Hypotension; Male; Shock; Shock, Hemorrhagic; Tachycardia; Thrombosis; Time Factors | 1969 |
Drug action--study of plasma protein variations in hyperthrombotic diseases using gel filtration chromatography on agarose.
Topics: Arteriosclerosis; Blood Protein Disorders; Blood Protein Electrophoresis; Blood Proteins; Blood Sedimentation; Cholesterol; Chromatography, Gel; Coronary Disease; Erythrocyte Count; Factor XII; Fibrinogen; Humans; Intracranial Arteriosclerosis; Methods; Molecular Weight; Plasminogen; Polysaccharides; Prothrombin Time; Retinal Vessels; Spectrophotometry; Thrombosis; Ultraviolet Rays | 1969 |
Intravascular coagulation in the lungs in experimental fat embolism.
Topics: Adipose Tissue; Animals; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Embolism, Fat; Factor V; Female; Fibrin; Fibrinogen; Fractures, Bone; Heparin; Hindlimb; Injections, Intravenous; Iodine Isotopes; Lipids; Lung; Pulmonary Embolism; Rabbits; Rats; Thrombosis | 1969 |
Spontaneous and experimental thrombosis in the mouse placenta.
Topics: Animals; Benzopyrans; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelet Disorders; Budd-Chiari Syndrome; Coronary Disease; Female; Fibrin; Fibrinogen; Fibrinolysis; Heparin; Mice; Microscopy; Microscopy, Electron; Placenta; Placenta Diseases; Pregnancy; Pregnancy Complications; Pulmonary Embolism; Renal Veins; Thrombosis; Veins | 1969 |
Defibrination syndrome in abruptio placentae and ABO blood type.
Topics: ABO Blood-Group System; Abruptio Placentae; Blood Coagulation Disorders; Blood Group Incompatibility; Female; Fetomaternal Transfusion; Fibrinogen; Humans; Pregnancy; Thrombosis | 1969 |
[Moschcowitz's disease: consumption coagulopathy?].
Topics: Adult; Anemia, Hemolytic; Blood Coagulation Disorders; Cerebrovascular Disorders; Factor V; Factor VII; Factor X; Fever; Fibrinogen; Hemostasis; Heparin; Humans; Ischemia; Kidney Failure, Chronic; Male; Neurologic Manifestations; Prothrombin Time; Purpura, Thrombotic Thrombocytopenic; Thrombin; Thrombosis | 1969 |
[Clinical significance of blood coagulation studies in lung surgery].
Topics: Blood Coagulation; Blood Coagulation Disorders; Cysts; Fibrinogen; Fibrinolysis; Heparin; Humans; Inflammation; Lung Diseases; Lung Neoplasms; Pneumonectomy; Postoperative Complications; Suppuration; Thrombosis; Time Factors | 1969 |
[Chronic latent intravascular coagulation in the pathogenesis of the thrombophilic syndrome of atheromatous disease].
Topics: Adult; Aged; Arteriosclerosis; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Thrombosis | 1969 |
Adsorption of fibrinogen on modified polytetrafluoroethylene surfaces.
Topics: Adsorption; Animals; Dogs; Fibrinogen; Fluorocarbon Polymers; Protein Denaturation; Solvents; Sulfonic Acids; Surface Properties; Thrombosis; Tritium | 1970 |
Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anemia, Hemolytic; Breast Neoplasms; Female; Fibrinogen; Humans; Lung Neoplasms; Male; Middle Aged; Mucins; Neoplasm Metastasis; Stomach Neoplasms; Thrombocytopenia; Thrombosis | 1970 |
[New methods for the diagnosis of thromboses].
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Radionuclide Imaging; Thrombophlebitis; Thrombosis | 1970 |
Blood coagulation in children with cyanotic congenital heart disease.
Topics: Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Child; Child, Preschool; Factor VII; Fibrinogen; Heart Defects, Congenital; Hemoglobins; Humans; Infant; Postoperative Complications; Tetralogy of Fallot; Thrombocytopenia; Thrombosis | 1970 |
[Studies on the blood coagulation system in arteriosclerotic patients].
Topics: Adult; Aged; Arteriosclerosis; Blood Coagulation; Blood Coagulation Tests; Cholesterol; Female; Fibrinogen; Heparin; Humans; Lipids; Lipoproteins; Male; Middle Aged; Thrombelastography; Thrombosis | 1970 |
he preparation of homografts: are they still homografts?
Topics: Anti-Infective Agents, Local; Fibrinogen; Heart Valve Prosthesis; Heart Valves; Humans; Postoperative Complications; Preservation, Biological; Sterilization; Thrombosis; Transplantation, Homologous | 1970 |
The use of ancrod to prevent thrombosis on prosthetic heart valves. An experimental study.
Topics: Animals; Anticoagulants; Cattle; Fibrinogen; Heart Valve Prosthesis; Male; Mitral Valve; Peptide Hydrolases; Thrombosis; Venoms | 1970 |
Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
Topics: Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Blood Vessels; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Phenformin; Plasminogen; Platelet Adhesiveness; Thrombosis | 1970 |
The euglobulin lysis time: a method for evaluating the plasma fibrinolytic activity of normal and arthritic rats and the therapeutic value of antiinflammatory (steroidal and non-steroidal) agents.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Blood Coagulation; Blood Proteins; Buffers; Chemical Precipitation; Fibrinogen; Fibrinolysis; Hydrocortisone; Hydrogen-Ion Concentration; Male; Methods; Phenylbutazone; Proteins; Rats; Serum Globulins; Thrombin; Thrombosis; Time Factors | 1970 |
[Functional state of the thrombocytes and blood coagulation in patients with myocardial infarct complicated by shock].
Topics: Adult; Aged; Blood Cell Count; Blood Coagulation; Blood Platelets; Capillaries; Cell Adhesion; Cell Aggregation; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Thrombelastography; Thrombosis; Time Factors | 1970 |
Blood hypercoagulability and thrombosis.
Topics: Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Factors; Cerebral Arterial Diseases; Chromatography; Chromatography, Gel; Diagnosis, Differential; Fibrin; Fibrinogen; Hematoma, Subdural; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Molecular Weight; Postoperative Complications; Thromboembolism; Thrombosis | 1970 |
[Animal experiment studies on thromboscintigraphy].
Topics: Animals; Computers; Fibrinogen; Indium; Iodine Radioisotopes; Methods; Rabbits; Radioisotopes; Radionuclide Imaging; Thrombosis | 1970 |
[Animal experimental studies on the scintigraphic diagnosis of recent thrombosis].
Topics: Animals; Fibrinogen; Iodine Radioisotopes; Jugular Veins; Rabbits; Radionuclide Imaging; Thrombosis; Time Factors; Vena Cava, Inferior | 1970 |
Coagulant activity deposited on the Kiil haemodialysis membranes.
Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Hemostatics; Heparin; Humans; Membranes, Artificial; Phospholipids; Renal Dialysis; Snakes; Thromboplastin; Thrombosis; Venoms | 1970 |
[Observations on the fibrinogen consumption rate in thrombotic and hemorrhagic disorders].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fibrinogen; Hemophilia A; Hemorrhage; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Myocardial Infarction; Raynaud Disease; Thrombophlebitis; Thrombosis | 1970 |
Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi.
Topics: Animals; Arteries; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Injections, Intravenous; Microscopy, Electron; Placebos; Rabbits; Streptokinase; Thrombosis; Time Factors | 1971 |
Congenital afibrinogenemia. Vascular changes and multiple thromboses induced by fibrinogen infusions and contraceptive medication.
Topics: Adult; Afibrinogenemia; Blood Transfusion; Blood Vessels; Brain; Cerebral Hemorrhage; Contraceptives, Oral; Female; Fibrinogen; Humans; Mestranol; Thrombosis | 1971 |
Embolization from arterial autografts in the rat.
Topics: Animals; Aorta, Abdominal; Embolism; Female; Fibrinogen; Iodine Radioisotopes; Rats; Thrombosis; Transplantation, Autologous | 1971 |
Small-vessel thrombosis following vascular injury. Successful treatment with a low-dose intra-arterial infusion of streptokinase.
Topics: Adult; Angiography; Fibrinogen; Humans; Injections, Intra-Arterial; Male; Plasminogen; Popliteal Artery; Saphenous Vein; Streptokinase; Thrombosis; Transplantation, Autologous; Wounds, Gunshot | 1971 |
[Routin diagnosis of postoperative thrombosis with 125-I labelled fibrinogen].
Topics: Fibrinogen; Humans; Iodine Radioisotopes; Postoperative Complications; Thrombosis | 1971 |
Thrombosis with epsilon aminocaproic acid therapy.
Topics: Adult; Aminocaproates; Bilirubin; Blood Platelets; Blood Transfusion; Blood Urea Nitrogen; Calcium Chloride; Creatinine; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Kidney Glomerulus; Postoperative Complications; Protamines; Prothrombin Time; Tetralogy of Fallot; Thrombin; Thrombosis | 1971 |
[State of the blood coagulation and anti-coagulation system in patients with chronic coronary insufficiency in the post-infarct period].
Topics: Blood Coagulation; Chronic Disease; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Myocardial Infarction; Prothrombin; Thrombin; Thrombosis | 1971 |
[Reptilase-induced molecular defect: treatment of thrombosis with Reptilase].
Topics: Animals; Dogs; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Iodine Isotopes; Peptide Hydrolases; Snakes; Thrombosis; Venoms | 1971 |
Further experience in the use of ancrod (Arvin) to prevent thrombosis on prosthetic heart valves.
Topics: Animals; Antibody Formation; Anticoagulants; Cattle; Fibrinogen; Heart Valve Prosthesis; Injections, Intravenous; Postoperative Complications; Thrombosis; Venoms | 1971 |
[Some indices of the blood coagulation system in rheumatic children].
Topics: Adolescent; Blood Coagulation Disorders; Blood Coagulation Tests; Child; Fibrinogen; Humans; Prothrombin; Rheumatic Fever; Thrombosis | 1967 |
[Thrombosis and embolism. I. Biological meaning of the physical status of blood].
Topics: Blood Coagulation; Embolism; Fibrinogen; Humans; Thrombosis | 1967 |
[Change in the thrombogenic properties of the blood during repeated reproduction of stress in rabbits].
Topics: Animals; Arteriosclerosis; Blood Coagulation; Fibrinogen; Fibrinolysis; Heparin; Immobilization; Male; Rabbits; Stress, Physiological; Thrombosis | 1967 |
[In vitro research on the action of dextran on the coagulation process].
Topics: Blood Coagulation; Dextrans; Fibrinogen; Hemostasis; Humans; In Vitro Techniques; Thrombelastography; Thromboplastin; Thrombosis | 1967 |
[The rate of activation of plasminogen and intrasvascular thrombus formation in rheumatism and atherosclerosis].
Topics: Arteriosclerosis; Fibrinogen; Humans; Plasminogen; Rheumatic Fever; Streptokinase; Thrombin; Thrombosis; Time Factors | 1967 |
Microangiopathic haemolytic anaemia: the experimental production of haemolysis and red-cell fragmentation by defibrination in vivo.
Topics: Aminocaproates; Anemia, Hemolytic; Animals; Blood Cell Count; Erythrocytes; Fibrin; Fibrinogen; Fibrinolysis; Hemoglobinometry; Hemolysis; Heparin; Iodine Isotopes; Iron Isotopes; Male; Plasma; Rabbits; Thrombosis; Trypsin Inhibitors; Venoms; Warfarin | 1968 |
[The use of fibrinogen labeled with I-131 in the diagnosis of thrombosis and atherosclerosis].
Topics: Animals; Arteriosclerosis; Fibrinogen; Iodine Radioisotopes; Rabbits; Thrombosis | 1968 |
Plasma antiheparin activity and the heparin precipitable fraction of plasma in rheumatoid arthritis.
Topics: Analysis of Variance; Arthritis, Rheumatoid; Blood Coagulation; Blood Proteins; Female; Fibrin; Fibrinogen; Fibrinolysis; Heparin Antagonists; Humans; Male; Mathematics; Middle Aged; Mononuclear Phagocyte System; Thrombosis | 1968 |
[Blood coagulation disorders in gynecology].
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Female; Fibrinogen; Fibrinolysis; Hemorrhagic Disorders; Heparin; Humans; Pulmonary Embolism; Thrombosis | 1968 |
Formation, consistency and degradation of artificial thrombi in severe renal failure. Effect of ABO blood groups.
Topics: ABO Blood-Group System; Acute Kidney Injury; Blood Cell Count; Blood Coagulation Tests; Blood Flow Velocity; Blood Platelets; Female; Fibrinogen; Humans; Kidney Failure, Chronic; Male; Methods; Thrombelastography; Thrombosis; Uremia | 1968 |
Diagnosis and treatment of intravascular coagulation.
Topics: Anemia; Blood Coagulation Disorders; Blood Coagulation Tests; Coumarins; Diagnosis, Differential; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Thrombosis | 1968 |
Disseminated intravascular coagulation. Pathology, diagnosis and therapy of disseminated intravascular coagulation.
Topics: Aminocaproates; Animals; Blood Coagulation Disorders; Blood Transfusion; Drug-Related Side Effects and Adverse Reactions; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Rats; Streptokinase; Thrombosis; Warfarin | 1968 |
[Thrombophilia and intravascular coagulation: new physiopathologic and therapeutic trends].
Topics: Aged; Anticoagulants; Arteriosclerosis; Blood Coagulation Disorders; Blood Platelets; Fibrinogen; Fibrinolysis; Humans; Nicotinic Acids; Thrombosis | 1968 |
Thrombus and coagulation factors in the genesis of arteriosclerosis.
Topics: Adolescent; Adult; Aged; Animals; Arteries; Arteriosclerosis; Blood Coagulation Factors; Cholesterol; Fibrinogen; Fibrinolysis; Humans; Injections, Intravenous; Middle Aged; Pulmonary Artery; Rabbits; Thrombosis | 1968 |
A new concept for the rationale of the Vineberg operation for myocardial revascularization.
Topics: Animals; Arteriovenous Fistula; Blood Flow Velocity; Blood Pressure; Cardiac Catheterization; Coronary Vessels; Dogs; Fibrinogen; Jugular Veins; Methods; Pleura; Regional Blood Flow; Thoracic Arteries; Thrombosis; Ventricular Function | 1969 |
Philippine hemorrhagic fever: a clinical, laboratory, and necropsy study.
Topics: Autopsy; Blood Cell Count; Blood Platelets; Dengue Virus; Fibrinogen; Hemorrhagic Fevers, Viral; Humans; Liver; Philippines; Plasma; Thrombosis | 1969 |
Regional and systemic clotting and fibrinolytic activity after myocardial injury.
Topics: Animals; Blood Circulation; Blood Coagulation; Blood Platelets; Coronary Vessels; Dogs; Epinephrine; Fibrinogen; Fibrinolysis; Heart Ventricles; Myocardium; Thromboplastin; Thrombosis | 1969 |
[Fresh arterial occlusions as complications of streptokinase infusion therapy].
Topics: Aortic Diseases; Blood Coagulation Tests; Femoral Artery; Fibrinogen; Humans; Iliac Artery; Infusions, Parenteral; Male; Middle Aged; Oscillometry; Popliteal Artery; Streptokinase; Thrombosis; Vascular Diseases | 1969 |
Initial events in interactions of blood with a foreign surface.
Topics: Acrylic Resins; Adsorption; Animals; Blood; Dogs; Fibrinogen; Germanium; Infrared Rays; Methods; Platelet Adhesiveness; Spectrum Analysis; Surface Tension; Thrombosis | 1969 |
Recent progress in thrombolytic therapy.
Topics: Fibrinogen; Humans; Plasminogen; Streptokinase; Thrombosis | 1969 |
[Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
Topics: Anticoagulants; Antithrombin III; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelet Disorders; Factor IX; Factor VII; Factor X; Fibrinogen; Hemostasis; Heparin; Humans; Prothrombin; Thrombelastography; Thrombin; Thromboplastin; Thrombosis; Vitamin K | 1969 |
Thrombosis and fibrinogen degradation products.
Topics: Cesarean Section; Female; Fibrinogen; Humans; Postpartum Period; Pregnancy; Thrombosis | 1969 |
Generalized Shwartzman reaction: role of the granulocyte in intravascular coagulation and renal cortical necrosis.
Topics: Agranulocytosis; Animals; Blood Cell Count; Endotoxins; Fibrinogen; Kidney Cortex Necrosis; Leukocytes; Mechlorethamine; Prothrombin Time; Rabbits; Shwartzman Phenomenon; Thorium Dioxide; Thrombosis; Tissue Preservation | 1969 |
[Hemostasis anomalies during toxic shock in man. Apropos of 30 cases, 9 of which are anatomo-biological comparison].
Topics: Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Factor V; Factor VII; Female; Fibrinogen; Humans; Male; Prothrombin; Shock, Septic; Thrombosis | 1969 |
Organ distribution of fibrin in disseminated intravascular coagulation.
Topics: Animals; Anticoagulants; Blood Coagulation Disorders; Bone Marrow; Fibrin; Fibrinogen; Iodine Isotopes; Kidney; Liver; Lung; Male; Rabbits; Thrombin; Thrombosis; Venoms | 1969 |
[The localization of the tissue activator of fibrinolysis in skin tumors].
Topics: Connective Tissue; Ectoderm; Fibrinogen; Fibrinolysis; Hemangioma; Humans; Melanoma; Skin Neoplasms; Thrombin; Thrombosis | 1969 |
[Hemostasis during delivery and the hypercoagulemic syndrome].
Topics: Blood Coagulation Disorders; Female; Fibrinogen; Humans; Obstetric Labor Complications; Pregnancy; Thromboplastin; Thrombosis | 1965 |
Dietary lipids and thrombosis. Study of factors in thrombogenic diets fed to rats accounting for increases in fibrinogen and cholesterol levels.
Topics: Animals; Bile Acids and Salts; Body Weight; Cholesterol; Dietary Fats; Fibrinogen; In Vitro Techniques; Liver; Male; Propylthiouracil; Rats; Thrombosis | 1965 |
Effect of moderate exercise on the fibrinolytic system in normal young men and women.
Topics: Adolescent; Adult; Arteriosclerosis; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Globulins; Humans; Male; Physical Exertion; Thrombin; Thrombosis | 1966 |
Studies of fibrinogen synthesis in rats fed thrombogenic diets.
Topics: Animals; Arachis; Blood Proteins; Butter; Carbon Isotopes; Cholesterol; Diet; Dietary Proteins; Fibrinogen; Glycine; In Vitro Techniques; Leucine; Liver; Microscopy, Electron; Microsomes; Nucleic Acids; Phenylalanine; Propylthiouracil; Protein Biosynthesis; Rats; Thrombosis; Toxicology | 1966 |
Hypofibrinogenaemia and massive thrombosis.
Topics: Adult; Afibrinogenemia; Blood Coagulation Tests; Blood Platelets; Electrophoresis; Fibrinogen; Humans; In Vitro Techniques; Male; Plasminogen; Thrombosis | 1966 |
General principles of anticoagulant therapy; criteria of effectiveness.
Topics: Adult; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Fibrin; Fibrinogen; Heparin; Humans; Iodine Isotopes; Perfusion; Phenindione; Streptokinase; Thrombosis; Venoms; Warfarin | 1966 |